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 A strong correlation exists between acute and chronic exposure to traffic derived 
pollutants and poor respiratory health. Specifically, diesel exhaust (DE) components such as 
NO2 and fine particles (PM2.5) have been related to impaired lung growth and increased 
respiratory and allergic symptoms in children and adults living near busy roads. On this basis, 
implementation of strategies to reduce diesel emissions and improve air quality should provide a 
measureable improvement in the respiratory health of populations resident in high traffic areas. 
The introduction of the London Low Emission Zone (LEZ), the largest of its kind in the world, 
covering an area of 2,644 km
2
 and a resident population of more than 8 million, provided a 
unique opportunity to examine this, as well to quantify the impact of DE emissions on the 
respiratory health of London's population.  
 London’s Low Emission Zone was introduced as part of the Mayor of London’s Air 
Quality Strategy, with the aim of improving public health through targeted reductions in tail 
pipe emissions from the most polluting vehicles entering the city. The objective of decreasing 
PM10 concentrations was to be achieved by restricting the entry of the oldest and most polluting 
diesel vehicles (heavy goods vehicles (HGVs), buses and coaches, larger vans and minibuses) 
into Greater London by providing incentives to operators to upgrade their fleets to lower 
emission vehicles.  The Low Emission Zone was enacted as a phased tightening of emission 
standards for each vehicle class, with the first phase coming into force at the beginning of 
February 2008. This applied to HGVs greater than 12 tonnes and restricted entry to the zone for 
those vehicles not meeting the Euro III emissions standard for PM10. Phase 2 followed in July 
2008 widening restrictions to include HGVs between 3.5 and 12 tonnes, buses and coaches. 
Vehicles failing to meet these emissions standards within the zone were initially charged £200 
(£100 for vans an minibuses) per day, with enforcement achieve using cameras to identify the 
registration numbers of vehicles and the Driver and Vehicle Licensing Agency (DVLA) 
database to identify a vehicle’s emissions standard. In its initial configuration phase 3, 
restricting access to heavier LGVs and mini-buses not meeting Euro III PM standard was 
planned for October 2008.   
 In our initial four year study design we planned to examine the respiratory health of 
cross sectional panels of 8-9 year old school children living within the zone from November 
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2008; encompassing the first two years post phases 1 and 2, and two years post phase 3 (see 
Figure s1). As the subject recruitment and health assessments began in November 2008, this 
afforded us the opportunity of addressing the impact of the third phase of the LEZ, by 
comparing lung function and respiratory symptoms in the two years before and after phase 3. 
We also planned to examine year-on-year changes related to projected reductions in vehicle 
emissions as newer cleaner vehicles entered the fleet, independent of the LEZ, and the increased 
period the children had lived within the zone, from 11-15 months (11.5-13.9% of lifetime) in 
year 1, to 44-60 months (45.8-55.6%) in year 4. During annual school visits, children were 
asked to perform spirometry and provide a urine sample for the assessment of exposure (metals, 
reflective of defined traffic sources) and response biomarkers (oxidative damage). In addition, 
the parents/guardians of the children completed a questionnaire on respiratory / allergic 
symptoms and the children provided DNA samples to investigate genetic susceptibility to the 
detrimental effects of air pollution, focusing on a panel of antioxidant and xenobiotic genes, as 
well as a genetic marker associated with the onset of childhood asthma. 
 
 
Figure s1 The original LEZ study design outlining the winter sampling periods (shaded gray) 
across the four year study with the introduction of phase 3 of the scheme permitting a two year 
pre- and post-assessment. The implementation dates of phase 1 and 2 restrictions are illustrated 
as in the increased proportion (light blue area) of the children lifetime spent resident within the 
zone over the study period. 
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In May 2008 Boris Johnson was elected the new Mayor of London, with a manifesto 
commitment to review ongoing traffic management schemes within the city, including the LEZ, 
and on the 2
nd
 February 2009 he announced intention to cancel the third phase of the LEZ, 
subject to the outcome of a public consultation later in the year. This political decision therefore 
robbed us of the original intervention we were planning to address in our original design. 
Following a further consultation, the scheme was finally fully implemented and expanded on 
the 3rd of January 2012 (LEZ phase 3 and 4), with Euro III emission standards for minibuses 
and vans and a further tightening of emission standards (Euro IV) on Lorries over 12 tonnes, 
between 3.5-12 tonnes, as well as buses and coaches. In light of this development we obtained 
additional funding to examine furthers panels of school children in Nov 2012 - March 2013 and 
Nov 2013 - March 2014, extending our study to six years, allowing a formal assessment of the 
three years pre and two years post LEZ phase 3 and 4, with year 4 straddling the periods of 
phase 3 and 4 implementation (Figure s2). Children at the conclusion of the study in March 
2014, who have been resident within the LEZ since birth will have lived within the zone for 
68.8-83.3% of their lives.  
 
Figure s2 The revised LEZ study design outlining the winter sampling periods across the six 




 The data presented in this thesis is therefore based upon the first three years of the study 
and therefore constitutes a baseline analysis of the relationship between air pollution in London 
and our key respiratory endpoints prior to the formal evaluation of Phase 3 and 4 in 2014/15.  
  In the first experimental chapter (Chapter 3) I evaluated the associations between 
traffic-related air pollutants and respiratory/allergic symptoms within our cross-sectional 
children's cohort.  Information on respiratory/allergic symptoms was obtained using a parent-
completed questionnaire and linked to modelled annual air pollutant concentrations based on the 
residential address of each child, using a multivariable mixed effects logistic regression 
analysis.  Exposure to traffic-related air pollutants was associated with current rhinitis (NOx 
[OR 1.01, 95% CI 1.00-1.02], NO2 [1.03, 1.00-1.06], PM10 [1.16, 1.04-1.28] and PM2.5 [1.38, 
1.08-1.78], all per g/m3), but not with other respiratory/allergic symptoms. Furthermore, over 
the first three years of the operation of London's LEZ I did not observe evidence of reduced 
ambient air pollution levels, or year-on-year changes in the prevalence of respiratory/allergic 
symptoms. I found no evidence that these associations were modified by polymorphisms in 
gasdermin B, located at the chromosome 17q12, associated with the risk of childhood asthma.   
These data confirm previously reported associations between traffic-related air pollutant 
exposures and symptoms of current rhinitis. Importantly, whilst the data is largely confirmatory, 
this remains one of the few studies that has addressed respiratory symptoms in urban children 
over the period of rapid dieselization within Europe.  
 In Chapter 4 I report evidence of reduced lung volumes (FVC - Forced Vital Capacity) 
in children living within the study area. This negative association was small and most strongly 
associated with modeled annual NOx concentrations, at the residential address level. A 
straightforward method to discriminate between acute versus chronic pollutant effects was 
developed for the study. Acute exposures were assessed by scaling annual mean concentrations 
according to a ‘Nowcast’ factor calculated for each pollutant for the period immediately prior to 
the health assessment. This factor was defined as the ratio between concentrations measured by 
a local subset of London Air Quality Network monitoring sites in the prior period, and the 
annual mean measured by the same sites. Using this approach I was able to dissect out whether 
basal lung function was related to short or long term exposures. In the absence of relationships 
between FEV1 and FVC with 24 hour and 7 day average exposures, the association between 
FVC and annual pollutant exposures was interpreted as reflecting evidence of impaired lung 
growth.  In this initial analysis I found no evidence that polymorphisms in the commonly 
studied glutathione S transferases (GSTM1 and GSTP1) and NADPH quinone oxidoreducatse 
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(NQO1) genes modified the association between lung function and pollutant exposure. In a 
secondary analysis I examined whether polymorphisms in Cytochrome P450, family 1, 
subfamily A, polypeptide 1 (CYP1A1) and the Aryl hydrocarbon receptor (AhR) might modify 
the association between pollutant exposures and lung function, based on their role in the 
xenobiotic metabolism of Polycyclic aromatic hydrocarbons (PAHs). This is the first time 
polymorphisms in these genes have been investigated in the context of air pollution – lung 
function interactions. I found evidence that two SNPs in CYP1A1 influenced acute lung 
function responses to air pollution, one being protective and the other detrimental. Again all the 
significant relationships were with FVC and not FEV1, in contrast to much of the pre-existing 
literature. No noticeable improvement in respiratory health was observed in the children studied 
over the first three years of the LEZ. 
 In the final results chapter (5) I explored the relationship between pollutant exposures in 
the same cohort of children with urinary biomarkers of oxidative stress: 8-oxo-2'-
deoxyguanosine (8-oxodG, as a marker of DNA damage) and 8-isoprostane (lipid oxidation). In 
addition, I also explored whether the determination of a panel of urinary metals would be 
informative as a biomarker of traffic exposure. These data demonstrated a positive relationship 
between urinary 8-oxodG concentrations and short term, acute particulate exposures (both PM10 
and PM2.5).  These responses appeared to reverse with longer term exposures (both 7 day and 
annual), i.e. high pollutant exposures were associated with lower urinary 8-oxodG 
concentrations, suggesting some form of biologic adaption to the pollutant stress. I therefore 
examined a panel of SNPs in genes, either directly related to oxidative stress (GCLM,  
Glutamate-cysteine ligase regulatory subunit and SOD3, extracellular superoxide dismutase), or 
the coordination of the antioxidant response (Nrf2, Nuclear factor (erythroid-derived 2)-like 2). 
Whilst polymorphisms in SOD3 did not modify the relationship between urinary markers of 
oxidative stress and the pollutant exposures, there was evidence that SNPs in Nrf2 appeared to 
blunt the sub-chronic exposure adaption. The work on the use of urinary metals as biomarkers 
did not prove fruitful.  Therefore overall this series of studies have demonstrated long term 
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1.1 Health Effects of Environmental Pollutants 
 Long term exposure to air pollution, either within indoor or outdoor 
environments, has been shown to be associated with serious adverse health effects in 
both healthy and compromised individuals. Short-term exposure to air pollution has 
been shown to result in increased mortality in sensitive sub-populations and is 
associated with increased hospital visits due to acute effects such as irritation of the 
nose and eyes, headache, fatigue, wheezing, and an increased susceptibility to 
respiratory infections. In contrast, long-term exposure may result in impaired lung 
growth, remodelling of the airway and increased susceptibility of individuals to chronic 
lung diseases such as asthma, or chronic obstructive pulmonary disease (COPD) (WHO 
2004). 
 
1.1.1 Impact on Mortality and Morbidity  
1.1.1.1 Epidemiological Studies 
 A large number of studies have been published reporting increased rates of 
pulmonary mortality and morbidity associated with exposure and elevated 
concentrations of ambient particulate matter (PM). These studies can be sub-divided 
into those addressing short- and long-term exposures in the general population and 
selected cohorts. Although studies focusing on short-term exposures of PM 
predominate, research on long-term exposures appears to be of greater importance.  One 
such study which resulted in the establishment of the current United States ambient air 
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quality standards (Krewski et al. 2005), was conducted by Dockery et al. (1993) which 
focused on the relationship between air pollution in six cities in the USA with adult 
mortality. This cohort study covered a period of 14-16 years during which the mortality 
of 8,111 adults aged 25 to 74 was followed and related to the pollutant concentrations in 
each of the six cities. The pollutants measured included ozone, sulphur dioxide, 
suspended sulphate particles and total PM2.5 (particles with an median aerodynamic 
diameter of less than 2.5m). Their study revealed significantly increased rates of pre-
mature death in the cities with the highest pollutant concentrations with the strongest 
associations observed with sulphate particles and PM2.5, with evidence that the excess 
deaths were attributable to cardiopulmonary causes. In one recent multicity study, 
exposure to elevated PM2.5 concentrations was associated with a significant increased 
risk of mortality from cardiovascular disease, respiratory disease, myocardial infarction 
and stroke (Zanobetti and Schwartz 2009).  
 In all of these studies, the health effects are related to the ambient concentration 
of PM, which is insensitive to regional variations in composition and hence source. 
Evidence that PM arising from certain sources may  cause a specific  risk is supported 
by studies examining the relationship between respiratory health and the proximity of 
populations to traffic (Hoek et al. 2002; Finkelstein et al. 2004), particularly in 
susceptible groups such as children and the elderly (Bobak and Leon 1992; Smargiassi 
et al. 2006; Woodruff et al. 2006). Janssen et al. (2003) measured the short-term effects 
of exposure to heavy-duty traffic-derived PM2.5 and NO2 on the respiratory health of 
children (7–-12 years) attending schools within 400 meters of busy motorways in the 
Netherlands. Over their study period (April 1997 – May 1998), respiratory and allergic 
symptoms, including persistent asthma, bronchitis and eczema were all significantly 
increased in children attending schools near motorways carrying a high percentage of 
heavy goods (diesel powered) vehicles. Children with pre-existing pulmonary or 
allergic conditions exhibited a worsening of their symptoms, which was related to their 





1.1.1.2 Human Exposure Studies 
 Whilst epidemiological studies provide evidence on the statistical association 
between air pollutant exposures and indices of health, they are unable to provide 
information on the mechanistic basis for the effects observed. With regard to exposure 
to vehicle derived pollutants healthy subjects exposed to diesel exhaust PM10 (100 and 
300 µg/m
3
) with associated gases, under controlled chamber conditions have been 
shown to exhibit transient increases in neutrophils, mast cells and T lymphocytes 
(Behndig et al. 2006; Salvi et al. 1999). This inflammatory response has been shown to 
be associated with alterations in the antioxidant composition of the airway lining fluids 
and an up-regulation/nuclear mobilization of redox sensitive transcription factors 
(Behndig et al. 2006; Pourazar et al. 2005). Exposure to a high dose of diesel (300 
µg/m
3 
for 1 hour) has also been shown to induce a delayed (24h post-diesel exposure) 
airway hyper-responsiveness to metacholine (Nordenhäll et al. 2001). This has been 
speculated to reflect an acute up-regulation of IL-10 in the bronchial mucosa (Holgate et 
al. 2003). A recent real-world experiment that examined the respiratory responses of 
asthmatics walking along Oxford Street in London (an entirely dieselized route, 
restricted to buses and taxis) also demonstrated airway inflammation (myeloperoxidase 
in induced sputum) and lung function (Forced Expiratory Volume in one second – 
FEV1) decrements compared to the responses observed during a low traffic route 
exposure (Hyde Park). Taken together, these data suggest that the capacity of traffic 
(specifically diesel) derived PM to elicit oxidative stress at the surface of the lung 
triggers inflammation and that recurrent cycles of airway irritation/inflammation may 
underpin many of the respiratory symptoms observed in exposed populations 
(McCreanor et al. 2007). 
 
1.1.2 Physical and Chemical Composition of Particulate Matter 
 Airborne particulate matter represents a heterogeneous mixture of solid particles 
or liquid droplets of varying composition and size. According to US Environmental 
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Protection Agency, reflecting a general consensus in the literature, ambient PM are 
classified based on their median aerodynamic diameter as: particles with an 
aerodynamic diameter less than 0.1µm (PM0.1) or ultrafine particles, particles with an 
aerodynamic diameter <2.5µm (PM2.5) also referred to as fine particles and, particles 
with an aerodynamic diameter between 2.5µm and 10.0µm (PM2.5-10), generally 
classified as coarse particles (Harrison and Yin 2000).  In terms of traffic pollution, PM 
is derived from three separate sources; tailpipe emissions, largely elemental and organic 
carbon in the ultrafine range; abrasion processes related to mechanical brake and tire 
wear (in the fine to coarse mode), and the resuspension of road dust in the wake of 
passing traffic (largely coarse mode) (Thorpe and  Harrison, 2008). 
 Particle size is important as it dictates the deposition pattern within the 
respiratory tract (Figure 1.1). Coarse particles with least surface area, largely deposit in 
the upper airways by impaction (thoracic PM), whilst fine and ultrafine particles having 
larger surface area penetrate to the lower airway and deposit in the alveoli (respirable 
fraction). Although, fine and ultrafine particles penetrate to the distal structures of the 
lung, the increasing surface area of the lung proximal to distal means that their effective 
tissue dose is comparatively low relative to particles depositing in the central airways 
(WHO 2004). Nasal versus oral breathing also affects particle deposition pattern in 
various regions. The additional deposition of particles in the nose results in an increased 
extrathoracic (ET) deposition. Consequently, it causes decreased deposition in the 
bronchial (Bb) and, the alveolar (Al) regions compared to mouth breathing (Kreyling et 
al. 2004) – Figure 1.1.  
 
1.1.3 Air Pollution Abatement Policies  
 It is now well established that ambient PM impacts on a range of 
cardiopulmonary health endpoints. The causal link between ambient PM with negative 
health effects is most strongly illustrated by studies that examined how reductions in 
pollutant concentrations have resulted in a measurable health dividend. For example, re-
examination of the cities initially studied in the seminal Harvard 6-cities study between 
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1974 and 1982 (Dockery et al. 1993) over the period 1990 to 1998, during which time 
PM2.5 concentrations fell markedly, demonstrated a significant reduction in the risk of 
pre-mature mortality (Laden et al. 2006). Similarly, a German study covering the period 
1991 to 2002 (Breitner et al. 2009) examining the respiratory health of residents living 
in congested and non-congested neighbourhoods of Erfurt, Germany, found that 
implementation of air pollution control measures resulted in marked improvements in 
respiratory health. Similar positive effects on respiratory symptoms following 
implementation of air pollution control measures have been observed in other studies 












Figure  1.1 Deposition probabilities of inhaled particles according to particle size for 
nose and mouth breathing in the respiratory tract (extra-thoracic (ET), bronchial airway 
(Bb) and, the alveolar (Al) compartment). (Source: Kreyling et al. 2004). 
 
 These observations, allied to the robust literature linking proximity to traffic and 
traffic related pollutants to impaired health, have led to an appreciation that regulation 
of the traffic fleet, both in terms of numbers and emission profile may result in 
improved public health, especially within the urban environment. Consequently, a 
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number of countries have introduced Low Emission Zone (LEZ) (Table 1.1). These 
LEZs adopt a variety of measures to regulate traffic emissions, with restrictions on 
vehicle emissions (related to Euro class), weight, size and type (petrol or diesel) within 
a designated zone, either by direct restriction or penalty fines for non-compliance. The 
largest such control zone was introduced into London in January 2008, covering the 
whole of greater London, 2,644km
2 
and a resident population of 8,505,000 (United 
Nations World Urbanization Prospects, 2005 estimate for London). The impact of the 
introduction of this zone on the respiratory health of children living in London will 
represent the major focus of this thesis. 
 
Table 1.1 National Low Emission Zones throughout Europe 
 
Note: The symbol (*) represents number of LEZ planned or estimated for future.  
(Source: modified from Low Emission Zone in Europe website-
http://www.lowemissionzones.eu/ overview-of-lezs-othermenu-209). 
 
1.2 Biological Responses to Air Pollution 
1.2.1    Induction of Oxidative Stress 
 Oxidative stress occurs in vivo due to imbalance in the prooxidant-antioxidant 
equilibrium resulting in oxidative damage (Sies 1991). Free radicals are defined as any 
species containing at least one unpaired electron capable of existing as individual entity 
(Halliwell 1991) and include the hydroxyl radical (OH•), the superoxide anion (O2•
-
), 
Country No. of LEZ areas Start Date Vehicle type restriction Euro PM size Retro-type allowed
Austria 1 1/1/2007 Over 7.5T Euro 2-4 No
Czech Republic 1 1/9/2008 All diesel-based over 3.5T - -
Denmark 3, 5* 1/2/2009 Over 3.5T Euro 3-4 Yes
Germany 32, 10* 1/3/2008 All petrol and diesel-based Euro 2-4 Yes
Italy 5, 1* 1/1/2007 All vehicles Euro 1-4 Yes
Netherland 8, 30* 1/7/2007 Over 3.5T Euro 2-4 Yes
Norway 1* 1/9/2010 Over 3.5T Euro 4 No
Sweden 5, 4* 1/1/2007 Over 3.5T Euro 2-3 No
United Kingdom 3, 3* 4/2/2008 Variable Euro 3-4 Yes
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and nitric oxide (NO) (Figure 1.2). Reactive Oxygen Species (ROS) include free 
radicals, but also contains reactive chemical species, without unpaired electrons, which 
are capable of participating in redox reactions, such as hydrogen peroxide (H2O2). The 
production of these species can result in damage to proteins, lipids and nucleic acids 
resulting in the disruption of normal cell function and ultimately cell death (Kidd 1997). 
It should be noted however that at low concentrations many ROS actually appear to 
perform regulatory roles in cells and that in certain cases even excess production of 
these species may be beneficial, e.g. oxidant production by phagocytic inflammatory 
cells during the respiratory burst. 
 
Figure 1.2 Pathway of oxygen reduction, illustrating the formation of the major 
physiologic reactive oxygen species. (Adapted from Li et al. 2003). 
 
1.2.1.1 Sources of Reactive Oxygen Species  
 PM-induced ROS generation may arise through a variety of pathways: the 
introduction of redox catalysts (Fe, Cu, quinones) into the lung, the xenobiotic 
metabolism of polyaromatic hydrocarbons (PAH), the induction of active inflammation 
and the disruption of the mitochondrial electron transport chain (Ayres et al. 2008). 
These will be discussed in the following sections. 
 
1.2.1.1.1 Introduction of Redox Catalysts to the Lung 
 Redox-active transition metals are present on the surfaces of ambient PM and 
include iron (Fe), copper (Cu), vanadium (V), nickel (Ni) and chromium (Cr). Their 
significance lies in the fact that they will catalyze the production of free radicals and 
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ROS in vivo (Comhair and Erzurum 2002) through Fenton and Haber–Weiss like 
reactions  (Equation 1). 
 Similarly, PM- associated quinone compounds produced during fuel combustion 
are able to redox cycle in vivo with the production of superoxide, with the degree of 
cycling dependent on the availability of NADPH-CYP450 reductase (Sioutas et al. 
2003). Notably quinone-induced oxidative stress can also occur as a consequence of the 
metabolism of PAHs associated with inhaled PM. PAHs are metabolized in vivo by 
three pathways involving action of CYP450 1A1, expoxide hydrolase, and dihydrodiol 
dehydrogenase, with CYP450 1A1 expression under the regulation of the aryl 
hydrocarbon receptor (AhR). The initial oxidation of particle-associated PAHs is 
catalyzed by CYP450 1A1 producing PAH dihydrodiol, which is then either hydrolysed 
by expoxide hydrolase producing PAH diol-epoxide, or acted upon by dihydrodiol 
dehydrogenase to produce catechol, which is subsequently converted into quinone. The 
quinone by the action of NADPH-P450 reductase and removal of one electron is 
converted into semiquinone, which can be converted back to quinone initiating redox 
cycling. In this process the electron is donated to oxygen producing O2•
-
. This process 
has been implemented as the basis for the generation of ROS in cells challenged with 
diesel exhaust particles, which upon inhalation introduce PAHs into the lung, as 
illustrated in Figure 1.3. 
 
1.2.1.1.2 ROS Production during Inflammation 
 When the lung is challenged by foreign material such as inhaled PM, the body’s 
defense system responds by initiating an acute inflammatory response, usually 
characterized by the migration and functional activation of phagocytes and 
lymphocytes. Under normal circumstances, this is a beneficial response, but aberrant 
over activation of this response, such as occurs during PM-challenge can result in 
significant tissue injury. Consistent with this scheme, healthy humans exposed to near 
ambient concentrations of diesel-derived PM10 have been shown to elicit an acute 
airway inflammation, with up-regulation of vascular adhesion molecules, production of 
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pro-inflammatory cytokines and  increased airway neutrophils, mast cell and T cell 
numbers (Salvi et al. 1999). This acute inflammatory response examined 6 hour post-
challenge, has been associated with the activation and nuclear migration of redox-
sensitive transcription factors such as nuclear factor KB (NF-KB) and activator protein 
1 (AP-1) (Pourazar et al. 2009). As these transcription factors drive the expression of a 
panel of pro-inflammatory mediators, these data have provided evidence for PM-















Figure 1.3 Quinone formations via PAH metabolism and the subsequent production of 






1.2.1.2 Pulmonary Antioxidant Defense Mechanisms 
 The lung possesses a robust antioxidant defense network to protect itself from 
oxidative injury. These include both low molecular weight (glutathione, α-tocopherol, 
ascorbate and urate) and enzymatic antioxidants (superoxide dismutases (SOD), 
catalase, peroxidases, peroxyredoxins, thioredoxins, and the glutaredoxins) distributed 
between the cellular and extra-cellular lung compartments. The first line of defense 
against inhaled materials resides within the respiratory tract lining fluids (RTLFs) that 
bathes the respiratory epithelium throughout the airways (Rahman et al. 2006; Wright et 
al. 1994).  
  
1.2.1.2.1 Low Molecular Weight Antioxidants 
 This group act directly on the pro-oxidants by donating an electron (hydrogen) 
thus elminating ROS. In this process, they are oxidized to low reactivity free radicals 
themselves. Glutathione (GSH) the major cellular low molecular weight antioxidant 
functions in the following ways: (i) by acting as a substrate for glutathione peroxidase, 
(ii) as a direct scavenger of ROS and (iii) by permitting the reduction of 
dehydroascorbate back to ascorbate by acting as a substrate for dehydrascorbate 
reductase (Townsend et al. 2003). Ascorbate itself can also act as a scavenger by 
donating an electron to ROS, forming the ascorbyl radical, which can undergo further 
oxidation to dehydroascorbic acid. However, ascorbate can also react with ferric ions to 
produce the highly reactive OH• radical. Thus, whether ascorbate functions as a pro- or 
anti-oxidant largely depends on its concentration relative to the availability of free Fe or 
Cu in the cell or extra-cellular fluid (Romieu et al. 2008). Urate produced by the 
oxidation of xanthine and catalysed by xanthine oxidoreductase has also been shown to 
be an important sacrificial antioxidant in vivo especially against reactive nitrogen 
species and the hydroxyl radical. There has also been speculation that urate may chelate 
iron, thus limiting deleterious Fenton chemistry, but this has yet to be confirmed in vivo 




1.2.1.2.2 Enzymatic Antioxidants 
 Three types of superoxide dismutase exist in humans: extracellular-SOD (EC-
SOD), intracellular Cu/Zn-SOD and Mn-SOD. These enzymes function to remove 
superoxide by catalyzing its dismutation to
 
H2O2. The H2O2 thus formed can then be 
further reduced to water by the action of catalase and glutathione peroxidase (GPx). The 
extra-cellular form of this enzyme is expressed by alveolar macrophages, bronchial 
epithelium, extracellular matrix and epithelial cells and appears particularly important in 
protecting the lung from oxidative injury. Due to its hydrophobic nature, EC-SOD binds 
to lipophilic cell surfaces by binding to type I and type IV collagen through its matrix 
binding sites (Bowler et al. 2002). In contrast, the expression of Mn-SOD is restricted to 
the mitochondrial matrix where it functions to limit injury from superoxide formed as 
electrons leak from proteins within the electron transport chain, whilst Cu/Zn-SOD has 
a more widespread cellular distribution.  
 Catalase and GPx are involved in the removal of biological peroxides, which 
otherwise would become substrates for the production of more damaging ROS. Catalase 
located within cellular peroxisomes in macrophages, pneumocytes and fibroblasts 
catalyses the conversion of H2O2 to water. Low expression of catalase and SOD has 
been associated with increased levels of oxidative stress (Matés 2000). Four selenium-
based cellular and extracellular GPx have been identified and are named according to 
their cellular location: (i) cytosolic, (ii) membrane-associated GPx, (iii) cytoplasmic 
GPx and, (iv) gastrointestinal GPx. These enzymes catalyse the removal of H2O2 and 
large molecular lipid peroxides. The reducing action of GPx requires GSH, which is 
converted to glutathione disulphide (GSSG) during this reaction. The formed GSSG can 
subsequently be converted back to GSH by glutathione reductase using NADPH as an 






1.2.2    Induction of Xenobiotic/Antioxidant Responses by Inhaled Pollutants 
 The initial response of cells/tissues exposed to oxidative stress via the inhalation 
of airborne xenobiotics is the induction of antioxidant and xenobiotic metabolizing 
enzymes. This occurs through the transcriptional activation of the antioxidant 
responsive element (ARE) by the transcription factors nuclear regulatory factor 2 (Nrf2) 
and activator protein-1 (AP-1). Nrf2/AP1 induction of ARE genes (heme oxidase-1 
(HO-1), NADPH quinone-oxidoreductase (NQO1), cytochrome P450 1 alpha 1 
(CYP450 1A1) (phase I), glutathione s transferase (GST)) represents the initial response 
to oxidative stress, and it has been suggested that variations in the capacity to mount 
these responses – protective adaptations – may play a role in individual susceptibility to 
air pollutants (Cho & Kleeberger 2010). If these initial adaptation reactions are 
insufficient to ‘cope’ with the oxidative insult the response shifts to a more pro-
inflammatory profile, with activation of mitogen-activated protein (MAP) kinase 
cascades and NFκB, driving cell proliferation and the expression of pro-inflammatory 
mediators (Figure 1.4). Finally, if the oxidative stress is sufficiently severe, cell arrest 
occurs (to allow DNA repair) and ultimately cell death (under the regulation of p53) 
will be triggered via apoptosis or necrosis (Gilmour et al. 2006). This hierarchical 
response model is illustrated in Figure 1.4, with the key regulatory pathways 
highlighted, corresponding to cellular adaption, inflammation and cell death. The 
scheme outlined overleaf has also been modified to illustrate the ‘initial’ tolerance of 
the airway to inhaled oxidants due to the endogenous aqueous antioxidants within the 








Figure 1.4 Diagrammatic representation of the hierarchical response of cells to PM-
induced oxidative stress at the air-lung interface.  
This diagram represents an extension of the earlier model proposed by (Xiao et al. 2003) to 
include the influence of the antioxidant defenses within the RTLF. In this modified model, the 
initial defense against PM-induced oxidative stress resides within the RTLFs, initially 
characterized by acute early losses of ascorbate (AA), urate (UA) and glutathione (GSH). In 
light of the previous findings, we suggest initial losses due to the inhalation of pollutant gases 
and particulates are partially offset by movements of these antioxidants, particularly GSH from 
the epithelium to the extra-cellular compartment (Mudway et al. 2006; Behndig et al. 2009; 
Sehlstedt et al. 2010). When these defenses are overwhelmed, the underlying cells initially 
induce adaptive strategies, under the regulation of Nrf2 and AP-1 to deal with the oxidative 
stress, or process the inhaled xenobiotics. The figure illustrates a number of genes known to be 
up-regulated in these adaptive responses, under the regulation of Nrf2 and AP-1, including the 
NQO1, SOD, HO-1, and GCL. Further oxidative stress, reflected by a decrease in the cellular 
GSH/GSSG ratio leads to the transcription of genes under the regulation of NFκB, such as pro-
inflammatory cytokines (TNF-α, IL-6, and IL-8) and inducible nitric oxide. Further oxidative 




1.2.2.1 Cytochrome P450 
 Cytochrome P450s are heme-containing enzymes, which catalyze Phase I 
metabolism reactions. Cytochrome P450 CYP1A1 is one of the three members of the 
CYP1 family, located mainly in extrahepatic tissues, which participates in the 
detoxification of numerous xenobiotics, including an important role in PAH 
metabolism. The metabolism of the PAHs is initiated by their binding to the cystolic 
aryl hydrocarbon receptor, which then translocates to the nucleus, where it 
heterodimerizes with the aryl hydrocarbon nuclear translocator protein forming a 
complex which interacts with AhREs (Aryl hydrocarbon response elements), XREs 
(Xenobiotic response elements) or DREs (Dioxin response elements), to activate gene 
transcription (Hankinson 1995). The human CYP1A1 gene contains many xenobiotic 
responsive elements (XRE) that suppport AhR mediated transcription. CYP1A1 
transforms PAHs to highly reactive diol epoxides, which are subsequently detoxified by 
phase II enzymes, including epoxide hydrolases and glutathione S-transferases (e.g. 
GSTM1 and GSTP1). The potency of diesel exhaust particles and their organic extracts 
to induce gene expression of CYP1A1 has previously been demonstrated in human lung 
samples ex vivo (Iba et al. 2010) and in human airway epithelial (16HBE) and human 
macrophage (U937) cell lines (Bonvallot et al. 2001, 2002; Vogel et al. 2005).  
 
1.2.2.2  Glutathione S Transferases (GSTs) 
 GSTs are important phase II isoenzymes, expressed both in the cystolic and 
membrane compartments of the cell. The cytosolic enzymes are dimeric and soluble, 
whilst the microsomal protein enzymes are trimeric in structure. Although, humans 
contain 16 such soluble enzymes, arranged in 8 groups, the major focus in the air 
pollution literature has been on the mu (GSTM1), pi (GSTP1) and theta (GSTT1) types. 
The main function of the GSTs is the detoxification of electrophiles by conjugation to 
glutathione. This includes the conjugation of substrates such as oxidized PAH epoxides, 
derived from action of phase 1 cytochrome P-450s. GSTP1 catalyses the conjugation of 
the diol epoxide of benzo(a)pyerene, benzo(c)phenanthrene and benzo(g)chrysene. In 
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contrast, GSTT1 can activate dichloromethane (DCM) by conjugation with GSH to 
form S-chloromethylglutathione. In addition, GSTM1 and GSTP1 cause detoxification 
of comparatively bulky aryl halides, whereas GSTT1 catalyzes small dihaloalkanes 
(Hayes and Strange 2000). 
 
1.2.2.3 NADPH-quinone Oxidoreductase (NQO1) 
 NQO1 is a phase II antioxidant enzyme, expressed in the cytosol of non-
phagocytic cells, polymorphonuclear leukocytes, monocytes and macrophages. It 
provides protection against quinone induced oxidative stress by reducing them to redox-
stable hydroquinones, in a single two-electron step utilizing either NADH or NADPH as 
a reducing cofactor. The redox stable hydroquinones can be quickly conjugated and 
excreted (Ross et al. 2000). NQO1 can also catalyze the bioreductive alkylation of 
quinones producing products capable of alkylating nucleophilic sites (Reddy 2008). 
NQO1 can catalyze reactions involving substrates such as ortho and para-quinones, 
menadione, quinone-imines, benzoquinone, dichlorophenolindolphenol and 
naphthoquinone. The reaction involves a hydride transfer between the NADH and flavin 
adenine nucleotide (FAD) cofactors and from FADH2 to the quinone substrate. 
Menadione conversion to hydroquinone by NQO1 using two-electron reduction has a 
direct competition with the cellular reductases using one-electron reduction (Hoidal 
2001).  
 
1.3       Population Susceptibility to Air Pollution Induced Health Effects 
  Assessing an individual’s susceptibility to an inhaled xenobiotic depends on 
multiple intrinsic (internal or host) and extrinsic (external) factors and their relationship 
to the genotype (Kleeberger 2005). The intrinsic or host factors include gender, age, 
diet, and ethnicity, whilst the external factors reflect social factors including provision 
of health care. The healthcare related factors include health behaviors and differential 
access to health resources (Lurie and Dubowitz 2007). In contrast, social factors include 
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socioeconomic status, exposure to environmental triggers such as allergens, air 
pollutants and tobacco smoke, family history, lifestyle, and culture (Collins 2004; Drake 
et al. 2008). 
  
1.3.1 Susceptibility of Children  
 Generally, children appear more susceptible to respiratory ailments than adults 
upon exposure to environmental pollutants. This disparity arises from physiological, 
metabolic and behavioral differences between the two populations (Bateson and 
Schwartz 2008; Cohen et al. 2000; Kimmel et al. 2005; Landrigan et al. 2003; Rogan 
1995). Children are born with undeveloped lungs, characterized by an immature 
epithelium and significantly fewer alveoli (20-50 million) than adults (Burri 1984; 
Dunnill 1962; Langston et al. 1984). However, a significant increase in the number of 
alveoli occurs during first year, reaching 300 million at the age of eight years (Burri 
2006; Reid 1977). During lung morphogenesis, the multiplication of alveoli begins, in 
addition to the branching of the respiratory bronchioles and the differentiation of 
epithelium (Joshi and Kotecha 2007; Kotecha 2000). Therefore, any air pollutant-related 
damage occurring to the developing lungs at this stage are likely to result in airway 
remodeling leading to changes in morphology persisting into adulthood. Animal studies 
have shown altered epithelial development and differentiation after just a single 
environmental insult during early life. In one such study exposure of neonatal mice to 
naphthalene resulted in enhanced epithelial injury compared with adult mice (Fanucchi 
et al. 1997, 2004).  
 Additionally, children have a higher basal breathing rate and their lungs have a 
larger surface area per unit body weight compared to adults (Gagliardi and Rusconi 
1997). Hence, the volume air/unit body mass passing through the lungs of an infant is 
approximately double than that of an adult, which will clearly result in an enhanced 
uptake of inhalable pollutants (Arcus-Arth and Blaisdell 2007; Iliff and Lee 1952; Poets 
et al. 1993). Children’s breathing rate decreases steadily during growth, implying that 
newborns would be most susceptible to inhaled xenobiotics, followed by infants, with 
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susceptibility decreasing with age (Plopper et al. 1994; Fanucchi et al. 1997; 2004; 
Gehring et al. 2002; Pierse et al. 2006). Children and adults also show differences in 
patterns of breathing which may affect the deposition of inhaled pollutants. At rest, 
children normally breathe through the mouth. In contrast, adults are obligate nasal 
breathers (Bennett and Zeman 2004). As the nose effectively filters larger particles from 
the air stream (Nikasinovic et al. 2003; Bennett et al. 2003; 2008), one might consider 
mouth-breathing to further enhance pollutant uptake into the airways. Consequently, 
low pollutant exposures that are largely asymptomatic in adults, may cause airway 
irritation in children.   
 In addition to the biological basis for increased susceptibility of children to air 
pollutants, it should also be noted that their exposures are elevated compared with 
adults due to the increased period of time they spend exercising in the outdoor 
environment. Children while playing, experience rapid and deep breathing, which not 
only increases the inhaled dose of any air borne pollutants but also increases deposition 
to the distal lung. This increased distal dose is compounded by the slower rate of 
particle clearance from region (Ekelund et al. 2004; Ginsberg et al. 2005).  
 From the evidence outlined above, there is a sound basis for believing that 
children are more susceptible than adults to air pollution hazards. This contention is 
supported by a large number of air pollution studies that have demonstrated strong 
association between exposures to ambient air pollutants with substantial increased rates 
of respiratory symptoms such as chronic cough, bronchitis, substantial decreased of 
lung function, airway sensitization, and  increased incidences of respiratory infections in 
children (Brunekreef et al. 1997; Venn 2000; Brauer 2002; Gehring et al. 2002). More 
recent cohort based studies have also demonstrated associations between long term 
traffic related pollutant exposures with impaired respiratory health in children 
(Gauderman et al. 2007b; Lindgren et al. 2009; Migliore et al. 2009; Morgenstern et al. 
2008; Nordling et al. 2008; Oftedal et al. 2009; Rosenlund et al. 2009; Schultz et al. 
2012). In many of these studies, the proximity of the schools the children attend to busy 
roads have been employed as a surrogate for pollutant exposure, and were related to a 
range of respiratory and allergic symptoms (Brauer et al. 2002; Gauderman et al. 2005; 
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Nordling et al. 2008). In addition, traffic density and type has also employed as an 
exposure surrogate in certain studies (Janssen et al. 2003; Ryan et al. 2005). A smaller 
panel of studies have actually employed direct pollutant measurements at the schools 
(Brunekreef et al. 1997), or the children’s residence (Duhme et al. 1996; Gehring et al. 
2002; Nordling et al. 2008), with modeled pollutant concentrations employed in larger 
cohort studies (Brauer et al. 2007; Morgenstern et al. 2008; Ryan et al. 2007). 
 
1.3.1.1  Respiratory Airway Disease 
 Numerous studies have demonstrated clear and robust associations between a 
worsening of cardiopulmonary symptoms in adults and children with increased 
exposures to traffic related air pollutants. Whilst the non-allergic respiratory symptoms 
such as mortality (Bobak and Leon 1999; Glinianaia et al. 2004) and birth weight 
(Bobak et al. 2001) reported in relation to traffic related air pollutants appear largely 
consistent amongst the studies performed to date. However, there is inconsistency in the 
results of studies examining the relationship between traffic pollutants and allergic 
symptoms: asthma, wheeze, allergic rhinitis and sensitization. This will be discussed in 
greater detail in the sections below.  
 
1.3.1.1.1 Asthma and Wheeze 
Whilst numerous studies illustrate positive associations between exposures to 
traffic derived pollutants with a worsening of asthma symptoms (Brauer et al. 2002; 
Duhme et al. 1996; Gauderman et al. 2005; Morgenstern et al. 2007, 2008) other studies 
have failed to confirm this observation (Ciccone et al. 1998; Migliore et al. 2009; 
Nordling et al. 2008; Oftedal et al. 2009). The reason for the lack of association 
observed in some studies is unclear, though it may reflect inconsistency in the 
methodologies employed between the different studies. Most of the studies diagnosed 
asthma based on self-reported wheeze, rather than an accurate doctor’s diagnosis, or 
evidence of airway reversibility upon salbutamol treatment. In addition, most of the 
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studies focused on young children where the diagnosis of asthma is challenging. 
Similarly to the asthma associations reported above, the association between wheeze 
and traffic pollution was inconsistent, with many studies demonstrating significant 
associations (Brauer et al. 2007; Brunekreef et al. 1997; Duhme et al. 1996; Nordling et 
al. 2008; Ryan et al. 2005), whilst others were unable to confirm this observation 
(Ciccone et al. 1998; Venn et al. 2000; Wyler et al. 2000).   
One statistically powerful way of investigating the relationship between 
exposures to traffic related pollutants and respiratory health has been to examine indices 
of respiratory morbidity in established birth cohorts and to relate these observations to 
modeled or measured pollutant concentrations over time. One such Dutch and German 
birth cohort TRAPCA (Traffic Related Air Pollution on Childhood Asthma) with 4,000 
children, aged 2 years and 1,756, aged 1-2 years has shown significant associations 
between traffic pollutants and the incidence of respiratory diseases (Brauer et al. 2002; 
Gehring et al. 2002). To improve the linkage between respiratory symptoms and 
pollutant exposures, Brauer et al. (2007) extended the initial analysis on this birth cohort 
to assess individual annual exposure to NO2, PM2.5, and soot using geographic 
information system (GIS) related to the cumulative incidence of reported symptoms at 
the age of 4 years. Elevated odd ratio for wheeze (1.2 (1.0-1.4)) and doctor diagnosed 
asthma (1.3 (1.0-1.7)) were observed in children per inter-quartile range of modelled 
soot exposure (0.58×10
−5 m−1). To further refine the likely actual exposure of children to 
traffic-related pollutants and to relate this to respiratory health, Morgenstern et al. 
(2007) performed a study including all the children (1-2 years) in the entire Munich 
metropolitan area, which employed buffer zone variables such as distance from the 
main road (50m) to further improve the individual exposure assessment. The results 
from this study refined the initial observations with stronger associations between 
respiratory symptoms and traffic related pollutants exposures noted in girls compared 
with boys (Morgenstern et al. 2007).  
Further research has demonstrated a correlation between increased freeway 
traffic, especially diesel powered heavy goods vehicles with asthma prevalence in 
children (Duhme et al. 1996; Brunekreef et al. 1997; Gauderman et al. 2005). 
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Subsequent studies, specifically the Cincinnati Childhood Allergy and Air Pollution 
Study (CCAAPS) have demonstrated that traffic density/volume appears to be less of a 
risk for poor respiratory health (wheezing) than the distance from the traffic source, the 
type of traffic, or driving scenario: major highways, stop and go, HGVs, and bus traffic 
(Ryan et al. 2005). Infants exposed to stop and go bus and truck traffic demonstrated a 
significant increased risk of wheeze compared to unexposed infants.  However, infants 
living nearby high volume traffic did not show significantly increased rates of 
wheezing. In their later study, Ryan et al. (2007) improved the exposure assessment by 
using land use regression (LUR) and reported a significant increased risk of wheeze 
associated with elemental carbon attributable to traffic sources within range of 0.30-
0.90 ug/m
3
 (Ryan et al. 2007). 
Gauderman and colleagues (2005) assessed the effect of multiple indicators of 
traffic/pollutant exposure on the doctor-diagnosed asthma and wheezing in 208 children 
from 10 southern California communities. The indicators chosen included NO2 
exposure, season and residential distance to the nearest freeway. The lifetime freeway 
exposure and measured NO2 concentrations were found in this study to be associated 
with doctor-diagnosed asthma and wheezing, however, no association was found with 
traffic volume in accord with the findings of Ryan et al. (2007).   
The Swedish BAMSE (Barn, Allergy, Milieu, Stockholm, Epidemiological) 
study, conducted in Stockholm and involving approximately 3,500 children followed 
from birth to 4 years of age also examined the relationship between respiratory health 
and allergic sensitization with exposure to traffic (Nordling et al. 2008). Traffic-NOx 
exposures, based on modeled concentrations were shown to be significantly associated 
with persistent wheeze (wheeze both at one and four years of age) only in females, but 
not with doctor-diagnosed asthma. In addition, the association between NOx and wheeze 
was stronger in non-atopic children. Similar but insignificant associations were 




1.3.1.1.2 Allergic Sensitization 
Traffic-related allergic sensitization, assessed either by skin prick or blood 
testing in the urban areas has been reported in a number of studies (Ciccone et al. 1998; 
Nordling et al. 2008), however this association is far from robust (Nicolai et al. 2003; 
Oftedal et al. 2007; Rosenlund et al. 2009). Studies have reported that children living in 
proximity to major roads exhibit impaired respiratory health, especially sensitization to 
pollen (Kramer et al. 2000; Wyler et al. 2000; Janssen et al. 2003; Morgenstren et al. 
2008). Janssen et al. (2003) investigated the effect of traffic density and composition on 
the allergic symptoms of children (2,500, aged 7-12 years) attending schools near roads 
(407±230 m) in The Netherlands. In this study, a greater risk of sensitization to pollen 
was observed in relation to exposure to diesel powered heavy goods vehicles, but not 
car traffic counts. This association was further supported by the results of a birth cohort 
study performed in the Munich metropolitan area examining allergic sensitization to 
pollen during the first six-years of life in 3000 children (Morgenstern et al. 2008). In 
this study, exposure to elevated PM2.5 and residential proximity to busy roads (less than 
50m) was associated with significant increased risk of sensitization to pollen (outdoor) 
allergens. In addition, the distance from the main road had a dose-response relationship 
i.e. the greater the distance from a road, the lower the PM2.5 exposure and the lower the 
degree of sensitization observed.  Furthermore, increased production of IgE antibodies 
has been associated with elevated exposures to PM10 and NOx in children at 4 years of 
age (Nordling et al. 2008). Overall, these results indicate that children living near busy 
roads are more likely to become sensitized by pollen. Possibly, due to pollen and air 
pollutant interactions.    
 
1.3.1.1.3 Allergic Rhinitis (hay fever)  
Several studies have also examined the relationship between traffic pollutant 
exposures and the incidence of hay fever. Again, as with the wheeze and asthma data 
whilst many studies have demonstrated significant interactions (Duhme et al. 1996; Lee 
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et al. 2003; Morgenstern et al. 2007, 2008) others have not (Ciccone et al. 1998; Krämer 
et al. 2000; Nicolai 2002) despite the application of standard procedures in most studies. 
Kramer et al. (2000) reported associations between hay fever with traffic-related, 
outdoor NO2, but not indoor sources of this gas. Lee et al. (2003) conducted a similar 
but larger study involving approximately 330,000 school children in Taiwan, with the 
actual application of monitored CO, NO, SO2 and PM10 from the pollution stations 
located within 2 km of the schools. They observed significant associations between 
doctor-diagnosed allergic rhinitis and increased concentrations of CO, NO, SO2 and 
PM10. The extended study of TRAPCA II (Morgenstren et al. 2007) also showed 
significant associations of PM2.5 with sneezing, runny/stuffed nose during the first two 
years of life, consistent with the previous research (Gehring et al. 2002).  
 
1.3.1.1.4 Atopic Dermatitis (eczema)  
 Studies have also been performed examining the relationship between traffic 
exposures and the presence of dermatitis in children, with mixed results. Whilst several 
studies have reported a significant association between the presence of childhood 
eczema with traffic exposures (Ising et al. 2003; Morgenstern et al. 2008) others have 
failed to confirm this linkage (Brauer et al. 2002, 2007; Kramer et al. 2000). 
 
1.3.1.1.5 Lung Function 
 Several cohort studies have assessed the effect of traffic pollutants on measures 
of lung function, including forced vital capacity (FVC), forced expiratory 
volume (FEV) and peak expiratory flow (PEF) in children (Barraza-Villarreal et al. 
2008; Brunekreef et al. 1997; Dockery et al. 1996; Gauderman et al. 2000, 2007b; 
Nordling et al. 2008; Oftedal et al. 2008; Rosenlund et al. 2009). A more detailed 
account of the more recent literature will be provided in Chapter 3. A study in 
Rome (Rosenlund et al. 2009) investigated respiratory symptoms of 2,107 children 
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(aged 9-14 years) from 40 schools, with spirometry performed on 1,359 children. Three 
indicators were investigated which included self-reported heavy traffic outside home, 
measured distance between home and busy roads and the residential NO2 concentration 
in the area. The results indicated significant association between the NO2 concentration 
and reduced expiratory flow, FEF25-75, FVC and PEF. The impact of ambient pollution 
(PM2.5) on the lung function of children was also assessed in 12 communities in 
Southern California over a period of 4 years (Gauderman et al. 2000) with evidence of a 
reduced FEV1 in children from polluted areas consistent with retarded lung growth. 
Additionally, in a later study, Gauderman et al. (2007) assessed the effect of the local 
exposure of major roads on lung function, demonstrating that children living within 
500m of freeways have a substantial reduction in lung growth (FEV1, –81 mL; MMEF, 
-127ml) compared with children living at least 1,500m away from the pollutant source. 
A significant association between traffic NOx and PM10 with the reduced lung function 
during the first year of life has also been reported (Nordling et al. 2008). In these 
studies, long term pollutant averages were used to approximate difference in life time 
pollutant exposures which is clearly an imperfect indicator of personal exposure. 
Therefore, Oftedal et al. (2008) calculated hourly concentrations of NO2, PM2.5 and 
PM10 to access individual exposure in children living in Oslo, Norway, since birth. 
Early and lifetime exposures to air pollution were associated with reduced lung growth 
especially in girls. In this analysis, NO2 showed both short and long term effects on lung 
function, whilst PM2.5 and PM10 was only associated with long-term effects.  
 
1.3.2 Genetic Susceptibility 
There is an increasing body of evidence demonstrating that a considerable 
proportion of the variation in the sensitivity of individuals to air pollutant insults can be 
attributed to polymorphisms in key genes related to xenobiotic and antioxidant defense, 
as well as the induction of inflammation. Single nucleotide polymorphisms (SNP) may 
occur in one of the following areas of the genome i.e. coding regions (cSNPs), 
regulatory regions (rSNPs) or 'junk' DNA regions and are therefore referred to as 
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anonymous SNPs. Table 1.2 shows the definition of certain important terms related to 
genetic polymorphisms. 
 Genetic contribution to the complex diseases is still not fully understood. 
However, it is believed that genetic contribution to disease is multi-factorial and may 
involve many common alleles, which differ in allelic frequency amongst major human 
sub-populations. Therefore, genetic variance has become an important intrinsic disease 
determinant and recent research has focused on the identification of genes involved in 
the numerous health disorders. However, due to the presence of polygenetic factors, the 
actual disease aetiology is yet to be established, but gene–gene and gene-environment 
interactions are believed to be the main causes.   
 




The genetic constitution (the genome) of a cell, an individual or an
organism, which is distinct from its expressed features, or
phenotype.
Allele
One of the different forms of a gene that can exist at a single locus.
Often implies a detectable phenotype difference, which may arise
from natural or experimentally induced variation.  
Polymorphism
Genetic variation at a locus present at a frequency of at least 1% in a
population. Naturally, occurring variations in the DNA sequence and
may not have detectable phenotypic variations. 
Single nucleotide 
polymorphism (SNP)
Genetic variation that arises from a change in a single nucleotide at
a locus and can be used as a marker for association mapping to
assess genetic variation within and among populations. 
Coding SNPs (cSNPs)
Present in the actual gene-coding region of a chromosome and have
a higher probability of influencing propensity to disease than SNPs
found outside gene regions. 
Regulatory SNPs (rSNPs)
These SNPs affect regulatory regions that govern gene
expression. Thought to be relatively uncommon and potentially as
valuable as cSNPs. 
Protein SNPs (pSNPs)
When a cSNP or a rSNP leads to an altered amino acid, which in turn
leads to altered protein function or expression and an observable
change in the organism’s phenotype.
Synonymous SNP 
A change in a coding region that alters the nucleotide sequence of a
codon without changing the amino acid. 
Non- synonymous SNP
A change in a coding region that alters the nucleotide sequence of a
codon which cause changing in amino acid. This could be missense
or nonsense mutation.
Anonymous SNP
No known effect on gene function. Thought to be the most common
type of SNPs and possibly valuable as markers for linkage
disequilibrium studies, when they are relatively close to the gene 
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1.3.2.1 Systematic Review on Genetic Association Studies  
 Systematic literature search was conducted for the identification of effect 
modification of antioxidant and xenobiotic genes on impact of air pollution on 
respiratory diseases or symptoms until year 2012. This exercise was undertaken to 
identify genetic variations, which have been associated to traffic derived pollutants and 
respiratory disease regardless of populations age. The search engines like PubMed and 
Scopus were utilized to search information related to air pollution using terms: “air 
pollution”, “nitrogen dioxide”, “PM”, “ozone”; for genes using terms: “polymorphism”, 
“genetic”, “SNP”, “antioxidant”, “xenobiotic”, “GSTP1”, “GSTM1”, “NQO1”, “Nrf2”, 
“AhR”, “CYP1A1”, “EPHX1”(microsomal epoxide hydrolase 1), “GCLM” and 
“GCLC” (glutamate-cysteine ligase modifier subunit and catalytic subunit), and for 
respiratory symptoms using terms: “lung function”, “asthma”, “respiratory” and 
“wheezing”. Tables 1.3 and 1.4 show summary of the published studies examining 
specific genetic variations in relation to effect of air pollutants and respiratory responses 
for adults (14 studies) and children (19 studies) respectively in chronological order. 
Some studies investigated the effects of SNPs conjointly with genetic variants other 
than xenobiotic and antioxidant genes (Li et al. 2006; Melén et al. 2008) such as TNF-α. 
In addition, due to lack of studies for association between gene of interest such as 
CYP1A1 and respiratory disease, the studies were still included to understand the 
mechanism involved in relation to air pollution and the genetic variance. There may be 
some studies, which are not included mainly due to repetition from the same group. 
Several studies have been performed using the Children’s Health Study population 
(Breton et al. 2011; Islam et al. 2009, 2008; Li et al. 2006; Salam et al. 2007). The last 
major study examining the interaction between pollutants and genotype in adults was 
published in 2010 whereas more genetic association studies have been performed in 
children since this period and will be reviewed in more detail in the results chapters. 
The increased interest in childrens research may reflect the established vulnerability of 
children exposed to ambient pollution. Moreover, studies have predominantly focused 




 Overall, the GST supergene family which comprises of mu, pi and theta 
(GSTM1, GSTP1 and, GSTT1) has been investigated the most extensively. These phase 
II xenobiotic metabolizing enzymes are critical in detoxifying the carcinogenic and 
ROS producing electrophiles in order to protect lung against insult and prevent further 
oxidative stress. The GSTM1 genotype, which is located on chromosome 1p13 appears 
to be the most intensively studied with twelve studies in children  (Buthbumrung et al. 
2008; David et al. 2003; Hong et al. 2007; Islam et al. 2009; Lee et al. 2008; Li et al. 
2006; Piacentini et al. 2010; Reddy et al. 2012; Romieu et al. 2004, 2006; Salam et al. 
2007; Tung et al. 2011) and in all adults studies bar two (Alexeeff et al. 2008; Yang et 
al. 2005). This is followed by GSTP1 genotype which is located on chromosome 11q13, 
with ten studies performed in children (Islam et al. 2009; Lee et al. 2004; Li et al. 2006; 
Melén et al. 2008; Piacentini et al. 2010; Reddy et al. 2012; Romieu et al. 2006; Salam 
et al. 2007; Schroer et al. 2009; Tung et al. 2011) and nine studies in adults (Alexeeff et 
al. 2008; Avogbe et al. 2005; Binkova et al. 2007; Castro-Giner and et.al 2009; Chen et 
al. 2007b; Gilliland et al. 2004; Novotna et al. 2007; Ren et al. 2010; Topinka et al. 
2007). In contrast the GSTT1 genotype on chromosome 22q11 has been examined in 
only 4 studies in children (Buthbumrung et al. 2008; Hong et al. 2007; Piacentini et al. 
2010; Salam et al. 2007) and 8 studies in adults (Avogbe et al. 2005; Binkova et al. 
2007; Castro-Giner and et.al 2009; Gilliland et al. 2004; Manini et al. 2006; Novotna et 
al. 2007; Ren et al. 2010; Topinka et al. 2007). 
 The majority of the published evidence indicates that polymorphisms in the 
GSTM1 genotype resulting in the homozygous deletion of GSTM1 alleles (GSTM1 
null) results in a significant increased susceptibility to air pollutants in children and 
adults with only two studies failing to confirm this association (Li et al. 2006; Manini et 
al. 2006). The study by Li et al. (2006) on acute exposure of ozone demonstrated 
decreased risk of wheeze in subjects who were GSTM1 null, whereas in the Manini et 
al. (2006) study, increased risk to benzene was observed in GSTM1pos alleles 
particularly in smokers. 
  In contrast, investigation of the GSTP1 genotype has yielded mixed results. SNP 
Ile105Val has been of particular interest in all studies, with evidence that individuals 
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with homozygous Val alleles exhibit significantly lower GST enzyme activity (Watson 
et al. 1998). In four studies, exposure to high ozone level demonstrated substantial risk 
to oxidative stress biomarkers (Avogbe et al. 2005) and significant decreased lung 
function (Alexeeff et al. 2008; Chen et al. 2007b) and breathing difficulties (Romieu et 
al. 2006) for those with both allele Valine. Similarly, amongst children with high 
EPHX1 activity and homozygous Val/Val, living near major road had increased 
susceptibility to asthma (Salam et al. 2007). Conversely, a substantial protective effect 
against wheezing was observed amongst subjects with variant Ile/Ile (Li et al. 2006), or 
with either one or both allele Val (Lee et al. 2008) when exposed to low air pollution 
and high ozone level respectively. However, another study (Schroer et al. 2009) showed 
significant increased risk of wheezing for subjects with homozygous Val/Val compared 
to wild type with respective of pollutant exposures. In a recent study, carriers with 
homozygous Val/Val showed increased FEV1 in relation to acute exposures to PM10 and 
SO2 compared to non-carriers (Reddy et al. 2012). Conversely, possession of wild type 
Ile/Ile, which has been shown to be associated with increased enzyme activity, indicated 
enhanced susceptibility to asthma in some studies (Islam et al. 2009; Lee et al. 2004) in 
individuals with high exposure to air pollution. In addition, in a crossover study, 
enhanced nasal sensitization was observed in subjects with homozygous Ile/Ile who 
were exposed to DEP (Gilliland et al. 2004). However, substantial increased risk to 
sensitization was demonstrated for children with heterozygous Ile/Val exposed to 
elevated levels of traffic NOx (Melén et al. 2008). Interestingly, subjects with Val/Val 
demonstrated a six fold decreased risk of asthma compared to controls (Fryer et al. 
2000). In these studies, it remains unclear to what extent the period of pollutant 
exposure contributes to the different outcome observed. In addition, how these 
functional polymorphisms relate to other aspects of the pulmonary antioxidant network 
is not well defined at this time. It is however notable that chromosome 11q13 has been 
shown to be hot spot for asthma related genes (Thomas et al. 1997; Ferreira et al. 2011), 
which has led to speculation as to whether the GSTP1 genotype may have a linkage to 
the atopic asthma phenotype.  
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Subjects with GSTM1 null greater 
↑ IgE and histamine after diesel 
exhaust particles plus allergen 
challenge. 
Subjects with GSTP1 Ile/Ile  
significant ↑ IgE and histamine 
after diesel exhaust particles plus 
allergen challenge.
Similarly in subjects with both 
GSTM1 null and GSTP1 Ile/Ile 


















250 ppb for 3 hours (44 
subjects) 
200 ppb for 4 hours (4 
subjects)






No significance changes in FEV1 














Gender/          
Age






















































Subjects with GSTT1 null 
genotype had  significant ↓ 
urinary S-PMA excretion.
Subjects with NQO1 Pro/Ser have 
strongest correlation between S-
PMA and SB.
Subjects with the GSTP1 Val/Val 
have strongest correlation 
between S-PMA and FPG sensitive 
sites.  
Stepwise gradients with respect 
to ambient UFP, S-PMA excretion 
and oxidative DNA damage with 
rural subjects < suburban subjects 
< residents living near highly 
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Age










































Subjects with GSTM1pos had 
significant ↑ excretion of S-PMA 











































Exposed subjects with GSTM1 
null, and XPD23 (Gln/Gln)  
significant ↑ total DNA adduct 
levels.
Control subjects with XPD6 (C/C) 













Gender/          
Age



















<18 year:   
M=46, F= 57
19 year:     
M=49,   F= 41
>20 year:      
















Female subjects with GSTM1 null/ 
NQO1 Pro1/Pro significant ↑ risk 
of ozone related ↓ in mean 
FEF(25-75%).    
Male subjects with GSTP1 Val/Val 
significant ↑ risk of ozone related 



































XPD- Lys751Gln        
hOGG1-Ser326Cys









rs13181            
rs1052133    
    
Exposed subjects with variant 
CYP1A1*2C (Ile/Val) and EPHX1-
medium (Tyr/His) phenotype 
significant ↑ susceptible to the 
induction of oxidative DNA 
damage.
Winter levels of oxidative DNA 
damage positively correlated with 
exposure to cPAHs, probably 
reflecting ↑ oxidative stress as a 












Gender/          
Age















Jan-2.65 ± 2.86, 
Mac-0.63 ± 0.35, June- 
0.48 ± 0.56 Sept- 1.15 
± 1.15 
cPAHs (ng/m3):
Jan- 16.6 ± 17.9 
Mac- 3.7 ± 1.8 
June- 3.5 ± 2.8 
Sept- 8.6 ± 7.3 
To cover high (winter) 





















Subjects with both CYP1A1 
(Ile/Val) and GSTM1 null had 
significant ↑ total and B[a]P-like 





















Ozone, 2-day mean, 









Subjects with a long (GT)n repeat 
in HMOX1 or Val105 in GSTP1 had 
significant ↓ in FEV1 with a 15 
ppb increase in O3.
Subjects carrying both the GSTP1 
105Val variant and the HMOX1 
long (GT)n repeat had a stronger 












Gender/          
Age





























Subjects with NQO1 CC genotype 
at 3’ downstream had significant 
association between modeled 
NO2 and asthma prevalence and 
also with new on-set asthma.




















































Subjects carrying wild type GSTP1 
(rs1799811) marginally 
significantly modified the 
protective effect of SO4
2- on 8-
OHdG (adjusted p =0.091). 
Subjects with the wild type of CAT 
(rs2284367) (adjusted p = 0.037), 
and the non-deletion of GSTM1 
(adjusted p = 0.037) significantly 




CYP1A1 = cytochrome P-450 enzymes; NQO1 = nicotinamide adenine dinucleotide (phosphate) reduced:quinone oxidoreductase; glutathione S-
transferase (GST) M1, GSTP1, GSTT1, GSTA1; GPX1  = glutathione peroxidase; EPHX1 = microsomal epoxide hydrolase 1; TNF-α = tumor 
necrosis factor alfa; LTA = lymphotoxin; TLR4 = Toll-like receptor 4; SOD2 = superoxide dismutase; XPD = xeroderma pigmentosum D; 
XRCC1 = X-ray repair cross-complementing group 1; MS = methionine synthase; MTHFR = methylenetetrahydrofolate reductase; hOGG1 = 8-
oxoguanine DNA glycosylase; Pro = proline; Ser = serine; Ile = isoleucine; Val = valine; Tyr = tyrosine; His = histidine; Arg = arginine; Ala = 
alanine; Gly = glycine; Gln = glutamine; Asp = aspartic acid; Leu = leucine; Cys = cysteine; A = adenine; C = cytosine; G = guanine; T = 
thymine; SNP = single nucleotide polymorphism; PM2.5  = particulate matter with aerodynamic diameter less than 2.5 microns; PM10 = particulate 
matter with aerodynamic diameter  less than 10 microns; NO2 = nitrogen dioxide; ppb = parts per billion; PEF = peak expiratory flow;  FEF =  
forced expiratory flow; FEV = ↑ = increase, high, more; ↓ = decrease, low; EBC= exhaled breath condensate; c-PAH= carcinogenic polycyclic 
aromatic hydrocarbons; S-PMA= S-phenylmercapturic acid ; SB= strand breaks; FPG= formamidopyrimidine DNA glycosylase; B[a]P = 













Table 1.4 Studies of interactions between genetic polymorphism and air pollution in children related to respiratory disease 
 
 







Gender/          
Age




















Subjects with NQO1 Pro/Ser have ↓ 
asthma risk only among GSTM1 null 

























Mean NOx = 41.2,
SO2=8.6ppb
GSTP1 -Ile105Val rs1695 Subjects with Ile/Ile (in high air 
pollution) have significant ↑ 
asthma risk but subjects in low/ 



















(1 h max ozone) 
GSTM1-deletion NA Subjects receiving placebo with 
GSTM1 null significant ↓ FEF22-75 
in 50ppb ozone. 
Subjects with GSTM1 null  













Gender/          
Age






























Subjects with TNF-308 GG  
significant ↓ asthma and lifetime 
wheezing risk in low ozone. 
Significant ↓ wheeze risk with TNF-
308 GG among GSTM1 null 
subjects in low ozone.
Significant ↓ wheeze risk with TNF-
308 GG among GSTP1 Ile/Ile 





























Subjects with GSTM1 null or GSTP1 
Val/Val significant ↑ in breathing 
difficulty with a 20ppb increase 
ozone exposure.
Similarly in subjects with both 


















Pb =0.051 ± 0.031 
Zn =0.021 ± 0.021
Al =0.085 ± 0.100





No significant effects of GSTM1 null 











Gender/          
Age






























Subjects who lived <75m with high 
EPHX1 activity, significant ↑ risk of 
lifetime asthma.
Subjects who lived <75m with high 
EPHX1 activity and with GSTP1 








































Subjects with GSTM1 null  
significant ↑ urinary muconic acid 
(MA) excretion of benzene effects.
No significant effects in other 

























Higher ozone= mean 
55.2 ppb












Non-Hispanic white subjects with 
HMOX1 "s" alleles  significant ↓ 
new on-set asthma risk especially 
in low ozone area.
Hispanic whites subjects with 
variant C-262T significant ↑ risk of 
new on-set asthma.
No significant effects between non-













Gender/          
Age
Exposure metrics Gene/Variants SNP ID Findings














Amongst the children with GSTP1-
105 Ile/Val or Val/Val and GSTM1 
null, children with the G allele of 
FcεRIβ had protective effect of 
wheezing compared with the wild 





































i)Intron 4 (C232+13A) 
ii) Exon 5- Ile105Val
iii) Intron 5 (C/T)
iv) Intron 5 (C/T)
v) Exon 6-Ala114Val
vi)Intron 6-C445-16T





iv) Intron 1 (C/T)
v) Intron 3 (A/G)
ADBR2
i) Exon 1-Glu27Gln 

















Subjects with heterozygote GSTP1 
Ile105Val significant ↑ risk of 
sensitization when exposed to 
elevated level of traffic NOx.
Interaction effect of GSTP1 
Ile105Val with traffic NOx 
significant ↑ risk of sensitization 
among subjects TNFG-308A.
No significant interactions 
between variants TNF and ADBR2 
with respiratory symptoms, PEF or 














Gender/          
Age























Higher ozone= mean 
55.2 ppb













Subjects who participated ≥ 3 
sports with GSTP1 105-Ile/Ile 
significant ↑ asthma risk in high 
ozone area.
Subjects with GSTM1 null 





























(DEP)= 0.34 µg/m3 
(range=0.23-0.88).
GSTP1- Ile105Val rs1695 Subjects carrying Val/Val alleles 
had significant ↑ risk of wheezing 













Gender/          
Age 
Exposure metrics Gene/Variants SNP ID Findings 
Piacentini  
















47.53 ± 2.05/ 
Age controls:  
50.70 ± 2.01 
PM10  
O3 


















Subjects with GSTA1 –69T/–69T 
and heterozygous genotype had 
↑ risk of asthma development, 
which was 7.15-fold higher than 
the risk in those with the 
homozygote wild type genotype. 
 
Subjects with GSTM1 null had ↑ 
risk of asthma development, 
which was 2.34-fold higher than 
the risk in those with the GSTM1 
positive genotype. 
 
Subjects with GSTO2 
homozygous Asp/Asp genotype 
had ↑ risk of asthma 
development, which was 9.10-
fold higher than the risk in those 
with the GSTO2 positive 
phenotype. 
 
Subjects with GSTT1 null 
genotype had a 3.61-fold ↑ risk 
of asthma than those with the 













Gender/          
Age
Exposure metrics Gene/Variants SNP ID Findings


















































Subjects carrying ‘‘0100000’’ 
haplotype in GSS, had negative 
effects of all the pollutants except 
ozone with  significant ↓ in 
average growth of FEV1, FVC, and 
MMEF over an 8-year period.
The magnitude of effects within 
this haplotype ranged from 2124.2 
to –149.1 for FEV1, from 292.9 to 
2126.7 for FVC, and from 2193.9 to 
–277.9 for MMEF for all pollutants 
except ozone.
*SNP haplotypes (0100000) were 
coded as “1” for variant and “0” for 
common variant allele. They were 
ordered as follows:  rs6087649, 













Gender/          
Age
Exposure metrics Gene/Variants SNP ID Findings







































Gender/          
Age
Exposure metrics Gene/Variants SNP ID Findings













Age= 12.8 ± 0.4
NO2 EPHX1  
i)Exon 3 Tyr113His 
ii)Exon 4 His139Arg






Children carrying Arg/His or 
Arg/Arg genotypes at EPHX1 
His139Arg locus, were significantly 
associated with significant ↑ risk 
of l ifetime asthma and early-onset 
asthma (adjusted OR [aOR] = 1.3; 
95% CI, 1.1-1.7; and aOR = 1.5; 95% 
CI, 1.1-2.1, respectively).
Children live in higher NO2 
communities with EPHX1 139Arg 
and 113Tyr-139Arg alleles have 
greater risk compared those live in 
lower NO2 communities.
This observation was most marked 
within children with GSTP1 Val 




















GSTP1 - Ile105Val 
NA
rs1695
Both GSTM1 and GSTP1 genotypes 
did not show any significant 
association with FEV1 intraday 
variability in crude analysis. 
Children carrying allele Val of 
GSTP1 show  significant ↑ FEV1 
variability of 3 days prior 24-hr 





NQO1 = nicotinamide adenine dinucleotide (phosphate) reduced:quinone oxidoreductase 1; glutathione S-transferase (GST) M1, GSTP1, GSTT1, 
GSTA1;  TNF-α = tumor necrosis factor alfa; GCLC = glutamate cysteine ligase catalytic subunit; GCLM = glutamate cysteine ligase modifier 
subunit; GSR = glutathione reductase; GSS = GSH synthetase; EPHX1 = microsomal epoxide hydrolase 1; TGF-ß1 = transforming growth factor 
beta 1; ADBR2 = beta 2-adrenergic receptor; CYP2E1 = cytochrome P-450 enzymes 1; CAT = catalase; HMOX1 = heme oxygenase 1; MnSOD = 
manganese superoxide dismutase; Pro = proline; Ser = serine; Ile = isoleucine; Val = valine; Tyr = tyrosine; His = histidine; Arg = arginine; Ala 
= alanine; A = adenine; C = cytosine; G = guanine; T = thymine; SNP = single nucleotide polymorphism; PM2.5  = particulate matter with 
aerodynamic diameter less than 2.5 microns; PM10 = particulate matter with aerodynamic diameter  less than 10 microns; NOx = total NO + NO2; 
NO = nitrogen oxide; NO2 = nitrogen dioxide; ppb = parts per billion; Fe = ferum; Mn = manganese; Pb = plumbum; Zn = zinc; Al = aluminium; 
PEF = peak expiratory flow;  ↑ = increase; ↓ = decrease. Phase I enzyme: CYP2E1. Phase II enzymes: EPHX1; GSTM1; GSTP1; GSTT1; GSTA1; 
GSR; GSS, GCLC, GCLM; MNSOD; Nrf2; NQO1. Inflammatory mediators: TNF-α; ADBR2; TGF-ß1. 
 







Gender/          
Age




















T/G 3′ UTR 















In case-only analysis revealed 
significant differences for 
combined genotype of SNPs 
rs2588882 and rs6721961 between 
asthma patients that lived in 
modestly or highly polluted 
environment (OR=0.43 




  Whilst the GSTT1 genotype has been widely studied, deletion of this gene has 
shown no relation to air-pollutant related respiratory symptoms in all but two studies 
(Avogbe et al. 2005; Piacentini et al. 2010). Notably, different GSTs metabolize distinct 
substrates with some overlap. GSTM1 is more sensitive to the quinone metabolites of 
catecholamines (dopachrome) while GSTP1 detoxifies lipid and DNA oxidation 
products (Fryer et al. 2000). The important substrates for GSTT1, for an example, 
ethylene oxide, does not appear to be present in ambient PM. Additionally, GSTP1 
enzyme accounts for more than 90% of GST activity in the lung, while GSTM1 has a 
much more restricted expression profile. GSTT1 is least expressed enzyme in the lung 
instead (Hayes and Strange 2000). Consequently, the GSTT1 genotype may not be a 
good candidate gene for genetic associations study related to ambient PM induced 
respiratory health effects. 
 The number of publications investigating the NQO1 genotype is still limited. 
Only 2 studies have examined this genotype in children, whereas 7 studies have been 
conducted in adults. One functional polymorphism in NQO1 results in a substitution at 
amino acid 187, from proline to serine, resulting in decreased enzyme activity. The 
enzyme activity of NQO1 in subjects decreased as follows: homozygous Ser/Ser < 
heterozygous Pro/Ser < wild type Pro/Pro (Nebert et al. 2002). The NQO1 enzyme 
catalyzes reduction of quinones directly to hydroquinones, avoiding the generation of 
intermediate semiquinone radical. Subjects with NQO1 Pro/Pro and GSTM1 deletion 
have been shown to have an increased sensitivity to oxidative stress (Bergamaschi et al. 
2001; Corradi et al. 2002) and reduced lung function (Chen et al. 2007) with acute and 
chronic exposure to ozone respectively. In contrast, the NQO1 Pro/Ser genotype has 
been shown to be protective against asthma risk in children exhibiting the GSTM1 null 
genotype in population of high ozone level exposure (David et al. 2003), whilst another 
study showed significant correlation with oxidative damage biomarker (Avogbe et al. 




Microsomal epoxide hydrolase (EPHX1) is a phase II enzyme, which detoxifies 
reactive epoxides from activated PAHs to water soluble trans-dihydrodiols. There is 
considerable evidence that polymorphisms in EPHX1 are associated with COPD (Hu et 
al. 2008). However, there is limited research related to air pollution, with only 2 studies 
in children (Salam et al. 2007; Tung et al. 2011) and 3 studies in adults (Manini et al. 
2006; Binkova et al. 2007; Novotna et al. 2007). Mainly, 2 SNPs have been examined in 
EPHX1, the functional polymorphisms Tyr113His at exon 3 and His139Arg at exon 4. 
An in vitro study has reported that subjects with His113 have 50% reduced enzymatic 
activity whereas subjects with Arg139 have an increased (25%) enzyme activity. 
Phenotypic classification of EPHX1 is based on polymorphisms in both exon 3 and 
exon 4 that exhibit fast (no mutation in exon 3 and at least one mutation in exon 4), 
medium (heterozygous in exon 3 and homozygous at exon 4) and low (homozygous 
mutation in exon 3 and no mutation in exon 4) enzyme activity (Hassett et al. 1994). 
One study performed on the CHS (Children’s Health Study) cohort provided a clear 
picture of the association between EPHX1 with traffic emissions. In this study, children 
with high EPHX1 activity living in proximity to major roads (<75m) had a significantly 
increased risk of lifetime asthma. In addition, in combination with GSTP1 105Val, 
which has a 7-fold higher efficiency for diol epoxides than 105Ile (Hayes and Strange 
2000), the increased risk of asthma amongst the children was further enhanced. 
Metabolism of PAHs to the metabolites producing harmless conjugates depends mainly 
on the activity of GST and EPHX1 enzymes. Here the biological explanation could be 
that GSTP1 105Val which has reduced enzymatic catalytic activity leads to 
accumulation of PAH epoxides. Subsequently, the PAH epoxides are metabolized by 
EPHX1 with increased conversion of the PAH epoxide to trans-dihydrodiol which 
undergoes redox reaction with the production of ROS.  
 Four studies in adults have investigated the modulating effects of CYP1A1 
polymorphisms on population responses to air pollutants however; none of the studies 
was investigated in relation to respiratory disease or symptoms. In addition, only 2 
studies (Novotna et al. 2007; Topinka et al. 2007) have shown positive associations, 
with enhanced susceptibility only apparent under high PAH exposures. The two most 
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common SNPs investigated in this gene are in the restriction site (T/C) at 3’ flanking 
region and the Ile462Val in exon 7. The polymorphism Ile to Val enhances the 
microsomal catalytic activity of CYP1A1. 
 Polymorphisms in TNF-α, have provided inconsistent results for its influence on 
air pollution-induced health responses. The common SNP at the 5’ untranslated region 
of the gene, G-308A has been studied in greatest detail because of its increased 
secretion and promoter activity (Wilson et al. 1997). In the study of Melen et al. (2008), 
a significant increased risk of allergic sensitization was observed in subjects with 
TNFG-308A in combination with the GSTP1 Ile105Val genotype. Conversely, TNF-
308G/G showed a protective effect on asthma prevalence and lifetime wheeze in 
children with GSTP1 Ile/Ile who live in areas of low ozone. Previously, genetic 
association studies had shown significant correlation of TNFG-308A with association 
between NO2 and asthma prevalence and new onset asthma (Castro-Giner et al. 2008).  
  
1.4 Project Aims 
 This thesis includes a series of studies examining the responses of children’s 
lungs to traffic pollutants and explores the basis for differences in individual 
susceptibility to these gaseous and particulate agents. The overarching hypothesis of 
the study was that the introduction of London’s Low Emission Zone would be 
associated with year-on-year improvements in the respiratory health of cross sectional 
panels of 8-9 year old children living within inner city London boroughs. Following 
the delay in the implementation of the third phase of the scheme from October 2010 to 
January 2012, my aim was somewhat modified to focus solely on the first three years of 
the scheme as a baseline case for the later intervention in 2010. Nevertheless, one might 
still expect to see year-on-year improvements in air quality as a function of the 
modernization of the fleet, partly driven by the existence of the scheme. The study 
therefore aimed to address the relationship between traffic pollutant exposures with 
respiratory symptoms (chapter 3) and measures of lung function (chapter 4) over the 
first three years of the schemes operation.  
 49 
 
As a secondary aim I investigated how polymorphisms in selected genes 
(reflecting toxicologically relevant pathways) impacted on the observed associations 
between children’s lung function and measures of oxidative stress with their estimated 
chronic, sub-chronic and acute exposures to NOx, NO2, PM10 and PM2.5. This work 
described in chapters 4 (lung function) and 5 (urinary measures of oxidative stress and 
metal exposure biomarkers) is based on a separate cross sectional panels of children, 
(school year 4, UK) sampled during the winter periods (Nov-Mar) of 2008-2009, 2009-
2010 and 2010-2011. This adjunct work focused on SNPs within key antioxidant and 
xenobiotic candidate genes. To examine the possible role of diesel derived polyaromatic 
hydrocarbons exposures on long term lung growth I examined SNPs in key phase I and 
II xenobiotic metabolism genes:  glutathione S transferases (GST), NAD(P)H quinone 
oxidoreductase (NQO1), cytochrome P450, family 1, subfamily A, polypeptide 1 
(CYP1A1), the aryl hydrocarbon receptor (AhR). For potential effect modification of 
the association between systemic (urinary) markers of oxidative stress and air pollutant 
exposures I focused on SNPs within glutamate-cysteine ligase (GCLM (modifier 
subunit) and GCLC (catalytic subunit), the nuclear factor (erythroid-derived 2)-like 2 
transcription factor (Nrf2) and extracellular superoxide dismutase (EC-SOD/SOD3), as 
each of these genes has been shown to play a significant role in protecting the lung from 
oxidative stress.  
In the final experimental chapter I have also presented preliminary work 
examining the potential utility of using urinary metals as biomarkers of personal 
exposure to traffic pollution. Here I have hypothesised that increased exposure to traffic 
pollution would be associated with increased urinary metals reflecting different 










Materials and Methods 
 
 2.1 Introduction 
 This methods section will focus on the saliva sampling performed on the 
children attending schools in East London and the subsequent genotyping of susceptible 
genes to air pollutants. These methods are therefore relevant to the data presented in 
chapters 3, 4 and 5. The experimental methods employed to optimize DNA extraction 
and quality control will be covered in detail here. For context however, a brief 
description will also be provided of the additional measurements being performed on 
the participating children. Detailed information on lung function testing is discussed in 
chapter 3 and urinary analysis for markers of oxidative stress and metal exposure 
biomarkers will be discussed in the chapter 5. As the work in this thesis represents part 
of a large epidemiological study, it was dependent on the teamwork and collaboration 
between number individuals across various institutions. Lung function measurements 
were performed by trained staff from Queen’s Mary hospital under the supervision of 
Dr Isobel Dundas, who was also responsible for quality assurance and quality control of 
the data. Urinary measurements of cotinine, creatinine and 8-isoprostane were 
performed by Dr Helen Wood of the MRC-HPA Centre for Environment and Health 
(chapter 5), who was also responsible for the maintenance of the master data base. 
Urinary 8-oxodG and metals determinations (chapter 5) were performed by Ellie Smith, 
an MSc student under my supervision, with Andy Cakebread of the Mass Spectroscopy 
unit at King’s College London providing expert guidance in the use of inductively 
coupled plasma mass spectroscopy (ICP-MS). Dr Nadine Marlin of the Pragmatic 
Clinical Trials Unit, Queen’s Mary University, performed statistical analysis of the data. 
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2.2 London Low Emission Zone Schools Study Design 
 We carried out yearly cross sectional surveys of 8-9 year old children’s 
respiratory health from 2008 onwards. We invited primary schools in the east London 
boroughs of Hackney and Tower Hamlets to take part in the study based on their 
proximity to major roads and LEZ indicator air pollutant monitoring sites. We visited 
schools to carry out assessments during November to March each year from 2008 
onwards. In this thesis, I will be concentrating on analysis performed on the first three 
years of the study, covering the winter periods 2008-2009, 2009-2010 and 2010-2011. 
Children’s respiratory health was assessed by spirometry (Microlab, Micromedical, 
Cardinal Health). Spirometry was performed according to American Thoracic Society 
guidelines (Pellegrino et al. 2005) with pre- and post-bronchodilator measurements, 
following salbutamol 400 µg administration by large volume spacer. Other assessments 
included: fraction of exhaled nitric oxide, FeNO (Niox Mino, Aerocrine), urinary 
cotinine, heavy metals, 8-isoprostane and 8-Oxo-2'-deoxyguanosine, as well as 
completion of an International Study of Asthma and Allergies in Childhood (ISAAC) 
questionnaire and the collection of saliva to gather DNA for genotyping. Health 
assessment data was linked to modeled air quality data supplied by the Environmental 
Research Group, Modeling team at King’s College London to give individual pollutant 
exposures for each child’s school and residential address.  
 
2.3 Consent and Ethics Approval 
 Approval of the study was obtained by regional ethics committees (East London 
& The City HA Local Research Ethics Committee 2, REC Ref Number 08-H0704-139) 
and conducted according to principles of the Declaration of Helsinki. Written informed 






2.4  Subject Recruitment 
 A different cross-sectional sample of children was examined each winter over a 
3-year period (2008-2012) in the London boroughs of Tower Hamlets and Hackney as 
the modeled impacts of the London LEZ had been predicted to be greatest in these 
areas, and detailed air pollution and traffic monitoring has been put in place to assess 
improvements in air quality following the introduction of this traffic amendment 
scheme (Kelly et al. 2011). Primary schools were selected that were either in close 
proximity to, or some distance from, a major roads (see Figure A1 in Appendix A). 
The study involved 8-9 years old, Year 4 children. The parents of the children from the 
participating schools were provided with study packs that contained detailed 
information about the study and the investigations to be carried out on the pupils and the 
parental and children’s consents were obtained prior to the investigation.  
 In total, 199 children from 10 schools (Nov 2008 – Feb 2009), 416 children 
from 19 schools (Nov 2009 – Feb 2010) and 404 children from 23 schools (Nov 2010 – 
Mac 2011) were sampled during the school visits for Year 1-3 which equals to 1019 
subjects. The distribution of the children participation by schools is presented in the 
Table A1 in Appendix A, whereas Table A2 in Appendix A summarized details of the 
sampling data obtained during each visit. 
 
2.5 Calculation of Body Mass Index 
 The weight and height of the child without shoes was measured in kilograms 
(kg), and centimeters (cm) respectively using a Stadiometer (Seca Ltd, Birmingham, 
UK). The height and weight were measured to determine body mass index (BMI) which 







2.6  Measurement of Lung Function  
 Forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) 
was determined for each subject using a Spiroflow Model 132 spirometer (P K Morgan; 
Gillingham, UK). A minimum of three procedures were performed on each subject in 
accordance with the American Thoracic Society guidelines (Pellegrino et al. 2005). The 
measurements were obtained pre and post inhalation of four puffs of Salbutamol, to 
examine airway reversibility using a large volume volumetric spacer. Details on lung 
function QA/QC are presented in chapter 4. 
 
2.7 Urinary Analysis 
 Urine samples were obtained from each of the participants on the morning of the 
school visit. It was not feasible to collect first morning void samples due to compliance 
issues. Once collected, urine samples were kept on ice until transported to King’s 
College London where they were split into 5 – 7 of 1 ml aliquots on the same day prior 
to longer term storage at -80
o
C. Samples were aliquoted for the following assays: 
quantification of urinary 8-isoprostane and 8-hydroxy-2’deoxyguanisine as markers of 
systemic oxidative stress and metal analysis as biomarker of exposure, which are 
covered in detail in chapter 5. In addition, urinary cotinine were to provide information 
on the child’s exposure to environmental cigarette smoke and creatinine, as a 
denominator of urine concentration both of which are reported in this chapter. However, 
the data of these two markers was not reported, instead used for the normalization of 8-
isoprostane and 8-hydroxy-2’deoxyguanisine concentrations in all statistical models. 
 
2.7.1  Analysis of Cotinine  
 Cotinine is a major nicotine metabolite, with a considerably longer half-life than 
nicotine (about 20 h versus 2 h). It can be detected in blood, saliva and urine for up to 
around 72 h after exposure to nicotine. It is the biomarker of choice for quantifying 
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exposure to environmental tobacco smoke (ETS, i.e. passive smoking), since it is more 
specific for tobacco smoke than other biomarkers, such as carbon monoxide and 
carboxyhaemoglobin. Cotinine concentrations in urine are on average 10 times those of 
serum; hence urine provides a better indicator of ETS exposure. Environmental tobacco 
smoke (ETS) refers to a mixture of side-stream smoke and exhaled mainstream smoke 
that pollutes the air in locations where tobacco is being smoked. Urinary cotinine was 
analysed by enzyme immunoassay (EIA). A micro plate EIA kit for serum (product no. 
M155B1, Concateno, Abingdon, UK) with urine standards were used since the urine-
specific kit is designed to measure direct tobacco exposure, i.e. from smoking, so the 
range of detection (50-5000ng/ml) is much higher than the levels expected in our 
samples (0-100 ng/ml). Farber et al. (2008) described using a cotinine saliva EIA kit to 
determine ETS exposure from urine samples (Chest 2008; 133:1367-1374). Cotinine 
levels are typically about six times greater in urine than in serum or saliva (Benowitz 
1999), hence we based our method on that used by Farber et al. (2008). Undiluted urine 
samples were analysed in duplicate, as per the manufacturer’s instructions. The kit is 
semi-quantitative, indicating a positive or negative result according to a cut-off point of 
25 ng/ml (>25 ng/ml is positive). The measurement was repeated if the duplicate 
readings fell on either side of this cut-off point, or if the readings fell on the same side 
of the cut-off point, but with a large SD. Individual variation in urine concentration 
were corrected by using the cotinine-to-creatinine ratio (CCR) in ng/mg. A positive 
sample was defined as having a CCR > 30 ng/mg (Henderson et al. 1989). A typical 
standard curve for cotinine assay is illustrated in Figure 2.1. 
 
2.7.2  Analysis of Creatinine 
 Creatinine is formed in vivo at a fairly constant rate, by the hydrolysis of 
creatine and phosphocreatine, and is cleared from the body through the kidneys, mainly 
by glomerular filtration. In the absence of renal disease, the excretion rate of creatinine 
into the urine is relatively constant (which makes urinary creatinine concentration 
inversely proportional to urine flow rate). Thus, urinary creatinine levels may be used as 
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an index of standardization for other tests. Creatinine normalization compensates for 
differences in urine concentration (i.e. diuresis) and hence, in biological monitoring, 
many compounds are expressed relative to the level of creatinine, permitting 
comparison between subjects and within subjects over time. Creatinine adjustment 
involves dividing the analyte concentration by the creatinine concentration. Urinary 
creatinine was analysed using a commercial kit based on the Jaffe reaction (product no. 
500701, Cayman Chemical, Ann Arbor, MI, USA), wherein a yellow/orange colour 
forms when the metabolite is treated with alkaline picrate. The colour derived from 
creatinine is then destroyed at acidic pH. The difference in colour intensity measured at 
500 nm before and after acidification is proportional to the creatinine concentration. 
Urine samples, diluted 20x were analysed in duplicate. The dynamic range of the kit is 
0-15mg/dL, with an intra-assay CV of 2.7% and an inter-assay CV of 3%. The 
measurement was repeated if the CV for duplicates was >10%. A typical standard curve 
for creatinine assay is illustrated in Figure 2.2. 
 
 





Figure 2.2 Representative of typical creatinine assay standard curve. Absorbance was plotted 
against standard creatinine concentration. 
 
2.8 Saliva Collection for SNP Analysis 
Saliva (a mixed saliva and buccal cell sample) was collected from children at the 
participating schools using the Oragene DNA kit OG-250 (DNA Genotek Inc, Canada). 
The collection was carried out according to the manufacturer’s instruction. Briefly, the 
Oragene sampling sponge was placed into the childs’ mouth and moved around the 
cheek pouches. Five sponges were performed per individual, with the saliva laden tips 
cut from their handle and placed in the supplied Oragene - DNA kit container. The 
containers were then capped with the release of a proprietary DNA stabilization solution 
(designed to preserve DNA in saliva samples at room temperature) and gently mixed by 
inverting five times. Once collected, the collection kit containing saliva samples were 
kept on ice until transported to King’s College London. Subsequently, all samples were 
stored at -80
o
C until required for processing. In addition, a preliminary study was also 
performed to optimize DNA recovery from two different types of saliva collection: 
saliva spit and saliva swabs. The preliminary study consisted of 10 volunteers, each 
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providing a sample of each type of collection. Details of preliminary work on DNA 
extraction and quantification optimization are summarized in Appendix B.  
 
2.8.1 DNA Recovery from Saliva Samples 
 Genomic DNA was recovered from the saliva swabs according to the following 
protocol. After removal from storage at -80
o
C the sample container was placed in an air 
incubator overnight at 50
o
C. This incubation step was to permit cell lysis and to ensure 
that the DNA was released from the matrix and that nucleases are permanently 
inactivated. After incubation, the maximum volume of free liquid was removed and the 
sample transferred to a 15 ml conical centrifuge tube (Greiner, UK). The barrel of a 5 
ml disposable plastic syringe was then placed into conical tube (without the plunger) 
into which the sponges were then transferred using fine sterile forceps. The conical tube 
containing sponges in the barrel was then centrifuged at 200 x g for 10 minutes at 20
o
C. 
After centrifugation, the syringe barrel containing dry sponges was removed and 
discarded according to Human Tissue Authority (HTA) regulations.  
 
2.8.2 DNA Extraction 
 Following incubation and extraction, samples were transferred to several 2.0 ml 
micro-centrifuge tubes with the total volume recorded. For RNase digestion, each 
sample was then treated with Ribonuclease A (final concentration 10 μg/ml) and 
Ribonuclease T1 (final concentration 25 Units/ml) both from Sigma Chemical 
Company Ltd (Poole, UK) and incubated at 37
o
C for 30 minutes. Subsequently, the 
sample was treated with a 1/25
th
 volume of proprietary DNA purifier (supplied as part 
of the Oragene DNA kit), vortexed briefly prior to 10 minute incubation on ice. This 
protein precipitation step resulted in a cloudy solution which was centrifuged at 13,000 
rpm for 15 minutes with the resultant clear supernatant transferred to a fresh 1.5 ml 
centrifuge tube. An equal volume of 100% ethanol was then added and the sample 
gently mixed by inverting 10 times to obtain a homogenous solution. The sample was 
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then allowed to stand at room temperature for 10 minutes to permit complete 
precipitation of DNA prior to centrifugation at room temperature at 13,000 rpm for 10 
minutes. The supernatant was discarded prior to the addition of 1 ml 70% ethanol to the 
DNA pellet and allowed to stand for 1 min at room temperature. The dehydrated DNA 
was then rehydrated by the addition of 100 µl of reduced TE buffer (10 mM Tris-HCl, 
0.1 mM EDTA, pH 8.0) from Invitrogen Technologies (Paisley, UK) followed by a 30 
second vortex prior to incubating for 1 hour at 50
o
C with occasional mixing or an 
overnight incubation at room temperature.  
 
2.8.3 DNA Quantification 
 DNA can be quantified either by UV absorbance or fluorescence-based 
techniques. However, the presence of impurities in saliva may cause interference in the 
UV spectra leading to increased absorbances at 280 nm, thereby lowering the A260/A280 
ratio. Fluorescence based methods are less subject to such variations due to the specific 
binding of selected fluorophores to double stranded DNA. In this study, DNA yields 
were determined using both UV absorbance and also fluorescence for comparison of 
accuracy and purity of DNA extracted from saliva. 
 
2.8.3.1 Determination of DNA by UV Absorbance  
DNA quantification by absorbance was performed using a Nanodrop ND-1000 
Spectrophotometer (Nanodrop Technologies, Wilmington, DE) in 1.5 µl samples. The 
samples were measured at 260nm to obtain an estimate of the concentration of nucleic 
acid and 280nm for the protein content. Generally an A260/A280 ratio >1.8 is accepted as 
indicator of limited protein and organic contamination. Similarly, a ratio of A260/A230 in 
the range of 1.8-2.0 illustrates limited salt, carbohydrates, ethanol and protein 




2.8.3.2 Determination of DNA by Fluorescence  
 Quantification of genomic DNA by using fluorescence was carried out by using 
Quant-iT™ PicoGreen® assay (Invitrogen). An aqueous working solution of Quant-
iT™ PicoGreen® reagent (200 fold dilutions) was prepared in TE buffer in a 50 ml 
conical tube, covered with foil just few hours prior to sample analysis, as the solution is 
prone to photodegradation. For the DNA standard curve, the lambda DNA standard 
provided at 100 μg/ml in the Quant-iT™ PicoGreen® kits was diluted by serial dilution 
to achieve a concentration range between 0.03 and 1 ng/µl (Table 2.1). For analysis, 
each sample was diluted 1:200 with TE buffer. Subsequently, 100 µl of each of the 
lambda DNA standards (1-6) and samples were added in triplicate to the wells of a 
black 96-well plate, to which 100 µl of the Picogreen working solution of reagent was 
added and incubated for 2 to 5 minutes at room temperature in the dark. Following the 
incubation, sample fluorescence was measured on a fluorescence microplate reader 
(Cary Eclipse) at an excitation of 480 nm and emission 520 nm. DNA concentrations 
were calculated with reference to the standard curve (Figure 2.3) having first subtracted 
the background fluorescence of the blank. Details of the DNA yield across the samples 
can be viewed in Table C1, Appendix C. 
 







Description Volume of Volume of lambda (λ) Final [DNA] in Quant-iT™ 
TE DNA Stock/Diluted PicoGreen® assay
(µl) (µl) (ng/µl)
Blank 100 0 0
Standard 1 1960 40 µl of 100ng/µl of DNA Stock 1
Standard 2 1000 1000 µl of Standard 1 0.5
Standard 3 1000 1000 µl of Standard 2 0.25
Standard 4 1000 1000 µl of Standard 3 0.125
Standard 5 1000 1000 µl of Standard 4 0.0625








Figure 2.3 Representative picogreen assay standard curve. Fluorescence emission 
intensity was plotted against standard DNA concentration. 
 
2.8.4 Genomic DNA Analysis 
DNA integrity was analyzed by agarose gel electrophoresis. Briefly, 100 ng of 
each sample was loaded and separated on a 0.75% gel containing ethidium bromide (0.5 
µg/ml) for 60 minutes at 90 volts. An instrument Syngene G:BOX was used to 
photograph the gel. Lambda DNA digested with HindIII (Sigma Aldrich) was used as a 
size reference (see Figure C1 in Appendix C). 
 
2.8.5 Whole Genome Amplification 
 High-throughput genotyping demands considerable quantities of genomic DNA. 
Therefore, due to the limited availability of the genomic DNA sources for the 
genotyping in certain samples, the genomic DNA present in the samples was amplified 
by using Whole genome amplification (WGA) technique, to permit genotyping on the 
Illumina platform. Although, WGA is a good technique to enhance DNA 
concentrations, it may also decrease the hybridization capacity of the amplified DNA. 
Considering that most genome-wide association studies generally involve concurrent 
genotyping of a huge amount of samples, this may lead to a modification in the 
positions of a fraction of SNPs in the genotype clusters, producing unclear clusters and 
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enhancing ambiguity of a call (Teo et al. 2009). Therefore, for the consistency of the 
study design, WGA by using the GenomePlex Complete Whole Genome Amplification 
Kit (WGA2) (Sigma Aldrich) was carried out as previously described  (Arneson et al. 
2008) on all collected samples. This amplification kit was employed as it has been 
tested in-house by Illumina to work in conjunction with the GoldenGate genotyping 
technology (Barker et al. 2004). 
  To begin with, the genomic DNA was normalized to 1 ng/µl. Subsequently, 1 μl 
of 10x DNA fragmentation buffer was added to 10 μl gDNA (1 ng/µl) in a 0.2 ml 
multiwell strip. The mixture was then heat-denatured at 95°C for exactly 4 min for 
random fragmentation and immediately cooled on ice. After a brief vortex and 
centrifugation to consolidate the products, 2 μl of 1 x library preparation buffer that 
contains degenerated adapters, and 1μl of library stabilization solution were added to 
the samples. Following that, the mixture was incubated at 95°C for 2 min and then 
immediately cooled on ice.  
 For Omniplex library construction (Figure 2.4), a standard PCR protocol was 
employed. Upon addition of 1 μl of Library Preparation Enzyme, the mixture was 
vortexed and centrifuged briefly. Then PCR reactions were performed in a thermal 
cycler as follows: 16°C for 20 min, 24°C for 20 min and finally at 37°C for 20 min. 
Then, the final extension step was performed at 75°C for 5 min. Each batch of 
amplification included a negative (no template DNA) control to identify non-specific 
amplification in the reaction and positive control (human gDNA) for the confirmation 
of negative amplification. The final step in the WGA was library amplification. This 
was accomplished via addition of a 60 μl of master mix containing 7.5 μl of 10X 
Amplification Master Mix, 47.5 μl of nuclease free dH2O and 5 μl of WGA DNA 
Polymerase to the sample. The mixture was then vortexed and centrifuged briefly. After 
an initial denaturation at 95°C for 3 min, a standard PCR reaction was followed: 14 
cycles of 95°C for 15s and annealing/extension at 65°C for 5 min. The PCR product 
was stored at -20°C. Whole genome amplification (WGA) was successfully carried out 
on all the DNA samples to achieve at least 50ng/µl, which is the minimum requirement 
for genotyping on the Illumina platform.  
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2.8.6 PCR Product Clean-up  
 The amplified genomic DNA was purified by using a PCR clean-up kit 
(GenElute PCR Clean-Up Kit (Sigma Aldrich)) to eliminate unincorporated primers, 
excess nucleotides, salts and enzymes, which is crucial for the success of the 
downstream applications. This kit employed positive selection purification and all steps 
were performed at room temperature at 16,000 x g unless specified. Upon inserting the 
GenElute Miniprep Binding Column into collection tube, 0.5 ml Column Preparation 
Solution was added into each column and centrifuged at 12,000 x g for 30 seconds. The 
eluate was discarded. Subsequently, 5 volumes of binding solution was added to 1 
volume of PCR product and mixed. The solution was then transferred into binding 
column and spun for 1 min. Subsequently, the eluent was discarded and the bound DNA 
was washed with 0.5 ml Wash Solution (70% ethanol) and centrifuged for 1 min. The 
elutant was again discarded and bound DNA centrifuged again for 2 min without 
additional wash solution for complete removal of excess ethanol. The collection tube 
was then discarded together with the elutant and a clean 2.0 ml collection tube was 
replaced. Finally, 30-50 μl TE buffer (Sigma Aldrich) was added to the column and the 
bound DNA was eluted by centrifuging for 1 min. The purified genomic DNA was 
stored at -20°C until required for further analysis.   
 
2.8.7 SNP Genotyping 
 It is not feasible or cost effectible to investigate large number of genes, or 
genetic variants using the conventional methods such as PCR. The bead-based 
multiplexed SNP assay has made it possible to resolve millions of SNPs in a single 
experiment. The Illumina GoldenGate Genotyping Assay, which uses single-base 
extension to call the SNP, was employed for SNPs genotyping in this study as it 
provides flexibility in array design, offers custom genotyping, and is appropriate for 
candidate gene association studies as in the present study. The details of different SNP 
genotyping methods are presented in Appendix D. The custom VeraCode GoldenGate 
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Assay on the BeadXpress platform which support mid- to low-plex (48 to 384-plex) 
genotyping panels was suitable for this study as in total 96 SNPs were genotyped.  
 The VeraCode technology is based on the generation of distinct digital 
holographic codes within each microbead, which ensures production of robust, precise 
and accurate data. It consists of cylindrical glass microbeads, 240 x 28 microns, each 
capable of carrying high density 24-bit codes to produce a large number of bead types. 
Upon laser excitation, each bead diffracts the beam into multiple components, 
generating a digital signature, which is captured by the camera in the BeadXpress 
Reader System, emitting a unique holographic code (Figure 2.5). The digital coding 
enables not only the identification of the target but also the sample ID, the kit as well as 
the laboratory ID. Desired multiplex levels ranging from one to several hundred are 
achieved by pooling uniquely coded non-overlapping beads, providing specific 
detection. 
 
Figure 2.4 Overview of GenomePlex WGA Kit Process. The process starts with the 
fragmentation of the DNA into short overlapping strand templates followed by two 
priming steps of these short strands leading to Omniplex library generation. PCR 
amplification is performed using the DNA template in the library pool. Purification of 
the amplified genomic DNA is undertaken once the amplification is complete. (Source: 




Figure 2.5 Schematic diagram showing generation of digital holographic code using VeraCode. 
Each bead contains a specific digital code, which diffracts the laser beam into various individual 
components. These components structure form the digital signature of the bead code when read 
by the CCD camera of the BeadXpress reader. (Source: Illumina Technical Note, 2007). 
 
  The BeadXpress reader evaluates the result generated through Veracode 
microbeads. It utilizes a two-fold colour identification system where it reads the distinct 
holographic code (code data), which is embedded in every Veracode microbead and 
also identifies the signal strength (fluorescence data) connected to the bead. Because the 
assay developed with VeraCode microbeads typically includes up to 30 replicates of 
each bead type, the data generated by the BeadXpress Reader is particularly robust. 
Each of the 30 replicates of the micrboead is optically visualized for a minimum of 12 
times, generating up to 300 individual data set points for each sample. In addition, the 
decoding procedure also serves as a robust quality control measurement demonstrating 
the hybridization efficiency of all the beads in the assay (Fan et al. 2005). 
 
2.8.8 SNPs Selection 
 The BeadXpress platform is preferred mainly due to its cost effectiveness, 
specifically for 96 SNP/sample tests. Therefore, based on their known or putative role, 
66 SNPs from 16 candidate genes were selected for the SNP analysis based on 
previously published data as discussed in Table 1.3 and Table 1.4. These genes can be 
subdivided into four broad groups: (1) genes primarily involved in xenobiotic 
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metabolism pathway; (2) antioxidants genes; (3) genes primarily involved in nitrosative 
stress; and 4) asthma related genes (Table 2.2). Additionally, a group of 30 random 
SNPs was included to provide information on population stratification. One marker 
from the long arm and the short arm of each autosome was selected using computer 
generated random numbers to identify the genomic position. Only SNPs not known to 
be associated with any specific disease and showing the greatest frequency variation 
across the HapMap populations (within 20kb of the selected position) were included in 
the ancestry informative marker SNP set. More information on the SNP selection 
criteria are included in Annex H. 
 These 96 SNPs were then examined for modification effects of air pollution 
exposure on respiratory health outcomes in the cross-sectional cohort London Low 
Emission Zone Schools study. Certain groups of SNPs on the array were selected a 
priori for use in the analysis of gene environment interactions on specific endpoints: For 
the lung function endpoints the modifying effects of SNPs in the glutathione 
transferases (GSTP1, GSTM1 and GSTT1) and NAD(P)H dehydrogenase, quinone 1 
(NQO1), cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) and the 
aryl hydrocarbon receptor (AhR), were investigated; for urinary markers of oxidative 
stress, epoxide hydrolase 1, microsomal (EPHX1), nuclear factor (erythroid-derived 2)-
like 2 (Nrf2), extra-cellular superoxide dismutase (SOD3) and glutamate-cysteine ligase 
catalytic/modifier subunit (GCLC and GCLM); and for FeNO, SNPs in arginase 1 
(ARG1) and 2 (ARG2), as well as inducible nitric oxide synthase (NOS2). In addition, 
single SNPs in gasdermin A (GSDMA) and B (GSDMB) were related to the presence of 
childhood asthma and wheeze. In the work described in this thesis, I will only address 
the SNPs, related to the modification of respiratory symptoms, lung function and 
oxidative stress biomarkers of air pollution interactions. Further details on the selection 
criteria used to identify the SNPs and their linkage disequilibrium are presents in the 






Table 2.2  List of Genes Genotyped in the Study 
 
 
Group Genes Official Symbol Chr No. of SNPs
(Other Symbol)
Phase I xenobiotic genes Cytochrome P450, family 1, subfamily A, polypeptide 1 CYP1A1 15 5
Phase II xenobiotic genes Glutathione S-transferase mu 1 GSTM1 1 1
Phase II xenobiotic genes Glutathione S-transferase theta 1 GSTT1 22 1
Phase II xenobiotic genes Glutathione S-transferase, pi 1 GSTP1 11 5
Phase II xenobiotic genes NAD(P)H dehydrogenase, quinone 1 NQO1 16 4
Phase II xenobiotic genes Epoxide hydrolase 1, microsomal (xenobiotic) EPHX1 1 2
Antioxidant genes Superoxide dismutase 3 SOD3 (EC-SOD) 4 6
Nitric oxide signalling Nitric oxide synthase 2, inducible NOS2 (iNOS) 17 14
Nitric oxide signalling Arginase 1 ARG1 6 6
Nitric oxide signalling Arginase 2 ARG2 14 9
Regulate phase I xenobiotic genes Aryl hydrocarbon receptor Ahr 7 5
Regulate phase I xenobiotic genes Nuclear factor (erythroid-derived 2)-like 2 NFE2L2 (Nrf2) 2 3
Asthma related genes Gasdermin A GSDMA (GSDM1) 17 1
Asthma related genes Gasdermin B GSDMB (GSDML) 17 1
Glutathione-related metabolism Glutamate-cysteine ligase catalytic subunit GCLC 6 1
Glutathione-related metabolism Glutamate-cysteine ligase modifier subunit GCLM 1 2
Ancestry markers Random SNPs Various 30
Total number of SNPs studied 96
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2.8.9 Oligo Pool Assay Design 
 Each custom genotyping kit contains Oligo Pool Assays (OPAs) assessed through 
Illumina's Assay Design Tool (ADT), to verify the functionality of the probes on 
GoldenGate technology, avoiding the necessity for multiplexed PCR optimization. Illumina 
allocates designability ranks and SNPs scores to demonstrate the ability to achieve 
successful assay. Initially, a total of 100 SNPs were selected for evaluation by Illumina. 
The final selection of SNPs for genotyping samples was based on a score of >0.6 and 
designability rank of 1.0, as these oligos were most likely to achieve success during the 
genotyping for whole genome amplified DNA (Cunningham et al. 2008). Although this is a 
quality parameter, it does not guarantee the success of the assay. Therefore, upon receipt of 
the sequence scoring, the SNPs that failed to achieve the minimum score (0.6) and 
designability rank less than 1.0 were excluded from the list and replaced by the ones which 
were initially short listed but not selected. SNP with failure reflected a number of issues 
including close proximity to another SNP of interest with a distance of just 61 nucleotides 
and a minor allele frequency (MAF) less than 0.05. As the success of the OPAs design 
depends on each SNP probe sequence as they form a mixture in one solution, this process 
was performed numerous times until a good match of sequences was achieved. Finally, 96 
SNPs were selected using the following criteria: designability rank of 1.0 and a minimum 
MAF of at least 0.1 in one of the HapMap populations. Following this, a final Score file 
was produced for the requisition of order. A system was developed of assigning names to 
all SNPs from SNP1-SNP96, which included relevant data for quick identification of each 
SNP. Appendix D shows reference sequence (rs), location of the SNP in the genomic DNA 
and polymorphic site in bracket with forward slash separating the two alleles. Most of the 





2.8.10   llumina GoldenGate Genotyping Assay 
 All the samples were genotyped at the Genomics Centre, Guy’s Hospital using the 
protocol described previously (Shen et al. 2005). The assays were conducted in 96 well 
plates. Each protocol ran for 3 days and two plates were processed simultaneously. DNA 
samples were added to each of the wells and the previously designed OPAs were then 
added for hybridization of the oligos. As all SNPs possess three oligos therefore 96 OPAs 
contain 288 probes in the VeraCode solution. Two of the three probes are exclusively for 
the two potential alleles at the SNP site, Allele Specific Oligos (ASO), which bind at the 
SNP site and the third binds downstream to the SNP site, the Locus Specific Oligo (LSO). 
Every 3’ end ASO sequence will hybridize to the target sequence that will match up to 
either of the two alleles, and the 5’ end will bind to a universal PCR primer sequence. The 
LSO possesses three regions. The 5’ end is used for hybridizing downstream of the SNP, 
the central one is the unique address sequence and the 3’ end corresponds to the universal 
PCR primer sequence.  The unique address sequence present on an individual bead in the 
Sentrix BeadChip, is later utilized for the identification of each genotyped SNP. 
 In the primer hybridization process, the oligos hybridized to the genomic DNA 
sample bound to paramagnetic beads. As hybridization took place prior to amplification, it 
removes amplification bias in the assay. Subsequent to hybridization, several washing steps 
were performed to reduce noise by removing excess and mis-hybridized oligos. The 
information about the genotype was obtained by extension of appropriate ASO and ligation 
of the extended full-length product to the LSO providing a template for PCR using 
universal PCR primers P1, P2 and P3. As the ligation depends on the hybridization of both 
oligos, this becomes a significantly important step. The primers P1 and P2 distinctly match 
up with one of the corresponding ASOs. Thus, just one primer will bind to the 
oligonucleotide depending on the hybridized ASO at the target DNA. In addition, primers 
P1 and P2 are labeled with Cy3- and Cy-5 in such a way that the dye ratio is suggestive of 
allele frequency. PCR amplification was then performed to enrich the number of labeled 
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SNPs available for the allele identification. The single strand DNA was hybridized to beads 
on the Sentrix Array Matrix through their unique address sequence. Following 
hybridization, the array was scanned using the BeadXpress reader to analyze the 
fluorescence signal. Each address corresponds to a specific locus, and the existence of 
either Cy3, Cy5, or both signals on a specified bead type representing either AA, BB or AB 
genotypes. Each genotype call was then assessed utilizing Illumina GenomeStudio software 
(Figure 2.6). In total, 988 samples were genotyped on twelve separate plates. On a final 












Figure 2.6 Illumina GoldenGate assay work flow. The overall assay takes place in approximately 9 
steps over 3 days. Firstly, the DNA is activated which is then added to the allele specific (ASO) and 
locus specific (LSO) oligonucleotides and hybridized. Subsequently, allelic specific extension and 
ligation is performed to generate the DNA template for amplification process. During this step, 
fluorescence label is incorporated for the identification of specific allele for the particular SNP. 
Hybridization of the amplicon with the VeraCode beads is accomplished and scanned using 
BeadXpress Reader. Intensities data is analyzed using GenomeStudio Software for automated 
genotype calling and clustering. (Source: Illumina Technical Note 2006). 
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2.8.11 Genotype Calling 
 The intensity data obtained from each plate was assessed using the Genotyping 
module (v1.9.4) of the Illumina GenomeStudio (v2011.1) software. A preliminary run is 
performed by selecting ‘‘Cluster SNPs’’ by using GenCall cutoff of 0.25 as recommended 
for GoldenGate Assay. Following that raw data is generated through automated genotype 
calling.  
 The GenomeStudio clusters the samples as “call” or “no call” in a Polar plot 
depending on the zygosity of the loci of the SNP genotypes. Here “calls” represent loci 
having GenCall score above the call region threshold; in this case, 0.25 while “no calls” are 
assigned to loci having GenCall scores below the call region threshold. Genotyping success 
rate was determined to demonstrate the quality of the genotyping by using the call rate 
measurement. Therefore, the call rate for each sample was calculated as follows:  calls/ (no 
calls + calls) x 100. The outcomes are represented in GenomeStudio as GenoPlots or SNP 
Graphs (see Figure 2.7) where each point corresponds to a single locus. The polar plot 
shows the normalized theta value (B allele frequency) on the X-axis (the angle of deviation 
from the pure A allele) corrected for the cluster position for the particular SNP of interest. 
The theta values range between 0 and 1 where value 0 refers to pure A signal and 1 refers 
to pure B signal. The Y-axis is based on normalized total intensity (R) for two alleles (A 
and B) for the given SNP. Therefore, Log R ratio (Robserved/Rexpected) is the normalized R 
value divided by the expected normalized R value. GenCall scoring for diploid samples 
normally produces three clusters of alleles; each distinguished by a corresponding distinct 
colour coding where AA (red) and BB (blue) represent homozygous allele and AB (purple) 
represents heterozygous allele and the scores range from 0 to 1. Scores 0 and 1 correspond 
to AA and BB homozygous alleles respectively whereas samples lying in between these 
two regions with score 0.5 represent  heterozygous AB allele. Samples falling anywhere in 




2.8.12 Quality Control Analysis  
Sample-dependent, sample-independent, and contamination controls were included 
in the OPAs to assess the performance of the GoldenGate assay. The controls were viewed 
using the GenomeStudio software to examine the reliability of the assays, reagents, 
BeadChips and equipment, in addition to the samples. Figure 2.8 shows typical images of 
controls from the GenomeStudio dashboard reporting information on allele-specific 
extension, PCR Uniformity, gender, extension gap, first hybridization, and second 
hybridization controls. The gender controls are used mainly to ascertain assay success 
and/or sample quality, such that failure to observe signal may indicate general process 
failure in any steps of the assay, or poor DNA sample quality. In addition, any gender 
mismatch of reported sex to the inferred sex based on the genotyping on the X-chromosome 
denotes possible sample contamination during the sampling or/and genotyping process. 
Since there are only two bead types for the gender control assays, the measurement is 
acknowledged to be prone to error. For this reason I did not a priori exclude gender 
mismatch samples from the analytical data set, as this does not infer that the other SNPs are 
in error. Rather, all analysis were ran with and without the 41 mismatched samples (<5% of 
all typed samples), to evaluate the extent that this influenced the associations observed. As 
no influence was observed here we report these data within the full analysis. 
 The use of various controls for testing efficiency of allele specific extension, PCR 
amplification efficiency, sample sex verification, gap extension efficiency, annealing 
specificity and hybridization specificity are important in the assessment of overall 
performance of the samples, reagents, equipment and BeadChips. These controls are 
already built into the GoldenGate assay (OPA) and is observed using GenomeStudio by 






















Figure 2.7 Genoplot. Illustration of a GenoPlot (top panel). Alleles are coded with specific 
colours,  red for allele AA, purple for AB the heterozygous allele and blue for BB, the homozygous 
allele. Genotypes are determined using signal intensity (Norm R, Y-axis) and B Allele frequency 
(Norm Theta, X-axis) for particular SNP. Genotype calling using GenomeStudio software (bottom 
panel). A representative Genoplot produced by BeadStudio for SNP rs2779253. Each dot represents 
an individual sample. Samples in the red zone are AA allele; samples in the purple zone are AB; 
and samples in the blue zone are BB allele. Based on the figure, a call score of 0 indicates that 364 
subjects are AA, a call score of 0.5 indicaes 381 subjects have BB homozygous allele and a call 
score of 0.5 demonstrating 229 subjects with AB heterozygous allele. There is one individual with 






















Figure 2.8 Typical Controls Dashboard Displayed in the GenomeStudio Module. 
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Despite a manufacturing issue in 2 plates (plate 5 and plate 11) where OPAs for 
controls were not added, most of the samples (>95%) showed good performance 
throughout the assay procedures and appeared to be within required specification, ensuring 
robustness of the assay to produce reliable genotype data (see Appendix E control 
dashboards for all samples in the study). Subsequently, all SNPs underwent manual 
investigation and adjustment (if needed) based on the following three criteria: (i) sample 
call rate; (ii) SNP call frequency and (iii) Hardy–Weinberg equilibrium. Sample call rates 
needed to achieve >0.90 with a GC cutoff score of 0.25, whereas SNPs call frequency 
should be >0.95 having cluster separation of approximately 0.25 or an average GenTrain 
score >0.60. In addition, Hardy–Weinberg equilibrium χ2 also needs to have p-values > 
0.05 (detail description as in Section 2.8.15). 
 
2.8.13  Evaluation of Samples 
 Investigation of samples that required reprocessing or removal from the analysis 
was performed based on the GenCall quality metric score, calculated for every genotype 
data point based on angle, dispersion, overlap of clusters and intensity. The samples with 
score equal to 1 are located in the center of the cluster, whilst a decreased GenCall score is 
indicative of a poorly performing sample. Scatter plots between sample call rate, as a 
function of sample number (see Figure F1 & F2 in Appendix F)  and a 10% GenCall score 
as a function of the sample call rate (see Figure F3 & F4 in Appendix F) were generated 
to identify poorly performing samples. The problematic samples (possessing low sample 
call rate, low 10% GenCall scores, and outliers) were then reprocessed. In total 29 samples 
were reprocessed. Subsequently, the reprocessed samples were included for reevaluation of 
the sample performance and quality. Samples with call rate below 0.90 after reclustering 




2.8.14  Evaluation and Manual Editing of SNP Clusters 
Manual editing is required with GoldenGate projects as not all SNPs perform well. 
Therefore, for the overall improvement in the call rates, it is important to detect the loci, 
which require manual editing or needs to be removed. This is generally achieved by 
evaluation of the reclustered SNPs based on the quality of the cluster separation. The 
quality of SNP clustering for a specific locus is determined by the GenTrain score (between 
0 and 1). To begin with, the SNPs with the poorest clustering based on the GenTrain score 
are highlighted. SNPs possessing GenTrain scores of less than 0.6 were removed (see 
Figure G1 in Appendix G1). Details on cluster separation, SNP frequency, GenTrain 
score, AB T mean, AB R mean and other distribution scores for all 96 SNPs are shown in 
Table G1 in Appendix G. Each SNP showing low cluster separation was then investigated 
for cluster overlapping. The cluster separation determines the distance between the three 
genotype clusters (AA, BB and AB) based on the theta value ranging from 0 to 1 as 
explained in the Section 2.5.4. The clusters showing no overlapping were then manually 
revised to obtain a better separation, while the overlapping clusters were removed from the 
final dataset (see Figure G2 in Appendix G). However, this indicator is far from ideal 
because cluster separation scores are derived from the degree of separation of the two 
homozygous clusters versus the heterozygous cluster instead of separation between the two 
of the homozygous clusters (Butler and Ragoussis 2008). Nevertheless, this method still 
yields useful evidence for the SNP quality and as shown in the current work that the SNPs 
having the cluster separation of even less than 0.25 may still act as a functional SNP.  
SNPs call frequency is also an important parameter when assessing the quality of 
the SNPs. It is determined as the percentage of all samples at each locus having a call score 
above the 0.25 threshold. Therefore, the SNPs showing a low call frequency were also 
zeroed and removed from the analysis. Some of the SNPs in the present study also 
displayed a high heterozygous ratio (see Figure G3 in Appendix G), which prevented 
manual re-clustering of these SNPs and they were therefore removed from the final 
analysis. Another criterion to evaluate the SNP functionality was the investigation of their 
 76 
 
AB R and AB T values. A SNP with an AB R mean value (low intensities) too low to be 
effectively called were also removed from the analysis. On the other hand, evaluation of 
AB T values helped in identifying SNPs with a possible shift of the heterozygote cluster to 
the homozygote. For this purpose, SNPs having AB T values from 0 to 0.2 and 0.8 to 1, i.e. 
not clustered around the centre were analysed. For clusters that were difficult to edit, the 
locus was zeroed and removed from the final data (see Figure G4 in Appendix G).  
 Using the internal controls is not mandatory in the genotyping workflow. However, 
by including a technical repeat plate it was possible to test the reproducibility and 
concordance of the data and confirm the robustness of the assay. This test was only 
performed following the manual editing and removal of poor quality samples and SNPs. 
Overall, technical repeat on both plates shows 100% reproducibility except for three 
samples. Two samples showed concordance of 0.99 whereas in another paired sample, the 
discordant SNP is simply because it was not called instead of miscalled.    
In general, once the clusters were manually edited (many samples had call rates of 
1.00) only 13 had call rates below 0.9 (of these, 3 had failed completely) and this is likely 
due to the samples themselves. Using the criteria outlined above, ten SNPs were classified 
as having failed: rs17072738 (SNP8: random SNP), rs1871042 (SNP28: GSTP1), 
rs2472299 (SNP68: CYP1A1), rs2074175 (SNP75: random SNP), rs8192290 (SNP53: EC-
SOD), rs1138272 (SNP18: GSTP1), rs2234922 (SNP47: EPHX1), rs17883901 (SNP19: 
GCLC), rs6599689 (SNP94: random SNP) and rs4147581 (SNP4: GSTP1). The dataset 
significantly improved after these SNPs were zeroed, indicating poor performance of the 
individual SNPs prior to the manual editing. Figure G5 & Figure G6 in Appendix G 
shows 8 SNP graphs representing some of the successfully genotyped SNPs prior to editing 
and subsequent to manual editing. 
Subsequently, using GenomeStudio, genders were estimated based on the intensities 
of X chromosome and the proportion of heterozygous genotype for this SNP. One would 
expect that samples marked as male have average intensities (R), half of the mean 
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intensities of female samples. This is because males are hemizygous at X chromosome 
SNPs. Generally, most of the males and females in the current project are grouped into two 
discrete clusters (see Figure E4 in Appendix E). Overall, samples reported as “female” 
exhibit X chromosome and have intensity higher than the samples marked as “male”. 
However, 41 (<5%) samples out of 974 appeared to be mismatched resulting in 22 males 
possessing X chromosome clustering at theta ~0 whilst 19 females showing the Y 
chromosome with theta value ~0.6. Consequently, all these mismatch samples were 
highlighted for sensitivity analysis. A test on equality of proportions using Stata 10.1 
(StataCorp, College Station, TX, USA) was performed to compare genotype distribution 
for each SNP before and after exclusions of the gender-mismatched samples to examine if 
there would be any significance difference in the proportions. As expected, none of the 
genotype distributions was significant and the lowest p value was 0.521.  
 Finally, downstream analysis application requires investigation of the distinct base 
for each SNP of every sample. Therefore, the genotype data was transferred to Excel for the 
creation of the Final Report. Of the remaining 975 samples, one appeared to be a duplicate 
(HF039b) as it had been identified previously for labeling error during the Year 3 sample 
collection and subsequently removed from the list. It is extremely difficult if not impossible 
to include the genotype data for each subject from the population investigation. Therefore, 
the genotype data of the entire study population (more than 80,000 genotype data) is 
presented in the accompanying CD-ROM with the thesis. 
 
2.8.15 Hardy Weinberg Equilibrium 
 Deviation from the Hardy Weinberg Equilibrium (HWE) may result from 
genotyping errors, inconsistency in the HWE assumptions, or simply by a random chance. 
The HWE frequency for a locus can be calculated by adding up the frequencies of all 
individual alleles on that locus. For example, considering p as the frequency of an allele 
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(A), and q the frequency for the alternative allele (a) then the expected HWE frequency for 
a locus containing two alleles of either genotypes AA, Aa or aa would be p
2
, 2pq and q
2
 
respectively. For the HW equilibrium, the combined value of all the three individual 
genotypes should be equal to 1 as do the allele frequencies (p
2
 + 2pq + q
2
 = 1). Therefore, 
the measurement of deviation from the HWE is essential for quality control purpose.   
 The goodness-of-fit χ2 test is the commonly used statistical tool to investigate the 
HWE based on the observed genotype frequencies from the dataset and expected genotype 
frequencies calculated from the HW equation.  The null hypothesis is that alleles selection 
are randomly, resulting in expected HWE frequencies (p
2
, 2pq and q
2
) in the population. 
The alternative hypothesis is that the alleles selection are non-randomly leading to HW 
disequilibrium in the population. The HWE is calculated by χ2 test using the following 
equation: n(n-1)/2df, with n being the number of allele at the locus, which is being 
investigated. Additionally, calculation of the degree of freedom (df) can be done by using 
the following equation: g-k, where g represents the number of genotypes while k stands for 
the number of alleles on each locus (Wittke-Thompson et al. 2005). For instance, the χ2 
test, which investigates the extent of deviation from the HWE, would provide df=1 for the 
SNP which consists of 2 alleles and 3 expected genotypes. In the current work, the 
statistical program STATA was utilized to conduct the standard χ2 test on all of the SNP 
markers in the population to identify any departure from the HWE. The p-values <0.05 
obtained from the χ2 test would mean significant deviations from the HWE (Wigginton et 
al. 2005).  
 A significant finding during the QA/QC procedure was that approximately 28% (33 
out of 86 SNPs) of the SNPs deviated from the HWE. Most of the association studies 
utilize repeat genotyping of some of the individuals as a quality control measure to identify 
the genotyping errors (Tintle et al. 2009). In the current study, the concordance rate for the 
repeat genotyping, (>99.99%) indicates that the deviation from the HWE is unlikely due to 
the genotyping errors. Since the study subjects were drawn from an ethnically diverse 
population, violations of the HWE may be related to the population stratification. 
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Therefore, HWE test was performed stratified by ethnicity. The stratification was 
performed based on the self-reported ethnicity where 4 major ethnicity groups were 
identified as: Asian, White, Black and Mixed as described in the Table H1 in Appendix H.  
Detail on Hardy Weinberg calculation for each ethnicity is tabulated in Table 2.3. This 
approach decreased the number of SNPs deviating from HWE to 15 in total, with the Asian 
population having the largest number of SNPs not in the HWE. Further investigation 
revealed that eight out of ten SNPs deviated from the HWE NOS2 genotypes. Six of them 
(rs4795080, rs2779253, rs1889022, rs10853181, rs2531866, rs1014025, and rs2531872) 
were selected based on the SNPs being in high linkage disequilibrium in the haplotype 
block (Islam et al. 2010). The Asian group is known for non-random mating with either 
first cousin or close relatives. Although non-random mating does not change the allele 
frequencies, it could lead to alteration in the genotype frequencies resulting in violation of 
Hardy Weinberg assumptions. Whereas, 8 SNPs are deviated from HWE in Black ethnicity 
group with half of them are random SNPs. In White population, 3 SNPs out of 7 SNPs 
which deviated from HWE are also random SNPs. Meanwhile, in mixed ethnicity group, 5 
SNPs do not conform to HWE. 
In addition, another factor which may contribute to the deviation of Hardy 
Weinberg could be non-random patterns of missing data or systematic errors in genotyping 
(for an example inconsistent missing data in heterozygotes may cause an imbalance 
between heterozygous and homozygous leading to an excess of homozygous) (Wittke-
Thompson et al. 2005). However, this effect is more prominent in case-control studies. 
Nevertheless, in this study, the exclusion of samples with genotyping call rate less than 
0.90 was minimal, involving just 1.4% of the population study. Therefore, it is unlikely that 
missing data has altered the genotype frequencies for the particular SNPs. 
       A flow diagram outlining all of the QA/QC processes employed on the genetic data set 




Table 2.3 Hardy Weinberg Equilibrium p-values of investigated SNPs  
 
 
Note: SNPs which are not in HWE (p<0.05) are highlighted in orange. 
 
SNP Index SNPs ID Gene Asian Black White Others
p-value p-value p-value p-value
SNP1 rs2917666 NQO1 0.331 0.693 0.476 0.453
SNP2 rs7782389 Random SNP 0.053 0.076 0.163 0.227
SNP3 rs997279 Random SNP 0.450 0.020 0.356 0.318
SNP5 rs3759757 ARG2 0.119 0.153 1.000 0.136
SNP6 rs1137933 iNOS (NOS2) 0.282 0.256 0.359 1.000
SNP7 rs2826003 Random SNP 0.627 0.518 0.749 0.811
SNP9 rs2246012 ARG1 0.436 0.095 0.358 0.460
SNP10 rs2074113 Ahr 0.709 1.000 0.719 0.432
SNP11 rs7232792 Random SNP 0.327 0.069 0.028 1.000
SNP12 rs2284659 EC-SOD (SOD3) 0.389 0.001 0.519 0.569
SNP13 rs2781668 ARG1 0.334 0.044 0.815 0.689
SNP14  rs2066853 Ahr 0.583 0.300 0.350 0.802
SNP15 rs2733262 Random SNP 0.802 0.208 0.324 1.000
SNP17 rs17599586 ARG1 0.645 1.000 0.590 0.735
SNP18 rs742869 ARG2 0.637 1.000 0.703 0.046
SNP20 rs2364723 Nrf2 0.064 0.438 0.880 0.839
SNP21 rs8078340 iNOS (NOS2) 0.039 0.368 0.543 1.000
SNP22 rs3742879 ARG2 1.000 0.222 0.547 1.000
SNP23 rs268691 Random SNP 0.278 0.087 0.713 0.573
SNP24 rs2301022 GCLM 0.133 0.524 0.183 0.162
SNP25 rs3170633 GCLM 0.375 0.448 1.000 0.178
SNP26 rs2779251 iNOS (NOS2) 0.005 0.587 0.245 1.000
SNP27 rs7132743 Random SNP 1.000 0.012 1.000 0.660
SNP29 rs6770096 Random SNP 0.228 0.858 1.000 1.000
SNP30 rs7557529 Nrf2 0.495 1.000 0.328 0.048
SNP31 rs2779253 iNOS (NOS2) 0.001 0.866 0.779 0.354
SNP32 rs2606345 CYP1A1 0.463 0.142 1.000 0.578
SNP33 rs8192287 EC-SOD (SOD3) 0.196 0.897 0.048 1.000
SNP34 rs2781666 ARG1 0.538 0.754 0.263 0.186
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Table 2.3 Hardy Weinberg Equilibrium p-values of investigated SNPs  
 
Note: SNPs which are not in HWE (p<0.05) are highlighted in orange. 
 
 
SNP Index SNP ID Gene Asian Black White Others
p-value p-value p-value p-value
SNP35 rs4795080 iNOS (NOS2) 0.003 0.328 0.388 1.000
SNP36 rs7144243 ARG2 1.000 0.854 0.571 0.059
SNP37  rs17722841 Ahr 0.600 0.696 0.403 0.562
SNP38 rs699473 EC-SOD (SOD3) 0.520 0.736 0.513 0.572
SNP39 rs1889022 iNOS (NOS2) 0.001 0.865 0.576 0.354
SNP40 rs9282799 iNOS (NOS2) 0.651 0.364 0.975 0.887
SNP41 rs7591449 Random SNP 0.651 0.606 0.445 0.074
SNP42 rs3894194 GSDM1 0.450 0.443 0.535 0.036
SNP43 rs1442293 Random SNP 0.763 0.202 1.000 0.239
SNP44 rs749174 GSTP1 0.278 0.863 0.791 1.000
SNP45  rs689453 NQO1 0.906 0.528 0.554 0.519
SNP46 rs3796644 Random SNP 0.906 0.846 1.000 0.052
SNP48 rs17779352 Ahr 0.264 0.575 0.705 0.659
SNP49 rs2128238 Random SNP 0.406 0.137 0.217 0.690
SNP50 rs1799814 CYP1A1 0.065 0.821 0.023 0.267
SNP51 rs10454231 Random SNP 0.762 0.020 0.353 1.000
SNP52 rs7776785 Random SNP 0.219 0.363 0.421 0.304
SNP54 rs7140310 ARG2 0.431 0.186 0.603 0.189
SNP55 rs1800566 NQO1 0.905 0.644 0.837 0.345
SNP56  rs17861115 CYP1A1 0.133 0.444 0.364 0.051
SNP57 rs11735827 Random SNP 1.000 0.389 0.461 0.432
SNP58 rs2531866 iNOS (NOS2) 0.001 0.768 0.779 0.346
SNP59 rs9900426 Random SNP 0.198 1.000 0.895 0.026
SNP60 rs10517 NQO1 0.405 1.000 0.190 1.000
SNP61 rs2282885 Ahr 1.000 0.582 0.896 0.124
SNP62 rs2001350 Nrf2 0.614 0.776 0.335 0.254
SNP63 rs527705 Random SNP 0.666 0.049 0.390 0.705
SNP64 rs4902503 ARG2 0.122 0.400 1.000 0.194
SNP65 rs7875663 Random SNP 0.743 0.210 0.324 0.239
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Table 2.3 Hardy Weinberg Equilibrium p-values of investigated SNPs  
 
Note: SNPs which are not in HWE (p<0.05) are highlighted in orange. 
 
 Moreover, genetic variation, caused by an increase or decrease in the allele 
frequencies, may also cause deviation from HWE. Furthermore, gene flow, representative 
SNP Index SNP ID Gene Asian Black White Others
p-value p-value p-value p-value
SNP66 rs407257 GSTT1 0.000 0.000 0.000 0.000
SNP67 rs2531872 iNOS (NOS2) 0.001 0.470 0.781 0.254
SNP69 rs221454 Random SNP 0.517 0.420 0.620 0.706
SNP70 rs2781667 ARG1 0.538 0.877 0.322 0.181
SNP71 rs13306703 EC-SOD (SOD3) 1.000 0.730 0.000 0.300
SNP72 rs2198843 CYP1A1 0.489 1.000 0.546 0.137
SNP73 rs778233 Random SNP 0.583 0.193 0.902 1.000
SNP74 rs7156352 ARG2 0.489 1.000 0.151 0.118
SNP76 rs3824781 Random SNP 0.645 0.230 0.414 0.420
SNP77 rs2236687 Random SNP 0.281 0.621 0.902 0.708
SNP78 rs10459953 iNOS (NOS2) 0.111 0.747 1.000 0.829
SNP79 rs10483801 ARG2 0.021 1.000 0.401 1.000
SNP80 rs2153747 Random SNP 0.563 0.180 0.043 1.000
SNP81 rs10853181 iNOS (NOS2) 0.001 0.769 0.674 0.346
SNP82 rs1014025 iNOS (NOS2) 0.228 0.208 0.220 0.845
SNP83 rs2779248 iNOS (NOS2) 0.159 0.700 1.000 0.695
SNP84 rs8192288 EC-SOD (SOD3) 0.196 0.898 0.056 1.000
SNP85 rs470411 Random SNP 0.293 0.757 0.417 0.823
SNP86 rs9394047 Random SNP 0.767 0.530 0.278 0.689
SNP87 rs11809289 Random SNP 0.280 0.268 0.044 0.432
SNP88 rs12885261 ARG2 0.517 0.701 0.380 0.451
SNP89 rs2297518 iNOS (NOS2) 0.675 0.546 0.130 1.000
SNP90 rs1695 GSTP1 0.889 0.123 0.595 1.000
SNP91 rs2305480 GSDMB 0.610 0.375 0.804 1.000
SNP92 rs2781659 ARG1 0.535 0.786 0.256 0.442
SNP93 rs366631 GSTM1 - - - -
SNP95 rs1051740 EPHX1 0.364 0.043 0.480 0.429
SNP96 rs6017870 Random SNP 0.874 0.237 0.085 1.000
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of transfer of new alleles to a population, caused by mating between two populations could 
also potentially cause HW disequilibrium. This may explain deviation of HW in ‘others’ 
group in five SNPs (rs742869, rs7557529, rs3894194, rs8192290 and rs407257) as this 
population mainly consists of mixed ethnicity and we are unable to stratify them to any 
specific ethnicity.  
 The GSTM1 variant is a copy number variant. The null genotype has no copies of 
the GSMT1 gene and therefore reduced expression/functional activity for this enzyme.  The 
alternate alleles may have 1, 2 or more copies. The pseudo-SNP rs366631 which represents 
a biomarker of GSTM1 deletion was selected for this study based on Huang et al. (2009) 
and only distinguishes whether it is homozygous deletion (null) or not. This pseudo-SNP is 
therefore unable to differentiate between the numbers of alternative alleles. It does not 
therefore behave like a true SNP, which is usually bi-allelic with 3 genotype options. The 
reason for using this SNP was the existence of the complex duplication/deletion patterns in 
the GSTM1 gene. There are 2 regions, one upstream and one within GSTM1 gene with 
shared high homology. Since there are common deletions in the GSTM1 gene, when both 
copies of the upstream region were deleted, the genotype call will be made solely based on 
homozygous variants (TT). When one copy of upstream region is deleted, the heterozygous 
genotype call (CT) is made (personal communication with Huang). By using the similar 
GoldenGate technology which was applied in the Huang et al. (2009) study, the genotype 
call is made for this pseudo-SNP to infer the GSTM1 deletion. Consequently, as this 
variant is multi-allelic, it does not necessarily have to conform to Hardy-Weinberg 
principle, which refers to truly bi-allelic variants.  
 Nonetheless, there is no simple single explanation for the observed deviation from 
the HWE. The major limitation of the HW investigation is that it fails to provide the basis 
of the deviation in the data and the only important information obtained from the test is 
whether or not the data meet the expected proportions calculated for HW. This observation 
























Figure 2.9 A flow chart overview of the QA/QC process for the genetic dataset.  
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2.9 Population Structure Analysis 
 As the study population consisted of multi- and mixed ethnic subjects, therefore, an 
attempt was made to categorize the study population to ‘true’ subpopulations based on 
genetic variations of ancestry markers. Population structure was investigated by employing 
a Bayesian clustering algorithm in the STRUCTURE software using genotype data derived 
from a set of random SNPs. Genotype data from random SNPs in all 974 subjects were 
analyzed to assign individuals into probable population clusters. However, assignment of 
the individuals to two or more populations occurs when their genotype data are consistent 
with admixture. In this population stratification exercise, analysis was based on an 11 
subpopulations classification (Table H1 in Appendix H), based on self-reported ethnicity. 
This model is based on the assumption that there are a unknown number (K) of population 
clusters in each data set defined by allele frequencies at each locus reflective of population 
ethnicity/ continental origin (Pritchard et al. 2000). 
 The admixture model was implemented in the STRUCTURE 2.3.3 to run a 100,000 
iteration (20,000 burn in) using Bayes' Rule Markov Chain Monte Carlo (MCMC) model 
with correlated allele frequencies and clustering without a priori information on sampling 
location. The main presumption of the admixture model was that individuals from unrelated 
populations might share ancestry that enables identification of subpopulation clusters in the 
study population. Therefore, by using the MCMC method and investigating the range of 
LnPr(D) a more accurate K value based on the highest likelihood at optimal K was 
identified. MCMC was run using the same iterations and burn in period at several values of 
K (Pritchard et al. 2007). This procedure was repeated using the same iterations and burn in 
period at least 10 times for each cluster with the K values between K=2 and K=5 yielding 
the most probable number of populations. This step is also important to validate the pattern 
of the population structure generated. In STRUCTURE, log likelihood, InP(D) referring to 
the probability Pr(X|K) given the data (X) forms the basis of the K value estimation. Visual 
examination of the plot of the log probability was performed to determine the most 
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appropriate K value as an ad hoc indicator and plateau method based on the Falush et al. 
(2007) was used to confirm the convergence. Subsequently, determination of K value was 
targeted to the smallest K value “that  captures the major structure in the data” (Pritchard et 
al. 2007) within the plateau region. In addition, the highest likelihood value was considered 
the most likely of the K value for the population investigated. Details on the analysis are 





Air Pollution, the London Low Emission Zone, and the 
Prevalence of Respiratory and Allergic Symptoms in 
Schoolchildren in East London 
 
3.1 INTRODUCTION 
 The International Study of Asthma and Allergies in Childhood (ISAAC) reported 
that Great Britain had the highest prevalence of asthma symptoms in children, worldwide 
(The International Study of Asthma and Allergies in Childhood (ISAAC) Steering 
Committee 1998). According to the most recent available data from the National Health 
Service in England, in 2011-12, 5.9% of patients or 3.3 million people had asthma and in 
2010-11, there were 23,452 emergency admissions to hospital of children with asthma 
(NHS Information Centre for Health and Social Care 2011). The recent Health Effects 
Institute review of the evidence relating traffic-related air pollution to health concluded that 
there is sufficient evidence to link traffic with exacerbation of asthma symptoms in 
children, and suggestive evidence for a link to asthma onset in childhood (HEI Panel on the 
Health Effects of Traffic-Related Air Pollution 2010). 
 Levels of traffic-related air pollution in London are the worst in the UK and among 
the worst in Europe, with European Union (EU) limit values for particulate matter with an 
aerodynamic diameter of less than 10µm (PM10) and nitrogen dioxide (NO2) being 
exceeded in many areas of the city. Recent prospective cohort studies in the United States 
have demonstrated that chronic exposure to traffic emissions has significant negative 
impacts on lung development during childhood, resulting in clinically important deficits 
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into adolescence (Gauderman et al. 2004; Gauderman et al. 2007). A recent study of 
children in the UK also demonstrated impaired lung function in children with a higher 
density of particulate carbon in their airway macrophages (Kulkarni et al. 2006). There are 
also significant short-term effects of air pollution on health, notably the exacerbation of 
symptoms in asthma sufferers. A number of studies have shown associations between 
increased concentrations of traffic-related air pollutants and hospital admissions for asthma 
in children (Delfino et al. 2009; Iskandar et al. 2012; Lee et al. 2006; Samoli et al. 2011). A 
study of adults with mild-to-moderate asthma demonstrated a significant reduction in lung 
function after walking on a busy London street for two hours, associated with exposures to 
ultrafine particles and elemental carbon – both pollutants arising from diesel exhaust 
(McCreanor et al. 2007). 
 In February 2008, a low emission zone (LEZ) covering most of Greater London was 
established, with the aim of reducing traffic-related air pollution and thereby improving air 
quality and the health of Londoners. The London LEZ is the largest in the world, covering 
an area of 2,644 km
2
 with a population of 8.2 million (ONS 2012). Modelling work 
undertaken to assess the potential impact of the LEZ (comparing scenarios with and 
without it) predicted reductions in emissions of PM10 from road traffic sources in Greater 
London of 2% in 2008 and 6% in 2012, with 4% and 10% reductions in emissions of 
nitrogen oxides (NOx) from road traffic in 2010 and 2012, following implementation of 
phases 1-3 of the scheme (Transport for London 2008). Greater reductions were predicted 
in areas where concentrations of PM10 and/or nitrogen dioxide (NO2) exceeded EU limit 
values prior to the scheme’s implementation. The LEZ study was therefore initiated  to 
assess the accrued health benefits of living within the LEZ on the respiratory health of 8-9 
year old schoolchildren in the east London boroughs of Hackney and Tower Hamlets. 
These boroughs are also areas of significant socioeconomic deprivation (Department of 
Health 2012a, b), with 77% and 67% of the populations in Hackney and Tower Hamlets, 
respectively, living in the most deprived areas, based on national quintiles of the 2010 
Index of Multiple deprivation in England (Department for Communities and Local 
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Government 2011). As our study was only initiated after phase 1 and 2 of the scheme, in 
November 2008 and due  to the delay in the implementation of phase 3 from October 2010 
to January 2012, the first three years of the life time of the scheme are treated here as a 
baseline study examining the associations between air pollution and respiratory/allergic 
symptoms prior to the interventions in January 2012.  
 In addition, we examined the associations between characteristics that could be 
described as an asthma ‘genotype’ (single nucleotide polymorphisms, SNPs, in gasdermin 
genes (gasdermin A, 17q21.1 and gasdermin B, 17q12), previously shown to be associated 
with child-onset asthma (Moffatt et al. 2010)) or ‘phenotype’ (significant bronchodilator 
response (Dundas et al. 2005)) and the prevalence of wheeze and asthma. It was logistically 
impossible to include a comparable control group in a low air pollution area.  
 We found that current rhinitis symptoms were associated with traffic-related air 
pollutants, that asthma ‘genotype’ was associated with lifetime asthma, and asthma 
‘phenotype’ was associated with lifetime asthma and current wheeze symptoms. We did not 
observe any year-on-year improvements in air pollution concentrations over the first three 
years of London's LEZ or any reduction in the prevalence of respiratory/allergic symptoms. 
 
3.2 METHODS 
3.2.1 Study Design and Recruitment 
 Schools in Tower Hamlets and Hackney were selected to achieve a range of annual 
exposures to NO2 (based on dispersion models (Transport for London 2008)). These schools 
were approached and asked to participate; in those, which agreed, all Year 4 children (aged 
8-9) were invited to participate. This was a sequential cross-sectional study, with data 
collected over three consecutive winters (Nov-Mar, 2008-11). Information about the study 
was sent home with each child, along with a consent form and a questionnaire for parents to 
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complete and return to the school. During a single study visit to each school each year, health 
assessments were conducted to examine lung function and collect biological samples, and 
completed questionnaires were collected. Parents were required to give their written consent, 
and children their verbal assent, to participate in the health assessment. The return of a 
completed questionnaire was taken to imply consent to use the information provided therein. 
The study was approved by the local research ethics committee (East London & The City 
HA Local Research Ethics Committee 2, REC Ref Number 08-H0704-139) and conformed 
to the standards set by the Declaration of Helsinki.  
 
3.2.2 Questionnaire 
The questionnaire included three sections; the core questions on asthma, rhinitis, 
and eczema from the ISAAC questionnaire for 6-7 year olds (The International Study of 
Asthma and Allergies in Childhood (ISAAC) Steering Committee 1998), see Panel A. 
Information on the questionnaires was entered exactly as recorded, regardless of apparent 
inconsistencies and whether or not a question should have been answered according to the 
instructions within the questionnaire. Where a question was not answered, it was coded as 
‘missing’. Details of missing and inconsistent data for each section of the questionnaire are 
reported in the Appendix I. Symptom prevalences were calculated by dividing the number 
of positive responses to each question by the total number of completed questionnaires. The 







Table 3.1 Definitions of current and lifetime respiratory/allergic symptoms 
Symptom Definition 
Current  
  Wheeze 
Has your child had wheezing or whistling in the chest 
in the past 12 months? 
  Severe wheeze 
Has your child had wheezing or whistling in the chest 
in the last 12 months? AND AT LEAST ONE OF: ≥4 
attacks of wheezing in the past 12 months;  
≥1night/week of sleep disturbed by wheezing in the 
past 12 months; wheezing severe enough to limit 
speech to only one or two words at a time between 
breaths in the past 12 months. 
  Rhinitis 
In the past 12 months, has your child had a problem 
with sneezing, or a runny, or a blocked nose when 
he/she DID NOT have a cold or the flu? 
  Eczema 
Has your child ever had an itchy rash which was 
coming and going for at least 6 months? AND Has 
your child had this itchy rash at any time in the last 
12 months? AND Has this itchy rash at any time 
affected any of the following places: the folds of the 
elbows, behind the knees, in front of the ankles, 
under the buttocks, or around the neck, ears or eyes? 
  Lifetime  
  Asthma Has your child ever had asthma? 
  Hayfever Has your child ever had hay fever?   
  Eczema Has your child ever had eczema? 
 
 
3.2.3 Health Assessment 
3.2.3.1 Demographics  
  Health assessments were conducted during the study visit to each school. Date of 
birth, home address and ethnicity were obtained from school records. Age was calculated as 
the date of the study visit to the school minus the date of birth. A deprivation score was 
assigned to the home postcode using the 2010 Index of Multiple Deprivation. Height in cm 
was measured using a Stadiometer and weight in kg was measured using a standard 
weighing scales. Body mass index (BMI) was calculated as body mass (kg) divided by 
height (m) squared. 
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Panel A: Questions provided in the study packs for the children's parents/guardian 
 
Core questions for asthma (from ISAAC questionnaire for 6-7 year-olds) 
1. Has your child ever had wheezing or whistling in the chest at any time in the past?  Yes/No 
IF YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 6 
2. Has your child had wheezing or whistling in the chest in the past 12 months?  Yes/No 
IF YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 6 
3. How many attacks of wheezing has your child had in the past 12 months?  None/1-3/4-12/More than 
12 
4. In the past 12 months, how often, on average, has your child’s sleep been disturbed due to wheezing?  
Never woken with wheezing/Less than one night per week/One or more nights per week 
5. In the past 12 months, has wheezing ever been severe enough to limit your child’s speech to only one 
or two words at a time between breaths?  Yes/No 
6. Has your child ever had asthma?  Yes/No  
7. In the past 12 months, has your child’s chest sounded wheezy during or after exercise?  Yes/No 
8. In the past 12 months, has your child had a dry cough at night, apart from a cough associated with a 
cold or chest infection?  Yes/No 
Core questions for rhinitis (from ISAAC questionnaire for 6-7 year-olds) 
1. Has your child ever had a problem with sneezing, or a runny nose, or blocked nose when he/she DID 
NOT have a cold or the flu?  Yes/No 
IF YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 6 
2. In the past 12 months, has your child had a problem with sneezing, or a runny nose, or blocked nose 
when he/she DID NOT have a cold or the flu?  Yes/No  
IF YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 6 
3. In the past 12 months, has this nose problem been accompanied by itchy-watery eyes?  Yes/No 
4. In which of the past 12 months did this nose problem occur?  (Please tick any which apply)  
January/February/March/April/May/June/July/August/September/October/November/ 
December 
5. In the past 12 months, how much did this nose problem interfere with your child’s daily activities?  
Not at all/A little/A moderate amount/A lot 
6. Has your child ever had hayfever?  Yes/No  
Core questions for eczema (from ISAAC questionnaire for 6-7 year-olds) 
1. Has your child ever had an itchy rash which was coming and going for at least six months?  Yes/No 
IF YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 7 
2. Has your child had this itchy rash at any time in the past 12 months?Yes/No  
IF YOU HAVE ANSWERED “NO” PLEASE SKIP TO QUESTION 7 
3. Has this itchy rash at any time affected any of the following places:  the folds of the elbows, behind 
the knees, in front of the ankles, under the buttocks, or around the neck, ears or eyes?  Yes/No 
4. At what age did this itchy rash first occur?  Under 2 years/Age 2-4 years/Age 5 or more 
5. Has this rash cleared completely at any time during the past 12 months?  Yes/No 
6. In the past 12 months, how often, on average, has your child been kept awake at night by this itchy 
rash?  Never in the past 12 months/Less than one night per week/One or more nights per week 




3.2.3.2 Urine Assays 
  Spot urine samples were collected and placed on ice for the duration of the visit, 
then frozen and stored at -80°C on return to the laboratory. Urine cotinine concentrations 
were determined using a commercial microplate enzyme immunoassay (EIA) kit (Cozart 
Forensic Microplate EIA for cotinine, product no. M155B1) from Concateno (Abingdon, 
UK). Urine was analysed undiluted, as per the kit instructions. This kit is designed to be 
semi-quantitative, i.e. to give a positive or negative result, based on a cut-off point of 25 
ng/mL (sample is positive if value > 25 ng/mL). A correction for individual variation in 
urine concentration was made using the cotinine to creatinine ratio (CCR) in ng/mg 
(calculated as: 100 x cotinine in ng/ml divided by creatinine in mg/dL), using a cut-off of 
value of 30 ng/mg to indicate a positive result (Henderson et al. 1989; Ehrlich et al. 1992). 
Urinary creatinine concentrations were also determined using a commercially available kit 
based on the Jaffe reaction (Cayman Chemical Company, Ann Arbor, MI, USA). 
Measurements were repeated if duplicates were either side of kit cut-off value (e.g. 24 and 
26 ng/mL), or if duplicates were on one side of cut-off but SD was large. 34 samples out of 
914 (3.7%) should have been repeated according to these criteria, but repeat samples were 
not available for 6 samples. All urinary analyses were performed by Dr Helen Wood at 
King’s College London. 
 
3.2.3.3 DNA Collection and Genotyping Assay 
 Saliva were collected using the Oragene DNA kit OG-250 (DNA Genotek Inc, 
Canada) as a source of DNA for genotyping. The collection was carried out according to 
the manufacturer’s instructions. Samples were placed on ice for the duration of the visit, 
then frozen and stored at -80°C on return to the laboratory. The collection was carried out 
according to the manufacturer’s instruction. Subsequently, genomic DNA was recovered 
from the saliva using salt out method, with genomic DNA concentrations and quality 
assessed using Nanodrop ND-1000 Spectrophotometer (Nanodrop Technologies, 
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Wilmington, DE) and Quant-iT™ PicoGreen® assay (Invitrogen). In addition, integrity and 
quality of DNA was confirmed by gel electrophoresis. Whilst the genomic DNA obtained 
was of a good quality and integrity, the yield requirement for the subsequent SNP analysis 
required whole genome amplification on all collected samples by using the GenomePlex 
Complete Whole Genome Amplification (WGA2) Kit (Sigma Aldrich) as previously 
described  (Arneson et al. 2008). Polymorphisms (SNPs) in gasdermin A (GSDMA) 
rs3894194  Arg18Gln (C/T) and gasdermin B (GSDMB) rs2305480 Pro298Ser (C/T) were 
analyzed by GoldenGate genotyping assay on IlluminaBeadXpress platform (Illumina Inc., 
San Diego, USA) and the genotype data was analyzed for quality control using the 
BeadStudio software.  
 
3.2.3.4 Lung Function 
 Children’s respiratory function was assessed by spirometry (Microlab, 
Micromedical, Carefusion), performed by trained investigators according to ATS-ERS 
guidelines (2005) with baseline and post-bronchodilator measurements, following 
salbutamol 400 µg administered by large volume spacer.  Before each measurement volume 
calibration with a 3L syringe was undertaken. A sterile disposable filter/ mouthpiece was 
attached to the spirometer for each child and the equipment wiped with alcohol wipes 
between subjects. A maximum of 10 attempts was normally made (exceptionally, more if 
needed) until three acceptable and two repeatable attempts were attained. Each spirometry 
assessment aimed to obtain three acceptable and two repeatable attempts both pre and post 
bronchodilator. A short acting bronchodilator (salbutamol) was administered after baseline 
spirometry. Four 100 microgram actuations were given from a metered dose inhaler (MDI) 
through a spacer device (Volumatic). The children took 4 tidal breaths through the 
Volumatic spacer after each actuation. A minimum of 15 minutes later post bronchodilator 
spirometry took place. Quality control was based on the ATS/ERS guidelines (2005), 
modified for children (Praud 2004). Additional acceptability requirements were: rapid onset 
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of expiration, high well defined peak flow and a clear plateau on volume-time curve 
together with no evidence of cough, glottis closure or leak during the maneuver (from 
Asthma UK/ Growing Lungs Guidelines). For quality control and reporting purposes 
spirometry results were uploaded from the 3 study spirometers to a Carefusion program 
“Spirometry” where individual inspection of efforts was undertaken in detail. Reporting of 
results was according to ATS-ERS Guidelines and the best overall individual effort from 
each child both pre and post salbutamol was selected as the highest value of FEV1 and 
FVC, together with FEF 25-75 from the best combined effort, reported from technically 
acceptable data, which met reproducibility requirements of 0.15 L agreement for FEV1 and 
FVC for 2 efforts. Data were then extracted into Excel and individual efforts were cross 
checked with original data before being exported into the main study Access database. Raw 
data were transformed into Z (or standard deviation) scores using most the “All-Age” 
equations by Stanojevic et al. (2009) available for White subjects aged 3 to 80 years of age. 
 
3.2.4 Air Pollution Modelling 
 Annual NOx, NO2, PM10 and PM2.5 concentrations were derived using the KCL 
urban model (Kelly et al. 2011; Beevers et al. 2013) using ADMS dispersion model v4 and 
road source model v2.3 (CERC19), measured hourly meteorological data, empirically 
derived NO-NO2-O3 and PM relationships and emissions from the London Atmospheric 
Emissions Inventory (GLA 2008). Separate annual surface maps for Greater London were 
produced for the years 2008, 2009 and 2010, available at a 20 m×20-m grid point 
resolution, linked to the following health assessment periods: Nov 2008 – March 2009, Nov 
2009 – April 2010 and Nov 2010 – April 2011 respectively. Each yearly model reflected a 
range of pollutant sources and emissions, including major and minor roads, with detailed 
information on vehicle stock, traffic flows, and speed on a link-by-link basis. Other sources 
within the model included large and small regulated industrial processes, boiler plants, 
domestic and commercial combustion sources, agriculture, rail, ships, airports, and 
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pollution carried into the area by prevailing winds. A comprehensive description of this 
model has been published previously, together with information on validation against 
measurements (Beevers et al. 2013) and its performance against other urban dispersion 
models (Carslaw 2011). All exposures were based on the annual mean within a 20m radius 
buffer zone around the residential address of the child. Initial investigations using the year 
1 data set examined the use of wider buffer zones, 50 and 100m found a high degree of 
correlation between the exposure estimates and therefore only the 20m buffer zone was 
employed in the final analysis (Figures 3.1 – 3.4). In addition, exposure estimates were 
weighted for periods spent at the home (H) and school (S) address points based on the 
following criteria: that each child spent 84.4% of their time at home and 15.6% at school, 
based on a 7 hour school day, for 5 days per week, 39 weeks per year. Thus each child’s 
weighted exposure was estimated by EH+S = 0.884*EH + 0.156*ES. Again, as these 
exposure estimates were highly correlated with the home exposure attributions only the 
later were employed in the analysis of the final data set (Appendix I, Figures I1-I4).  
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Figure 3.1 Correlations between annual NOx concentrations for the subjects recruited into the first 
year of the study, n=196, based on various buffer radii around their residential address. Data are 
presented with their linear trend line, together with the line of identify (hatched line).  
Figure 3.2 Correlations between annual NO2 concentrations for the subjects recruited into the first 




Figure 3.3 Correlations between annual PM10 concentrations for the subjects recruited into the first 
year of the study, n=196, based on various buffer radii around their residential address.  
 
Figure 3.4 Correlations between annual PM2.5 concentrations for the subjects recruited into the first 
year of the study, n=196, based on various buffer radii around their residential address.  
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3.2.5 Statistical Models 
 The primary outcome of the study was to detect a 4% improvement year-on-year in 
the average forced expiratory volume in 1 sec (FEV1), hence the sample size was 
determined according to this variable rather than respiratory/allergic symptom prevalence. 
It was initially determined that 200 children would be needed per year, but this was revised 
upwards following the first year of data collection. From Year 1 data, the mean FEV1 was 
1.71 litres (SD=0.276 litres) and valid measurements of FEV1 were obtained from 150/202 
i.e. 74% of children. In order to detect a 4% increase in mean FEV1, from 1.71 to 1.79 litres 
in two successive years, with 80% power at the 5% significance level, would require 245 
children under simple random sampling. Assuming 74% (from Year 1) of children give 
valid FEV1 measurements; the cluster size would be 22 children (out of a class of 30). The 
design effect, based on an intra-cluster correlation coefficient (ICC) of 0.02, is 1 + (22-
1)*0.03 = 1.63, inflating the sample size to 399 children per year. Therefore, the number of 
classes to be sampled in Year 2 and subsequently is 399/22 = 19 classes (rounded up from 
18.1).  
 All respiratory symptoms analysed were recorded as binary variables. Therefore, a 
multilevel mixed effects logistic regression model was applied allowing a random effect for 
school. Wherever enough outcomes were observed, we added age, sex, BMI, IMD score, 
ethnicity and ETS exposure to each model. If the observed outcome frequency was too low, 
we added only a subset of the covariates to the model to avoid over-fitting. To account for 
any potential year-on-year changes we also included study year as a coefficient in each 
model and individual measurements of air pollutant exposure were added to the models 
where applicable. The effects of asthma ‘genotype’ and ‘phenotype’ on the prevalence of 
current wheeze and lifetime asthma were assessed in those individuals reporting symptoms 
only, using separate models including genotype for GSDMA and GSDMB or 
bronchodilator response (BDR, expressed both as a continuous variable and as a yes/no 
variable with a positive value being ≥9% (Dundas et al. 2005)), excluding air pollution 
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exposures. PM10 was subsequently included in the model to examine any interactions 
between asthma ‘genotype’ and ‘phenotype’ and air pollution exposure. All analysis was 
performed using Stata 10.1. Models were examined at the 5% significance level for two-
sided tests.  
3.3 RESULTS 
3.3.1 Demographics 
 Completed questionnaires were returned by 995 Year 4 pupils from a total of 1808 
at the 23 participating schools (55% response rate). Of those 995, 901 were returned by 
pupils who also completed the health assessment and 94 questionnaires were returned by 
pupils who either declined to participate in the health assessment, or were absent from 
school on the day of the study visit (Figure 3.5). The participants are described in Table 
3.2. Information on sex and ethnicity was missing for a small number of children (1.7 and 
1.4%, respectively). 
 
Figure 3.5 Data and sample availability for the subjects recruited into the study across years 1-3. 
The inset box provides detailed information on the 1000 subjects who attempted spirometry.  
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Table 3.2 Characteristics of the study sample, for all respondents and for those with current 




















Sex     
  Male (%) 497 (49.9) 70 (14.1) 70 (14.1) 69 (13.9) 
  Female (%) 481 (48.3) 40 (8.3) 54 (11.2) 76 (15.8) 
  Not specified (%) 17 (1.7) 1 (5.9) 1 (5.9) 3 (17.6) 
Ethnicity     
  Asian (%) 360 (36.2) 34 (9.4) 48 (38.4) 57 (15.8) 
  Black (%) 240 (24.1) 24 (10.0) 30 (24.0) 45 (18.8) 
  White (%) 268 (26.9) 41 (15.3) 33 (26.4) 31 (11.6) 
  Mixed/other (%) 113 (11.4) 12 (10.6) 13 (10.4) 12 (10.6) 
  Not specified (%) 14 (1.4) 0 1 (0.8) 3 (21.4) 
Percentages are for rows, except for first column, which reads vertically (i.e. percent of all respondents); percentages may 
not add to 100.0 due to rounding. 
 
3.3.2 Modeled Exposures 
The annual dispersion models employed for the exposure attributions are illustrated in 
Figures 3.6 – 3.9, for NOx, NO2, PM10 and PM2.5, with the address point for each subject and 
school illustrated. These surface maps of the study area clearly demonstrate the marked yearly 
difference in modelled concentrations, with the air quality in 2009, being significantly worse than 
that in 2008 and 2010. With reference to the NO2 map for 2009 (Figure 3.6) it was significant that 
all but one of the subjects lived at locations that failed the attain the UK limit value for annual NO2, 
40 μg/m3.  Across the three years of the study over 85% of the study volunteers lived in areas non-
compliant with the UK limit value. The distribution of annual pollutant concentrations (over years 





Figure 3.6 Annual NO2 maps covering the London boroughs of 
Hackney and Tower Hamlets for the years 2008 -2010. Individual 
points reflect the residential address of the volunteers tested during 











Figure 3.7 Annual NOx maps covering the London boroughs of 
Hackney and Tower Hamlets for the years 2008 -2010. Individual 
points reflect the residential address of the volunteers tested during 








Figure 3.8 Annual PM10 maps covering the London boroughs of 
Hackney and Tower Hamlets for the years 2008 -2010. Individual 
points reflect the residential address of the volunteers tested during 







Figure 3.9 Annual PM2.5 maps covering the London boroughs of 
Hackney and Tower Hamlets for the years 2008 -2010. 
Individual points reflect the residential address of the volunteers 
tested during the winter periods, with the school locations 







Figure 3.10 Overall distributions of NOx, NO2, PM10 and PM2.5 exposure attributions assessed at 
residential address level. 
 
3.3.3 Symptom Prevalence 
 The prevalence of asthma symptoms amongst all children, including those with 
current wheeze are shown in Table 3.3. Current wheeze was reported by 11.2% of children 
and lifetime asthma by 14.4%; however, only 66.7% of those with current wheeze also 
reported lifetime asthma. Severe wheeze symptoms were reported by 5.5% of children, 
with 3.9% reporting ≥4 attacks of wheezing in the last year (see Table 3.3). However, 
among children with current wheeze, the prevalence of severe symptoms was high: 29.7% 
had ≥4 attacks in the last year, 24.3% had ≥1 night/week of disturbed sleep, and 21.6% had 
wheeze-limited speech, suggesting poor control or lack of asthma diagnosis.  
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Table 3.3 Prevalence of current symptoms and symptom severity, and of lifetime asthma, hay fever 
and eczema (%) 
   All 
(n=995) 
Of those with 
current wheeze 
(n=111) 
Of those with current 
rhinoconjunctivitis 
(n=125) 
Of those with 
current eczema 
(n=148) 
Asthma     
   Current symptoms:      
  Wheeze 
11.2 - 16.8 11.5 
  Wheeze with exercise 
11.2 63.1 - - 
  Dry cough at night 
26.2 70.3 - - 
  Severe wheeze* 
5.5 49.5 - - 
  ≥4 attacks of wheeze 
3.9 29.7 - - 
  ≥1 night/wk of sleep 
disturbed by wheeze 
3.0 24.3 - - 
  Speech limited by 
wheeze 
3.0 21.6 - - 
 Asthma ever 
14.4 66.7 - - 
Rhinitis     
 Current symptoms: 
    
  Runny nose and 
itchy/watery eyes 
12.6 18.9 - 12.8 
  Runny nose only 
24.3 - - - 
  Daily activities 
disturbed a lot by 
runny nose  
1.9 - 11.2 - 
 Hay fever ever 
27.6 - 66.4 - 
Atopic eczema     
 Current symptoms: 
    
  Itchy flexural rash 
14.9 15.3 15.2 - 
  ≥1 night/wk kept 
awake by itchy rash  
4.6 - - 18.9 
 Eczema ever 
25.4 - - 
62.2 
 
* Severe wheeze indicates reported YES to current wheeze, and 1 or more of: ≥4 attacks of wheeze, ≥1 
night/wk of sleep disturbed by wheeze, speech limited by wheeze within last 12 months. Prevalence should be 
read vertically, e.g. 14.4% of all participants reported asthma ever; 66.7% of those who reported current 
wheeze reported asthma ever.  
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 Current rhinoconjunctivitis was reported by 12.6% of children (see Table 3.3); 
rhinitis (i.e. without symptoms affecting the eyes) was much more common (24.3%). Of 
those with rhinoconjunctivitis, 11.2% reported that their daily activities were affected a lot 
by their symptoms, with a similar proportion reporting that they were not at all affected 
(10.4%). Children with rhinoconjunctivitis most commonly experienced these symptoms 
during the spring and summer (86.4% during at least one month between March and 
September), with 6.4% reporting symptoms year round (every month from January to 
December). Lifetime hay fever was reported by 27.6% of all children, and 66.4% of those 
with rhinoconjunctivitis. 
 Current eczema was the most common of the three conditions, reported by 14.9% of 
children. Of these, 18.9% had ≥1 night/week of disturbed sleep, and for 37.2% their itchy 
rash had not completely cleared at any time during the last year. Eczema symptoms had 
most commonly first occurred recently (since the age of 5; 41.2% of those with current 
eczema), although for 35.8% they had first occurred when the child was <2 years old. 
Lifetime eczema was reported by 25.4% overall, and 62.2% of those with current eczema. 
 The overlap between current symptoms of wheeze, rhinoconjunctivitis and eczema 
is shown in Figure 3.11. 28.8% of children (n=287) had symptoms of at least one 
condition, 7.7% had symptoms of at least two, and 2.0% had symptoms of all three 
conditions. Among those children with current symptoms, wheeze was most commonly 
associated with other conditions; 36.9% of children with current wheeze also reported 
rhinoconjunctivitis, 33.3% also reported eczema, and 18.0% reported symptoms of both the 




Figure 3.11 Reported prevalence of current respiratory/allergic symptoms. Prevalence 
(% of total study population, n=995) of wheeze, allergic rhinoconjunctivitis and atopic 
eczema symptoms within the last 12 months, and co-existence of these symptoms. Overall, 
28.8% of children (n=287) had symptoms of at least one condition. Summed prevalences 
may not match totals shown in Table 4 due to rounding.  
 
 
3.3.4 Associations with Demographic Variables and Time 
 The prevalence of current wheeze was negatively associated with age (OR 0.41, 
95% CI 0.21-0.82, p=0.011), positively associated with BMI (1.07, 1.00-1.14, p=0.041), 
was lower in children of Asian background compared with White children (0.46, 0.26-0.81, 
p=0.008), and was lower in girls than boys (0.47, 0.30-0.74, p=0.001) (see Table 3.4a), as 
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was the prevalence of severe wheeze (0.32,0.12-0.84, p=0.021). Current rhinoconjunctivitis 
was not associated with any of the demographic variables included in the model; however, 
the prevalence of current rhinitis was lower in girls compared with boys (OR 0.69, 95% CI 
0.50-0.94, p=0.020) and was positively associated with BMI (1.06, 1.01-1.11, p=0.012). 
The prevalence of eczema was higher in Black than White children (OR 1.85, 95% CI 1.05-
3.29, p=0.035). The prevalence of lifetime asthma was negatively associated with age (OR 
0.49, 95% CI 0.27-0.90, p=0.021), positively associated with BMI (1.07, 1.01-1.13, 
p=0.021) and with IMD score (1.02, 1.00-1.04, p=0.042) and was lower in girls than boys 
(0.62, 0.42-0.93, p=0.019) (see Table 3.4b). The prevalence of lifetime hay fever was twice 
as high in children of all other ethnicities compared with White children (Asian OR 2.08, 
95% CI 1.36-3.19, p=0.001; Black 2.09, 1.32-3.30, p=0.002; mixed/other 2.09, 1.22-3.59, 
p=0.008), while the prevalence of lifetime eczema was lower in children of Asian (OR 
0.45, 95% CI 0.28-0.72, p=0.001) and of mixed/other (0.55, 0.31-0.96, p=0.037) ethnic 
backgrounds compared with White children, and was negatively associated with ETS 
exposure (0.57, 0.36-0.90, p=0.015). 
The prevalence of current respiratory/allergic symptoms and of lifetime hay fever 
and lifetime eczema did not change over the three-year study period. However, the 
prevalence of lifetime asthma was lower in Year 3 compared with Year 1 (OR 0.51, CI 
0.29-0.90, p=0.020). Overall, 14.4% of children reported lifetime asthma, but year-by-year 
this percentage decreased significantly from 21.2% in Year 1 to 14.5% in Year 2 to 12.2% 
in Year 3 (Fishers exact test, p=0.038). However, it should be noted that the study sample 
size was doubled in Years 2 and 3 compared to Year 1 and included a greater number of 












(n = 111) 
 
Rhinoconjunctivitis 
(n = 125) 
 
Eczema 
(n = 148) 
 
Rhinitis 




0.42 (0.21 - 0.82)* 
 
0.83 (0.45 - 1.54) 
 
1.01 (0.55 - 1.84) 
 
1.11 (0.68 - 1.80) 
Sex (Female vs. 
Male) 
0.47 (0.30 - 0.74)** 0.88 (0.59 - 1.32) 1.14 (0.77 - 1.68) 0.69 (0.50 - 0.94)* 
BMI 1.07 (1.00 - 1.14)* 1.05 (0.99 - 1.11) 1.01 (0.95 - 1.07) 1.06 (1.01 - 1.11)* 
ETS exposure 1.14 (0.66 - 1.95) 0.74 (0.43 - 1.29) 0.95 (0.56 - 1.61) 1.01 (0.67 - 1.52) 
IMD score 1.01 (0.99 - 1.04) 1.00 (0.98 - 1.02) 0.99 (0.98 - 1.01) 1.00 (0.99 - 1.02) 
Ethnicity (Asian 
vs. White) 
0.46 (0.26 - 0.81)** 1.02 (0.60 - 1.75) 1.69 (0.98 - 2.93) 1.19 (0.78 - 1.80) 
Ethnicity (Black 
vs. White) 




0.73 (0.35 - 1.50) 1.02 (0.50 - 2.09) 0.90 (0.41 - 1.98) 1.22 (0.71 - 2.10) 
Study year 
(Yr 2 vs. Yr 1) 
 
0.97 (0.52 - 1.80) 0.74 (0.42 - 1.32) 0.90 (0.49 - 1.65) 0.97 (0.61 - 1.56) 
Study year 
(Yr 3 vs. Yr 1) 
0.60 (0.31 - 1.16) 0.57 (0.32 - 1.04) 1.02 (0.56 - 1.87) 0.69 (0.43 - 1.13) 
 
Data shown as odds ratio (OR) for unit increase in variable unless otherwise stated, with 95% 
confidence intervals in brackets; OR for each variable adjusted for all other variables shown in 






Table 3.4b Odds ratios for associations of personal variables with prevalence of lifetime 


















0.49 (0.27 to 0.90)* 
 
0.99 (0.62 to 1.59) 
 
1.41 (0.85 to 2.35) 
Sex (Female vs. Male) 0.62 (0.42 to 0.93)* 1.03(0.76 to 1.40) 1.19 (0.86 to 1.64) 
BMI 1.07 (1.01 to 1.13)* 1.00 (0.95 to 1.04) 1.03 (0.98 to 1.09) 
ETS exposure 1.40 (0.87 to 2.27) 1.11 (0.74 to 1.65) 0.57 (0.36 to 0.90)* 
IMD score 1.02 (1.00 to 1.04)* 0.99 (0.98 to 1.01) 0.99 (0.98 to 1.01) 
Ethnicity (Asian vs. White) 0.67 (0.39 to 1.16) 2.08 (1.36 to 3.19)** 0.45 (0.28 to 0.72)** 
Ethnicity (Black vs. White) 0.92 (0.52 to 1.63) 2.09 (1.32 to 3.30)** 0.76 (0.48 to 1.21) 
Ethnicity (mixed /other vs. White) 1.37 (0.72 to 2.57) 2.09 (1.22 to 3.59)** 0.55 (0.31 to 0.96)* 
Study year  (Yr 2 vs. Yr 1) 0.64 (0.37 to 1.10) 1.11 (0.68 to 1.81) 1.43 (0.83 to 2.48) 
Study year  (Yr 3 vs. Yr 1) 
 
0.51 (0.29 to 0.90)* 
 
1.25 (0.76 to 2.04) 
 
1.22 (0.70 to 2.13) 
 
Data shown as odds ratio (OR) for unit increase in variable unless otherwise stated, with 95% 
confidence intervals in brackets; OR for each variable adjusted for all other variables shown in 
table; ETS exposure = urinary cotinine concentration adjusted for creatinine concentration, * 
p<0.05, **p<0.01. 
 
3.3.5 Associations with Air Pollution 
  Air pollutant concentrations across the study area changed little during the first 
three years of the study (Table 3.5). Concentrations were assessed between 2008-2010 
based on data obtained from sites within the London Air Quality Network (Environmental 
Research Group) in and surrounding the study area. For PM2.5 all sites across London were 
included, due to the more limited monitoring of the pollutant with London and the UK. For 
both NOx and NO2 there was no evidence of a reduction at either urban background or 
roadside locations. Similarly, PM2.5 and PM10 concentrations were unaltered at background 
sites over the first three years of the LEZ. Some evidence of a roadside decrease in PM10 
was noted between 2008 and 2009, but only when measurements based on Tapered 
Element Oscillating Microbalance (TEOM) masses were employed (p=0.027), with a 
similar trend in PM2.5 TEOM concentrations (p=0.06). Similar reductions were not apparent 
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between 2009 and 2010. These small changes were not reflected in the modelled exposure 
attributions based on the children’s residential addresses (Table 3.6). 
 
Table 3.5 Measured annual mean pollutant concentrations (µg/m
3
) at selected background and 




















68.4 ± 19.8 
(40.2-101.5, n=8) 
41.1 ± 8.7 
(26.0-52.6, n=8) 
22.0 ± 1.5 
(20.7-24.9, n=8) 
No data 
10.5 ± 0.4 
(10.3-11.0, n=3) 




66.1 ± 22.1 
(36.9-105.2, n=8) 
40.8 ± 10.1 
(23.5-57.2, n=8) 
22.5 ± 1.91 
(20.4-25.8, n=6) 
14.7 ± 1.8 
(13.2-17.6, n=6) 
10.3 ± 0.9 
(9.7-11.6, n=4) 




67.4 ± 23.4 
(36.8-100.6, n=6) 
40.5 ± 10.5 
(24.3-48.6, n=6) 
21.9 ± 0.5 
(21.5-22.7, n=5) 
14.7 ± 1.4 
(12.8-16.5, n=7) 
10.4 ± 1.4 
(9.4-12.5, n=4) 




135.9 ± 41.1 
(89.8-223.0, n=13) 
57.2 ± 10.8 
(43.7-70.3, n=13) 
28.7 ± 6.1 
(20.3-40.9, n=11) 
17.1 ± 1.2 
(16.0-18.5, n=4) 
14.9 ± 3.3 
(11.5-20.2, n=8) 




131.9 ± 47.4 
(87.2-255.7, n=14) 
56.8 ± 12.1 
(44.2-82.3, n=14) 
26.9 ± 5.1* 
(20.5-36.9, n=11) 
15.1 ± 3.1 
(11.7-19.0, n=4) 
14.2 ± 3.0 
(11.1-18.6, n=7) 




131.7 ± 40.2 
(82.7-220.3, n=14) 
56.7 ± 11.7 
(41.8-74.0, n=14) 
26.2 ± 3.6 
(19.9-32.6, n=12) 
17.6 ± 1.7 
(15.1-19.9, n=5) 
13.9 ± 2.1 
(11.4-16.4, n=4) 
      
 
Annual mean ± SD pollutant concentrations (range, number of sites included), based on sites within and 
surrounding the London boroughs of Hackney and Tower Hamlets. Annual means were calculated for 
each of the included sites with greater than 75% data capture across the given year. PM10 is expressed as 
reference equivalent concentration, based on the correction of Tapered Element Oscillating Microbalance 
(TEOM) masses for the loss of volatiles components using the volatile correction method (Green et al. 
2009) and combined with measurements made using the Filter Dynamics Measurement System (FDMS). 
As no empirical method is available for correcting PM2.5 TEOM masses the TEOM and FDMS mass 
concentrations are given separately. The average annual mean concentrations across each of the site types 
was compared using a one way ANOVA, with post hoc testing performed using paired t-tests: *, 






Table 3.6 Modelled annual pollutant attributions for the children recruited into the study, 
















71.0 ± 10.6 
(61.5-122.8) 
41.9 ± 3.9 
(38.4-61.0) 
22.9 ± 1.3 
(21.7-29.8) 




79.3 ± 13.1 
(50.8-235.4) 
44.9 ± 4.9 
(32.9-98.9) 
23.9 ± 1.2 
(20.7-32.7) 




73.8 ± 16.4 
(47.1-220.8) 
42.7 ± 6.1 
(30.9-90.8) 
23.0 ± 1.5 
(20.4-33.2) 
13.3 ± 0.6 
(12.0-17.3) 
Years 1-3 993 
 
75.7 ± 14.8 
(47.1-235.4) 
 
43.5 ± 5.5 
(30.9-98.9) 
 
23.4 ± 1.5 
(20.4-33.2) 
 
13.7 ± 0.8 
(12.0-18.0) 
 
Values are mean ± SD (range); * air pollution data were not available for two participants (one in each of 
Years 1 and 2 of the study) because their residential addresses were outside the Greater London area. 
  
The prevalence of current rhinitis was positively associated with annual mean NOx 
(OR 1.01, 95% CI 1.00-1.02, p=0.033), NO2 (1.03, 1.00-1.06, p=0.034), PM10 (1.16, 1.04-
1.28, p=0.006) and PM2.5 (1.38, 1.08-1.78, p=0.011) (Figure 3.12, ORs for an increase of 1 
µg/m
3
). The prevalence of current wheeze, rhinoconjunctivitis and eczema symptoms and 
of lifetime asthma, hay fever and eczema ever was not associated with air pollution levels. 
 
3.3.6 Associations with Asthma ‘Genotype’ and ‘Phenotype’ 
 The prevalence of lifetime asthma was higher with the homozygous genotype ‘TT’ 
SNP in GSDMA, compared with the wild type genotype ‘CC’ (OR 1.99, 95% CI 1.15-3.45, 
p=0.013), whereas no association was found for the heterozygous genotype CT (vs. 
genotype CC, see Table 3.7). In contrast, the prevalence of lifetime asthma was lower with 
the homozygous genotype ‘TT’ SNP in GSDMB, compared with the wild type genotype 
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‘CC’, suggesting a protective effect (OR 0.44, 95% CI 0.19 to 0.99, p=0.046), while no 
association was found for the heterozygous genotype CT. The prevalence of current wheeze 




Figure 3.12 Exposure to air pollution as a risk factor for current and lifetime 
respiratory/allergic symptoms. Risk expressed as adjusted odds ratio (OR 95% CI), 
calculated by multiple logistic regression analyses adjusted for year of study, age, sex, 
BMI, socio-economic deprivation (IMD score), and exposure to environmental tobacco 
smoke exposure, with a random effect for school. Single-pollutant models were calculated 
for each air pollutant. Odds ratios are for unit increase in pollutant, in µg/m
3
. Current 
symptoms defined as within the last 12 months; lifetime conditions defined as ‘having ever 
had’ asthma, hay fever or eczema (see methods for full definitions). Vertical dotted line 






Table 3.7 Odds ratios (95% confidence intervals) for associations of gasdermin A and B 








   
GSDMA 






CT 0.70 (0.42 to 1.15) 
(n=40) 
1.09 (0.69 to 1.73) 
(n=58) 
TT 1.28 (0.71 to 2.32) 
(n=23) 
1.99 (1.15 to 3.45)* 
(n=32) 
GSDMB  






CT 0.93 (0.57 to 1.50) 
(n=43) 
0.81 (0.52 to 1.24) 
(n=50) 
TT 0.55 (0.23 to 1.30) 
(n=8) 
0.44 (0.19 to 0.99)* 
(n=9) 
   
 
* p<0.05, n number shown in brackets below; of those with wheeze, 10 subjects were not genotyped 
for GSDMA or GSDMB; of those with asthma, 13 subjects were not genotyped for GSDMA and 12 
subjects were not genotyped for GSDMB. 
 
 A subset of children with poorly-controlled or undiagnosed asthma was identified as 
those with a significant BDR. The prevalence of current wheeze and of lifetime asthma was 
positively associated with BDR when expressed as a continuous variable (OR 1.07, 95% CI 
1.03-1.12, p=0.001 and 1.05, 1.02-1.09, p=0.014, respectively), and when expressed as a 
yes/no variable (current wheeze 2.51, 1.44-4.39, p=0.001; lifetime asthma 1.91, 1.12-3.25, 
p=0.018). As such, this objective measurement of airway hypersensitivity helps to validate 




 Including the annual PM10 level in the models revealed no effect modification of 
either gasdermin SNPs or airway hypersensitivity; PM10 level had no effect on the 
prevalence of current wheeze or lifetime asthma regardless of asthma ‘genotype’ or 
‘phenotype’.   
 
3.4 DISCUSSION 
 The present study addressed the allergic and respiratory symptoms of children 
residing with London’s LEZ, over the first three years of its operation. Of the symptoms 
examined, only current rhinitis was positively associated with annual modelled NOx, NO2, 
PM10 and PM2.5 exposures and we observed no evidence of a reduction in symptom 
prevalence over the study period. However, we also failed to observe the predicted 
improvements in air quality. A high prevalence of severe asthma symptoms was also 
observed among children with current wheeze, with low numbers reporting lifetime asthma, 
indicating poor asthma control, under-diagnosis or under-reporting.  
 
3.4.1 Comparison with Previous Studies 
 Only one other study  has examined the potential health benefits of introducing a 
Low Emission Zone in an urban area (Cesaroni et al. 2012). Cesaroni and co-workers 
investigated the effects of two LEZs in Rome, Italy; however, they did not measure any 
health parameters at the individual level; rather they estimated ‘years of life gained’ using 
concentration-response functions derived from cohort studies in the USA and Europe 
(Cesaroni et al. 2012). Using this approach, they reported that residents living along busy 
roads gained 3.4 days/person as a result of the zones being introduced, based on the 
modelled projections of the impact of the scheme. Notably, no formal confirmation of the 
impact of these LEZs upon air quality in Rome was performed in this study and indeed 
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subsequent examination of the air monitoring data within the zone failed to demonstrate the 
modeled reductions in fine particulate. 
 The observations over the first three years of the LEZ are consistent with those of 
Anderson and colleagues (Anderson et al. 2010), who used data from ISAAC Phase I and 
modelled city-level residential PM10 data to explore associations with the prevalence of 
asthma, rhinoconjunctivitis and eczema. This analysis included data for over 500,000 
children from 51 countries. Weak negative associations were found for city-level PM10 and 
various outcomes, while for country-level PM10 (for 24 countries with >1 centre) most 
associations were weakly positive. The authors concluded that urban background PM10 had 
little or no association with the prevalence of childhood asthma, rhinoconjunctivitis or 
eczema, either within or between countries (Anderson et al. 2010). 
 Later findings from ISAAC Phase III, have however, shown a positive relationship 
between symptoms of asthma and allergic disease and traffic-related pollution (Brunekreef 
et al. 2009). An environmental questionnaire, including a question on frequency of truck 
traffic on the street of residence, was included in this phase. A highly significant exposure-
response relationship between truck traffic frequency and respiratory/allergic symptoms 
was reported, with the strongest relationship for symptoms of severe asthma (Brunekreef et 
al. 2009).  
 Other studies using self- or parent-reported symptom data from questionnaires have 
shown positive associations between respiratory/allergic symptoms and air pollution. 
Frequency of (self-reported) heavy truck traffic on the street of residence was positively 
correlated with the prevalence of wheezing and allergic rhinitis among schoolchildren in 
Bochum, Germany (Weiland et al. 1994). Zuraimi et al. (2011) found significant dose-
response relationships between (self-reported) traffic density and asthma and rhinitis 
symptoms in pre-school children in Singapore, which were stronger among children 
sleeping in non-air-conditioned homes. A number of studies have used objective measures 
of traffic density as a proxy for air pollution exposure. In Munich, Germany, an increase of 
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25,000 cars daily passing through the school district on the main road was associated with a 
significant increase in the prevalence of recurrent wheezing with dyspnoea and of recurrent 
dyspnoea in 9-11 year-old schoolchildren (Wjst et al. 1993). Children living on busy streets 
(based on modelled NO2 concentrations) reported significantly higher prevalence of wheeze 
than children living on quiet streets in Haarlem, The Netherlands (Oosterlee et al. 1996). 
Dales et al. (2009) found that roadway density was significantly associated with wheeze 
(OR 1.23), wheeze with dyspnoea (OR 1.27) and asthma (OR 1.08) in elementary 
schoolchildren in Windsor, Ontario. In this study, the measure of traffic exposure was only 
resolved to the level of the child’s neighbourhood, as road density was calculated from the 
summed length of all roadways within a 200m radius of the home postcode. 
 Other studies have used data from ambient air pollution monitoring sites to assign 
exposure at the individual level. Using a validated three-year dispersion model, exposures 
were assigned to school addresses for 9-11 year-old schoolchildren in the French Six Cities 
Study (Penard-Morand et al. 2010). PM10 levels were associated with asthma, eczema and 
allergic rhinitis, and NOx was associated with asthma. A number of studies from The 
Netherlands have shown significant associations between proxy or actual measures of 
traffic pollution and respiratory symptoms, but only among subgroups of children with 
chronic respiratory symptoms (van der Zee et al. 1999), or bronchial hyper-responsiveness 
and allergic sensitization (Boezen et al. 1999; Janssen et al. 2003).  
 Differences in study design may explain some of the inconsistencies in reported 
associations between air pollution and respiratory/allergic symptoms, e.g. differences in 
study area, measured pollutants or proxy measure of pollutant exposure, wording of 
symptom questions or study population (Hoek et al. 2012). A recently published meta-
analysis has attempted to address these issues by combining the original data from 11 
studies on PM10 and respiratory symptoms, including data on >45,000 children from 12 
countries (Hoek et al. 2012). This study found that symptoms of wheeze and asthma 
diagnosis were not associated with PM10, although there was a weak association with hay 
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fever diagnosis. An earlier meta-analysis by the same group examined associations between 
NO2 and respiratory symptoms and included original data from 5 studies (24,000 children 
from 5 countries). Pattenden et al. (2006) found no overall evidence of associations 
between ambient NO2 and asthma diagnosis or wheeze.   
 In the current study, NO2 and PM10 concentrations were within a similar range to 
most of the studies cited above, at least for urban areas (Boezen et al. 1999; Hoek et al. 
2012; Pattenden et al. 2006; Penard-Morand et al. 2010; van der Zee et al. 1999). 
Interestingly, for 84% of the children in our study, the annual mean residential NO2 level 
was above the London air quality objective (and World Health Organization, WHO, 
guideline) of 40 µg/m
3
. The objective for PM10, also 40 µg/m
3
, was not exceeded for any of 
the children. However, air quality guidelines published by WHO in 2005 (WHO 2006) 
recommended an annual mean of 20 µg/m
3
 for PM10, which was exceeded for all the 
children in the current study. 
 Compared with symptom prevalence data for Great Britain from ISAAC Phase I, 
prevalence among our study population was considerably lower; a third of schoolchildren 
reported wheeze in the past year (vs. 11.2% in our study) and a fifth recalled a diagnosis of 
asthma (vs. 14.4% in our study) (Kaur et al. 1998). However, data from ISAAC UK was for 
12-14 year-olds, only a small number of the schools were located in London and most were 
in non-metropolitan areas. In comparison, our data are strikingly similar to those for the 8-
10 year-old group from a survey of asthma prevalence and severity in Great Britain in 1992 
(Strachan et al. 1994). The prevalence of current wheeze was somewhat higher than in our 
study (15% overall in 5-17 year-olds), but a larger proportion of children with current 
wheeze reported frequent asthma attacks in our study – almost one in three, vs. one in six 
(Strachan et al. 1994). These authors (Strachan et al. 1994) found that wheezing and 
symptom severity was associated with lower socioeconomic status, which we did not; 
however, this could be due to a lack of range within the IMD 2010 score among our study 
population, since the level of deprivation is high throughout Tower Hamlets and Hackney 
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(Department for Communities and Local Government 2011). Strachan et al. (1994) stated 
that wheezing illness ‘is clearly a major public health problem’; given the similarity to the 
current data this still appears to be the case 20 years later, at least in east London.  
 Although over 10% of the children in our study reported current wheeze, of those, 
only two-thirds reported lifetime asthma. Similarly, Strachan et al. (1994) reported that 
asthma had been diagnosed in only 54% of the wheezy children in that study. The apparent 
disparity between reports of current wheeze symptoms and having asthma could reflect 
under-diagnosis or GPs not specifically using the term ‘asthma’, or possibly that medical 
advice/care has not been sought regarding these symptoms. We also found a high 
prevalence of severe asthma symptoms among those with current wheeze, which could 
again indicate a lack of diagnosis or medical care, or poor symptom control. We included 
bronchodilator response in our analysis, and found an elevated response to be associated 
with current wheeze and lifetime asthma, which would appear to confirm this finding using 
an objective measure of airway hypersensitivity. A published ‘factsheet’ regarding asthma 
in the borough of Tower Hamlets acknowledges that under-diagnosis or recording issues 
may explain why the prevalence is lower than in London and England (Tower Hamlets 
Council 2011), but also indicates that the hospital admission rate for asthma is higher than 
the London average, when adjusted for age, which suggests that poor asthma control may 
be an issue – especially for children – in this area of London.  
 A recent study investigated the association of GSDMA and GSDMB variants with 
asthma in Korean children and found that polymorphisms in these genes may be associated 
with asthma susceptibility and intermediate phenotypes of asthma, such as bronchial hyper-
responsiveness in children with asthma (Yu et al. 2011). These results suggested an 
important role for gasdermin genes in the development of childhood asthma. We report 
here a positive association between the same SNP in GSDMA and lifetime asthma, which 
concurs with its apparent involvement in childhood-onset asthma. The SNP in GSDMB 
analysed in our study was different from that in Yu et al. (Yu et al. 2011) and has been 
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found to have a negative association with childhood-onset asthma (Moffatt et al. 2010). 
Similarly, our results indicate a negative association with lifetime asthma, suggesting a 
possible protective effective of this polymorphism in GSDMB.  
 
3.4.2 Strengths and Limitations 
 This study was designed to target areas with high levels of air pollution, where the 
greatest air quality improvements were predicted to result from the LEZ. It was a 
population survey based on school classes, including children from a wide diversity of 
ethnic groups, which have often been excluded in previous studies. We employed a 
validated, widely-used questionnaire to measure respiratory/allergic symptoms, and linked 
these parent-reported responses to a large number of biological measurements, including 
lung function, and genotype of the gasdermin genes involved in childhood onset asthma. In 
addition we employed a validated, high-resolution air pollution model, providing exposure 
measurements at the level of residential address, over a period that encompasses the recent 
dieselisation of the London vehicle fleet and the resulting changes in the air pollutant mix.  
 A limitation of the type of parent-reported symptom data used herein is the 
possibility of recall bias or exaggeration of symptoms, especially given that parents were 
told we were investigating the effects of the LEZ on children’s health. However, given that 
the symptom prevalences reported here were lower than those from the ISAAC UK study 
(Austin et al. 1999; Kaur et al. 1998) exaggeration does not appear to have been a problem. 
Some inconsistencies in the data may be explained by language issues since English was 
probably not the first language for a large number of respondents. The term ‘wheeze’ does 
not translate exactly into all languages, as noted by the ISAAC study (The International 
Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee 1998). We 
administered the ISAAC questionnaire in English, as it was beyond our resources to get 
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translations made and validated in all the languages required, or to verbally administer the 
questionnaire to speakers of Sylheti, which has no written form.  
 There are several reasons why the predicted air quality improvements from the LEZ 
have not occurred, including the delay in implementing phase III (originally scheduled for 
October 2010, which would have applied the Euro III PM standard to light goods vehicles), 
the increasing proportion of diesel cars within the fleet (Cames and Helmers 2013), and 
evidence that NOx emissions from newer diesel engines (Euro 3-5) have not fallen as 
predicted by the current emission inventories (Carslaw et al. 2011). As the delayed phase 
III was introduced with phase IV (requiring  heavy goods vehicles, buses and coaches to 
meet the Euro IV PM standard) in January 2012, it is feasible that the predicted 
improvements may only become apparent in the subsequent years, although this is critically 
dependent on the emission technologies delivering under real-world driving conditions. Our 
study is on-going for a further three years, permitting continued analysis of any LEZ-
related effects on air quality and subsequent changes in the prevalence of 
respiratory/allergic symptoms.  
 
3.4.3 Conclusions 
 Over the first three years of the LEZ there was no evidence of a decrease in the 
respiratory/allergic symptoms of schoolchildren living in east London. Consistent with 
previous studies current rhinitis was positively associated with traffic-related air pollutants, 
while symptoms of other respiratory/allergic conditions were not. Associations were found 
between lifetime asthma and SNPs in gasdermin genes, which have previously been shown 
to be associated with child-onset asthma. Positive associations were also noted between 
current wheeze and lifetime asthma and significant bronchodilator responses, an objective 
measure of airway hypersensitivity. An additional unexpected finding was the high 
prevalence of severe asthma symptoms among children with current wheeze, and high 
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proportion of these who did not report having asthma. These findings indicate possible 
issues with under-diagnosis of asthma, under-use of health care services, and/or lack of 
control of asthma symptoms. Exploring these issues in more depth should help GPs and 
other healthcare workers to understand how best to ensure these children get the most 








Impact of Traffic-Related Pollution on Respiratory Function in 
Children Living within London’s Low Emission Zone 
 
4.1 INTRODUCTION 
  As outlined previously in the present study I hypothesised that year-on-year 
improvements in air quality following the introduction of the LEZ would results in 
corresponding improvements in children's lung function and airway respiratory symptoms. 
In Chapter 3 I demonstrated that whilst there was a relationship between annual pollutant 
exposures and rhinitis, there was no year-on-year change in symptoms over the first three 
years of the schemes operation. This was argued to reflect the absence of quantifiable 
improvements in air quality, related to the failure of Euro IV and V engines to produce their 
envisaged emission improvements in the real world.  In this study I present an analysis of 
the relationship between lung function and air pollutant exposures in children (8-9 years of 
age) living within the LEZ for the first three years of its operation (post the implementation 
of phases 1 and 2, but prior to phase 3, which was introduced in January 2012). We focused 
on children because their developing respiratory systems appear particularly sensitive to 
adverse air quality (Gauderman et al. 2007; Schultz et al. 2012). Children are especially 
vulnerable to traffic emissions for a number of reasons: First, lung development is still 
occurring in early life and therefore injury in this crucial period may have long term 
consequences for respiratory health; in particular, failure to attain maximum potential lung 
function means children have a greater likelihood of early chronic lung disease in 
adulthood. Second, children are likely to spend a greater period of time outdoors than 
adults, exposing them to higher doses of pollutants.  
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 Numerous studies have already demonstrated evidence of impaired lung function 
(cross sectionally) and growth (longitudinally) in young populations exposed to urban 
and/or traffic pollution (Jedrychowski et al. 1999; Peters et al. 1999; Horak et al. 2002; 
Gauderman et al. 2004, 2007; Rojas-Martinez et al. 2007; Oftedal et al. 2008; He et al. 
2010; Roy et al. 2012; Schultz et al. 2012). Of these studies the most coherent evidence was 
obtained  from the Californian Children’s Health Study, which reported associations 
between community-average concentrations of acid vapour, PM2.5 and elemental carbon 
and diminished lung function development in children aged 10–18 years, (Gauderman et al. 
2000; Gauderman et al. 2002; Gauderman et al. 2004). Of particular relevance to this study, 
a subsequent follow up of children who moved between the 12 communities from high to 
less polluted areas appeared to show they experienced diminished deficits in lung growth 
(Avol et al. 2001). Similar associations have been reported in Poland and Austria 
(Jedrychowski 1999; Horak 2002). Whilst these studies focused on pollutant 
concentrations, similar associations have been noted in relation to simple proxies of traffic 
exposures, with evidence of impaired lung growth in children living within 500m of a 
freeway, compared with children living at least 1,500 m from a major road  (Gauderman et 
al. 2007). Whilst not all studies addressing the adverse effects of air pollutants on lung 
function have demonstrated similar reduction in lung volume, or flow variables (Dockery et 
al. 1989; Hirsch et al. 1999; Nicolai et al. 2003; Hoek et al. 2012), the overall consensus 
view supports a negative relationship (Gotschi et al. 2008; HEI 2010). These early life 
decrements in lung volume (in particular FEV1) though small are highly important as they 
have been shown to be a strong determinant of life expectancy (Higgins and Keller 1970; 
Ashley et al. 1975; Hole et al. 1996), as well as for respiratory effects in later life 
(Turnovska et al. 2009; Moshammer et al. 2006; Gabriele et al. 2008; Clark et al. 2010).  
 Traffic emissions are the major source of airborne pollutants in urban areas, with the 
combustion aerosol containing  numerous harmful substances such as benzene, particulate 
matter (PM) and oxides of nitrogen; many of which have been shown to induce oxidative 
stress in vivo (Valavanidis et al. 2009). In particular, diesel vehicles contribute significantly 
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to road side fine particle concentrations, elemental carbon, particle number concentrations 
and oxides of nitrogen, especially in Europe where they represent a major source of  
polycyclic aromatic hydrocarbons (PAHs) and their derivatives like quinones and 
carboxylic and nitro- PAHs in the airshed (Shinyashiki et al. 2009). Respirable PAHs are 
genotoxic, causing DNA adduct formation  resulting in oxidative DNA damage and  are 
associated with an increased risk of cancer (Shimada et al. 1992). The metabolism of the 
PAHs is initiated by its binding to the aryl hydrocarbon receptors, followed by the 
transformation by phase I enzymes, cytochrome P450 (CYP)1A1 to highly reactive diol 
epoxide, which is subsequently detoxified by phase II enzymes, including epoxide 
hydrolases and glutathione S-transferases (e.g. GSTM1 and GSTP1). The capacity of an 
individual to up-regulate these detoxification pathways in response to pollutant challenge 
has therefore been proposed as a determinant of an individual’s susceptibility to these 
inhaled xenobiotics (Sandstrom and Kelly 2009).  
 To date the majority of studies examining the influence of genetic variants in these 
genes on air pollutant, respiratory health associations have focused on the phase II 
xenobiotic enzymes, often incongruously referred to as antioxidants in the literature. These 
studies (reviewed in Chapter 1, section 1.3.2.1, and summarized in Table 1.3 and Table 
1.4) have predominately focused on polymorphisms in members of the GST supergene 
family, with  GSTM1 (Buthbumrung et al. 2008; David et al. 2003; Hong et al. 2007; Islam 
et al. 2009; Lee et al. 2008; Li et al. 2006; Piacentini et al. 2010; Reddy et al. 2012; Romieu 
et al. 2004, 2006; Salam et al. 2007; Tung et al. 2011), GSTP1 (Avogbe et al. 2005; 
Alexeeff et al. 2008; Chen et al. 2007; Romieu et al. 2006) and GSTT1 (Avogbe et al. 
2005; Piacentini et al. 2010) being the most widely studied; followed by NQO1 (Nebert et 
al. 2002; Bergamaschi et al. 2001; Corradi et al. 2002; Chen et al. 2007; David et al. 2003; 
Avogbe et al. 2005), microsomal epoxide hydrolase (Salam et al. 2007; Tung et al. 2011; 
Manini et al. 2006; Binkova et al. 2007; Novotna et al. 2007), and more recently enzymes 
involved in glutathione synthesis: glutathione synthase ligase, GSSG reductase, and 
glutamate cysteine (Breton et al. 2011).  Only relatively few of these studies have examine 
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polymorphisms in these genes on lung function, air pollutant interactions, with the majority 
focused on symptom prevalence and  markers of exhaled or systemic oxidative stress 
(Table 1.3 and Table 1.4).  Those studies examining lung function have focused on genetic 
variants in GSTM1 (null), GSTP1(Ile105Val) and NQO1 (Pro187Ser) in adults and 
children with high ambient ozone exposures, demonstrating either enhance decrements in 
FEV1 (Bergamaschi et al. 2001; Alexreef et al. 2008; Romieu et al. 2004), decreased FEF25-
75 (Chen et al. 2007), or increased difficulty in breathing (Romieu et al. 2006). In studies 
examining PM2.5 or PM10, the impact of these genetic variants on lung function are less 
clear (Hong et al. 2007). There is consequently an absence of studies investigating the 
influence of phase II xenobiotic genes on lung function changes related to primary roadside 
emissions. Many of the studies cited above are also based on very small group sizes, with 
the effect often only observed as an interaction term between SNPs, which the studies are 
seldom adequately powered to address (as reviewed in Minelli et al. 2010). There are also 
significant limitations on the exposure attributions used in these studies, with the 
assessments often limited to data from a single or restricted subset of monitoring sites, and 
with limited or no attempt made to demarcate acute from chronic effects.  
  In the present study I therefore examined how SNPs in a panel of selected genes: 
GSTM1, GSTP1 and NQO1 (selected based on the literature review present in Table 1.3 
and Table 1.4), and referred to throughout as the confirmatory panel, influenced lung 
function air pollutant interactions. For this assessment I employed post bronchodilator lung 
function and exposure attributions based on the residential address expressed over various 
temporal domains: acute (24 hour pre-health assessment), sub-chronic (7 day average) and 
chronic (annual) exposures, based on a high resolution dispersion model and a NOWCAST 
scaling factor, developed for this project to provide spatially refined acute exposure 
estimates. In addition to the confirmatory panel of SNPs previously reported to influence 
pollutant, lung function interactions, I also examined an exploratory panel based on 
polymorphisms in the aryl hydrocarbon receptor (AhR) and CYP1A1. Most of the previous 
studies examining phase I xenobiotic genes have focused on the occupational exposures of 
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workers to pollutants such as PAHs (Chen et al. 2007; Bin et al. 2008) and cigarette smoke 
(Figueroa et al. 2008; Chen et al. 2009). To the best of my knowledge, there is no literature 
on the effect of genetic variations of the AhR and CYP1A1 on ambient air pollution, lung 
function interactions.  
 My primary objective in this study was to quantify the impact of urban air pollution 
on indices of lung function and to examine whether any such changes were the result of 
long or short-term exposures to NOx, NO2, PM10 or PM2.5. As a secondary objective, I also 
examined whether variation in genes related to the phase I and II xenobiotic metabolism of 
PAHs impacted upon lung function and the interaction between pollutant exposures and 
indices of lung capacity (FVC and FEV1). I examined two panels of SNPs, the first 
confirmatory, based on previously reported gene interactions between lung function and air 
pollutant exposures, focused on polymorphisms in glutathione-S-transferases and 
NADPH:quinone reductase. The second panel was exploratory, examining SNPs in 
CYP1A1 and AhR due to their role in PAH metabolism and previous in vitro and in vivo 
evidence that these proteins are involved in modulating the toxicity of diesel exhaust 
particles.  I also examined whether there were any year-on-year improvements in lung 
function related to residence within the LEZ, based on the assumption that accrued 
improvements in air quality would be associated with better respiratory health. As stated in 
the previous chapter however, given the absence in of a change in the pollutants examined 
over the first three years of London's LEZ, this study should be viewed predominately as 
establishing a baseline understanding of the underlying pollutant lung function interactions 





4.2.1 Study Design and Study Population 
 Details of the study design and general health assessment were as provided in 
Chapter 3 (sections 3.2.1 and 3.2.3).  
 
4.2.2 Lung Function Assessments 
 Children’s respiratory function was assessed by spirometry (Microlab,  
Micromedical, Carefusion), performed by trained investigators according to ATS-ERS 
guidelines (2005) with baseline and post-bronchodilator measurements, following 
salbutamol 400 µg administered by large volume spacer. Before each measurement, volume 
calibration with a 3L syringe was undertaken. A sterile disposable filter/ mouthpiece was 
attached to the spirometer for each child and the equipment wiped with alcohol wipes 
between subjects. A maximum of 10 attempts was normally made (exceptionally, more if 
needed) until three acceptable and two repeatable attempts were attained. Each spirometry 
measurement aimed to obtain three acceptable and two repeatable attempts both pre and 
post bronchodilator. A short acting bronchodilator (salbutamol) was administered after 
baseline spirometry. Four 100 microgram actuations were given from a metered dose 
inhaler (MDI) through a spacer device (Volumetric). The children took 4 tidal breaths 
through the volumetric spacer after each actuation. A minimum of 15 minutes later post 
bronchodilator spirometry took place. 
 Quality control was based on the ATS/ERS guidelines (2005), modified for children 
(Praud 2004). Additional acceptability requirements were: rapid onset of expiration, high 
well defined peak flow and a clear plateau on volume-time curve together with no evidence 
of cough, glottis closure or leak during the manoeuvre (from Asthma UK/ Growing Lungs 
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Guidelines). For quality control and reporting purposes spirometry results were uploaded 
from the 3 study spirometers to a Carefusion program “Spirometry” where individual 
inspection of efforts was undertaken in detail. Reporting of results was according to ATS-
ERS Guidelines and the best overall individual effort from each child both pre and post 
salbutamol was selected as the highest value of FEV1 and FVC, together with FEF25-75 from 
the best combined effort, reported from technically acceptable data, which met 
reproducibility requirements of 0.15 L agreement for FEV1 and FVC for 2 efforts. Data 
were then extracted into Excel and individual efforts were cross checked with original data 
before being exported into the main study Access database. Raw data were transformed into 
Z (or standard deviation) scores using most the “All-Age” equations by Stanojevic et al. 
(2009) available for white subjects aged 3 to 80 years of age. 
 
4.2.3 Urine Collection and Analysis 
 Spot urine samples were collected and placed on ice for the duration of the visit, 
then frozen and stored at -80°C on return to the laboratory. Urine cotinine concentrations 
were determined using a commercial microplate enzyme immunoassay (EIA) kit (Cozart 
Forensic Microplate EIA for cotinine, product no. M155B1) from Concateno (Abingdon, 
UK). Further details are as outlined in Chapter 3 (section 3.2.3.2). 
 
4.2.4 Long and Short Term Exposure Attributions 
 Annual NOx, NO2, PM10 and PM2.5 concentrations were derived using the KCL 
urban model (Kelly et al. 2011; Beevers et al. 2013) using ADMS dispersion model v4 and 
road source model v2.3 (CERC19), measured hourly meteorological data, empirically 
derived NO-NO2-O3 and PM relationships and emissions from the London Atmospheric 
Emissions Inventory (GLA 2008). Full details of the model and the selection of the 20m 
buffer zone around each volunteer’s residence were provided in Chapter 3 (section 3.2.4). 
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In this analysis these long term, annual exposure estimates were also weighted for periods 
spent at home (H) and school (S) address points based on the following criteria: that each 
child spending 84.4% of their time at home and 15.6% at school, based on a 7 hour school 
day, for 5 days per week, 39 weeks per year. Thus each child’s weighted exposure was 
estimated by EH+S = 0.884*EH + 0.156*ES. Again, as these exposure estimates were highly 
correlated with the home exposure attributions only the later were employed in the analysis 
of the final data set (Appendix I, Figures I1-I4).  
 Acute exposure estimates were derived at the address point by scaling annual mean 
concentrations according to a ‘Nowcast’ factor calculated for each pollutant for periods 
immediately prior to lung function evaluation. This factor (f) is defined as the ratio between 
concentrations measured by a local subset of continuous air pollution monitoring sites (L) 
in the prior period (t), and the annual mean (a) measured by the same sites. Thus, the acute 
exposure concentration estimate [P] at time t for point (x,y) was calculated as: 
 
[P]_t^((x,y) )= f.[P]_a^((x,y) )    where f=  ([P]_t^L)/([P]_a^L ) 
 
 For this study ‘Nowcast’ scaling factors were calculated for the 24 hours and 7 days 
prior to the school visits, working back from 10 am on the visit day to reflect both acute 
and subchronic exposure periods. To derive NOx and NO2, scaling factors measurements 
were averaged across 14-17 urban background and roadside sites within and surrounding 
the London boroughs of Tower Hamlets and Hackney, based on data availability. The 
decision to use both site types in deriving this factor, as opposed to the background sites 
only was based on the close residential proximity of many of the children within this study 
to busy roads. For the PM10 and PM2.5 scaling factors, measurements from 9-13 and 14-20 




4.2.5 Sample Collection and SNP Genotyping 
 Saliva was collected from the children using the Oragene DNA kit OG-250 (DNA 
Genotek Inc, Canada), with genomic DNA recovered using salt out method, followed by 
whole genome amplification using the GenomePlex Complete Whole Genome 
Amplification (WGA2) Kit (Sigma Aldrich) as previously described  (Arneson et al. 2008). 
Two panels of SNPs were investigated using the GoldenGate genotyping assay on Illumina 
BeadXpress platform (Illumina Inc., San Diego, USA).  The confirmatory panel consisted 
of 7 SNPs selected as known, or hypothesized susceptibility loci including GSTM1 
(rs366631), GSTP1 (rs749174, rs1695) and NQO1 (rs2917666, rs689453, rs1800566, 
rs10517) genes. These candidate SNPs were selected based on a review of the published 
literature, presented in Chapter 1, Tables 1.3 and 1.4. The second exploratory panel 
consisted of 9 SNPs, including 5 SNPs of AhR (rs2074113, rs2066853, rs17722841, 
rs17779352 and rs2282885) and 4 SNPs within the CYP1A1 gene (rs2606345, rs1799814, 
rs17861115 and rs2198843). For AhR, the non-synonymous SNP rs2066853 (Arg554Lys) 
within the transactivation domain (exon 10), which plays an essential role in regulating 
expression of target genes; and the synonymous SNP rs17779352 (Asn44Asn), within the 
basic helix-loop-helix domain (exon 2), involved in DNA biding, were selected.  The 
former (rs2066853) represents the most widely studied AhR polymorphism, with evidence 
that it influences inhaled PAH metabolism in occupational settings (Chen et al., 2007; Chen 
et al., 2009). In vitro studies have also shown it exerts a strong influence on receptor 
function (Harper et al., 2002). In addition, the following Tagging SNPs were also 
examined, rs2074113 (33G/T); rs17722841, (4640G/A) and rs2282885, 3946G/A, all 
located in intervening sequences, to capture information on other SNPs not explicitly 
included in the present study (Ng et al., 2009).  
 For CYP1A1 4 SNPS were examined, one non-synonymous SNP (rs1799814, exon 
7, Thr461Asn), and three Tagging SNPs (rs2606345 (606T/G), rs17861115 (-9893G/A) 
and rs2198843 (11599 C/G)), previously shown to be associated with markers of PAH 
metabolism: PAH-DNA adducts in blood (Wang et al., 2008; Abnet et al., 2007), increased 
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cancer risk in smokers (Rotunno et al., 2009), or increased risk of adult respiratory distress 
syndrome in patients with nosocomial pneumonia (Salnikova et al., 2013). The non-
synonymous SNP rs1799814 (Thr461Asn) has been related to greater enzyme catalytic 
efficiency, related to structural changes in the haeme-binding domain.  
Genotype data was analyzed for quality control using the BeadStudio software. To 
further improve the genotype dataset, manual editing was also performed as an additional 
quality control and any poor quality samples were excluded from the final analysis at this 
step. Hardy-Weinberg equilibrium values and genotype & allele frequencies for all SNPs 
are shown in Tables I1 (Panel 1) and Table I2 (Panel 2) in the Appendix I. All SNPs 
included for analysis were in HWE (p>0.05) except for SNP rs1799814 in white population 
and had a genotyping success rate of 99%. All SNPs displayed a >5% minor allele 
frequency, determined from the published web based data sets (1000 genome data set: 
integrated phase 1, version 3, March 2012; HapMap (Thorisson et al., 2005)). Details of 
linkage disequilibrium are presented in Appendix I, Table I3. 
 
4.2.6 Statistical Analysis 
 Before applying any models, the distributional form of the outcomes was assessed 
using quantile plots of the variable against the normal distribution. Any outliers were 
identified using box plots and their influence on the model was evaluated using deviance 
residuals where possible. For each model, residuals were assessed for normality using 
quantile plots of the variable against the normal distribution and checked for hetero 
scedasticity by plotting residuals against the fitted values on the school level. For lung 
function, the data were normally distributed. 
 Linear mixed models with a random effect for school were used to examine the 
effects of individual air pollutant exposures on lung function outcomes. To address the 
influence of bias introduced by the study population, a number of baseline characteristics 
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were selected a priori to be included in the models: age, sex, height, body mass index 
(BMI), self-reported ethnicity (Asian, Black, White, Other/Mixed) and exposure to tobacco 
as measured by a urinary cotinine to creatinine ratio >30ng/ml. To assess the assumption of 
no change over time study year was also included as a covariate in the models.  
 For the selected SNPs, genotype was recorded as a nominal categorical variable 
representing wild type, heterozygous and homozygous mutant. Hardy Weinberg 
Equilibrium was assessed for each SNP and the Fst statistic was calculated for each SNP 
over reported ethnicity to assess if results from children with different ethnicities could be 
analysed together. In the next step, we assessed whether genotype modified the effect of air 
pollution on the measurements of lung function. In order to distinguish any direct effects of 
genotype on outcomes a crude and an adjusted analysis was first performed for each SNP. 
The adjusted analysis included the same covariates as described above but no air pollution 
exposures. Next, to test for effect modification of the SNPs, interaction terms of each 
categorical SNP and each continuous air pollution variable were added to the linear mixed 
models. For each SNP the wild type genotype was used as the reference category for the 
comparison between the three groups. For cases where the effect modification was 
significant for only one comparison but not the other a global Wald test was performed to 
assess influence of the SNP overall. Additionally we performed all analysis combining 
heterozygous and homozygous mutant into one category, which increased the power to 
detect effects of mutations in each SNP and also aimed to confirm results from the global 
tests. This method has been applied in other gene modification studies.  
 Multiple testing was performed on all significant and non-significant p-values using 
a step-up false discovery rate (FDR) procedure as originally proposed by Simes (1986) and 
later justified by Benjamini and Yekutieli (2001). As described by both groups controlling 
the false discovery rate is less conservative than using the family-wise error rate and 
therefore results in more differences being significant at the cost of some confidence in the 
results. The Simes FDR procedure calculates a corrected critical p-value for each p-value of 
interest (effects of air pollutant variables or interaction terms), so that an individual null 
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hypothesis can be rejected if its corresponding p-value is smaller than the corrected critical 
p-value. 
 Models were examined on the 5% significance level for two-sided tests of 
individual associations and on the 10% significance level for interaction terms of effect 
modification. All statistical analyses were performed using Stata 10.1 (StataCorp, College 




4.3.1  Subject Demographics 
 Details of participant characteristics are presented in Table 4.1, for each individual 
year and combined across the first three years of the study. The majority of the study 
population was of central Asian background, predominately Bangladeshi. Data on lung 
function were available for 1,000 children at an average age of 8.8 years. Of these, 
technically acceptable FEV1 and FVC measures were available for 951 and 920 children 
respectively. The smoking exposure status (urinary cotinine) was obtained for 954 children; 
of whom 222 had an exposure level above 25 ng/ml and were therefore considered as being 
exposed to environmental tobacco smoke. Following adjustment for sample dilution using 
urinary creatinine 212 children were found to be above the threshold. Table 4.2 illustrates 
the post-bronchodilator FVC and FEV1 measurements for all of the subjects from whom 
complete sets of covariant were available and were thus included in the full analysis. The 
mean FEV1 and FVC combined across the first 3-years of the study (2008-11) were 1,692 
ml and 1,891 ml, respectively. Saliva samples were collected for 182 children from 10 
schools (Nov – Feb 2008/2009), 415 children from 19 schools (Nov/Feb 2009/2010) and 
404 children from 22 schools (Nov – Mac 2010/2011). Of the 1001 samples collected from 
children during the school visits for Year 1-3, 13 (1.3%) samples were lost due to technical 
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error during samples handling. DNA was successfully extracted from all of the remaining 
988 saliva samples, but subsequently 14 poorly performing samples were excluded to 
improve the genotype data set leaving 974 samples in total for downstream analysis. Of the 
974 children with genotype data, 894 performed acceptable FEV1 (92%), and 864 (89%) 
had a technically acceptable FVC measurement.  
 
4.3.2 Exposure Attributions 
  Whilst the spatial resolution of the dispersion model was good I also explored 
whether short term exposure might influence the lung function determinations on the day of 
the actual school visit, or in more extended periods running up to the visit date. The 
importance of considering visit date is illustrated in Figure 4.1, which shows the daily 
variation in NO2 concentrations at roadside and urban background sites surrounding the 
study area over the three successive winter sampling periods. The distance of the school 
from a major road was also illustrated. Addressing the influence of acute air pollution 
exposures on lung function is a critical question as it has been shown that exposure to both 
diesel (Holgate et al. 2003a, 2003b) and roadside (McCreanor et al. 2007) air pollution can 
elicit transient decrements in lung function.  To date only two studies have attempted to 
address this issue, by including daily background measurements from their study area as a 
covariant in their regressions model (Oftedal et al. 2008; Schultz et al. 2012). Whilst this 
approach has some merit, it does not address acute versus chronic pollutant exposures on 
the same geographical scale, which is problematic in urban settings where exposures are 
highly influenced by a subject’s residential proximity to roads. A straightforward method of 
aiding the demarcation of acute effects, [triggered by recent pollutants exposures] from 






Table 4.1 Descriptive data for study participants by year and for year 1-3 combined (for all 
















(n = 182) 
 
(n = 414) 
 
(n = 404) 
 
(n = 1000) 
 
 
Girls, n (%) 77 (42.3) 198 (47.8) 208 (51.5) 483 (48.3) 
Age, yrs; mean (SD) 8.8 (0.3) 8.8 (0.3) 8.8 (0.3) 8.8 (0.3) 
Height, cm; mean (SD) 133.9 (6.4) 133.8 (7.0) 133.7 (6.6) 133.8 (6.7) 
Weight, kg; mean (SD) 32.5 (7.6) 32.8 (8.3) 32.4 (7.8) 32.6 (7.9) 
BMI, kg/m
2
; mean (SD) 17.9 (3.0) 18.1 (3.3) 17.9 (3.4) 18.0 (3.3) 
 
Ethnicity, n (%)     
 - Asian 69 (37.9) 152 (36.7) 138 (34.2) 359 (35.9) 
 - Black 45 (24.7) 104 (25.1) 101 (25.0) 250 (25.0) 
 - White 53 (29.1) 115 (27.8) 104 (25.7) 272 (27.2) 
 - Other 15 (8.2) 43 (10.4) 61 (15.1) 119 (11.9) 
 
IMD score; mean (SD) 46.0 (11.6) 45.6 (10.1) 44.8 (12.0) 45.3 (11.2) 
ETS exposure, n (%) 51 (28.0) 95 (22.9) 66 (16.3) 212 (21.2) 
     
 
MD score = IMD 2010; ETS exposure = cotinine: creatinine ratio >30 ng/mg. Percentages may not 
sum exactly to 100 % due to rounding. 
 
Notes: Of the 359 subjects coded as Asian, 87% (314) gave their self reported ethnicity as 
Bangladeshi. The population, reporting themselves as black, was more diverse, with the major 
contributions being Caribbean (19%), Nigerian (18%), other black (27%), or black African (14%). 
The mixed other group consisted of 46% of mixed and 54% other, where it was difficult to 
discriminate  continental origin, with the largest group being children reporting themselves as 


























FEV1, L 951 1.69 0.28 0.84 - 2.73 1.68 
FEV1, % predicted 950 94.4 11.8 59.4 - 131.3 94.3 
FVC, L 920 1.89 0.32 1.11 - 3.19 1.87 














Chronic exposures were assessed using annual mean concentration maps at 20m 
resolution, with subjects assigned exposure levels based on their residential and/or school 
address. Acute exposures were then assessed by scaling these annual mean concentrations 
according to a ‘Nowcast’ factor calculated for each pollutant for the period immediately 
prior to the biomarker extraction. This factor was defined as the ratio between 
concentrations measured by a local subset of London Air Quality Network monitoring sites 
in the prior period, and the annual mean measured by the same sites. Nowcast factors 
varied between 0.4 and 3.0 for PM2.5, i.e., PM2.5 concentrations assigned to the subject’s 
address for the acute assessment were up to three times higher than the chronic assessment. 
This temporal variation was far greater than the annual mean spatial variation in PM2.5. A 
similar pattern was apparent for each of the modelled pollutant species. Using these 
approaches exposure attribution for each individual were derived based on annual (chronic 
exposure), 7 day (referred to throughout as sub-chronic) and 24 hour (acute exposures). 
Descriptive data on each of the modelled pollutant data are presented in Table 4.3 for the 
1,000 children who attempted spirometry, based on home residential address and weighted 
for periods spent at the school location. This approach was based on observations made by 
McConnell et al (2010) where combined school and home exposure was related to 







Figure 4.1 Daily mean NO2 variation at roadside (red line) and urban back ground (blue 
line) sites within and bordering the London boroughs of Tower Hamlets and Hackney over 
the first three years of the LEZ study. The dates of the school visits are illustrated with open 
circles with the position on the y-axis reflecting the proximity of the school to major roads. 
The dashed line represents the mean London NO2 concentration for each study period 




 From the data presented in Table 4.3 it was apparent that there was little difference 
between the exposure estimates based on residential address alone, or weighted for the time 
spent in school, probably reflecting the close proximity of the children to their primary 
schools in Central London. The ‘Home’ and ‘Average’ exposure attributions were also 
highly correlated (Appendix I, Figures I1 – I4), therefore the decision was made to focus 
only on the former, to limit the number of exposure metrics applied to the health data. It is 
also important to note that each of the four pollutants modelled at the same temporal scale 
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were highly correlated (Table 4.4), which precluded the subsequent use of multi-pollutant 
models in the subsequent analysis. The degree of association between the pollutants 
significantly degraded as shorter exposure intervals were considered. 
 
Table 4.3 Descriptive exposure data on the 1000 participants attempting lung function 
testing across the first three years of the Low Emission Zone Study. Exposures are 
expressed as annual, weekly, or 24 hour average (µg/m
3



















Home NOx (Annual) 996 75.74 14.62 47.52 235.44 73.11 
Home +  school NOx (Annual) 996 78.83 13.86 53.06 224.17 76.39 
Home NOx (7 day) 996 46.51 16.83 16.90 181.29 45.93 
Home +  school NOx (7 day) 996 48.39 16.93 17.93 172.61 48.67 
Home NOx (24 hours) 996 58.14 43.40 9.49 396.17 46.35 
Home +  school NOx (24 hours) 996 60.42 44.40 9.97 389.04 48.67 
       
Home NO2 (Annual) 996 43.52 5.45 31.16 98.93 42.51 
Home +  school NO2 (Annual) 996 45.30 5.20 34.05 95.89 44.38 
Home NO2 (7 day) 996 24.99 6.04 12.21 67.27 25.24 
Home +  school NO2 (7 day) 996 26.01 6.13 12.83 65.21 26.42 
Home NO2 (24 hours) 996 27.76 10.90 8.12 75.45 27.35 
Home +  school NO2 (24 hours) 996 28.88 11.16 8.50 75.20 28.63 
       
Home PM10 (Annual) 996 23.38 1.44 20.41 33.16 23.06 
Home +  school PM10 (Annual) 996 24.30 1.35 21.60 34.00 24.06 
Home PM10 (7 day) 996 22.69 5.49 13.55 60.00 22.35 
Home +  school PM10 (7 day) 996 23.60 5.73 14.10 61.03 23.31 
Home PM10 (24 hours) 996 24.30 9.37 8.67 65.98 23.62 
Home +  school PM10 (24 hours) 996 25.27 9.73 9.02 66.77 24.65 
       
Home PM2.5 (Annual) 996 13.73 0.82 11.68 17.97 13.62 
Home +  school PM2.5 (Annual) 996 14.27 0.81 12.38 18.27 14.17 
Home PM2.5  (7 day) 996 13.65 3.71 8.16 35.30 13.16 
Home +  school PM2.5  (7 day) 996 14.20 3.87 8.49 36.03 13.71 
Home PM2.5  (24 hours) 996 14.89 6.50 6.32 44.95 13.70 




Table 4.4 Associations (Pearson correlations) between annual, 7-day and 24 hour exposure 
attributions 
 
  Annual 7 day 24 hours 







NOx 1.00            
NO2 1.00 1.00           
PM10 0.93 0.94 1.00          






NOx 0.39 0.39 0.33 0.10 1.00        
NO2 0.41 0.42 0.34 0.12 0.95 1.00       
PM10 0.26 0.26 0.20 0.07 0.51 0.46 1.00      








NOx 0.21 0.22 0.24 0.15 0.56 0.49 0.11 0.15 1.00    
NO2 0.29 0.30 0.30 0.18 0.59 0.59 0.10 0.11 0.91 1.00   
PM10 0.19 0.20 0.22 0.18 0.42 0.38 0.25 0.23 0.80 0.76 1.00  
PM2.5 0.11 0.12 0.13 0.11 0.41 0.36 0.21 0.25 0.79 0.72 0.94 1.00 
 
 
4.3.3 Lung Function Associations with Modeled Exposures 
 The adjusted coefficients for the association of the demographic variables with lung 
function, adjusted for all pollutant attributions are summarized in Table 4.5. For both FEV1 
and FVC significant associations were observed with sex, height and BMI, but not IMD 
score or ETS exposure, confirmed using the urinary cotinine to creatinine ratio. Clear 
differences in lung function variables between the ethnicities were observed with the Black 
and Asian children having smaller lung volumes in accord with recent reports (Kirkby et al. 




Table 4.5 Adjusted coefficients for the association between demographic variables and 




The relationship between post-bronchodilator FVC and the modeled pollutant 
concentrations, across the acute to chronic exposure windows are illustrated in Figure 4.2. 
Data are presented separately for each individual year and aggregated across the first three 
years of the study for additional power. Overall no evidence of any association between 
FVC and the acute (24h) or sub-chronic (7 day) exposure attributions were observed, and 
there was no clear pattern in the year by year data consistent with a beneficial effect of the 
LEZ over the first three years of its lifetime. Significant associations (P<0.05) were 
apparent at the nominal level for all four pollutants in annual exposure attributions with 
FVC, with the association with NOx remaining significant after correction for multiple 
testing to account for the different exposure periods examined. In contrast, no associations 
Outcome DISPERSION MODELLING NOWCAST MODELLING 7 DAYS NOWCAST MODELLING 1 DAY
FEV1 Annual 7-days 1-day
Age (years) 0.0165[-0.0233,0.0563] 0.0202[-0.0204,0.0608] 0.0186[-0.0212,0.0585]
Sex (Girls vs Boys) -0.0821***[-0.1069,-0.0573] -0.0840***[-0.1088,-0.0592] -0.0822***[-0.1070,-0.0574]
Height (cm) 0.0259***[0.0237,0.0280] 0.0259***[0.0237,0.0281] 0.0259***[0.0237,0.0281]
BMI 0.0099***[0.0059,0.0139] 0.0096***[0.0056,0.0136] 0.0099***[0.0058,0.0139]
IMD Score -0.0007[-0.0019,0.0004] -0.0005[-0.0016,0.0006] -0.0005[-0.0016,0.0007]
ETS Score 0.0028[-0.0287,0.0343] 0.0002[-0.0311,0.0315] 0.0019[-0.0295,0.0334]
Ethnicity Black vs Asian -0.1315***[-0.1656,-0.0975] -0.1343***[-0.1685,-0.1002] -0.1347***[-0.1691,-0.1003]
Ethnicity White vs Asian 0.1099***[0.0767,0.1432] 0.1040***[0.0703,0.1377] 0.1051***[0.0711,0.1391]
Ethnicity Others vs Asian 0.1090***[0.0676,0.1503] 0.1035***[0.0617,0.1452] 0.1062***[0.0645,0.1478]
Study Year 2 vs 1 -0.0356[-0.1610,0.0898] -0.0129[-0.0533,0.0275] -0.0199[-0.0601,0.0204]
Study Year 3 vs 1 -0.0072[-0.0527,0.0383] 0.0162[-0.0261,0.0585] 0.002[-0.0388,0.0429]
NOx (ug/m3) -0.0084[-0.0176,0.0008] -0.001[-0.0036,0.0017] 0[-0.0008,0.0008]
NO2 (ug/m
3) 0.0236[-0.0032,0.0503] 0.0057[-0.0015,0.0128] 0.0015[-0.0017,0.0046]
PM10 (ug/m
3) -0.0127[-0.0712,0.0459] -0.0067[-0.0144,0.0010] -0.0022[-0.0067,0.0023]
PM2.5 (ug/m
3) 0.0126[-0.1097,0.1349] 0.0068[-0.0044,0.0179] 0.0018[-0.0042,0.0078]
FVC
Age (years) 0.0291[-0.0170,0.0753] 0.0295[-0.0175,0.0766] 0.0317[-0.0146,0.0780]
Sex  (Girls vs Boys) -0.1424***[-0.1711,-0.1138] -0.1433***[-0.1720,-0.1146] -0.1421***[-0.1709,-0.1134]
Height (cm) 0.0280***[0.0254,0.0305] 0.0279***[0.0253,0.0304] 0.0278***[0.0252,0.0303]
BMI 0.0153***[0.0106,0.0199] 0.0148***[0.0101,0.0194] 0.0151***[0.0104,0.0197]
IMD Score -0.0004[-0.0017,0.0010] -0.0001[-0.0014,0.0012] -0.0003[-0.0016,0.0011]
ETS Score 0.0035[-0.0327,0.0396] 0.0029[-0.0331,0.0389] 0.0033[-0.0328,0.0395]
Ethnicity Black vs Asian -0.1312***[-0.1713,-0.0912] -0.1341***[-0.1735,-0.0948] -0.1290***[-0.1694,-0.0886]
Ethnicity White vs Asian 0.1524***[0.1133,0.1915] 0.1514***[0.1126,0.1902] 0.1529***[0.1131,0.1928]
Ethnicity Others vs Asian 0.1141***[0.0657,0.1625] 0.1111***[0.0626,0.1595] 0.1177***[0.0690,0.1664]
Study Year 2 vs 1 -0.0548[-0.1985,0.0889] -0.0457[-0.0922,0.0008] -0.0509*[-0.0979,-0.0038]
Study Year 3 vs 1 0.0078[-0.0447,0.0603] 0.0201[-0.0285,0.0686] 0.0064[-0.0412,0.0541]
NOx (ug/m3) -0.0067[-0.0173,0.0039] -0.0029[-0.0060,0.0002] 0.0002[-0.0008,0.0012]
NO2 (ug/m
3) 0.0147[-0.0161,0.0456] 0.0087*[0.0005,0.0170] -0.0001[-0.0038,0.0036]
PM10 (ug/m
3) -0.0039[-0.0713,0.0635] -0.0048[-0.0136,0.0040] 0.0013[-0.0041,0.0066]
PM2.5 (ug/m
3) 0.0124[-0.1276,0.1524] 0.0056[-0.0073,0.0186] -0.0032[-0.0102,0.0038]
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were noted between any of the exposure attributions examined and FEV1 (Table 4.6a and 
4.6b). As a secondary analysis, we also explored how these annual associations with lung 
capacity varied across the 4 ethnic groups. This analysis, illustrated in Figure 4.3 
demonstrated that the reduction in FVC associated with annual NOx and NO2 exposures 
was predominately experienced in the white population,. 
 
Figure 4.2 Association between each of the 4 selected pollutant attributions, based on 24 hour, 7 
day and annual exposures and the measured FVC, post bronchodilator. Effect estimates are 
presented with 95% confidence intervals, based on exposures model by home residential address 
only (filled circles), and weighted for periods spent at school (open circles). Data are presented by 
year, as well as pooled across the first three years of the study: * p<0.05.   
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Table 4.6a Effect estimates for the association between annual NOx and NO2 exposures with lung function. Data are expressed per 
µg/m
3
 of pollutant and per interquartile range (IQR) of exposure 
 





  b 95
th
 CI IQR b 95
th

















(L.g.m-3) 7 day  0.0006 [-0.0002,0.0014] 0.014 0.002 [-0.0002,0.0042] 0.017 
 Annual  -0.0004 [-0.0012,0.0004] -0.004 -0.0008 [-0.0030,0.0014] -0.003 
        
Post FVC 24 hour  0.0000 [-0.0003,0.0004] 0.000 0.0001 [-0.0012,0.0015] 0.001 
(L.g.m-3) 7 day  -0.0002 [-0.0011,0.0007] -0.005 0.0003 [-0.0022,0.0029] -0.041 
 Annual  -0.0012* [-0.0021,-0.0002] -0.012* -0.0030* [-0.0055,-0.0005] -0.012* 
        
 
 
Table 4.6b Effect estimates for the association between PM10 and PM2.5 with lung function. Data are expressed per µg/m
3
 of pollutant 
and per interquartile range (IQR) of exposure 
 





  b 95
th
 CI IQR b 95
th

















 7 day -0.0007 [-0.0031,0.0017] -0.004 -0.0004 [-0.0038,0.0031] -0.002 
 Annual -0.0032 [-0.0118,0.0053] -0.004 -0.007 [-0.0276,0.0137] -0.009 
        
        
Post FVC 24 hour -0.0002 [-0.0017,0.0014] -0.003 -0.0006 [-0.0028,0.0017] -0.023 
 7 day -0.0013 [-0.0041,0.0015] -0.007 -0.0016 [-0.0057,0.0025] -0.008 
 Annual -0.0104* [-0.0202,-0.0006] -0.014* -0.0240* [-0.0477,-0.0003] -0.030* 




Figure 4.3 The impact of ethnicity on the associations between annual NOx and NO2 
exposure attributions with FVC. 
 
4.3.4 Impact of SNPs in Phase II Xenobiotic Genes on Air Pollution, Lung Function 
Interactions - Confirmatory Analysis 
 The distribution of the genotype and allele frequencies for GSTP1, GSTM1 and 
NQO1 SNPs for total population and for the population stratified by ethnicity is shown in 
Table 4.7. Overall, all the four ethnic groups in the study population, shared similar 
common genotypes except for GSTM1 SNP rs366631 and NQO1 SNP rs2917666. Pseudo-
SNP GSTM1 rs366631 (C/T), was used to infer GSTM1 deletion based on methods 
described by Huang et al. (2009). Hence, it only distinguishes whether there is a 
homozygous deletion (null) or not, and is unable to differentiate between the numbers of 
alternative alleles. Therefore, when both copies of the upstream region were deleted, the 
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genotype call was made solely based on homozygous variants (TT). Approximately, 45% 
of the Asian and ‘Others’ exhibited the GSTM1 deletion. In contrast, Black and White 
demonstrated ~30% and ~60% of GSTM deletion respectively. These values were within 
the ranges previously reported for these ethnic groups (Carlsten et al. 2008). With regards 
to GSTP1 SNP rs749174 (C/T), all ethnicities shared the same common genotype ‘CC’ 
with MAF varying between 22% to 36%, with the White population having the highest 
MAF and  the Asian the lowest. For SNP rs1695 (Ile/Val), ‘Ile/Ile’ was the common 
genotype for all ethnicities, with the MAF showing little variation between the Black (45%) 
and other ethnic groups (ranging between 25% and 36%). All NQO1 SNPs except 
rs2917666 showed same common genotype for all the ethnic groups. Whilst Asian, Black 
and ‘Others’ exhibited ‘G’ as the minor allele for SNP rs2917666 with a MAF between 
41% to 48%, in the White population ‘C’ was the minor allele with a MAF of 31%. With 
respect to SNPs rs689453 and rs10517, all ethnic groups had a MAF of approximately 4% 
and 18% respectively. In addition, despite sharing the same common genotype in SNP 
rs1800566 (Pro/Ser) with the rest of ethnic groups, the Asian populations had the highest 
MAF of the allele Ser with ~34% compared to Black who had the lowest MAF with ~17%.  
 Tables I3 in Appendix I shows the crude and adjusted effects of the studied GSTs 
and NQO1 genotypes on FEV1 and FVC. Following model adjustment  for age, sex, 
ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year,GSTP1 
(rs1695, Ile105Val) was found to be associated with significant reductions in both FEV1 (-
32mL) and FVC (-42mL) when Ile/Val+Val/Val genotypes were combined and compared 
against the reference genotype (Ile/Ile). In contrast, NQO1 (rs1800566, Pro187Ser) was 
associated with a significant increase in FVC (+33mL) when the Pro/Ser + Ser/Ser 
genotype were combined and compared against Pro/Pro. Despite these associations with 
basal lung function I observed  no significant modifying effects of polymorphisms in the 
studied GSTs or NQO1 genes on the relationship between lung function and annual (FEV1, 
Table 4.8; FVC, Table 4.9), sub-chronic (Appendix I: FEV1, Table I6; FVC, Figure I7), 
or acute (Appendix I: FEV1, Table I4; FVC, Figure I5) exposures.  
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n % n % n % n % n %
rs366631  C/T
CC 0 0 0 0 0 0 0 0 0 0.0
CT 195 56.4 171 69.2 112 42.1 60 52.6 481 55.8
TT 151 43.6 76 30.8 154 57.9 54 47.4 381 44.2
Allele C 195 28.2 171 34.6 112 21.1 60 26.3 481 27.9
Allele T 497 71.8 323 65.4 420 78.9 168 73.7 1243 72.1
 rs749174 Intron 5 C/T
CC 213 61.4 142 57.5 108 40.6 56 49.1 453 52.5
CT 113 32.6 90 36.4 125 47.0 48 42.1 339 39.3
TT 21 6.1 15 6.1 33 12.4 10 8.8 71 8.2
Allele C 539 77.7 374 75.7 341 64.1 160 70.2 1245 72.1
Allele T 155 22.3 120 24.3 191 35.9 68 29.8 481 27.9
rs1695 Exon 5 Ile105Val 
Ile/Ile 191 55.0 82 33.2 110 41.5 49 43.0 377 43.7
Ile/Val 132 38.0 110 44.5 118 44.5 51 44.7 370 42.9
Val/Val 24 6.9 55 22.3 37 14.0 14 12.3 115 13.3
Alelle Ile 514 74.1 274 55.5 338 63.8 149 65.4 1124 65.2
Alelle Val 180 25.9 220 44.5 192 36.2 79 34.6 600 34.8
rs2917666 3´ UTR (C/G)
CC 76 21.9 39 15.8 123 46.2 24 21.1 228 26.4
CG 163 47.0 123 49.8 120 45.1 62 54.4 424 49.1
GG 108 31.1 85 34.4 23 8.6 28 24.6 211 24.4
Allele C 315 45.4 201 40.7 366 68.8 110 48.2 880 51.0
Allele G 379 54.6 293 59.3 166 31.2 118 51.8 846 49.0
rs689453 Exon 2 Glu24 (G/A)
GG 336 96.8 221 89.5 238 89.5 101 88.6 796 92.2
GA 11 3.2 25 10.1 27 10.2 13 11.4 65 7.5
AA 0 0.0 1 0.4 1 0.4 0 0.0 2 0.2
Allele G 683 98.4 467 94.5 503 94.5 215 94.3 1657 96.0
Alelle A 11 1.6 27 5.5 29 5.5 13 5.7 69 4.0
rs1800566 Exon 6 Pro187Ser 
Pro/Pro 153 44.1 173 70.0 179 67.3 58 50.9 502 58.2
Pro/Ser 154 44.4 66 26.7 78 29.3 50 43.9 311 36.0
Ser/Ser 40 11.5 8 3.2 9 3.4 6 5.3 50 5.8
Allele Pro 460 66.3 412 83.4 436 82.0 166 72.8 1315 76.2
Alelle Ser 234 33.7 82 16.6 96 18.0 62 27.2 411 23.8
rs10517 3´ UTR region (C/T)
CC 220 63.4 171 69.5 197 74.1 70 61.4 581 67.4
CT 116 33.4 68 27.6 67 25.2 39 34.2 257 29.8
TT 11 3.2 7 2.8 2 0.8 5 4.4 24 2.8
Allele C 556 80.1 410 83.3 461 86.7 179 78.5 1419 82.3
Alelle T 138 19.9 82 16.7 71 13.3 49 21.5 305 17.7
Minor allele frequency for this ethnicity is different with other ethnicities for the particular SNP.
Genotype distribution for this ethnicity are not similar with other ethnicity groups despite sharing same major/minor allele.
Similar genotype frequencies for both ethnicity group for the particular SNP.
Allele frequencies calculation for wild type (AA) = AA/(AA+AB+BB)
Allele frequencies calculation for heterozygotes (AB) = AB/(AA+AB+BB)





Asian Black White Others  Population
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Table 4.8 Effects of GSTM1, GSTP1 and NQO1 genotypes on FEV1 outcomes by annual 
mean pollutant exposure 
 
 
   
FEV1 
 
Genotype Subjects NOx β (95% CI) NO2 β (95% CI) PM10 β (95% CI) 
 
PM2.5 β (95% CI) 
 
GSTM1     
rs366631  (C/T)     
CT 482 Reference Reference Reference Reference 
TT 383 0.0007[-0.0012,0.0025] 0.0016[-0.0032,0.0064] 0.0051[-0.0122,0.0225] 0.0193[-0.0111,0.0496] 
GSTP1     
rs749174 (intron 5 C/T)     
CC 455 Reference Reference Reference Reference 
CT 340 0.0006[-0.0010,0.0023] 0.0016[-0.0029,0.0060] 0.0066[-0.0105,0.0236] 0.0180[-0.0131,0.0491] 
TT 71 0.0036#[-0.0007,0.0079] 0.0087[-0.0022,0.0197] 0.0170[-0.0223,0.0562] 0.0210[-0.0367,0.0788] 
CT + TT 411 0.0008[-0.0008,0.0024] 0.0021[-0.0022,0.0064] 0.0072[-0.0093,0.0238] 0.0181[-0.0113,0.0476] 
rs1695 (Exon 5 Ile105Val)    
Ile/Ile 379 Reference Reference Reference Reference 
Ile/Val 371 0.0004[-0.0014,0.0022] 0.0010[-0.0037,0.0058] 0.0029[-0.0149,0.0207] -0.0083[-0.0403,0.0236] 
Val/Val 115 0.0011[-0.0012,0.0033] 0.0032[-0.0031,0.0094] 0.0090[-0.0173,0.0353] 0.0098[-0.0362,0.0557] 
Ile/Val + Val/Val 486 0.0006[-0.0010,0.0022] 0.0016[-0.0027,0.0060] 0.0041[-0.0126,0.0208] -0.0042[-0.0340,0.0256] 
NQO1     
rs2917666 (3´ UTR (C/G))    
CC 231 Reference Reference Reference Reference 
CG 424 0.0010[-0.0008,0.0029] 0.0028[-0.0021,0.0078] 0.0116[-0.0079,0.0312] 0.0197[-0.0158,0.0551] 
GG 211 0.0002[-0.0019,0.0023] 0.0007[-0.0050,0.0065] 0.0070[-0.0149,0.0290] 0.0135[-0.0268,0.0539] 
CG + GG 635 0.0007[-0.0009,0.0024] 0.0021[-0.0024,0.0065] 0.0099[-0.0079,0.0278] 0.0173[-0.0153,0.0499] 
rs689453 (Exon 2 Glu24 (G/A))    
GG 799 Reference Reference Reference Reference 
GA 65 -0.0004[-0.0046,0.0039] -0.0014[-0.0123,0.0094] -0.0064[-0.0440,0.0311] -0.0045[-0.0636,0.0545] 
AA 2 -0.0101[-0.0347,0.0144] -0.0264[-0.0898,0.0371] -0.0780[-0.2669,0.1108] -0.1947[-0.6650,0.2756] 
GA + AA 67 -0.0003[-0.0044,0.0038] -0.0013[-0.0118,0.0092] -0.0059[-0.0418,0.0301] -0.0019[-0.0587,0.0550] 
rs1800566 (Exon 6 Pro187Ser)    
Pro/Pro 505 Reference Reference Reference Reference 
Pro/Ser 311 0.0004[-0.0015,0.0024] 0.0010[-0.0042,0.0061] 0.0051[-0.0136,0.0238] 0.0044[-0.0281,0.0369] 
Ser/Ser 50 -0.0015[-0.0040,0.0010] -0.0041[-0.0108,0.0026] -0.0089[-0.0348,0.0170] -0.0060[-0.0591,0.0472] 
Pro/Ser + Ser/Ser 361 -0.0003[-0.0019,0.0014] -0.0008[-0.0052,0.0036] 0.0006[-0.0159,0.0172] 0.0014[-0.0283,0.0312] 
rs10517 (3´ UTR (C/T))     
CC 584 Reference Reference Reference Reference 
CT 257 0.0001[-0.0018,0.0021] 0.0005[-0.0048,0.0058] 0.0005[-0.0192,0.0201] -0.0076[-0.0418,0.0265] 
TT 24 0.0026[-0.0050,0.0102] 0.0058[-0.0131,0.0248] 0.0051[-0.0557,0.0659] -0.0061[-0.1011,0.0888] 








   
FVC 
 
Genotype Subjects NOx β (95% CI) NO2 β (95% CI) PM10 β (95% CI) 
 
PM2.5 β(95% CI) 
 
 
GSTM1     
rs366631  (C/T)     
CT 482 Reference Reference Reference Reference 
TT 383 0.0000[-0.0021,0.0021] 0.0001[-0.0054,0.0057] 0.0021[-0.0179,0.0222] 0.0043[-0.0309,0.0395] 
 
GSTP1     
rs749174 (intron 5 C/T)     
CC 455 Reference Reference Reference Reference 
CT 340 0.0008[-0.0011,0.0027] 0.0020[-0.0031,0.0070] 0.0070[-0.0125,0.0265] 0.0221[-0.0136,0.0577] 
TT 71 0.0015[-0.0039,0.0068] 0.0030[-0.0109,0.0169] 0.0055[-0.0422,0.0532] 0.0242[-0.0444,0.0929] 
CT + TT 411 0.0008[-0.0010,0.0027] 0.002[-0.0029,0.0069] 0.0067[-0.0122,0.0256] 0.0222[-0.0116,0.0561] 
rs1695 (Exon 5, Ile105Val)    
Ile/Ile 379 Reference Reference Reference Reference 
Ile/Val 371 0.0003[-0.0017,0.0024] 0.0008[-0.0045,0.0062] 0.0019[-0.0185,0.0222] -0.0097[-0.0464,0.0270] 
Val/Val 115 0.0011[-0.0015,0.0037] 0.0029[-0.0044,0.0101] 0.0053[-0.0252,0.0357] 0.0113[-0.0421,0.0647] 
Ile/Val + Val/Val 486 0.0006[-0.0013,0.0024] 0.0014[-0.0036,0.0063] 0.0025[-0.0167,0.0216] -0.005[-0.0392,0.0293] 
 
NQO1     
rs2917666 (3´ UTR (C/G))    
CC 231 Reference Reference Reference Reference 
CG 424 0.0009[-0.0011,0.0030] 0.0028[-0.0029,0.0084] 0.0105[-0.0120,0.0330] 0.0127[-0.0282,0.0536] 
GG 211 0.0002[-0.0022,0.0026] 0.0011[-0.0054,0.0076] 0.0055[-0.0195,0.0305] 0.0112[-0.0349,0.0573] 
CG + GG 635 0.0007[-0.0012,0.0025] 0.0022[-0.0029,0.0073] 0.0088[-0.0116,0.0292] 0.0122[-0.0253,0.0497] 
rs689453 (Exon 2, Glu24 (G/A))    
GG 799 Reference Reference Reference Reference 
GA 65 -0.0013[-0.0061,0.0036] -0.0036[-0.0160,0.0089] -0.0110[-0.0541,0.0322] -0.0214[-0.0897,0.0468] 
AA 2 -0.0050[-0.0328,0.0227] -0.0131[-0.0849,0.0588] -0.0385[-0.2527,0.1756] -0.0973[-0.6305,0.4360] 
GA + AA 67 -0.0013[-0.0060,0.0034] -0.0036[-0.0156,0.0084] -0.0112[-0.0525,0.0301] -0.021[-0.0866,0.0445] 
rs1800566 (Exon 6, Pro187Ser)    
Pro/Pro 505 Reference Reference Reference Reference 
Pro/Ser 311 0.0002[-0.0020,0.0024] 0.0005[-0.0054,0.0064] 0.0007[-0.0207,0.0222] -0.0029[-0.0403,0.0344] 
Ser/Ser 50 -0.0016[-0.0044,0.0012] -0.0044[-0.0120,0.0033] -0.0136[-0.0432,0.0160] -0.0194[-0.0804,0.0416] 
Pro/Ser + Ser/Ser 361 -0.0005[-0.0024,0.0014] -0.0013[-0.0063,0.0038] -0.004[-0.0229,0.0149] -0.0075[-0.0416,0.0267] 
rs10517 (3´ UTR (C/T))    
CC 584 Reference Reference Reference Reference 
CT 257 0.0009[-0.0014,0.0031] 0.0026[-0.0034,0.0086] 0.0095[-0.0130,0.0321] 0.0065[-0.0329,0.0459] 
TT 24 0.0024[-0.0062,0.0111] 0.0060[-0.0155,0.0276] 0.0084[-0.0605,0.0772] 0.0084[-0.0999,0.1167] 







4.3.5 Impact of SNPs in Phase I Xenobiotic Genes on Air Pollution, Lung 
Function Interactions - Exploratory Analysis 
   
Table 4.10 illustrates the genotype and allele distributions for the examined 
SNPs in AhR and CYP1A1 for the total population and stratified by ethnicity. The 
genotype distributions of the AhR SNPs were similar for all ethnic groups except for 
SNPs rs2066853, rs17722841 and rs2282885. The ‘Arg” allele of rs2066853 (Arg/Lys) 
was the major allele in the Asian (67%) and White (79%), but not the Black (34%) 
population. Whereas for SNP rs17722841 (G/A), although ‘G’ was the major allele for 
all ethnicities, the genotype frequency varied between the White (67%) and other ethnic 
groups: Asian 95%, Black 95%, and ‘Others’ 84%. For SNP rs2282885 (T/C), ‘T’ was 
the major allele for all ethnic groups, however, with a different genotype distribution. 
Asian and Black populations had a similar genotype frequency of ‘TT’, 68% and 89% 
respectively, whilst White and ‘Others’ had  a 39% and 44% genotype frequency 
respectively. Only one SNP of CYP1A1 displayed a similar minor allele frequency 
between the ethnicities, rs17861115 with the MAF varying between 4-12%. For SNP 
rs2606345 (G/T), although ‘G’ was the major allele for Asian and Black population, the 
genotype distribution was very different: 46% and 86% respectively. In contrast, ‘TT’ 
was the common genotype for White population, 64%. The allele ‘G’ was the major 
allele for all ethnicities for SNP rs2198843 (G/C) with the exception of the Black 
population where ‘C’ was the major allele. Whilst, Asian and ‘Others’ had a similar 
allele frequency of ‘G’, 63% and 67% respectively, the allele frequency was  higher in 
White population (81%).  
 Tables I8 and I9 in Appendix I show the crude and adjusted effects of the 
studied AhR and CYP1A1 genotypes on lung function. While unadjusted estimates 
suggested significant associations of children genotypes of AhR: rs2066853, 
rs17722841, rs2282885 and CYP1A1: rs2606345, rs2198843 with both FEV1 and FVC, 
this effect could not be confirmed after adjustment for possible confounders, indicating 
that  SNPs of AhR and CYP1A1 do not have a direct effect on lung function.  
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Table 4.10 Distribution of genotype and allele frequencies in AhR and CYP1A1      
 




n % n % n % n % n %
AhR
rs2074113  C/A
CC 235 0.68 174 0.70 216 0.82 85 0.75 710 0.73
CA 102 0.29 67 0.27 45 0.17 25 0.22 239 0.25
AA 9 0.03 6 0.02 3 0.01 3 0.03 21 0.02
Allele C 572 0.83 415 0.84 477 0.90 195 0.86 1659 0.86
Allele A 120 0.17 79 0.16 51 0.10 31 0.14 281 0.14
 rs2066853 Exon 10 Arg554Lys (G/A)
Arg/Arg 232 0.67 83 0.34 211 0.79 63 0.55 589 0.61
Arg/Lys 105 0.30 113 0.46 50 0.19 45 0.39 313 0.32
Lys/Lys 9 0.03 51 0.21 5 0.02 6 0.05 71 0.07
Allele Arg 569 0.82 279 0.56 472 0.89 171 0.75 1491 0.77
Allele Lys 123 0.18 215 0.44 60 0.11 57 0.25 455 0.23
 rs17722841  G/A
GG 328 0.95 235 0.95 177 0.67 95 0.84 835 0.86
GA 19 0.05 12 0.05 83 0.31 17 0.15 131 0.13
AA 0 0.00 0 0.00 6 0.02 1 0.01 7 0.01
Allele G 675 0.97 482 0.98 437 0.82 207 0.92 1801 0.93
Allele A 19 0.03 12 0.02 95 0.18 19 0.08 145 0.07
rs17779352 T/C
TT 278 0.80 230 0.93 222 0.83 104 0.92 834 0.86
TC 63 0.18 17 0.07 43 0.16 9 0.08 132 0.14
CC 6 0.02 0 0.00 1 0.00 0 0.00 7 0.01
Alelle T 619 0.89 477 0.97 487 0.92 217 0.96 1800 0.92
Allele C 75 0.11 17 0.03 45 0.08 9 0.04 146 0.08
rs2282885 T/C
TT 233 0.68 219 0.89 103 0.39 50 0.44 605 0.62
TC 101 0.29 27 0.11 126 0.48 56 0.50 310 0.32
CC 11 0.03 1 0.00 36 0.14 7 0.06 55 0.06
Alelle T 567 0.82 465 0.94 332 0.63 156 0.69 1520 0.78
Allele C 123 0.18 29 0.06 198 0.37 70 0.31 420 0.22
CYP1A1
rs2606345 G/T
GG 161 0.46 213 0.86 34 0.13 33 0.29 441 0.45
GT 146 0.42 31 0.13 123 0.46 54 0.47 354 0.36
TT 40 0.12 3 0.01 109 0.41 27 0.24 179 0.18
Allele G 468 0.67 457 0.93 191 0.36 120 0.53 1236 0.63
Allele T 226 0.33 37 0.07 341 0.64 108 0.47 712 0.37
rs1799814 Exon 7 Thr461Asn
Thr/Thr 330 0.97 240 0.97 234 0.88 101 0.90 905 0.94
Thr/Asn 8 0.02 7 0.03 28 0.11 10 0.09 53 0.05
Asn/Asn 1 0.00 0 0.00 4 0.02 1 0.01 6 0.01
Allele Thr 668 0.99 487 0.99 496 0.93 212 0.95 1863 0.97
Allele Asn 10 0.01 7 0.01 36 0.07 12 0.05 65 0.03
 rs17861115 C/T
CC 271 0.78 224 0.91 245 0.92 102 0.89 842 0.86
CT 68 0.20 22 0.09 20 0.08 10 0.09 120 0.12
TT 8 0.02 1 0.00 1 0.00 2 0.02 12 0.01
Allele C 610 0.88 470 0.95 510 0.96 214 0.94 1804 0.93
Allele T 84 0.12 24 0.05 22 0.04 14 0.06 144 0.07
rs2198843 G/C
GG 142 0.41 45 0.18 177 0.67 55 0.48 419 0.43
GC 155 0.45 121 0.49 78 0.29 43 0.38 397 0.41
CC 50 0.14 80 0.33 11 0.04 16 0.14 157 0.16
Allele G 439 0.63 211 0.43 432 0.81 153 0.67 1235 0.63
Allele C 255 0.37 281 0.57 100 0.19 75 0.33 711 0.37
Ethnicity
Asian Black White Others Combined Ethnicity
SNP which is not in HWE by ethnicity and total population.
Minor allele for this ethnicity is different with other ethnicities for the SNP.
Genotype distribution for this ethnicity are not similar with other group despite sharing same major/minor allele with the majority of the ethnicity.
Different getnoype distribution compared to other ethnicity.
Similar genotype/allele frequencies within the block for the particular SNP.
Similar genotype/allele frequencies within the block for the particular SNP.
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 Next, the effects of the selected SNPs in AhR and CYP1A1 on the association 
between the modeled air pollution exposures and lung function were examined. The 
interactions between Ahr genotypes and lung function for all annual pollutant exposures 
are shown in Tables 4.11 (FEV1) - 4.12 (FVC), with the acute and sub-chronic exposure 
interactions presented in Appendix I, Tables I10-I13. I observed no evidence of an 
interaction of any of the Ahr SNPs on the relationship between FEV1 (Table 4.11) or 
FVC (Table 4.12) with the annual modeled pollutant exposures, demonstrating that 
genetic variants in this gene do not influence the association between annual NOx 
exposures and reduced FVC. A nominally significant association between rs17722841 
genotypes and FEV1 in relation to sub-chronic NOx (7 day) exposures was also 
observed (Table I12), and with all pollutants when acute 24h exposures were 
considered (Table I10). However, none of these associations survived the multiple 
testing corrections. 
 The impacts of genetic variants in CYP1A1 on the relationship between long 
term exposure to air pollutants and FEV1 and FVC are presented in Tables 4.13 and 
4.14, respectively; with additional information on the acute and sub-chronic exposures 
in Appendix I, Tables I14-I17. For CYP1A1, rs2198843 there was an apparent 
protective effect on lung function (FVC) in relation to both the sub-chronic and acute 
exposure attributions to both NOx and NO2 that was robust to the multiple testing 
procedures, when the full multiethnic population was examined (Figure 4.4). Compared 
to children carrying wild type GG, children carrying the homozygous CC genotype had 
an increase in FVC of 5.2ml (2.6, 7.9; p=0.0013) per g/m3 and 14.0ml (7.1, 21.0; 
p=0.0008) per g/m3 in relation to average 7 day exposures to NOx and NO2 
respectively. Slightly smaller protective increments were observed in subjects with the 
homozygous genotype when the acute 24h exposures were considered: FVC 1.8ml (0.6, 
3.0; p=0.0032) per g/m3 and 6.6ml (2.4, 10.7; p=0.0032) per g/m3 with respect to 
NOx and NO2 exposure (Figure 4.4). A similar pattern was observed with the annual 





Table 4.11 Effects modification of AhR genotypes on the association between FEV1 and annual mean pollutant exposures  
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) (n) β(95% CI) β (95% CI) β (95% CI)
rs2074113  C/A
CC 624 Reference Reference Reference Reference
CA 218 -0.0004[-0.0021,0.0012] -0.0015[-0.0060,0.0030] -0.0049[-0.0231,0.0132] -0.0105[-0.0444,0.0235]
AA 20 -31.0E-06[-0.0079,0.0079] -0.0002[-0.0200,0.0196] -0.0315[-0.0991,0.0360] -0.0577[-0.1755,0.0601]
CA+AA 238 -0.0004[-0.0020,0.0012] -0.0015[-0.0058,0.0029] -0.0063[-0.0239,0.0113] -0.0133[-0.0462,0.0195]
 rs2066853 Exon 10 Arg554Lys (G/A)
Arg/Arg 516 Reference Reference Reference Reference
Arg/Lys 281 -0.0001[-0.0019,0.0018] -0.0005[-0.0054,0.0043] -0.0004[-0.0187,0.0180] -0.0175[-0.0508,0.0159]
Lys/Lys 68 0.0004[-0.0018,0.0026] 0.0008[-0.0052,0.0068] 0.0041[-0.0210,0.0291] -0.0020[-0.0495,0.0455]
Arg/Lys+Lys/Lys 349 30.2E-06[-0.0016,0.0016] -0.0003[-0.0046,0.0041] 0.0004[-0.0161,0.0169] -0.0147[-0.0447,0.0153]
 rs17722841  G/A
GG 742 Reference Reference Reference Reference
GA 116 -0.0005[-0.0038,0.0028] -0.0010[-0.0095,0.0075] -0.0055[-0.0344,0.0233] -0.0113[-0.0577,0.0350]
AA 7 -0.0095[-0.0450,0.0260] -0.0164[-0.0988,0.0660] -0.0431[-0.3422,0.2560] -0.0847[-0.3756,0.2061]
GA+AA 123 -0.0005[-0.0037,0.0027] -0.0012[-0.0095,0.0071] -0.006[-0.0344,0.0223] -0.0132[-0.0586,0.0322]
rs17779352 T/C
TT 746 Reference Reference Reference Reference
TC 115 0.0009[-0.0015,0.0033] 0.0025[-0.0039,0.0090] 0.0054[-0.0180,0.0288] 0.0298[-0.0145,0.0741]
CC 4 -0.0192[-0.0488,0.0104] -0.0456[-0.1167,0.0255] -0.1665[-0.4473,0.1143] -0.2639[-0.6246,0.0969]
TC+CC 119 0.0007[-0.0016,0.0031] 0.0021[-0.0042,0.0085] 0.0042[-0.0189,0.0274] 0.0263[-0.0173,0.0700]
rs2282885 T/C
TT 547 Reference Reference Reference Reference
TC 264 -0.0002[-0.0020,0.0016] -0.0005[-0.0055,0.0045] -0.0006[-0.0194,0.0183] 0.0004[-0.0326,0.0334]
CC 51 -0.0007[-0.0080,0.0065] -0.0019[-0.0204,0.0166] -0.0336[-0.0978,0.0305] -0.0284[-0.1074,0.0506]
TC+CC 315 -0.0001[-0.0019,0.0017] -0.0003[-0.0051,0.0045] -0.0018[-0.0200,0.0164] -0.0023[-0.0337,0.0290]
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Table 4.12 Effects modification of AhR Genotypes on association between FVC and annual mean pollutant exposures 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) (n) β (95% CI) β (95% CI) β (95% CI)
rs2074113  C/A
CC 604 Reference Reference Reference Reference
CA 210 -0.0002[-0.0021,0.0017] -0.0011[-0.0062,0.0040] -0.0034[-0.0242,0.0174] -0.0099[-0.0490,0.0293]
AA 20 0.0045[-0.0045,0.0134] 0.0119[-0.0104,0.0343] 0.0161[-0.0604,0.0927] -0.0039[-0.1374,0.1297]
CA+AA 230 -0.0001[-0.0019,0.0018] -0.0006[-0.0056,0.0044] -0.0025[-0.0227,0.0178] -0.0096[-0.0474,0.0283]
 rs2066853 Exon 10 Arg554Lys (G/A)
Arg/Arg 498 Reference Reference Reference Reference
Arg/Lys 270 0.0002[-0.0019,0.0023] -42.5E-06[-0.0056,0.0055] 0.0023[-0.0188,0.0233] -0.0050[-0.0435,0.0336]
Lys/Lys 68 0.0008[-0.0017,0.0033] 0.0023[-0.0045,0.0090] 0.0129[-0.0156,0.0413] 0.0108[-0.0433,0.0649]
Arg/Lys+Lys/Lys 338 0.0004[-0.0015,0.0022] 0.0006[-0.0043,0.0056] 0.005[-0.0139,0.0239] -0.0016[-0.0361,0.0329]
 rs17722841  G/A
GG 717 Reference Reference Reference Reference
GA 113 -0.0011[-0.0049,0.0028] -0.0027[-0.0126,0.0072] -0.0098[-0.0440,0.0244] -0.0134[-0.0681,0.0412]
AA 7 -0.0061[-0.0464,0.0342] -0.0092[-0.1026,0.0842] -0.0107[-0.3500,0.3287] -0.0285[-0.3586,0.3017]
GA+AA 120 -0.001[-0.0048,0.0027] -0.0026[-0.0123,0.0071] -0.0095[-0.0431,0.0240] -0.0136[-0.0670,0.0399]
rs17779352 T/C
TT 722 Reference Reference Reference Reference
TC 110 30.4E-06[-0.0028,0.0028] 0.0001[-0.0075,0.0077] -0.0017[-0.0288,0.0255] 0.0031[-0.0487,0.0550]
CC 4 -0.0148[-0.0484,0.0187] -0.0351[-0.1157,0.0455] -0.1313[-0.4495,0.1870] -0.1977[-0.6071,0.2118]
TC+CC 114 -46.7E-06[-0.0028,0.0027] -0.0001[-0.0076,0.0073] -0.0025[-0.0293,0.0244] 0.0002[-0.0509,0.0512]
rs2282885 T/C
TT 528 Reference Reference Reference Reference
TC 257 -0.0002[-0.0023,0.0019] -0.0009[-0.0066,0.0047] -0.0041[-0.0257,0.0176] -0.0030[-0.0410,0.0350]
CC 48 0.0010[-0.0075,0.0094] 0.0032[-0.0183,0.0247] -0.0133[-0.0921,0.0656] -0.0161[-0.1072,0.0751]





Table 4.13 Effect modification of CYP1A1 genotypes on the association between FEV1 and annual mean pollutant exposures  
 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 
#p<0.1, *p<0.05, **p<0.01. 
 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) (n) β(95% CI) β (95% CI) β (95% CI)
rs2606345 G/T
GG 391 Reference Reference Reference Reference
GT 319 -0.0024**[-0.0041,-0.0006] -0.0064**[-0.0112,-0.0016] -0.0217*[-0.0401,-0.0034] -0.0213[-0.0542,0.0117]
TT 156 -0.0002[-0.0026,0.0021] -0.0011[-0.0073,0.0051] -0.0045[-0.0273,0.0182] 0.0011[-0.0399,0.0420]
GT+TT 475 -0.0017*[-0.0034,-0.0001] -0.0048*[-0.0093,-0.0004] -0.0159#[-0.0326,0.0007] -0.0136[-0.0432,0.0160]
 rs17861115 C/T
CC 749 Reference Reference Reference Reference
CT 106 -0.0005[-0.0042,0.0033] -0.0007[-0.0102,0.0087] 0.0014[-0.0334,0.0361] 0.0094[-0.0452,0.0640]
TT 11 0.0047[-0.0044,0.0138] 0.0121[-0.0108,0.0349] 0.0538[-0.0208,0.1284] 0.1218[-0.0281,0.2717]
CT+TT 117 0.0003[-0.0032,0.0038] 0.0012[-0.0075,0.0099] 0.0107[-0.0209,0.0423] 0.0216[-0.0296,0.0729]
rs2198843 G/C
GG 373 Reference Reference Reference Reference
GC 349 0.0001[-0.0019,0.0020] 0.0001[-0.0048,0.0051] -0.0002[-0.0183,0.0180] -0.0085[-0.0409,0.0240]
CC 144 0.0033*[0.0002,0.0065] 0.0087*[0.0007,0.0167] 0.0245#[-0.0046,0.0535] 0.011[-0.0369,0.0589]
GC+CC 493 0.0008[-0.0009,0.0026] 0.0022[-0.0024,0.0068] 0.0056[-0.0112,0.0225] -0.0032[-0.0335,0.0270]
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Table 4.14 Effect modification of CYP1A1 genotypes on association between FVC and annual mean pollutant exposures 
 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 
#p<0.1, *p<0.05. 
 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) (n) β (95% CI) β (95% CI) β (95% CI)
rs2606345 G/T
GG 380 Reference Reference Reference Reference
GT 310 -0.0026*[-0.0046,-0.0005] -0.0071*[-0.0126,-0.0016] -0.0253*[-0.0463,-0.0043] -0.0306[-0.0684,0.0072]
TT 147 -0.0003[-0.0030,0.0024] -0.0015[-0.0086,0.0056] -0.0047[-0.0309,0.0214] 0.0051[-0.0421,0.0522]
GT+TT 457 -0.0019*[-0.0038,-48.0E-6] -0.0055*[-0.0106,-0.0004] -0.0186#[-0.0377,0.0005] -0.0188[-0.0529,0.0152]
 rs17861115 C/T
CC 723 Reference Reference Reference Reference
CT 103 -0.0029[-0.0075,0.0018] -0.0066[-0.0183,0.0051] -0.0210[-0.0627,0.0207] -0.0294[-0.0945,0.0356]
TT 11 0.0068[-0.0035,0.0171] 0.0177[-0.0081,0.0436] 0.0742#[-0.0102,0.1586] 0.1596#[-0.0101,0.3293]
CT+TT 114 -0.0012[-0.0055,0.0030] -0.0025[-0.0132,0.0081] -0.0028[-0.0403,0.0348] -0.0063[-0.0671,0.0544]
rs2198843 G/C
GG 354 Reference Reference Reference Reference
GC 340 -0.0006[-0.0027,0.0016] -0.0012[-0.0069,0.0046] -0.0037[-0.0245,0.0170] -0.0135[-0.0508,0.0237]
CC 143 0.0034[-0.0002,0.0070] 0.0094*[0.0002,0.0187] 0.0291#[-0.0050,0.0632] 0.0126[-0.0433,0.0685]





Figure 4.4 Influence of rs2198843 (CYP1A1) on the association between post-
bronchodilator FVC and 24 hour, 7-day or annual pollutant attributions to NOx, NO2, 
PM10 and PM2.5. Data are expressed relative to the major allele across the whole multi-
ethnic population- GG (Table 4.10). Models are adjusted for age, sex, ethnicity, height, 
BMI, IMD, urinary CCR for smoking exposure and study year, including effect for 
school location. Nominal significant differences relative to the reference genotype are 
illustrated as follows: #p<0.1, *p<0.05 and **p<0.01. Where these differences remained 
significant (P<0.05) after adjusted for multiple comparisons this is illustrated by ‘†’. 
 
The analyses were repeated separately for the three major ethnic groups within the 
present study. This was necessary for rs2198843, as the major allele differed between the Asian 
and White (G, major allele fregency 63 and 81% respectively), versus the black populations (C, 
major allele fregency 57%). The results of these separate analyses are summarised in Table 
4.15. Overall these data supported the view that possession of the 'C' allele is protective against 
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pollutant associated reductions in FVC, but this effect was only strongly evident in the Asian 
and black children and was predmoniately related to the acute (24h) to sub-chronic (7-day) 
exposures. For the Asian children the protective effect was seen in individuals homozygous for 
the C allele for each pollutant examined, and in the combined models (GC+CC) for 7 day 
average PM10 and PM2.5 exposures. In contrast, in the black children possession of the G allele 
was associated with an increased negative association between acute (for all pollutants) and sub-
chronic (NOx and NO2) pollutant exposures and FVC. The magnitude of the effect increased 
from heterozygotes to homozygotes for the acute 24h exposures, but was only evident in the 
heterozygotes and in the combined model (CG+GG) using the 7 day exposure estimates, likely 
reflecting the small number of homozygous subjects (n=39).  
In contrast, an increased decrement in FVC in relation to sub-chronic and acute 
exposures to NOx and NO2 was observed with rs2606345, in both the combined and 
heterozygous genotype when the whole population was considered together (Figure 
4.5). Children carrying heterozygous genotype (GT) demonstrated a significant 
decrement in FVC related to their sub-chronic exposure to NOx and NO2, relative to the 
dominant GG genotype (63%). When these data were analysed separately by ethnicity, 
with reference to each populations major allele: G for the Asian (67%) and black (93%) 
populations and T for the white children (64%), the sensitizing affect of possession of 
the T allele was still apparent, but as for for rs2198843, this was limited to the Asian 
and black children, Table  4.16. For the Asian children possession of the T allele was 
associated with a significant negative impact of the underlying association between sub-
chronic exposures to NOx, NO2 and PM10 in the heterozygotes and in the combined 
model, but not in the homozygotes, again likely reflecting the small number of subjects 
(n=29). For the black children this addative negative impact was only apparent in 







Table 4.15 Influence of rs2198843 (CYP1A1) on the association between post-bronchodilator 
FVC and 24 hour, 7-day or annual pollutant attributions to NOx, NO2, PM10 and PM2.5 for each 
of the major ethnicities in the current population. Data are expressed relative to the major allele 
for each ethnic population 
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
GG 132
GC 45 0.0000 [-0.0016,0.0016] -0.0006 [-0.0056,0.0044] -0.0023 [-0.0081,0.0034] -0.0014 [-0.0106,0.0079]
CC 290 0.0006 [-0.0015,0.0027] 0.0044 [-0.0029,0.0117] 0.0014 [-0.0063,0.0091] 0.0011 [-0.0101,0.0123]
GC+CC 177 0.0001 [-0.0014,0.0017] 0.0006 [-0.0042,0.0053] -0.0014 [-0.0067,0.0040] -0.0006 [-0.0093,0.0081]
CC 74
CG 104 -0.0022* [-0.0041,-0.0004] -0.0065* [-0.0130,-0.0000] -0.0094* [-0.0171,-0.0016] -0.0091 [-0.0201,0.0018]
GG 39 -0.0035** [-0.0060,-0.0010] -0.0096* [-0.0183,-0.0010] -0.0156** [-0.0256,-0.0055] -0.0171* [-0.0307,-0.0035]
CG+GG 143 -0.0025** [-0.0043,-0.0006] -0.0073* [-0.0136,-0.0010] -0.0106** [-0.0181,-0.0030] -0.0109* [-0.0213,-0.0004]
GG 159
GC 69 -0.0001 [-0.0010,0.0008] -0.0001 [-0.0044,0.0042] -0.0007 [-0.0057,0.0042] -0.0005 [-0.0075,0.0064]
CC 9 0.002 [-0.0013,0.0054] 0.008 [-0.0047,0.0208] 0.0087 [-0.0036,0.0209] 0.0113 [-0.0063,0.0290]
GC+CC 78 0.000 [-0.0009,0.0009] 0.0003 [-0.0039,0.0046] 0.0001 [-0.0047,0.0048] 0.0006 [-0.0062,0.0073]
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
GG 132
GC 45 0.0012 [-0.0016,0.0040] 0.0035 [-0.0047,0.0118] 0.0055 [-0.0016,0.0125] 0.0094 [-0.0016,0.0204]
CC 290 0.0049* [0.0005,0.0093] 0.0164* [0.0039,0.0289] 0.0134* [0.0025,0.0243] 0.0166* [0.0011,0.0320]
GC+CC 177 0.0019 [-0.0007,0.0046] 0.0064 [-0.0014,0.0142] 0.0072* [0.0006,0.0138] 0.0112* [0.0010,0.0213]
CC 74
CG 104 -0.0054* [-0.0096,-0.0013] -0.0109* [-0.0214,-0.0003] -0.0052 [-0.0191,0.0087] -0.0083 [-0.0289,0.0124]
GG 39 -0.005 [-0.0110,0.0010] -0.0103 [-0.0258,0.0052] -0.0139 [-0.0309,0.0031] -0.0179 [-0.0418,0.0061]
CG+GG 143 -0.0054** [-0.0095,-0.0014] -0.0111* [-0.0214,-0.0009] -0.0074 [-0.0205,0.0056] -0.0104 [-0.0291,0.0083]
GG 159
GC 69 0.002 [-0.0013,0.0053] 0.0074 [-0.0020,0.0169] -0.0004 [-0.0139,0.0131] -0.0029 [-0.0223,0.0165]
CC 9 0.0021 [-0.0094,0.0137] 0.0048 [-0.0253,0.0349] 0.0232 [-0.0164,0.0628] 0.0297 [-0.0170,0.0764]
GC+CC 78 0.002 [-0.0012,0.0052] 0.0073 [-0.0019,0.0166] 0.0007 [-0.0124,0.0139] 0.0009 [-0.0178,0.0195]
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
GG 132
GC 45 -0.0007 [-0.0041,0.0028] -0.0015 [-0.0104,0.0074] 0.0009 [-0.0328,0.0346] -0.0082 [-0.0717,0.0552]
CC 290 0.0055 [-0.0004,0.0114] 0.015 [-0.0001,0.0301] 0.039 [-0.0200,0.0980] 0.024 [-0.0703,0.1183]
GC+CC 177 0.0008 [-0.0024,0.0039] 0.0022 [-0.0059,0.0104] 0.0087 [-0.0227,0.0401] -0.0004 [-0.0598,0.0590]
CC 74
CG 104 -0.0023 [-0.0084,0.0038] -0.0061 [-0.0218,0.0096] -0.0237 [-0.0787,0.0313] -0.0105 [-0.0987,0.0778]
GG 39 -0.002 [-0.0089,0.0049] -0.0046 [-0.0224,0.0133] -0.0249 [-0.0878,0.0380] 0.0012 [-0.1128,0.1153]
CG+GG 143 -0.0022 [-0.0080,0.0036] -0.0056 [-0.0205,0.0094] -0.0232 [-0.0761,0.0296] -0.0052 [-0.0910,0.0805]
GG 159
GC 69 0.0004 [-0.0035,0.0042] 0.0022 [-0.0077,0.0121] 0.0059 [-0.0298,0.0417] -0.0164 [-0.0794,0.0466]
CC 9 0.0012 [-0.0150,0.0174] 0.0051 [-0.0354,0.0457] 0.0319 [-0.1073,0.1712] 0.1078 [-0.0869,0.3025]
GC+CC 78 0.0003 [-0.0035,0.0041] 0.002 [-0.0078,0.0118] 0.0058 [-0.0295,0.0410] -0.0075 [-0.0693,0.0542]
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Reference Reference Reference Reference
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Reference Reference Reference Reference
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Reference Reference Reference Reference
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Figure 4.5 Influence of rs2606345 (CYP1A1) on the association between post-bronchodilator 
FVC and 24 hour, 7-day or annual pollutant attributions to NOx, NO2, PM10 and PM2.5. Data are 
expressed relative to the major allele across the whole multi-ethnic population- GG (Table 
4.10). Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking 
exposure and study year, including effect for school location. Nominal significant differences 
relative to the reference genotype are illustrated as follows: #p<0.1, *p<0.05 and **p<0.01. 
Where these differences remained significant (P<0.05) after adjusted for multiple comparisons 








Table 4.16 Influence of rs2606345 (CYP1A1) on the association between post-bronchodilator 
FVC and 24 hour, 7-day or annual pollutant attributions to NOx, NO2, PM10 and PM2.5 for each 
of the major ethnicities in the current population. Data are expressed relative to the major allele 
for each ethnic population 
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
GG 138
GT 123 -0.0009 [-0.0023,0.0005] -0.0048* [-0.0096,-0.0000] -0.0029 [-0.0086,0.0027] -0.0019 [-0.0105,0.0066]
TT 29 -0.0003 [-0.0029,0.0023] -0.0016 [-0.0095,0.0063] -0.0003 [-0.0093,0.0087] 0.0001 [-0.0154,0.0156]
GT+TT 152 -0.0008 [-0.0021,0.0005] -0.0042 [-0.0088,0.0003] -0.0022 [-0.0075,0.0030] -0.0013 [-0.0094,0.0067]
GG 187
GT 29 -0.0024 [-0.0052,0.0005] -0.0064 [-0.0165,0.0037] -0.0101 [-0.0206,0.0003] -0.0109 [-0.0267,0.0049]
TT 1 . . . . . . . .
GT+TT 30 -0.0024 [-0.0052,0.0005] -0.0064 [-0.0164,0.0035] -0.01 [-0.0202,0.0003] -0.0107 [-0.0260,0.0047]
TT 98
TG 113 -0.0008 [-0.0027,0.0011] -0.0025 [-0.0095,0.0045] -0.003 [-0.0110,0.0050] -0.005 [-0.0171,0.0071]
GG 26 -0.0013 [-0.0032,0.0007] -0.0041 [-0.0113,0.0032] -0.0048 [-0.0129,0.0032] -0.0084 [-0.0205,0.0037]
TG+GG 211 -0.001 [-0.0028,0.0009] -0.0032 [-0.0099,0.0036] -0.0039 [-0.0115,0.0038] -0.0067 [-0.0184,0.0049]
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
GG 138
GT 123 -0.0039** [-0.0066,-0.0012] -0.0145*** [-0.0225,-0.0065] -0.0084* [-0.0153,-0.0016] -0.0102 [-0.0208,0.0003]
TT 29 -0.0003 [-0.0049,0.0044] 0.0002 [-0.0132,0.0136] -0.0017 [-0.0189,0.0156] -0.0061 [-0.0327,0.0204]
GT+TT 152 -0.0034* [-0.0059,-0.0008] -0.0122** [-0.0199,-0.0044] -0.0079* [-0.0147,-0.0012] -0.01 [-0.0203,0.0004]
GG 187
GT 29 -0.001 [-0.0069,0.0049] -0.0026 [-0.0173,0.0121] -0.0221* [-0.0421,-0.0021] -0.0241 [-0.0511,0.0028]
TT 1 . . . .
GT+TT 30 -0.001 [-0.0069,0.0049] -0.0026 [-0.0173,0.0120] -0.0222* [-0.0421,-0.0022] -0.0241 [-0.0508,0.0026]
TT 98
TG 113 -0.0012 [-0.0067,0.0043] -0.0023 [-0.0171,0.0125] -0.0062 [-0.0277,0.0153] -0.0169 [-0.0455,0.0117]
GG 26 -0.0002 [-0.0061,0.0057] -0.0013 [-0.0170,0.0144] 0.0051 [-0.0169,0.0272] -0.0026 [-0.0314,0.0262]
TG+GG 211 -0.0009 [-0.0063,0.0045] -0.0019 [-0.0164,0.0125] -0.0012 [-0.0220,0.0196] -0.01 [-0.0373,0.0174]
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
GG 138
GT 123 -0.0028 [-0.0056,0.0000] -0.0079* [-0.0157,-0.0001] -0.0237 [-0.0571,0.0098] 0.0019 [-0.0594,0.0632]
TT 29 0.0001 [-0.0037,0.0039] -0.0006 [-0.0112,0.0099] -0.004 [-0.0498,0.0418] 0.0317 [-0.0617,0.1251]
GT+TT 152 -0.0021 [-0.0048,0.0006] -0.0062 [-0.0137,0.0013] -0.0193 [-0.0517,0.0130] 0.0088 [-0.0498,0.0674]
GG 187
GT 29 -0.0077 [-0.0175,0.0021] -0.0195 [-0.0442,0.0051] -0.0666 [-0.1487,0.0154] -0.1174 [-0.2390,0.0042]
TT 1 . . . .
GT+TT 30 -0.0077 [-0.0176,0.0021] -0.0196 [-0.0442,0.0051] -0.0667 [-0.1488,0.0154] -0.1177 [-0.2386,0.0033]
TT 98
TG 113 0.0015 [-0.0047,0.0076] 0.0039 [-0.0125,0.0202] -0.0003 [-0.0498,0.0493] -0.0157 [-0.1096,0.0783]
GG 26 0.0032 [-0.0034,0.0098] 0.0078 [-0.0097,0.0253] 0.019 [-0.0328,0.0709] 0.0202 [-0.0763,0.1167]
TG+GG 211 0.0019 [-0.0042,0.0080] 0.005 [-0.0112,0.0212] 0.0075 [-0.0401,0.0552] -0.0002 [-0.0908,0.0904]
Reference Reference Reference
PM2.5 24 hours
Reference Reference Reference Reference
Asian (G/T)




Reference Reference Reference Reference
NOx 7 days NO2 7 days PM10 7 days PM2.5 7 days
Asian (G/T)
Reference Reference Reference Reference
White (T/G)
White (T/G)
Reference Reference Reference Reference
Reference Reference Reference Reference
NOx annual NO2 24 annual PM10 annual PM2.5 annual
Asian (G/T)
Reference Reference Reference Reference
Black (G/T)
Reference Reference Reference Reference
White (T/G)








 Roughly half of the world’s population - 3.4 billion people - live in urban areas 
(United Nations 2009).  By 2030, 60% of the global population are projected to live in 
cities (van Ginkel et al. 2007), and with increasing population growth and continuing 
urbanization air quality has emerged as an important determinant both of the global 
burden of disease (Lim et al. 2012) and of  health within cities (Lepeule et al. 2012; 
Gauderman et al. 2007; Grigg 2012). Larger urban populations are associated with 
increased vehicle ownership and consequently greater emissions of traffic-derived 
pollutants and adverse air quality. Exposure to traffic emissions adversely affects both 
respiratory and cardiovascular health (HEI 2010). In addition, studies following 
children's lung function over time have demonstrated that traffic fumes damage the 
development of children’s lungs (Gauderman et al. 2004, 2007). Children living close to 
main roads also report more respiratory symptoms such as a worsening of asthma 
symptoms and cough (Janssen et al. 2003; Hoek et al. 2012). 
 Interventions that aim to improve health by controlling or reducing traffic 
emissions are therefore increasingly important elements of city planning to maintain 
good public health in metropolitan areas. The introduction of low emission zones within 
cities, restricting the entry of the most polluting vehicles, or promoting the uptake of 
improved emission controls, has therefore been employed in an attempt to improve air 
quality (Kelly et al. 2011, 2012). In February 2008, London established such a Low 
Emission Zone, encompassing most of greater London, an area of 2,644km
2
, 
representing the world’s largest such initiative, impacting upon a resident population of 
8,174,100 (2011 UK census), plus 790,000 (2009 TFL traffic survey) daily commuters 
from outside the city. The London scheme was designed to have progressive tightening 
of the emission standards applied to increased proportions of the vehicle fleet over time. 
The initial two phases in 2008 applied Euro III PM10 emission standards to heavy goods 
vehicles (over 12 tonnes – phase 1) and subsequently to all vehicles (3.5-12 tonnes) and 
buses/ coaches (phase 2). Feasibility studies predicted that these changes would deliver 
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a reduction in NOx and PM10 emission of 1288 and 81 tonnes respectively. Whilst the 
overall impact of these changes on air quality were predicted to be small throughout the 
London, significant benefits were predicted in high traffic areas (Kelly et al., 2011). As 
was stated previously, the present study did not begin until November 2008, after the 
introduction of the first two phases of the LEZ. Whilst these two phases were predicted 
to result in reductions in PM10, the actual reduction was always going to be small and 
only measureable at defined hot spots. The present study is still ongoing and has just 
completed its fifth year of sampling, Nov 2012 – March 2013. In the interim period the 
phases III and IV of the LEZ were introduced in Jan 2012, with EURO IV emission 
standards applied to a broader range of vehicle types (all goods vehicles over 3.5 tonnes, 
including buses/coaches). This has been predicted to achieve reductions of 3,139 tonnes 
of NOx and 204 tonnes of PM10 respectively. Thus, the current data effectively 
constitutes a baseline to further interrogate the effectiveness of this traffic management 
scheme. In the present study, I therefore examined the relationship between lung 
function and acute to chronic pollutant exposures in children living in two inner-city 
boroughs within the LEZ; Tower Hamlets and Hackney. These areas are highly 
polluted, as reviewed in Chapter 3. 
 This study focused on children as a vulnerable group, with high pollutant 
burdens for both biologic and social reasons. Children have a larger lung-to-body 
volume ratio, their airway epithelium is more permeable to air pollutants, and their lung 
defense mechanisms against particulate matter (PM) and gaseous pollutants are not 
considered to be fully matured (Schwartz 2004).  It has been estimated, based on these 
facts that a child breathing polluted urban air will receive up to a 2- to 4-fold higher 
dose than an adult (Ginsberg 2005). There is also a growing evidence base suggesting 
that the mother’s exposure to air pollution during intrauterine development is associated 
with increased rates of infant mortality (Lipfert et al. 2000), prematurity (Sagiv et al. 
2005), congenital defects (Gilboa et al. 2005), and lower birth weight (Lee et al. 2003; 
Dugandzic et al. 2006); as well as increased respiratory symptoms (Jedrychowski et al. 
2005), decreased lung function (Turnovskaa and Marinov 2009) and poor cognitive 
development (Edwards et al. 2010) in early life.  
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 Consistent with this perceived sensitivity small deficits in lung function and 
growth have been reported in children living near busy roads with high long-term 
exposures to traffic-related air pollutants (Jedrychowski et al. 1999; Peters et al. 1999; 
Horak et al. 2002; Gauderman et al. 2004, 2007; Rojas-Martinez et al. 2007; Nordling et 
al. 2008; Oftedal et al. 2008; He et al. 2010; Roy et al. 2012; Schultz et al. 2012; 
Eenhuisen et al. 2013). However, it is important to note that the literature for a negative 
association between air pollutant exposures in children and lung function is not wholly 
coherent and numerous studies have failed to report significant associations (Dockery et 
al. 1989; Hirsch et al. 1999; Nicolai et al. 2003), or have reported effects only in sub-
groups (Peters et al. 1999). This literature has been reviewed extensively in recent times 
(Gotschi et al. 2008; HEI 2010), but due to variations in study design, exposure 
attribution (modelling versus measurement), the lung function variables used and the 
populations examined no simple clear message has emerged. A recent meta-analyis by 
Hoek et al. (2012) examined the relationship between PM10 exposure and  lung function 
(FVC, FEV1, PEF, FEF25-75) in  22,809 children, based on historic cohorts in Linz, 
Austria (6-8 year old children, study period, Jan 1996 – Dec 1998 (Moshammer et al. 
2006)), various study centres in central and Eastern Europe (9-12 year olds, Spring 1996  
(Pattenden et al. 2000)); three towns in East Germany (6-12 years, September 1992 – 
July 1993 – (Heinrich et al. 1999)); 24 schools within the Netherlands (7-12 years, 
study period, April 1997 – July 1998 (Janssen et al. 2003)) and 24 cities in the USA and 
Canada (8-12 years, 1988-1991 (Dockery et al. 1996; Raizenne et al. 1996). In this 
analysis, they found no evidence of a relationship with PM10 and lung function, 
consistent with previous studies (Dockery et al. 1989; Hirsch et al. 1999; Nicolai et al. 
2003).  
  An attempt to address discrepancies between study designs was performed as 
part of the recently completed European Study of Cohorts for Air Pollution Effects 
(ESCAPE) project. This study pooled equivalent lung function data collected from 
children (6-8 years) across five European cohorts, between 2002-2007 and related these 
to annual pollutant exposures based on residential address using Land Use Regression 
models. In addition, the influence of short term exposures on the lung function 
 166 
 
measurements were assessed based on measurements made at regional and urban 
background monitoring sites (Gehring et al. 2013). This study, with a combined 
population of 5,921 children demonstrated significant reductions in FEV1, associated 
with annual exposures to NO2, NOx, PM2.5 and PM2.5 absorbance.  
 The present study therefore appears to confirm this observation and the bulk of 
the existing literature demonstrating negative associations between lung function and 
exposure to urban air, particularly to NOx and NO2, good tracers of diesel emissions 
within London. The fact that this effect was only apparent in the post-bronchodilator 
FVC measurements and not FEV1 and only with the annual and not the shorter term 
exposure attributions strongly imply that this result reflects reduced lung growth. The 
negative impact of primary traffic derived pollutants on children's lung function has 
recently been further reinforced in a US study, where traffic exposures (again estimated 
using Land Use Regression models) were associated with reduced FEV1 and FVC in a 
cohort of 1,811 5-7 year old children (Urman et al. 2013). It is notable that compared 
with these recent studies the annual exposure to pollutants in our London cohort, 
particularly for NOx and NO2, are very high; greater than the NO2 concentrations in the 
high pollution communities (Anaheim, Glendora and San Dimas) in the study by Urman 
et al. (2013), and almost two-fold higher than the concentrations in the highest exposure 
cohort in the ESCAPE project (GIMI/LISA North): 43.52 ± 5.45 versus  23.4 ± 2.8  
g/m3 (Gehring et al. 2013). With reference to the ESCAPE study the range of NO2 
exposures observed within the Swedish BAMSE cohort, the largest of the ESCAPE 
children's cohorts (44% of the total population) with the lowest exposures varied 
between 6.0-33.0 g/m3 (Gehring et al. 2103). Therefore, all of the annual NO2 
exposures attributions within this cohort were below the range observed in London: 
31.2-98.9 g/m3. The higher concentrations observed in the current study, both reflect 
the more urban nature of the London cohort, but also the increase concentrations of NO2 
and NOx observed within European cities since the mid 2000's, due to the increased 
dieselization (Cames and Helmers 2013).   
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 In the present study, I also examined the extent to which the lung function 
changes observed upon exposure to the urban air shed were modified by genetic 
variation in genes related to the metabolism of PM components. Environmental 
pollutants have been shown to be potent inducers of the expression of phase I and phase 
II metabolizing enzymes (Fujii-Kuriyama and Mimura 2005; Köhle and Bock 2007), 
with the metabolism PAHs, particularly from diesel exhaust particles inducing oxidative 
stress (Ma and Lu 2007). The AhR upon activation by PAHs, is translocated to the 
nucleus where it drives the transcription of numerous detoxification enzymes including 
NQO1, the GSTs and CYP1A1. These responses can then be further augmented by the 
imposition of oxidative stress, which also drives NQO1 and GST expression through the 
activation of the transcription factor Nuclear factor (erythroid-derived 2)-like 2 (Nrf2), 
which orchestrates the adaptive response of cells to various stressors (Cho et al. 2006).   
As there is considerable inter-individual variation in lung function, symptomatic and 
inflammatory responses to air pollutant exposures it has been argued that there is likely 
a genetic basis to individual sensitivity (Kleeberger et al. 2005; Cho & Kleeberger 
2010). Two panels of SNPs were selected for these analysis, the first, designated the 
exploratory set examining SNPs in genes for which there was a previous literature 
demonstrating a potential  influence on lung cancer, or lung function and symptom 
responses to air pollutants (Romieu et al. 2006; Wenten et al. 2009; Castro-Giner et al. 
2009; Ren et al. 2010;  Timofeeva et al. 2010); and the second exploratory set focused 
on genetic variants in AhR and CYP1A1, examining SNPs not previously associated 
with lung function/symptom interactions with ambient air pollution. 
  Of the selected candidate genes in the confirmatory panel, GSTM1 is the most 
widely studied. GSTM1 is located on chromosome 1p13.1, within the highly 
polymorphic GSTmu1 gene cluster (Pearson et al. 1993). Two major polymorphisms 
exist in GSTM1, GSTM1*O (a deletion allele), with the homologous allele (GSTM1-
null) expressing no protein and GSTM1*A / GSTM1*B, with the later two alleles 
varying by a single base in exon 7, giving rise to active homo and heterodimeric 
enzymes (Strange et al. 2001). GSTM1 is predominately found in the liver, but is also 
expressed in the lung with the highest concentration in the major conducting airways 
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(Cantlay et al. 1994). The null genotype has been associated with enhanced airway 
inflammation in response to a diverse range of inhaled toxins: ozone (Alexis et al. 
2009), endotoxin (Dillion et al. 2011), environmental tobacco smoke (Gilliland et al. 
2006) and diesel exhaust particles (Gilliland et al. 2004). Numerous studies have also 
associated GSTM1 null with an increased risk of cancer (Carlsten et al. 2008; Hou et al. 
2000),  increased asthma susceptibility and reduced lung function (Gilliland et al. 2002; 
Tamer et al. 2004; Hanene et al. 2007), though the association of GSTM1 genotypes 
and asthma remains contentious (Reddy et al. 2010; Minelli et al. 2010). There is also 
some evidence that genetic variants in GSTM1 may be related to the rate of lung 
function decline in patients with chronic obstructive pulmonary disease, either 
singularly (Lakhdar et al. 2011), or in combination with other genetic polymorphisms 
(Chen et al. 2004). The potential role of GSTM1 in modulating pulmonary responses to 
pollutants was illustrated in recent in vitro work where the production of inflammatory 
mediators by primary bronchial epithelial cells challenged with diesel exhaust particles 
was shown to be enhanced by GSTM1 knockdown (Wu et al. 2012). Similarly, ozone-
induced pulmonary inflammation has been shown to be augmented under controlled 
exposure conditions in subjects with the null genotype (Alexis et al. 2009). Individuals 
with the null genotype have been shown to have enhanced allergic responses to diesel 
exhaust particles (Gilliland et al. 2004).  
 In the present study I employed the tagging SNP rs366631 as a GSTM1 deletion 
marker, based on the work of Huang et al. (2009) demonstrating an association between 
this SNP and GSTM1 expression. I found no evidence that the GSTM1 null genotype 
was associated with basal lung function after adjustment for the available covariants, or 
the impacts of acute to chronic air pollutant exposures on lung function. This is broadly 
in line with the literature, where only a single published study has shown an interaction 
with the null genotype alone, reporting heightened small airway responsiveness 
(decreased FEF25-75) and increased respiratory symptoms in asthmatic children (n=151-
158) exposed to high ambient ozone exposures (Romieu et al. 2004, 2006). More 
commonly associations between the null genotype and pulmonary responsiveness have 
been reported as joint interactions with polymorphisms in other genes, predominately 
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NQO1 (Chen et al. 2007; Bergamaschi et al. 2001). Both the studies by Bergamaschi et 
al. (2001) and Chen et al. (2007) addressed lung function responses in adults exposed to 
ambient ozone, with the former showing a combined effect of NQO1 wild type 
(Pro187Pro) and GSTM1 null on airway function in cyclists before and after rides 
(>80ppb, n=24); and the later, a relationship between life time exposure to ozone and 
decreased FEF25-75, for the same combined genotype, though only in female subjects 
(n=210). Whilst in the present study I also examined rs1800566 (Pro187Ser) there was 
no sufficient statistical power to examine genotype interactions. This is an important 
consideration as in the above studies there was no attempt to control for multiple 
comparisons made, in what were very small numbers of subjects. The results of the 
quoted interactions should therefore be interpreted with caution and overall one would 
have to conclude that the evidence that the GSTM1 null genotype is associated with 
poorer respiratory outcomes upon acute or chronic air pollutant exposures is weak, or at 
least unconfirmed.  
 GSTP1 (rs1695, Ile105Val, located at 11q13) is the predominate glutathione S 
transferase in the human airway (Fryer et al. 1986), with the GSTP1 valine allele 
(Val/Val), associated with reduced enzyme activity (Watson et al. 1998), reduced lung 
function (Caroll et al. 2005; Lee et al. 2005; Chen et al. 2007), increased susceptibility 
to tobacco smoke (Gilliland et al. 2006) and increased risk of early asthma (Melen et al. 
2008; Tamer et al. 2004).  In the present study we observed a valine allele frequency of 
34.8% across the total population, consistent with previous reports (Kellen et al. 2007), 
with a particularly high frequency in the black population (44.5%). The majority of 
published studies looking at interactions between air pollutant exposures and GSTP1 
polymorphisms have shown some evidence of effect modification, either alone or in 
combination with other SNPs, though the risk allele varies between studies (London and 
Romieu 2009; Minelli et al. 2010). Melen et al. (2008) reported increased allergic 
sensitization in children with the GSTP1 AG+GG genotypes in relation to their early 
life NOx exposures, whilst asthmatic children  with the GG genotype (valine allele) in 
Mexico City experience enhanced ozone-related respiratory symptoms, though no 
evidence of enhanced FEV1 or FVC responses (Romieu et al. 2006). A recent study 
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examining small cohort of South African children (9-11 years) demonstrated greater 
pollution-associated (PM10 and SO2) increases in FEV1 intra-day variability for the 
GSTP1 AG+GG genotype (Reddy et al. 2012). In contrast, in the present study, we 
observed no modifying effect of the polymorphisms in GSTP1 (rs1695 and rs749174) 
on the observed relationship between lung function and modeled pollutant exposures. 
 The final gene considered in the exploratory panel was NAD(P)H quinone 
oxidoreductase 1, which is involved in the detoxification of quinone compounds, either 
inhaled as a component of ambient PM (Baeza-Squiban et al. 1999), or formed as a 
consequence of PAH metabolism in vivo (Zhang et al. 2012). Of the polymorphisms 
considered, rs1800566 (Pro187Ser) is the most widely studied, with the serine allele 
associated with reduced (heterozygotes), or no (homozygotes) enzyme activity (Siegel 
et al. 1999). The combined GSTM1-NQO1 (Pro187Ser) genotype has been investigated 
with respect to ozone exposures in children where it has been associated with increased 
exhaled breath condensate (EBC) biomarkers of inflammation and oxidative stress 
(Corradi et al. 2002), increased pulmonary permeability (Bergamaschi et al. 2001), and  
decreased FEF25-75% (Chen et al. 2007). In addition, genetic variants in NQO1 (rs10517, 
rs1800566, and rs2917666) have been shown to have increased asthma susceptibility in 
relation to their NO2, exposure (Castro-Giner et al. 2009). In the present study, we 
observed no impact of 4 NQO1 SNPs on the association between air pollutant 
exposures, over any interval and changes in lung volume. It should be stated that where 
these, or similar associations have been examined in the previously quoted literature, no 
such associations have been reported. 
 Genetic variants in CYP1A1 and AhR genes were also investigated for their 
potential influence on the association between traffic-related air pollution and lung 
function. This represents the first time variants in these genes have been related to lung 
function air pollution interactions in the general population. In this exploratory analysis, 
9 SNPs were examined, including 5 SNPs of AhR (rs2074113, rs2066853, rs17722841, 
rs17779352 and rs2282885) and 4 SNPs of CYP1A1 gene (rs2606345, rs1799814, 
rs17861115 and rs2198843). The aryl hydrocarbon receptor (AhR) is a member of the 
basic helix-loop-helix/PAS transcription factors family, located on chromosome 7, 
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known to be involved in chemical carcinogenesis. It can be activated to its DNA 
binding form by several exogenous xenobiotic ligands such as 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) and importantly in terms of its likely involvement 
in modifying air pollutant effects, polycyclic aromatic hydrocarbons (PAHs). The 
activation of the AhR results in induction of CYP450 1A1, 1A2 and 1B1 enzymes 
(Denison and Nagy 2003). A  number of genetic variants have been identified in the 
AhR (Harper et al. 2002), mainly present in exon 10, a region encoding most of the 
transactivation domains of the receptor, which regulates the expression of other genes, 
in particular CYP1A1 (Whitelaw et al. 1994). The most studied SNP located at exon 10 
is Arg554Lys (rs2066853) was first identified in the Japanese population (Kawajiri et 
al. 1995). The same group has also discovered Asn44 (132T/C, rs17779352) located at 
exon 2. Subsequently, Smart and Daly (2000) identified SNPs at Val570Ile (1708G/A, 
rs4986826) and Pro517Ser (1549C/T, rs72552768) also within exon 10. Several studies 
have also reported polymorphisms at intronic regions such as rs2074113 (Chen et al. 
2009; Kim et al. 2007), rs17722841 (Ng et al. 2010) and rs2282885 (Bin et al. 2008; Ng 
et al. 2010). There is growing evidence indicating that genetic polymorphisms in AhR 
cause significant changes in the response to xenobiotics (Maier et al. 1998), their 
toxicity in animal models (Nebert 1989; Okey et al. 1989) and increased cancer 
susceptibility in humans (Berwick et al. 2004; Gu et al. 2012; Long et al. 2006; Ng et al. 
2010; Zhang et al. 2009). SNPs in  the AhR (rs10250822 and rs2282885) have 
previously been shown to be associated with the increased excretion of urinary 1-
hydroxypyrene in PAH exposed workers (Bin et al. 2008), though this association is yet 
to be observed in urban populations despite evidence of increased concentrations of this 
urinary metabolite (Lee et al. 2009). In the present study, no modifying effect of any of 
the studied Ahr SNPs was identified on the association between air pollutant exposure 
and lung function.  
 Cytochrome P450 1A1 (CYP1A1) is expressed in extra-hepatic tissues including 
the lung, where it is known to play an important role in PAHs metabolism and via AhR 
induction (Nebert & Ross 1996). There are a number of CYP1A1 polymorphisms, most 
notably the CYP1A1 Ile462Val (m2) allele, which has been shown to double the 
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activity of the microsomal enzyme in the heme-binding domain. In addition, mutations 
in CYP1A1 MspI (m1) have been shown to significantly increase catalytic activity in 
the Caucasian population (Landi et al. 1994). Polymorphisms in CYP1A1 have been 
investigated due to their important role in xenobiotic metabolism in relation to 
respiratory disease (Muñoz et al. 2012) and symptoms (Chen et al. 2011) associated 
with environmental tobacco smoke (ETS) exposure. However a recent  genome wide 
association study  failed to highlight CYP1A1 as a gene related to lung function risk in 
relation to cigarette smoking (Curjuric et al. 2012). Whilst several studies have 
investigated the influence of CYP1A1 polymorphisms on the relationship between air 
pollutant exposure and the generation of oxidative stress or traffic exposure biomarkers 
(Apostoli et al. 2003; Binkova et al. 2007; Novotna et al. 2007; Topinka et al. 2007; 
Adonis et al. 2003; Apostoli et al. 2003), this is the first investigation of their potential 
influence on pollutant and lung function interaction.  
 In the present study, genetic variation in the CYP1A1 gene was found to 
significantly modify the acute to sub-chronic effect of air pollution on lung volume, 
with rs2198843 (CYP1A1), being protective against and rs2606345 (CYP1A1) 
augmenting the reduction in FVC. Previous studies have shown that  the variant allele 
‘T’ of CYP1A1 rs2606345 (G/T) is significantly associated with the risk of smoking 
induced lung cancer (Canova et al. 2010; Rotunno et al. 2009). When these analyses 
were performed separately for each of the major ethnic groups it was apparent that these 
protective and sensitizing effects of the C and T alleles for rs2198843 and rs2606345, 
respectively, were seen only in the Asian and black populations.  Thus the examined 
polymorphisms did not explain the larger negative association between annual pollutant 
exposures to NOx and NO2 and FVC, observed in the white children. 
There are notable differences between the current study and all of the previously 
cited literature. First, this is the only study examining the interaction of urban air 
pollution on lung function where measurements have been obtained post-
bronchodilator. This is a significant issue, as this removes confounding due to 
undiagnosed or poorly managed asthma, which is high in this population (as reviewed 
in Chapter 3). Our study population is also multi-ethnic and lives in one of the most 
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deprived and polluted areas in the UK and perhaps most importantly this study reflects 
the contemporary urban air shed. A review of the previous literature, even that 
published within the last two years reveals that most of the cohorts investigated have 
linked air pollutant exposures to lung function measurement made in the 1990’s to the 
early to mid-2000’s (Gruzieva et al. 2013 [years covered 1994-2008]; Schultz et al. 
2012 [1994-2001]; Gao et al. 2013 [1996-2003]; Nordling et al. 2008 [1998-2000]; 
Gehring et al. 2013 [2000-2007]; Eenhuizen et al. 2013 [2000-2001]; Hoek et al. 2012 
[1988-1999]; Roy et al. 2012 [1993-1996]). Consequently, these studies largely report 
on associations based on historic air pollution and do not reflect the dramatic changes 
that have occurred in many European cities since the rapid dieselization of the fleet, and 
the introduction of particle traps. Globally, diesel cars have increased their share of the 
car market worldwide, with much of this growth in Europe, where more than one out of 
every two new cars is a diesel (Cames and Helmers 2013). A further important 
innovation in the present study was the use of scaling factors applied to the separate 
annual dispersion models to obtain spatially resolved estimates of shorter term 
exposures. As controlled and real world exposures to diesel derived aerosols have been  
shown to elicit rapid lung function decrements (McCreanor et al. 2007; Stenfors et al. 
2004), it was therefore necessary to isolate acute from long term impacts on the 
measured lung function parameters. By employing the NOWCAST scaling factors, we 
were able to examine the short term effects of exposure on the same spatial domain as 
the annual exposures, which is key innovation in the present study. In my analyses, I 
examined three exposure intervals: acute (24h pre-visit), sub-chronic (7 day average 
pre-visit) and annual attributions. These intervals were selected based on known 
pathological mechanisms of inhaled xenobiotics, based on acute airway irritation 
(McCreanor et al. 2007; Stenfors et al. 2004), sub-chronic tissue adaptation and 
sensitization (Maes et al. 2010; Porter et al. 2007) and chronic airway remodelling 
(Churg et al. 2003; Novaes et al. 2007). Complex lag structures were not examined to 
prevent a high statistical penalty in relation to testing multiple exposure intervals. It is 
notable, that whilst many studies have taken considerable care to control for multiple 
comparisons in gene-environment interaction studies, exposure attributions have seldom 
been treated in a similar fashion (Baja et al. 2013; Ren et al. 2010). 
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 There are a number of limitations with the present study. First, and perhaps most 
importantly, it was not possible due to the high mobility of children between schools in 
Hackney and Tower Hamlets to examine the impact of the introduction of the LEZ in a 
longitudinal cohort. Rather, we were reliant on separate cross sectional panels of 
children within each study year. Similar to the approach adopted by Schultz et al (2012) 
in the BAMSE cohort we attempted to dissect out the contribution of long versus short 
term exposures on lung function to infer information on lung growth, but it is important 
to state that even with our refined modeling approaches this is an imperfect solution. In 
terms of evaluating the impact of the LEZ itself on children lung function we were 
again challenged, both by the lack of a control population outside the zone, but also by 
the lack of evidence of a clear air pollution signal in NO2 and PM10 related to the 
schemes implementation. Nevertheless the measured association between FVC and 
NOx, does suggest that effective reduction of this pollutant, or targeting it is 
predominate source (traffic within London) would achieve an important health 
dividend.  
  In summary, I observed significant negative associations (P<0.05) between 
FVC and each of the examined pollutants: using NO2 as an illustration:  -3.0 (-5.0-0.0) 
mL per g/m3 of pollutant, based only on the long term exposure attributions in a 
population of 8-9 year old children only, 85% of whom lived at a locations failing meet 
the European limit value for this pollutant.  To place this in context, within the range of 
modelled annual NO2 exposure attributions for the children in this study (30.9-98.9 
g/m3, Table 3.6), assuming a mean FVC of 1.91L for the whole population, this would 
equate to losses varying between 92.7-296.7 mL, 4.85-15.5% of average FVC, 
assuming a linear dose function to zero and the absence of a plateu at the higher 
concentrations. More informatively, as a significant proportion of the studied children 
lived in areas exceeding the annual limit valued for NO2 (40 g/m
3
), this would mean 
the at least 85% of the children in the cohort would have lost in excess of 120 ml 
(6.28%) of FVC, representing a large population with a clinically significant decrement. 
 Polymorphisms in GSTP1 and possession of the GSTM1 null genotype did not 
modify the underlying relationship between the modeled exposures and FVC, but clear 
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effect modification of the pollutant, FVC association was observed with polymorphisms 
in CYP1A1 with possession of the C allele being protective for rs2198843, whilst 
possession of the T allele for rs2606345 augmented the negative association. These data 
therefore demonstrate that exposure of primary school aged children to urban pollution 
is associated with decreased lung volume, even within areas where exposure contrasts 






Examination of Biomarkers of Response (Oxidative Injury) 




5.1  INTRODUCTION 
 
In urban environments high exposures to primary traffic emissions, particularly 
from diesel vehicles have been shown to have negative health impacts on allergic 
(Janssen et al. 2003) and respiratory endpoints (Peters et al. 1999), including lung 
growth (Gauderman et al. 2004, 2007; Roy et al. 2012b; Schultz et al. 2012). This 
evidence base has been reviewed extensively in the recent USA Health Effects Institute 
review on the health effects of traffic pollutants (HEI 2010) and has been supported by 
the data presented in chapters 3 and 4. Mechanistically, these symptomatic responses 
have been related to the capacity of inhaled particulate and gaseous pollutants to elicit 
oxidative injury to the lung, related to their intrinsic capacity to oxidise biomolecules 
(nitrogen dioxide), or in the case of particulate matter their content of organic 
(polyaromatic hydrocarbons and quinones) and inorganic redox catalysts (transition 
metals) (Ciccone et al. 1998; Gerde et al. 2001; Li et al. 2003a/b; Valavanidis et al. 
2008). Thus biomarkers of oxidative injury, or perturbations in antioxidant defences 
have been proposed as informative biomarkers of the biologic impact of pollutants on 
exposed populations (Barbato et al. 2010; Møller and Loft 2010; Weimann et al. 2012). 
Two biomarkers of oxidative stress that have been widely employed in the literature are 
the nucleotide and lipid oxidation products 8-oxo-7,8-dihydro-2-deoxyguanosine (8-
oxodG) and 8-isoprostane respectively (Valavanidis et al. 2009). Air pollution exposure 
has been associated with an increased urinary excretion of 8-isoprostane (Lai et al. 
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2012) and 8-oxodG ( Avogbe et al. 2005; Barbato et al. 2010). Therefore, in the present 
study these two markers were quantified in the children’s urine to examine whether 
elevated exposures to urban air pollution was associated with evidence of systemic 
oxidative stress.  
As the concentration of oxidised biomolecules in the body reflects an imbalance 
between the generation of reactive oxygen species and the endogenous antioxidant 
defences, I also examined whether the concentration of these biomarkers were 
influenced by polymorphisms in a panel of genes related to antioxidant defence: The 
transcription factor Nuclear factor (erythroid-derived 2)-like 2 (Nrf2), which also plays 
a major role in the induction phase I xenobiotic enzymes (Osburn and Kensler 2008); 
the glutamate-cysteine ligase regulatory subunit (GCLM), which regulates intracellular 
glutathione concentrations (Breton et al. 2011) and extra-cellular superoxide dismutase 
(SOD3), which represents the major antioxidant enzyme at the air-lung interface of the 
lung (Li et al. 2004). A previous in vitro study has demonstrated that genetic disruption 
of Nrf2 is associated with increased oxidative stress and DNA lesions (Reddy et al. 
2008). Genetic polymorphisms in the Nrf2, GCLM and SOD3 have recently been 
associated with cardiovascular risk, acute lung injury and reduced lung function 
(Nakamura et al. 2002; Marzec et al. 2007; Dahl et al. 2008; Siedlinski et al. 2009). 
As a secondary exploration within this analysis, I also examined whether 
quantification of urinary metals could be employed as an exposure biomarker for traffic. 
Previous studies have employed urinary metals analysis to assess occupational or 
environmental exposures to aluminum (Riihimäki and Aitio 2012), arsenic (Saoudi et al. 
2012), mercury (Zubero et al. 2010; Castaño et al. 2012), cadmium (Zubero et al. 2010; 
Castaño et al. 2012; Cerná et al. 2012), nickel (Aguilera et al. 2010; Huang et al. 2013), 
copper (Aguilera et al. 2010; Callan AC et al. 2012; Huang et al. 2013), lead (Zubero et 
al. 2010; Castaño et al. 2012) and chromium (Aguilera et al. 2010; Zubero et al. 2010). 
Therefore, I examined an expanded panel of 15 metals, selected to reflect different 
source contributions in ambient air (Thorpe and Harrison 2008). These have been 




Table 5.1 Sources of the most abundant metals associated with ambient PM 
 
Based on information reviewed in Copper and Harrison (2009); Godri et al. (2011); Harrison and Yin 
(2011); Thorpe and Harrison (2008), Kelly et al. (2011b). 
Metal Environmental Sources
Copper (Cu)
Copper emissions are from a variety of sources including copper processing, smelting, and other metal production.
It is also a byproduct of municipal incineration and coal and oil combustion. In terms of traffic related sources,
copper is a large component of brake wear.
Iron (Fe)
Iron emissions are primary sourced from abrasion emissions, such as non-exhaust traffic emissions and as a by-
product of the iron and steel industry. It used to be a large component of fuel oil combustion, but its content in
modern fuel has decreased significantly.
Manganese (Mn)
Most commonly enters the air through the production of ferromanganese compounds in blast furnaces. Also,
found in welding rods, the incineration of manganese-containing products and is also used as a fuel additive.
Nickel (Ni)
The direct sources of nickel in the atmosphere are from nickel ore mining and smelting as well as secondary and co-
product nickel recovery. There are also a number of indirect sources of nickel in the air including: coal and oil
combustion, and petroleum processing. Small amounts can be attributed to municipal refuse and sewage
incineration.
Chromium (Cr)
Direct sources of chromium are chromite ore refining, ferrochromium and refractory and chromium chemical
production, steel production and leather tanning. Indirect sources are coal and oil combustion, cement
production, cooling towers and municipal refuse and sewage incineration.
Antimony (Sb)
Antimony is used as part of various alloys in the production of many different metals, such as various
semiconductor devices. It is also a common constitute of paint pigments as well as rubber compounding. As well
as being released directly into the air through wear of various items which contain antimony, such as brake lining
pads, antimony in the atmosphere is often released into the air from smelting plants.
Cadmium (Cd)
Pure cadmium is not found naturally in the environment; therefore, any component of cadmium in air particulates
is sourced as a by-product of refining other metals, mostly zinc. It is also found in numerous fertilizers and can be
produced as non-exhaust emission from traffic.
Arsenic (As)
Although there are a variety of sources of arsenic in the environment, the majority of the particulate matter of
arsenic is sourced from combustion of various products including, fuel, various types of waster as well as from
lime kilns and crematories.
Molybdenum 
(Mo)
Molybdenum in the environment can come from a variety sources including weathering, agriculture and industrial
processes. However the largest component comes from the burning of fossil fuels.
Barium (Ba)
The major source of barium in the atmosphere is emitted from smoke emissions either from diesel engines or as
by-products from various industrial processes such as mining and refining. Barium is also a byproduct of brake
wear from various motor vehicles.
Vanadium (V)
The major sources of vanadium in the atmosphere include vanadium refining and alloy production, power plants
and combustion of vanadium-rich oils.
Zinc (Zn)
Zinc is emitted into the atmosphere from refineries for which zinc is either the primary or the secondary product,
or as a by-product of the production of other metals. It is also a product of non-exhaust traffic emissions,
specifically tyre wear from motor vehicles.
Titanium (Ti)
Approximately 90% of the atmospheric emissions of titanium are not associated directly with the titanium
industry. Instead, the major source of titanium in the air is from the combustion of coal, and fossil fuels.
Tungsten (W)
Tungsten is not found naturally as a pure metal; it has to be extracted from mineral ores to produce pure tungsten
metal, alloys or compounds. It is released into the atmosphere as windblown dusts. In automobiles, it is sourced
from abrasion at the road surface.
Tin (Sn)
Tin is released into the atmosphere from a variety of different sources. Tin is a common component of soil and
therefore can be released into the air through weathering or agricultural activities. It is also released into the
atmosphere from abrasion of items containing tin and in dusts from wind storms and roads.
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Whilst the aim of this secondary study was to examine whether urinary metals 
could be used as informative traffic biomarkers, it was appreciated that diet would be a 
major confounding factor. Thus, it was important to understand the potential source of 
the studied metals in food. Important dietary sources of these metals are listed in the 
Table 5.2. Most of these metals are classified as essential or trace elements and are only 
found in small quantities in the body to maintain the homeostasis.  
This study therefore represents one of the largest simultaneous examinations of 
urinary biomarkers of oxidative stress and traffic exposure performed on a school age 
urban population. It also represents the first time that the concentrations of these 
biomarkers have been related to modelled pollutant exposures at the residential address 
level, over a range of exposure windows, allowing the short – versus long-term impacts 
of air pollution on these markers to be investigated. In this analysis I hypothesised that 
children with high pollutant exposures would have elevated urinary concentrations of 8-
isoprostane and 8-oxodG, associated with increased concentrations of urinary metals, 
related to both exhaust and non-exhaust traffic sources. I also examined whether 
polymorphisms in three key antioxidant genes resulted in increased concentrations of 
the oxidative biomarkers, reflecting an impaired capacity of the lung to adapt against 




















Dietary sources include shellfish, whole grains and organ meats (kidney, liver), as well as dark leafy greens
(Trumbo et al. 2001).
Iron (Fe)
Dietary iron sources can be divided into two separate forms, heme and nonheme. Heme iron is sourced
from animal foods and non-heme iron comes from plant foods (Hurrell 1997).
Manganese (Mn)
Higher manganese exposure is normally seen in vegetarians as grains, beans and nuts have high
manganese contents. There is also a higher exposure to manganese in people who drink large amounts of
tea (Department of Health and Human Services 2008). 
Nickel (Ni)
A large proportion of the dietary intake of nickel is due to leeching of nickel-containing alloys in food
processing equipment. Certain foods such as oatmeal, dried beans, peas, nuts and soya products are all
high in nickel content (Barceloux 1999; Arnich et al. 2012). 
Chromium (Cr)
Although chromium is found in a variety of foods, it is often only in very small quantities. The foods with the 
highest concentrations are meat and whole grain products (Anderson 1992).
Antimony (Sb) The most common dietary source are meats and fishes, but concentrations are very low (Arnich et al. 2012).
Cadmium (Cd)
The most common dietary sources of Cadmium are shellfish and organ meats as well as leafy vegetables
and soya produces. Food is one of the most common sources of cadmium exposure in non-smokers
(Robards and Worsfold 1991).
Arsenic (As) Arsenic is commonly found in rice and rice products (Jackson et al. 2012; Arnich et al. 2012). 
Molybdenum (Mo)
The foods with the highest concentration of molybdenum are normally animal items, specifically liver and
kidneys (Schroeder et al. 1970).
Barium (Ba)
Dietary sources with the highest concentration of Barium include brazil nuts, seaweed and fish
(Department of Health and Human Services, 2007).
Vanadium (V)
While most foods naturally contain low concentrations of vanadium, the highest concentrations can be
found in seafood products (Badmaev et al. 1999).
Zinc (Zn)
Zinc is found in highest concentrations in meats, fish and poultry. However the largest dietary contributor to 
zinc intake is water and other beverages, especially if these beverages are stored in metal containers
(Gibson 2012).
Titanium (Ti)
Amongst the sources contain titanium are chocolate, candies, chewing gums, and powdered sugar toppings
(Weir et al. 2012).
Tungsten (W)
Limited information available, but dietary intake appears to be extremely low (Agency for Toxic Substances
and Disease Registry (ATSDR) 2005).
Tin (Sn)
As tin is naturally found in soil, it can be present in low amount in vegetables and fruit and the most
common source of tin is through consuming canned foods (Shimbo et al. 2013). 
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5.2  METHODS 
 
5.2.1  Study Design and Population 
Details of study design and volunteer population are presented in Chapter 4, 
Table 4.1. Subjects provided urine samples during the study visits, aliquots of which 
were then stored at -80
o
C until required for analysis. Excess urine was discarded 
according to the regulations stipulated by the Human Tissue Authority.  
 
5.2.2  Urinary Analysis 
Details of creatinine and cotinine measurements are presented in Section 2.3.5 
(Chapter 2).  
 
5.2.2.1  Determination of Urinary Biomarkers of Oxidative Stress 
5.2.2.1.1 Analysis of 8-hydroxy-2’deoxyguanisine  
The concentration of 8-hydroxy-2’-deoxyguanisine or 8-oxodG, a biomarker for 
oxidative DNA damage, was determined using a commercial competitive enzyme-
linked immunosorbent assay (ELISA) (Oxis Health Products, Inc –Cat#:21026, Portland 
OR, USA). 50 µl sample or standard, plus 50 µl of monocolonal 8-oxodG antibody 
(diluted in phosphate buffered saline - PBS) were added to wells pre-coated with 8-
oxodG and the plate incubated at 37
o
C for an hour. To avoid edge effects, the outermost 
wells of the plate were not used. The incubation conditions creates a competitive 
environment between 8-oxodG derived from the sample with that pre-bound to the plate 
for monoclonal antibody binding. After the incubation period, the unbound antibodies 
were washed away and a secondary enzyme-labelled antibody added, diluted in PBS. 
Any unbound secondary HRP-conjugated antibody was then washed away after a 
second incubation at 37
°
C for 1 hour, prior to the addition of the chromogen (3,3',5,5'-
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Tetramethylbenzidine diluted in hydrogen peroxide/citrate-phosphate buffered saline). 
After a further 15 mins incubation at room temperature in the dark, the colour 
development was stopped by the addition of 100 L of the supplied stop solution (1M 
phosphoric acid). The absorbance of the plate was then measured at 450nm using a plate 
reader (SpectraMAX 190; Molecular Devices). Concentrations were determined with 
reference to a 6 point standard curve (0.5 ng to 200 ng/ml) using a 4-parameter logistic 
curve fit. Final concentrations were normalised against urinary creatinine 
concentrations. A representative of 8-hydroxy-2’deoxyguanisine standard curve is 
illustrated in Figure 5.1.  
 
Figure 5.1 Representative of 8-oxodG assay standard curve. The y-axis represents the 
mean absorbance values at 450 nm, the x-axis the log of the standard concentration. 
 
5.2.2.1.2 Analysis of 8-isoprostane 
A commercially available competitive ELISA assay (Cayman Chemical) was 
used for the determination of 8-isoprostane concentrations in the urine samples. The 
Concentration












y = ( (A - D)/(1 + (x/C)^B ) ) + D: A B C D R^2
Std (Standards: Concentration vs MeanValue) 1.347 0.686 5.866 0.098 0.997
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assay was based on the competition of 8-isoprostane within the sample with a 8-
isoprostane-acetylcholinesterase (AChE) tracer for a limited number of 8-isoprostane-
specific rabbit antisera binding sites within the plate wells. As the tracer concentration 
is held constant, whilst the 8-isoprostane varies between samples and standards, the 
amount of AChE that binds to the antisera is inversely proportional to the 8-isoprostane 
concentration in the samples. For the actual assay, 100 ul buffer was added to the non 
specific binding wells, whilst the maximum binding wells received 50 ul of the buffer, 
plus 50 ul of samples (urine samples were diluted 20-times prior to the assay) or 
standards (0.8-500 pg/ml). 50 ul of 8IsoP tracer and 50 ul of 8-isoprostane antiserum 
were then added to each well, with the exception of the total activity and blank wells 
after which the plate was incubated at 4
o
C for 18 hours. After the incubation period the 
wells were emptied and washed five times with the supplied wash buffer, prior to the 
addition of 200 ul of Ellman's Reagent. Following further 90 mins incubation in the 
dark, the absorbance of the plate was measured at 412 nm using a plate reader 
(SpectraMAX 190; Molecular Devices). Quantification was achieved relative to the 
standard curve, with a detection limit of 2.7 pg/ml (Figure 5.2). The analysis was 
repeated when coefficient of variation (CV) was >10% for 8-isoprostane concentration 
of >32 ng/mmol and >20% for the concentration <32 ng/mmol. The expected 8-
isoprostane concentration in urine was normalised against creatinine concentrations by 
converting the values from ng/mmol to mmol/ml. 
 
5.2.2.2 Determination of Urinary Metals Concentrations  
5.2.2.2.1 Acid Digests of Urine Samples 
Metal free conical bottom centrifuge tubes of 15 ml capacity with screw cap 
necks were used for the urine digestions (Elkay Laboratory Products, Basingstoke, 
England – product No 2086-500). Prior to use, the tubes were thoroughly washed in two 
stages in order to reduce potential metal contamination. First, with Chelex-resin treated 
water (3 times), after which they were dried in a fume cupboard for 48 hours, followed 
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by washing with 3 ml of 6.5% nitric acid solution (10.8 ml of 60 % HNO3 (Merck. 
Darmstadt, Germany – product code 1.01518.05800) and 89.2 ml of Chelex-100 resin 
treated water). 500 ul of urine was then added to 1500 ul of freshly prepared 6.5% Nitric 
acid solution in the presence of 20 ul internal standard Yttrium (1ppm Yttrium (Heeman 
Lab, Inc, Lowell, MA, USA) in 6.5% Nitric acid) and samples incubated at 90
o
C for 1.5 
hours in a thermostatically regulated water bath. After cooling overnight at room 
temperature, samples showing precipitation were centrifuged for 10 mins at 4000 rpm. 
Subsequently, the supernatants were transferred to new acid-prewashed tubes and stored 
at 4°C until analysed. All water used for tube washing and dilution of nitric acid was 
deionised and ultra-filtered using an Elga-stat filtration system, prior to Chelex-100 
resin treatment: 3 g of Chelex-100 resin per 100 ml, with overnight stirring at 4
o
C. The 
resin was subsequently removed by centrifugation (3,000 rpm for 15 mins, 4
o
C). Prior 
to use the pH of the water-methanol solution was adjusted to neutrality using Chelex 
resin treated 1M HCl or 1M NaOH. 
 
 
Figure 5.2 Representative of 8-isoprostane assay standard curve. Absorbance (A450 nm) 
was plotted against standard 8-isoprostane concentration. The sensitivity and minimum 
detection limit of this assay was defined as 2.7 pg/ml and the intra- and inter-assay 
variability range 12.6 - 34.8% and 10.5 - 39.1%, respectively. 
Concentration








y = ( (A - D)/(1 + (x/C)^B ) ) + D: A B C D R^2
Std (Standards: Concentration vs MeanValue) 0.653 1.086 16.499 0.21 0.999
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5.2.2.2.2 ICP-MS Analysis  
Samples were then transferred to the Mass Spectroscopy Unit at King’s College 
London for the quantification of Cu (isotope 63; natural abundance 69.17%), Ba (137; 
11.23%), Fe (56; 91.75%), Mn (55; 100%), Mo (95; 15.92%), Ni (60; 26.22%), Cr (52; 
83.79%), V (51; 99.71%), Sb (121; 57.21%), Zn (66; 27.90%), Cd (111; 12.80%), As 
(75; 100%), Ti (47; 7.44%), W (184; 30.64%), Sn (118; 24.22%) and the internal 
standard Y (89; 100%) (Audi et al. 1995; Rosman and Taylor 1995) by ICP-MS using a 







 interference for the major isotope of iron (
56
Fe) was removed using 
the dynamic reaction cell through its reaction with ammonia. The use of the DRC was 
































































). Sn was also measured following 
reaction with ammonia in the DRC to remove the high background, probably reflecting 




. Elemental concentrations were determined with 
reference to a 7-point standard curve based on an ICP multi element standard solution 
VI CertiPUR (Merck, Lot. No. OC529648). Antimony which is not present in this 
multi-elemental standard was analysed against its own standard curve (Antimony ICP 
standard, MERCK). All concentrations were corrected for the background elemental 
concentrations determined in the Chelex-100 resin treated water blank ran in parallel to 
each batch of samples.  
 
5.2.3  DNA Sample Collection and SNP Genotyping 
Details of DNA sample collection and the genotyping procedure are presented in 
Section 2.4. Briefly, saliva samples were collected from the children using the Oragene 
DNA kit OG-250 (DNA Genotek Inc, Canada) as a source of genetic material. The 
collection was carried out according to the manufacturer’s instruction. Subsequently, 
genomic DNA was recovered from the saliva using ethanol precipitation technique. In 
total, 10 SNPs were investigated in three genes with functions related to protection 
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against or adaption to oxidative stress: Nrf2 (rs2364723, rs7557529, rs2001350), 2 
SNPs of GCLM (rs2301022, rs3170633) and 5 SNPs of SOD3 gene (rs2284659, 
rs8192287, rs699473, rs13306703, rs8192288). Three Tag SNPs in Nrf2 (NFE2L2) 
were selected based on their reported asscociation with oxidant-related disease risks. 
SNP rs2364723 has been associated with lower basal FEV1 in two Dutch cohorts, as 
well as with increased FEV1 in smokers (Siedlinski et al., 2009). In addition, minor 
allele carriers of rs2364723 have been reported to have reduced risk of cardiovascular 
mortality in the same cohort (Figarska et al., 2014). This SNP is in almost complete 
linkage disequilibrium with the recently described promoter polymorphism rs35652124, 
suggesting the above assocation may reflect a functional impairment of Nrf2 signalling.  
Similarly, rs2001350 has been associated with the annual rate of FEV1 decline, in a 
haplotype (containing the functional SNP, rs6721961) within the japanesse population 
(Masuko et al., 2011).  This SNP has also been associated with Parkinson disease risk, 
as has rs7557529 (5238G>A) (von Otter et al., 2010). The two candidate SNPs in 
GCLM (A/G), rs3170633 (A/G), were based on those examined by Ren et al (2010), 
which had previously been associated with decreased glutathione concentrations in 
schizophrenics, as well as increased risk of this condition (Tosic et al., 2006). For SOD3 
we examined rs8192287 (within the noncoding, 5′ untranslated region in exon 1) and 
rs8192288 (first interon) based on the previous observation of Dahl et al (2008) that 
individuals homozygous for the minor alleles had reduced FVC in two large, 
population-based studies. The remaining Tagging SNPs, rs2284659, rs699473 and 
rs13306703 were selected based on the analysis of Arcaroli et al (2009) to caputure 
haplotypes with a frequency greater than 2% in the European American population. 
 All selected SNPs displayed a >5% minor allele frequency, determined from the 
published web based data sets (1000 genome data set: integrated phase 1, version 3, 
March 2012; HapMap (Thorisson et al., 2005)). Details of linkage disequilibrium are 
presented in Appendix J, Table J2. 
Subsequently, all the subjects were typed for the SNPs by GoldenGate 
genotyping assay on Illumina BeadXpress platform (Illumina Inc., San Diego, USA) 
and the genotype data was analyzed for quality control using the BeadStudio software. 
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Details of Hardy-Weinberg equilibrium p-values, genotype and allele frequencies for all 
SNPs are presented in Appendix K, tables K1 and K2. All SNP markers included in 
the analysis conformed to HWE (p>0.05) except for SNP SOD3 rs2284659, therefore 
this SNP was excluded from further analysis. Overall genotyping success rate was 
>99.6% (Table G1 in Appendix G).  
 
 
Figure 5.3 Representative elemental standard curves for Cu, Fe, Ni and Cr.  
 
5.2.4  Assessing Air Pollution Exposures 
The generation of modelled annual and temporally adjusted PM10, PM2.5, NO2 





5.2.5  Statistical Analysis 
All urinary biomarkers displayed highly skewed distributions and not normally 
distributed, based on the Shipiro-Wilks test and examination of quantile plots. For the 





 percentiles). A one way ANOVA using Kruskal-Wallis rank 
test was used to investigate any differences between groups, defined by school location 
or ethnicity, with the Mann-Whitney U-test employed for post-hoc testing. The 
Spearman Rank Order Correlation test was used to assess association between the 
measured biomarkers and the modelled pollutant exposures.  
A more detailed examination of the data was performed using a linear mixed 
model approach with random effect for school; to examine the effects of individual 
modeled pollutant exposures on natural log transformed urinary oxidative stress and 
metal outcomes. Due to the strongly right skewed urinary metal distributions, a 
generalized linear model with gamma errors was applied. Negative values (generated 
after subtraction of the blank digest concentrations) and extreme outliers were excluded 
from the analysis. To address the influence of bias introduced by the study population a 
number of baseline characteristics were selected prior to their inclusion in the models: 
age, sex, height, body mass index (BMI), self-reported ethnicity (Asian, Black, White, 
Others) and exposure to tobacco as measured by urinary cotinine:creatinine ratio 
>30ng/ml. To assess the assumption of no change over time, study year was also 
included as a covariate in the models. All results were back transformed and can be 
interpreted as a % change. 
Of the 90 single nucleotide polymorphisms (SNPs) studied, 10 were selected a 
priori in three genes related to the regulation of oxidative stress (Nrf2, GCLM and 
SOD3) for the purpose of examining their influence on the relationship between 
concentrations of urinary biomarkers of oxidative stress and modeled pollutant 
exposures. Each genotype was recorded as a categorical variable representing wild type, 
heterozygous or homozygous genotype. In order to distinguish any direct effects of 
genotype on oxidative stress a crude and an adjusted analysis was first performed for 
 189 
 
each SNP. The adjusted analysis included the same covariates as described above 
except air pollution exposures. To then test for effect modification of the SNPs, 
interaction terms of each categorical SNP and each continuous air pollution exposure 
attribution were added to the linear mixed models. For each SNP, the genotype with 
largest frequency for the total population (see Table K2 in Appendix K for genotype 
and allele frequency for each SNP) was deemed to be the wild type and used as 
reference category for the comparison between the three categories. For cases where the 
effect modification was significant for only one comparison but not the other, a global 
test was performed to assess influence of the SNP overall. Additionally, we performed 
all analysis combining heterozygous and homozygous into a single category, which 
increased the power to detect effects and also confirmed results from the global 
analysis.  
For each model, residuals were assessed for normality using quantile plots of the 
variable against the normal distribution and checked for heteroscedasticity by plotting 
residuals against the fitted values on the school level. Multiple testing was performed on 
all significant and non-significant p-values using a step-up false discovery rate (FDR) 
procedure as originally proposed by Simes (1986) and later justified by Benjamini & 
Yekutieli (2001). As described by both groups, controlling the false discovery rate is 
less conservative than using the family-wise error rate and therefore results in more 
differences being significant at the cost of some confidence in the results. The Simes’ 
FDR procedure calculates a corrected critical p-value for each observation, so that an 
individual null hypothesis is considered to be acceptable if its p-value is greater than its 
corresponding corrected critical p-value. Models were examined on the 5% significance 
level for two-sided tests of individual associations and on the 10% significance level for 
interaction terms of effect modification. All statistical analyses were performed using 
Stata 10.1 (StataCorp, College Station, TX, USA) and SPSS, version 17.0 (SPSS 





5.3  RESULTS 
 
5.3.1  Sociodemographic Characteristics of Study Population 
In total 1019 children participated in the study between Nov 2008 and April 
2011, with 974 providing a spot urine sample for biomarker analysis. The demographics 
related to this restricted group are summarized in Table 5.3, together with information 
on the pollutant attributions for study years 1 – 3 combined, based on annual, 7 day and 
24 hour exposures modeled on the subject’s residential address, as previously described 
Chapter 3. In addition, Table 5.3 also provides raw descriptive statistics on the urinary 
biomarker concentrations. For the 8-isoprostane determinations urine was available 
from 972 subjects, for 8-oxodG, 922, and for the metal analysis 883, reflecting sample 
availability. These data demonstrate that the biomarker concentrations, particularly of 
the selected metals (Ni and Cu) are highly skewed.  
 
5.3.2  Descriptive Analysis of Oxidative Stress Biomarkers  
Both 8-isoprostane and 8-oxodG concentrations varied significantly (P<0.001) 
across the 23 school sites, for the children recruited over the first 3 years of the study – 
Figure 5.4, Panels A and B. The two biomarkers of oxidative stress were weakly, but 
significantly associated (p=0.150, P<0.001 - Spearman Rank Order correlation), Figure 
5.4, Panel C. Children from Asian backgrounds showed significantly higher values for 
8-isoprostane, with Black children having the lowest values (Figure 5.4, Panel D). 
Similar results were obtained for 8-oxodG. No evidence was apparent for sex 







Table 5.3 Baseline characteristics for subjects in the London Low Emission Zone 





n % or Mean  Min Max
Age, mean (SD) 974 8.8 (0.3) 8.1 9.7
Sex
     Girls 466 47.8
     Boys 508 52.2
Height (cm), mean (SD) 965 133.8 (6.7) 111.7 156.2
Weight (kg), mean (SD) 965 32.5 (7.9) 18.8 65
BMI, mean (SD) 965 18.0 (3.2) 11.8 31.3
    Overweight (define as BMI 91st centile UK90 growth reference) 86/965 8.9
Ethnicity
     Asian 345 35.4
     Black 245 25.3
     White 269 27.6
     Mixed 115 11.8
Ɨ Household second hand smoke exposure (cotinine) 229/971 23.6
Ɨ Social deprivation (IMD), mean (SD) 972 45.4 (11.1) 5.6 66.2
8-isoprostane (ng/mg, corrected for creatinine), (log) mean (SD) 972 0.1 (0.4) -1.3 2.1
8oxodG (nmol/mmol, corrected for creatinine), (log) mean (SD) 922 1.9 (0.7) -1.4 5.5
Copper (nm/mmol, corrected for creatinine), (log) mean (SD) 953 4.4 (0.7) 1.9 11.5
Nickel (nm/mmol, corrected for creatinine), (log) mean (SD) 882 2.5 (0.8) -0.008 6.5
8-isoprostane (ng/mg, corrected for creatinine), median 972 1.06 0.28 8.43
8-oxodG (nmol/mmol, corrected for creatinine), median 922 6.72 0.24 251.86
Copper (nm/mmol, corrected for creatinine), median 953 72.64 6.55 4814.71
Nickel (nm/mmol, corrected for creatinine), median 882 10.69 0.99 653.81
Annual NOx 20m (µg/m3), mean (SD) 971 75.8 (14.7) 47.5 235.4
Annual NO2 20m(µg/m
3), mean (SD) 971 43.5 (5.5) 31.2 98.9
Annual PM10 20m(µg/m
3), mean (SD) 971 23.4 (1.4) 20.5 33.2
Annual PM2.5 20m(µg/m
3), mean (SD) 971 13.7 (0.8) 12 18
7 days NOx  20m, (µg/m3), mean (SD) 971 46.5 (16.6) 16.9 181.3
7 days NO2 20m, (µg/m
3), mean (SD) 971 25.0 (6.0) 12.2 67.3
7 days PM10 20m, (µg/m
3), mean (SD) 971 22.7 (5.5) 13.6 60
7 days PM2.5 20m, (µg/m
3), mean (SD) 971 13.6 (3.7) 8.2 35.3
24 hour NOx 20m, (µg/m3), mean (SD) 971 58.1 (43.3) 9.5 396.2
24 hour NO2 20m, (µg/m
3), mean (SD) 971 27.8 (10.8) 8.1 75.5
24 hourPM10 20m, (µg/m
3), mean (SD) 971 24.3 (9.4) 8.7 66
24 hour PM2.5 20m, (µg/m







Figure 5.4 Descriptive statistics for the urinary 8-isoprostane and 8-Oxo-2'-
deoxyguanosine. Data are illustrated as box plots, with the central line illustrating the 




 percentiles and the 
whiskers the 95% confidence intervals. Panels A and B show the concentrations of two 
biomarkers (8-isoprostane and 8-OxodG) in all subjects for years 1-3 grouped according 
to the school locations. Panel C depicts the correlation between 8-isoprostane and 8-
OxodG concentrations. Panels D and E represent 8-isoprostane and 8-OxodG 
concentrations segregated by ethnicity and sex. For Panel D ‘a’ represents a significant 
statistical difference (P<0.05) between the various populations compared to the Asian 
population; ‘b’ compared with the Black population; ‘w’ related to the White population 
and ‘o’ shows comparison with the subjects of ‘Others’ group.  
 
The exposure of children to the environmental tobacco smoke (ETS) at home 
was also investigated. Figure 5.5 shows the comparative concentrations of 8-
isoprostane and 8-oxodG in children exposed to ETS with the non-ETS exposed 
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children, based on their measured cotinine / creatinine ratio – as described in section 
3.2.3.2. The results indicated that the children exposed to ETS showed significantly 
higher concentrations of both 8-isoprostane and 8-oxodG: for 8-IsoP, 118.59 (92.76 - 
153.2) (n=750), versus 125.47ng/mM (101.43 - 160.42) ng/mM creatinine (n=219), 
P<0.05; and for 8-oxodG, 6.51 (4.61 - 9.12) nM/mM creatine versus (5.52 - 9.93) 




Figure 5.5 Effect of ETS exposures on the 8-isoprostane and 8-oxodG concentrations. 
Notes: n=no, not exposed to ETS; y=yes, exposed to ETS. 
 
The associations between the urinary oxidative stress markers and modeled 
exposures to NOx, NO2, PM10 and PM2.5 are illustrated in Figure 5.6 – 5.9. Overall, 
there was evidence of weak but significant negative associations between acute 24 hour 
exposures to NOx and NO2 and urinary 8-isoP concentrations – Figure 5.6 and 5.7. No 
significant associations were seen with acute to chronic exposure attributions for PM10 
or PM2.5. The pattern with 8-oxodG was somewhat different with weakly positive 
associations with 24 hour NOx, NO2 (Figure 5.6 and 5.7) and PM10 (Figure 5.8) 




Figure 5.6 Correlations between urinary biomarkers and NOx exposures. The 
association between exposures and urinary biomarkers were examined using the 
Spearman Rank Order correlation. For each panel, the number of samples included in 
the analysis ‘n’, the correlation coefficient ‘ρ’ and the level of significance of the 
correlation ‘P’ is listed in the upper right hand corner of the image. Panels A-C 
illustrates the associations between 8-isoP and the various modeled exposures to NOx, 




Figure 5.7 Correlations between urinary biomarkers and NO2 exposures. The 
association between exposures and urinary biomarkers were examined using the 
Spearman Rank Order correlation. For each panel, the number of samples included in 
the analysis ‘n’, the correlation coefficient ‘ρ’ and the level of significance of the 
correlation ‘P’ is listed in the upper right hand corner of the image. Panels A-C 
illustrates the associations between 8-isoP and the various modeled exposures to NO2, 




Figure 5.8 Correlations between urinary biomarkers and PM10 exposures. The 
association between exposures and urinary biomarkers were examined using the 
Spearman Rank Order correlation. For each panel, the number of samples included in 
the analysis ‘n’, the correlation coefficient ‘ρ’ and the level of significance of the 
correlation ‘P’ is listed in the upper right hand corner of the image. Panels A-C 
illustrates the associations between 8-isoP and the various modeled exposures to PM10, 




Figure 5.9 Correlations between urinary biomarkers and PM2.5 exposures. The 
association between exposures and urinary biomarkers were examined using the 
Spearman Rank Order correlation. For each panel, the number of samples included in 
the analysis ‘n’, the correlation coefficient ‘ρ’ and the level of significance of the 
correlation ‘P’ is listed in the upper right hand corner of the image. Panels A-C 
illustrates the associations between 8-isoP and the various modeled exposures to PM2.5, 
Panels D-F, the associations with 8-oxodG.  
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When these relationships were examined in the linear mixed modeled controlled 
for the covariants, previously outlined, significant negative associations were noted for 
8-isoprostane with 24 hour, but not 7 day or annual modeled exposures for NOx and 
NO2 equivalent to a 0.1 and 0.4% reduction in urinary 8-isoprostane per µg/m
3
 increase 
in NOx and NO2 respectively – Table 5.4. No associations were apparent for any of the 
modeled PM10 and PM2.5 exposures with urinary 8-isoprostane concentrations. In 
contrast, urinary 8-oxodG concentrations were positively associated with the 24h 
modeled exposures for all four of the pollutants examined, with the associations for 
PM10 and PM2.5 remaining significant after the correction for multiple testing. This 
equated to a 0.12% to 1.62% increased in urinary 8-oxodG per mg/m
3
 PM10 and PM2.5 
respectively – Table 5.4. Conversely, there was a negative association between 8-
oxodG and 7 day average NOx. No significant effects were apparent between the long 
term exposure to NOx, NO2, PM10 and PM2.5 estimates and 8-oxodG. 
 
Table 5.4 Effect estimates (ratio of gemetric means) for the association between 
modeled air pollutant concentrations and oxidative stress biomarkers (8-isoprostane and 
8-oxodG) concentrations 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking 
exposure and study year including effect for school.  *p<0.05, **p<0.01, ***p<0.001. Ŧ 




NOx NO2 PM10 PM2.5 
Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
8-isoprostane
Annual 1.0005[0.9987,1.0022] 1.0013[0.9967,1.0060] 1.0025[0.9848,1.0205] 1.005[0.9626,1.0492]
7 days 0.999[0.9973,1.0007] 0.9992[0.9943,1.0041] 0.9965[0.9912,1.0019] 0.9947[0.9869,1.0025]
24 hour Ŧ0.9990**[0.9984,0.9997] Ŧ0.9963**[0.9937,0.9989] 0.9975[0.9946,1.0004] 0.9978[0.9935,1.0021]
8-oxodG
Annual 0.9994[0.9963,1.0025] 0.9985[0.9902,1.0068] 0.9898[0.9599,1.0208] 0.9449[0.8774,1.0177]
7 days Ŧ0.9950**[0.9919,0.9981] 0.993[0.9843,1.0017] 0.9921[0.9822,1.0022] 0.9844*[0.9698,0.9993]





5.3.3  Descriptive Statistics of Urinary Metal Concentrations 
Fifteen urinary metals were analyzed to investigate their predictive value as 
biomarkers of traffic exposure. Figure 5.10 illustrates the overall data for the 
investigated metals in all subjects, in addition to stratification by exposure to ETS 
(environmental tobacco smoke). Antimony (Sb) and tungsten (W) showed values below 
detection limit, whereas titanium (Ti) showed values higher than Zn, which was 













. Zinc (Zn) showed the highest urinary concentration, 
followed by a panel on medium abundance metals, Cu, Fe, Mo and As, with trace 
concentrations of Ba, Mn, Ni, Cr, Cd, V and Sn. The lower panel of Figure 5.10 
illustrates differences in metal concentration between ETS-exposed and non-ETS 
exposed subjects. There was a noticeable pattern of increased urinary metal 
concentrations associated with ETS exposure: for Ni, 9.9 (5.8 - 17.4) versus 10.9 (6.5 - 
19.2) nM/mM creatinine, p=0.06; Ba 4.81 (2.86 - 8.79) versus 6.18 (3.74 - 9.54) 
nM/mM creatinine, p<0.01); Mn 2.79 (1.36 - 6.76) versus 6.18 (3.74 - 9.54) nM/mM 
creatinine, p<0.05) and Sn 2.56 (1.37 - 5.23) versus 3.65 (2.03 to 7.86) nM/mM 
creatinine, p<0.001. Molybdenum in contrast was significantly lower in the subjects 
with evidence of ETS exposure: 153.3 (102.9 - 210.9), p<0.01, versus 170.93 (118.65 - 
246.08) nM/mM creatinine, p<0.01. 
Crude correlations between the measured urinary metals and the modeled 
pollutant concentrations are illustrated in Table 5.5. The correlation matrix revealed a 
number of significant interactions between the various metals: 71 significant 
associations from 144 potential interactions. Overall, many of the observed significant 
associations were either weakly positive or negative, with only the  trace elements of oil 
combustion (Cr and V) being strongly associated with chronic exposure to PM2.5: For 





Figure 5.10 Urinary metal concentrations in school children. The data in the upper 
panel is associated with the overall study population stratified by concentration. The 
lower panel classifies the data by exposure to ETS. Data are presented as box plots, as 
described in the legend of Figure 5.4. Comparison between the ETS and non-ETS 
exposed groups was performed using the Mann-Whitney U test. Notes: n= no (not 
exposed to ETS), y=yes (exposed to ETS). 
 
For the subsequent analyses, I focused only on Cu and Ni, as biomarkers of 
vehicular abrasion and oil combustion. Figures 5.11 and 5.12 illustrates urinary 
concentrations of Cu (vehicular abrasion) and Ni (exhaust emission) respectively, based 
on school location, ethnicity and sex. Significant geographical differences (p<0.001) in 
the urinary concentrations of the two metals were observed, grouping the year 1-3 
volunteers by school location (Figures 5.11 and 5.12, Panel A).  Significant differences 
in urinary metal concentrations were observed between the different ethnic groups. The 
results largely concurred with oxidative stress biomarkers analysis, with children of 
Asian ethnicity having significantly higher urinary metal concentrations than Black and 
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White, Figures 5.11 and 5.12, Panel C. Female subjects also showed significantly 
higher levels of both metals compared to males (Figures 5.11 and 5.12, Panel D). The 
correlation between urinary Cu concentrations and the measured biomarkers of 
oxidative stress demonstrated weak through significant positive associations; for 8-
isoprostane (ρ= 0.149, p<0.01, n= 953 sample) and 8-oxodG (ρ = 0.106, p=0.001, 
n=911) – Figure 5.11, Panel B. Similar, though weaker positive associations were also 
noted between Ni and 8-isoprostane and 8-oxodG (Figure 5.12, Panel B). 
 
Table 5.5 The correlation matrix for the attribution of urinary metals to the modeled 
pollutants 
 
Notes: The upper number indicates the correlation coefficient between the metal with 
the exposure parameter; the lower number (blue) number of values included in the 
correlation. Significant correlations are highlighted: blue cells, *=p<0.05; orange cells, 





Figure 5.11 Descriptive analyses of urinary Copper. Panel A illustrates the 
geographical variation in urinary Cu concentration by school location. Panel B 
illustrated the association between urinary copper with 8-isoprostane and 8-Oxo-2’-
deoxyguanosine concentrations. Difference in urinary Cu concentrations between 
different ethnicities and sex are illustrated in Panels C and D respectively. Details of 
analysis are identical to those described in the legend of Figure 5.4. 
 
The adjusted associations between the measured urinary copper and nickel 
concentrations with modeled NOx, NO2, PM10 and PM2.5 over the 24h, 7 days and 
annual periods are presented in Table 5.6. Urinary Cu was not associated with the 
annual modeled exposures of any of the pollutants; however, significant negative 
associations were noted for 7 day average NOx (0.02% per g/m3) and 24 hour PM2.5 
(0.06%, per g/m3) exposures. In contrast, urinary nickel was significantly decreased by 
0.3% and 0.7% when related to the 7 day average PM10 and PM2.5 respectively. No 
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Figure 5.12 Descriptive analyses of urinary Nickel. Panel A illustrates the geographical 
variation in urinary Ni concentration by school location. Panel B illustrated the 
association between urinary Ni with, 8-isoprostane and 8-oxo-2’-deoxyguanosine 
concentrations. Differences in urinary Ni concentrations between ethnicities and sex are 
illustrated in Panels C and D respectively. Details of analysis are identical to those 
described in the legend of Figure 5.4.  
 
5.3.4  Genetics Analysis 
5.3.4.1 Allele and Genotype Frequencies 
The distribution of the genotype and allele frequencies for Nrf2, GCLM and 
SOD3 SNPs for the total population and the population stratified by ethnicity is shown 
in Tables J2 and J3 (Appendix J). The genotype distributions between the ethnicities 
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for Nrf2 were only similar for one SNP, rs2001350 (A/G) with a minor allele frequency 
(MAF) of ~12%. For SNP rs2364723 (G/C), Black, White and ‘Others’ shared the same 
common genotype, ‘GG’, however, there was little variation amongst the ethnicities, 
with MAF of 20%, 28% and 36% each. In contrast, ‘C’ represented the major allele for 
the Asian population with MAF of 44%. Whereas for SNP rs7557529 (T/C), although 
Asian, Black and ‘Others’ shared the same common genotype, there was high 
heterozygosity for Black and ‘Others’.  
 
Table 5.6 Effect estimates (% change) for the association between urinary Cu and Ni 
concentrations with annual, 7 day and 24 hour modeled pollutant exposures 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for 
smoking exposure and study year including effect for school.  *p<0.05, **p<0.01, 
***p<0.001. Ŧ Significant after the multiple testing procedures has been applied. Notes: 
Blank cells indicate non-converged data. 
 
For  GCLM SNP rs2301022 (G/A), all the ethnicities shared the  same common 
genotype ‘GG’ with a MAF between 29% to 38%, except for the Black population, 
where ‘AA’ was the common genotype with a MAF of 47%. For SNP rs3170633 (G/A), 
all ethnicities shared the same common genotype ‘GG’ with Asians having 15% higher 
MAF. In contrast, ‘AA’ was the major allele for Black with a MAF of 30%. In addition, 
all the ethnicities shared the same common genotype for all SOD3 SNPs, except 
rs699473 (C/T). While the Asian and ‘Others’ populations had a similar allele 
frequency of ‘C’, 50%, allele ‘T’ was the minor allele for Black population (25%) and 
‘C’ is minor allele for White group (38%). 
NOx NO2 PM10 PM2.5 
Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
Copper
Annual 1.0000[0.9999,1.0002] 1.0000[0.9996,1.0004] 1.0019[0.9983,1.0055]
7 days Ŧ0.9998**[0.9997,0.9999] 0.9999[0.9996,1.0003] 0.9997[0.9993,1.0001] 0.9997[0.9991,1.0003]
24 hour 1.0000[0.9999,1.0000] 0.9999[0.9997,1.0001] 0.9998[0.9996,1.0001] Ŧ0.9994***[0.9991,0.9997]
Nickel
Annual 1.0005[0.9998,1.0012] 1.0040[0.9971,1.0110] 1.0150[0.9982,1.0320]
7 days 0.9998[0.9992,1.0003] 1.0011[0.9996,1.0026] Ŧ0.9968**[0.9948,0.9988] Ŧ0.9930***[0.9902,0.9958]
24 hour 0.9999[0.9998,1.0001] 1.0009*[1.0001,1.0017] 1.0002[0.9993,1.0011] 0.9998[0.9984,1.0011]
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5.3.4.2 Assessing the Modifying Effect of Genotype on the Relationship between 
Biomarkers of Oxidative Stress and Ambient Pollutant Exposures 
Tables 5.7 and 5.8 illustrate the crude and adjusted effects of Nrf2, GCLM and 
SOD3 genotypes on urinary 8-isoprostane and 8-oxodG concentrations. While 
unadjusted and adjusted estimates suggested significant associations with some of the 
genotypes, with 8-isoprostane (Nrf2, rs7557529) and 8-oxodG (Nrf2, rs7557529, 
rs2001350), these interactions were no longer significant after correction for multiple 
testing. This indicates that the studied SNPs in Nrf2, GCLM and SOD3 do not have 
direct effects on measured biomarkers of oxidative stress. 
 
Table 5.7 Unadjusted and adjusted effect estimates (β) with 95% confidence intervals 
(95% CI) for the association between biomarkers of oxidative stress and Nrf2 and 
GCLM genotypes  
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking 
exposure and study year including effect for school. *p<0.5, **p<0.01.  
Genotype
Unadjusted Adjusted Unadjusted Adjusted
(n=943) (n=932) (n=894) (n=886)
rs2364723 G/C
GG Reference Reference Reference Reference
GC 1.0167[0.9619,1.0747] 1.0076[0.9527,1.0658] 0.9923[0.9038,1.0895] 0.9767[0.8891,1.0731]
CC 1.0834*[1.0056,1.1674] 1.0305[0.9523,1.1152] 1.033[0.9098,1.1728] 1.0185[0.8922,1.1627]
GC+CC 1.0338[0.9815,1.0888] 1.0128[0.9600,1.0684] 1.0027[0.9185,1.0946] 0.986[0.9014,1.0785]
rs7557529 T/C
TT Reference Reference Reference Reference
TC 0.9217**[0.8723,0.9738] 0.9405*[0.8899,0.9940] 0.9069*[0.8269,0.9946] 0.8997*[0.8205,0.9866]
CC 0.9374[0.8689,1.0113] 0.9476[0.8772,1.0236] 1.0514[0.9251,1.1950] 1.0329[0.9078,1.1752]
TC+CC 0.9255**[0.8787,0.9748] 0.9422*[0.8940,0.9930] 0.94[0.8612,1.0260] 0.929[0.8509,1.0143]
rs2001350 A/G
AA Reference Reference Reference Reference
AG 0.9814[0.9227,1.0439] 0.9805[0.9227,1.0418] 0.9597[0.8656,1.0639] 0.9585[0.8660,1.0608]
GG 0.9278[0.7260,1.1858] 0.9497[0.7460,1.2090] 1.4541[0.9751,2.1683] 1.4921*[1.0073,2.2103]
AG+GG 0.9788[0.9213,1.0399] 0.979[0.9224,1.0391] 0.9797[0.8853,1.0841] 0.9795[0.8866,1.0822]
rs2301022 G/A
GG Reference Reference Reference Reference
GA 0.9508[0.9001,1.0043] 0.9647[0.9131,1.0191] 0.9367[0.8540,1.0274] 0.9484[0.8648,1.0401]
AA 0.9605[0.8897,1.0369] 0.9848[0.9105,1.0651] 0.8429**[0.7419,0.9575] 0.8938[0.7846,1.0182]
GA+AA 0.9532[0.9055,1.0034] 0.9692[0.9200,1.0210] 0.9118*[0.8360,0.9945] 0.9354[0.8570,1.0210]
rs3170633 G/A
GG Reference Reference Reference Reference
GA 0.9876[0.9326,1.0458] 1.0038[0.9469,1.0641] 0.9359[0.8501,1.0303] 0.9602[0.8710,1.0585]
AA 0.9907[0.9216,1.0650] 1.0379[0.9578,1.1248] 0.8898[0.7857,1.0077] 0.988[0.8617,1.1328]






Table 5.8 Unadjusted and adjusted effect estimate (β) and 95% confidence intervals 
(95% CI) for the association between biomarkers of oxidative stress and SOD3 
genotypes  
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and 
study year including effect for school. *p<0.5, **p<0.01.  
 
Subsequently, the interaction effects of Nrf2, GCLM and SOD3 SNPs on the 
relationship between pollutant exposure and oxidative stress biomarkers were 
examined. After adjustment for multiple comparisons, no significant interactions of the 
studied polymorphisms were observed on the relationship between urinary oxidation 
markers and the acute 24 hour exposure attributions – Appendix J, Tables J4– J7. In 
contrast, based on the 7 day (sub-chronic) exposure attribution, SNPs in Nrf2 were 
found to have positive effect on the urinary concentrations of 8-isoP (rs7557529) in 
relation to NO2 concentrations, and 8-oxodG (rs2364723), with respect to PM10 – 
Appendix J, Tables J8 and J9 respectively. In the former case (rs7557529 – Nrf2) 
possession of the ‘C’ allele was associated with significant 1.5% increase in urinary 8-
IsoP concentrations per g/m3 NO2 in the heterozygote’s compared with the reference 
‘TT’ genotype (Figure 5.13). Similar associations were observed with the 7-day NOx 
exposure attributions, but these failed to attain statistical significance after adjustment 
Genotype Unadjusted Adjusted Unadjusted Adjusted
(n=941) (n=930) (n=892) (n=884)
rs8192287 G/T
GG Reference Reference Reference Reference
GT 1.0194[0.9502,1.0936] 1.0029[0.9338,1.0772] 1.0488[0.9316,1.1806] 1.0055[0.8922,1.1332]
TT 0.8661[0.6689,1.1214] 0.8889[0.6888,1.1472] 1.1656[0.7653,1.7753] 1.0473[0.6912,1.5868]
GT+TT 1.0098[0.9429,1.0815] 0.9958[0.9287,1.0677] 1.0555[0.9405,1.1846] 1.0081[0.8972,1.1327]
rs699473 C/T
CC Reference Reference Reference Reference
CT 0.9829[0.9270,1.0421] 0.9582[0.9028,1.0171] 1.0194[0.9243,1.1244] 0.9895[0.8950,1.0941]
TT 1.0266[0.9580,1.1000] 1.0087[0.9380,1.0847] 1.1499*[1.0245,1.2907] 1.0721[0.9491,1.2109]
CT+TT 0.9972[0.9444,1.0531] 0.9727[0.9191,1.0293] 1.0614[0.9687,1.1630] 1.0131[0.9209,1.1146]
rs13306703 C/T
CC Reference Reference Reference Reference
CT 0.9763[0.9229,1.0329] 0.9851[0.9307,1.0426] 0.9953[0.9055,1.0941] 1.0079[0.9168,1.1081]
TT 1.0236[0.9037,1.1594] 1.0359[0.9149,1.1729] 1.0524[0.8585,1.2901] 1.0723[0.8754,1.3135]
CT+TT 0.9824[0.9310,1.0366] 0.9917[0.9395,1.0468] 1.003[0.9166,1.0974] 1.0166[0.9290,1.1125]
rs8192288 G/T
GG Reference Reference Reference Reference
GT 1.027[0.9579,1.1010] 1.0106[0.9415,1.0848] 1.0487[0.9324,1.1795] 1.0043[0.8918,1.1310]
TT 0.8665[0.6695,1.1214] 0.8898[0.6898,1.1478] 1.1652[0.7653,1.7739] 1.0451[0.6900,1.5831]




for multiple testing (Figure 5.13). When these data were examined stratified according 
to the three major ethnic groups it was evident that the positive effect of the ‘C’ allele 
was largely restricted to the black children for the 7 day exposures to NOx and NO2, 
and only seen in the heterozygotes (TC) and in the combined model (TC+CC) (Table 
5.8). In addition, these was some evidence that the ‘C’ allele was associated with lower 
urinary 8-isoP concentrations in relation to annual exposures to PM10 and PM2.5, which 
was not apparent in the combined analysis. 
 
Figure 5.13 Influence of rs7557529 (Nrf2) on the association between urinary 8-isoP 
concentrations and 24 hour, 7-day or annual pollutant attributions to NOx and NO2. 
Data are expressed relative to the major allele across the whole multi-ethnic population- 
TT (Appendix J, Table J2). Models are adjusted for age, sex, ethnicity, height, BMI, 
IMD, urinary CCR for smoking exposure and study year, including effect for school 
location. Nominally significant differences relative to the reference genotype are 
illustrated as follows: #p<0.1, *p<0.05 and **p<0.01. Where these differences remained 
significant (P<0.05) after adjusted for multiple comparisons this is illustrated by ‘ǂ’. 
 
For rs2364723 (Nrf2) possession of the ‘C’ allele, in the combined model was 
associated with a 2.8% increase in urinary 8-oxodG concentrations per unit increase in 
the sub-chronic (7 day) modeled PM10 concentrations compared with the GG reference 
genotype (Figure 5.14). A similar pattern was observed with 7 day exposure 
attributions to both NO2 and PM2.5, but these failed to reach statistical significance after 
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correction for multiple comparisons. Similar, though non-significant trends were also 
observed with this pollutant using the acute 24h exposure attributions (Figure 5.14).   
Table 5.8 Influence of rs7557529 (Nrf2) on the association between urinary 8-isoP 
concentrations and 24 hour, 7-day or annual pollutant attributions to NOx and NO2 for 
each of the major ethnicities within the study population. Data are expressed relative to 
the major allele for each population. 
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
TT 176
TC 128 1.0005 [0.9977,1.0033] 1.0004 [0.9914,1.0095] 1.0005 [0.9906,1.0105] 0.9987 [0.9836,1.0141]
CC 26 0.9983 [0.9955,1.0013] 0.9853* [0.9722,0.9985] 0.9883 [0.9726,1.0043] 0.9777 [0.9551,1.0007]
TC+CC 154 0.9995 [0.9972,1.0018] 0.9964 [0.9882,1.0047] 0.9978 [0.9887,1.0071] 0.9937 [0.9797,1.0078]
TT 79
TC 116 1.0007 [0.9977,1.0037] 1.0027 [0.9914,1.0141] 1.0063 [0.9935,1.0192] 1.008 [0.9898,1.0266]
CC 39 1.0032 [0.9986,1.0079] 1.0128 [0.9968,1.0291] 1.0086 [0.9905,1.0271] 1.0118 [0.9864,1.0379]
TC+CC 155 1.0011 [0.9982,1.0040] 1.0049 [0.9940,1.0159] 1.0069 [0.9946,1.0193] 1.0092 [0.9918,1.0268]
CC 68
CT 117 1.0017 [0.9997,1.0037] 1.0051 [0.9961,1.0143] 1.0032 [0.9931,1.0135] 1.0054 [0.9914,1.0196]
TT 65 1.0013 [0.9987,1.0039] 1.0018 [0.9914,1.0124] 1.0011 [0.9886,1.0137] 1.0032 [0.9851,1.0216]
CT+TT 182 1.002 [0.9996,1.0035] 1.0038 [0.9954,1.0123] 1.0022 [0.9926,1.0119] 1.0043 [0.9907,1.0180]
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
TT 176
TC 128 1.0022 [0.9969,1.0074] 1.0042 [0.9887,1.0199] 1.0087 [0.9953,1.0223] 1.0146 [0.9940,1.0357]
CC 26 0.995 [0.9873,1.0028] 0.981 [0.9558,1.0069] 0.9915 [0.9702,1.0133] 0.9827 [0.9507,1.0157]
TC+CC 154 1.0003 [0.9955,1.0051] 0.9992 [0.9849,1.0137] 1.0048 [0.9925,1.0172] 1.0071 [0.9883,1.0263]
TT 79
TC 116 1.0054 [0.9988,1.0121] 1.0196* [1.0026,1.0368] 0.9971 [0.9750,1.0198] 0.9926 [0.9602,1.0262]
CC 39 1.0108* [1.0006,1.0211] 1.0288* [1.0034,1.0550] 0.9962 [0.9624,1.0311] 0.9931 [0.9463,1.0422]
TC+CC 155 1.0067* [1.0004,1.0130] 1.0218** [1.0056,1.0382] 0.9977 [0.9768,1.0190] 0.9943 [0.9638,1.0258]
CC 68
CT 117 1.0056 [0.9997,1.0114] 1.0165 [0.9994,1.0338] 0.9986 [0.9742,1.0236] 0.9987 [0.9640,1.0347]
TT 65 1.0005 [0.9929,1.0082] 0.9989 [0.9778,1.0204] 0.9781 [0.9488,1.0083] 0.9734 [0.9324,1.0163]
CT+TT 182 1.0041 [0.9987,1.0094] 1.011 [0.9956,1.0266] 0.9915 [0.9687,1.0148] 0.9899 [0.9574,1.0235]
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
TT 176
TC 128 1.0027 [0.9946,1.0109] 1.0067 [0.9861,1.0278] 1.0283 [0.9529,1.1096] 1.0325 [0.9162,1.1636]
CC 26 0.9898 [0.9724,1.0075] 0.9742 [0.9316,1.0187] 0.9637 [0.8187,1.1344] 0.952 [0.7669,1.1817]
TC+CC 154 1.0007 [0.9932,1.0083] 1.0015 [0.9823,1.0210] 1.018 [0.9480,1.0933] 1.0173 [0.9093,1.1381]
TT 79
TC 116 0.9933 [0.9849,1.0018] 0.9839 [0.9624,1.0059] 0.9256* [0.8584,0.9980] 0.8582* [0.7539,0.9769]
CC 39 1.0072 [0.9931,1.0215] 1.0161 [0.9806,1.0529] 1.0489 [0.9263,1.1876] 0.9815 [0.8059,1.1954]
TC+CC 155 0.9958 [0.9877,1.0039] 0.9898 [0.9692,1.0109] 0.9464 [0.8809,1.0167] 0.8791* [0.7766,0.9952]
CC 68
CT 117 1.0032 [0.9962,1.0103] 1.0082 [0.9899,1.0268] 1.0177 [0.9508,1.0893] 0.9866 [0.8748,1.1127]
TT 65 1.0014 [0.9938,1.0090] 1.0021 [0.9823,1.0222] 1.0129 [0.9359,1.0962] 1.0346 [0.8995,1.1901]
CT+TT 182 1.0026 [0.9968,1.0084] 1.006 [0.9907,1.0216] 1.0164 [0.9559,1.0808] 1.0035 [0.8986,1.1207]
White (C/T)
NOx 24 hours NO2 24 hours PM10 24 hours PM2.5 24 hours
Asian (T/C)
Reference Reference Reference Reference
Black (T/C)
Reference Reference Reference Reference
Black (T/C)
Reference Reference Reference Reference
NOx 7 days NO2 7 days PM10 7 days PM2.5 7 days
Asian (T/C)
Reference Reference Reference Reference
White (C/T)
Reference Reference Reference Reference
Reference Reference Reference Reference
Reference Reference Reference Reference
NOx annual NO2 24 annual PM10 annual PM2.5 annual
Asian (T/C)
Reference Reference Reference Reference
Black (T/C)






Figure 5.14 Influence of rs2364723 (Nrf2) on the association between urinary 8-oxodG 
concentrations and 24 hour, 7-day or annual pollutant attributions. Data are expressed 
relative to the major allele across the whole multi-ethnic population- GG (Appendix J, 
Table J2). Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR 
for smoking exposure and study year, including effect for school location. Nominally 
significant differences relative to the reference genotype are illustrated as follows: 
#p<0.1, *p<0.05 and ** p<0.01. Where these differences remained significant (P<0.05) 
after adjusted for multiple comparisons this is illustrated by ‘ǂ’. 
 
When these analyses were repeated separately referenced againt the major allele 
for each ethnicity: Asian (C, 56%), black (G, 80%) and white (G, 72%), the ‘C’ allele 
was only associated with increased excretion of 8-oxodG in the white population (GC 
and GC+CC) for acute and sub-chronic exposures to PM10, Table 5.9. 
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Table 5.9 Influence of rs2364723 (Nrf2) on the association between urinary urinary 8-
oxodG concentrations and 24 hour, 7-day or annual pollutant attributions to NOx and 
NO2 for each of the major ethnicities within the study population. Data are expressed 
relative to the major allele for each population 
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
CC 105
CG 145 1.0022 [0.9969,1.0074] 1.0093 [0.9911,1.0277] 1.0072 [0.9868,1.0279] 1.0092 [0.9789,1.0404]
GG 72 0.9972 [0.9918,1.0025] 0.9889 [0.9684,1.0098] 0.9845 [0.9606,1.0091] 0.9728 [0.9353,1.0118]
CG+GG 217 0.9997 [0.9952,1.0043] 1.0016 [0.9849,1.0184] 0.9994 [0.9805,1.0187] 0.9979 [0.9697,1.0269]
GG 138
GC 79 1.0009 [0.9970,1.0050] 1.0046 [0.9891,1.0202] 1.002 [0.9845,1.0199] 0.9994 [0.9736,1.0260]
CC 8 0.9947 [0.9803,1.0094] 0.9648 [0.9116,1.0210] 0.9925 [0.9449,1.0426] 0.9967 [0.9221,1.0774]
GC+CC 87 1.0007 [0.9968,1.0046] 1.0029 [0.9878,1.0182] 1.0016 [0.9847,1.0189] 0.9998 [0.9747,1.0255]
GG 126
GC 92 1.0013 [0.9985,1.0041] 1.0095 [0.9964,1.0228] 1.0150* [1.0009,1.0294] 1.0186 [0.9989,1.0387]
CC 19 1.0008 [0.9938,1.0079] 1.0037 [0.9799,1.0280] 1.0105 [0.9769,1.0451] 1.0045 [0.9497,1.0623]
GC+CC 111 1.001 [0.9985,1.0040] 1.0086 [0.9961,1.0212] 1.0144* [1.0007,1.0284] 1.0173 [0.9980,1.0370]
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
CC 105
CG 145 0.9992 [0.9886,1.0098] 1.0003 [0.9693,1.0323] 1.0055 [0.9780,1.0339] 1.0046 [0.9635,1.0475]
GG 72 0.9878 [0.9751,1.0006] 0.9682 [0.9304,1.0075] 0.9682 [0.9318,1.0059] 0.9533 [0.9008,1.0088]
CG+GG 217 0.9956 [0.9857,1.0055] 0.9908 [0.9618,1.0207] 0.9968 [0.9705,1.0237] 0.9915 [0.9529,1.0317]
GG 138
GC 79 1.0028 [0.9935,1.0123] 1.0105 [0.9875,1.0340] 1.0057 [0.9741,1.0383] 1.0001 [0.9537,1.0488]
CC 8 0.9819 [0.9586,1.0057] 0.9537 [0.8962,1.0148] 1.0245 [0.9376,1.1194] 1.0345 [0.9132,1.1719]
GC+CC 87 1.0009 [0.9920,1.0099] 1.006 [0.9838,1.0288] 1.0085 [0.9779,1.0401] 1.0054 [0.9608,1.0522]
GG 126
GC 92 1.0044 [0.9951,1.0139] 1.0139 [0.9872,1.0413] 1.0375* [1.0000,1.0763] 1.0415 [0.9887,1.0971]
CC 19 1.0017 [0.9821,1.0217] 0.9853 [0.9317,1.0419] 1.0444 [0.9631,1.1327] 1.0392 [0.9387,1.1505]
GC+CC 111 1.004 [0.9955,1.0134] 1.0112 [0.9858,1.0372] 1.0385* [1.0023,1.0759] 1.0413 [0.9905,1.0946]
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
CC 105
CG 145 1.0046 [0.9937,1.0156] 1.0124 [0.9834,1.0422] 1.0575 [0.9444,1.1842] 1.1512 [0.9279,1.4283]
GG 72 1.0031 [0.9815,1.0252] 1.007 [0.9531,1.0639] 1.0557 [0.8741,1.2751] 1.2178 [0.9157,1.6195]
CG+GG 217 1.0044 [0.9938,1.0151] 1.0116 [0.9834,1.0406] 1.0572 [0.9479,1.1790] 1.1698 [0.9556,1.4320]
GG 138
GC 79 0.9969 [0.9851,1.0088] 0.9941 [0.9641,1.0251] 0.9649 [0.8670,1.0738] 0.9512 [0.7962,1.1364]
CC 8 0.9865 [0.9612,1.0126] 0.9647 [0.8998,1.0342] 0.91 [0.7148,1.1586] 0.8337 [0.5438,1.2782]
GC+CC 87 0.9958 [0.9845,1.0073] 0.9911 [0.9622,1.0209] 0.9596 [0.8657,1.0636] 0.9399 [0.7908,1.1170]
GG 126
GC 92 1.0008 [0.9884,1.0134] 1.0015 [0.9699,1.0341] 0.9758 [0.8691,1.0957] 0.9224 [0.7585,1.1218]
CC 19 1.0085 [0.9938,1.0235] 1.0215 [0.9829,1.0615] 1.086 [0.9390,1.2560] 1.2069 [0.9026,1.6139]
GC+CC 111 1.004 [0.9939,1.0145] 1.0097 [0.9831,1.0370] 1.0149 [0.9177,1.1224] 0.9924 [0.8311,1.1850]
White (G/C)
NOx 24 hours NO2 24 hours PM10 24 hours PM2.5 24 hours
Asian (C/G)
Reference Reference Reference Reference
Black (G/C)
Reference Reference Reference Reference
Black (G/C)
Reference Reference Reference Reference
NOx 7 days NO2 7 days PM10 7 days PM2.5 7 days
Asian (C/G)
Reference Reference Reference Reference
White (G/C)
Reference Reference Reference Reference
Reference Reference Reference Reference
Reference Reference Reference Reference
NOx annual NO2 24 annual PM10 annual PM2.5 annual
Asian (C/G)
Reference Reference Reference Reference
Black (G/C)





Of the SNPs examined in GCLM only SNP rs3170633 demonstrated a 
significant negative impact on the association between urinary 8-isoprostane 
concentrations and the 7 days exposures to PM2.5 (Appendix J, Table J8). No 
interactions were observed between SNPs in GCLM and the relationship between air 
pollutant exposures and urinary 8-oxodG concentrations (Appendix J, Table J8). For 
rs3170633 children carrying the ‘A’ allele demonstrated a 2.2% reduction in urinary 8-
isoprostane concentrations per unit PM2.5. Interestingly, a similar, though non-
significant negative association was noted when 24h exposures were considered 
(Figure 5.15). Examining associations by individual ethnic group in relation to their 
major allele: Asian (G, 81%), black (A, 70%) and white (64%), demonstrated that the 
AG genotype was associated with reduced excretion of 8-isoP in the white population, 
in relation to 24h exposures to PM10 and PM2.5, Table 5.10.  This effect was not 
significant for the homozygotes, or in the combined model, but in all cases the effect 
appeared protective, even though it failed to attain statistical significance.  
 
Figure 5.15 Influence of rs3170633 (GLCM) on the association between urinary 8-isoP 
concentrations and 24 hour, 7-day or annual pollutant attributions to PM10 and PM2.5. 
Data are expressed relative to the major allele across the whole multi-ethnic population- 
GG (Appendix J, Table J2). Models are adjusted for age, sex, ethnicity, height, BMI, 
IMD, urinary CCR for smoking exposure and study year, including effect for school 
location. Nominally significant differences relative to the reference genotype are 
illustrated as follows: #p<0.1, *p<0.05 and **p<0.01. Where these differences remained 
significant (P<0.05) after adjusted for multiple comparisons this is illustrated by ‘ǂ’. 
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Table 5.10 Influence of rs3170633 (GLCM) on the association between urinary 8-isoP 
concentrations and 24 hour, 7-day or annual pollutant attributions to NOx and NO2 for 
each of the major ethnicities within the study population. Data are expressed relative to 
the major allele for each population. 
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
GG 216
GA 105 1.0008 [0.9979,1.0036] 1.0029 [0.9936,1.0123] 1.0061 [0.9960,1.0163] 1.0092 [0.9942,1.0244]
AA 9 0.9928 [0.9800,1.0059] 0.9887 [0.9592,1.0192] 0.9929 [0.9606,1.0263] 0.9968 [0.9384,1.0588]
GA+AA 114 1.0004 [0.9976,1.0032] 1.0018 [0.9928,1.0109] 1.005 [0.9951,1.0149] 1.0082 [0.9935,1.0232]
AA 119
AG 92 0.9995 [0.9970,1.0020] 0.9968 [0.9869,1.0068] 1.0008 [0.9886,1.0131] 0.9997 [0.9816,1.0182]
GG 25 1.0001 [0.9947,1.0055] 1.0004 [0.9832,1.0179] 1.0137 [0.9932,1.0347] 1.0173 [0.9906,1.0448]
AG+GG 117 0.9996 [0.9971,1.0021] 0.9976 [0.9881,1.0071] 1.0036 [0.9921,1.0152] 1.0049 [0.9882,1.0219]
GG 99
GA 116 0.9987 [0.9966,1.0008] 0.9933 [0.9847,1.0020] 0.9898* [0.9802,0.9995] 0.9858* [0.9726,0.9991]
AA 34 1.0007 [0.9985,1.0030] 1.0035 [0.9931,1.0141] 0.9981 [0.9866,1.0097] 0.9962 [0.9803,1.0123]
GA+AA 150 1.000 [0.9978,1.0015] 0.997 [0.9890,1.0050] 0.9928 [0.9839,1.0017] 0.9895 [0.9772,1.0019]
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
GG 216
GA 105 0.9980 [0.9931,1.0030] 0.9939 [0.9792,1.0087] 0.9851* [0.9734,0.9969] 0.9747** [0.9570,0.9928]
AA 9 0.9881 [0.9691,1.0075] 0.9807 [0.9269,1.0376] 0.9722 [0.9143,1.0337] 0.9557 [0.8850,1.0320]
GA+AA 114 0.9976 [0.9927,1.0025] 0.9934 [0.9791,1.0080] 0.9848* [0.9732,0.9965] 0.9740** [0.9564,0.9919]
AA 119
AG 92 1.0007 [0.9941,1.0074] 1.0011 [0.9843,1.0183] 1.0073 [0.9851,1.0301] 1.0039 [0.9712,1.0378]
GG 25 1.002 [0.9903,1.0139] 1.004 [0.9750,1.0338] 1.0557** [1.0145,1.0986] 1.0943** [1.0334,1.1587]
AG+GG 117 1.0012 [0.9947,1.0076] 1.0025 [0.9864,1.0189] 1.0163 [0.9948,1.0382] 1.0222 [0.9903,1.0550]
GG 99
GA 116 0.9972 [0.9905,1.0040] 0.9901 [0.9721,1.0085] 0.9935 [0.9700,1.0176] 0.9946 [0.9622,1.0281]
AA 34 1.0006 [0.9939,1.0075] 1.0039 [0.9836,1.0246] 1.0027 [0.9667,1.0401] 0.9991 [0.9487,1.0522]
GA+AA 150 0.999 [0.9932,1.0052] 0.9961 [0.9794,1.0131] 0.9961 [0.9735,1.0193] 0.9969 [0.9659,1.0289]
Genotype Subjects
(n) b ci95 b ci95 b ci95 b ci95
GG 216
GA 105 1.0009 [0.9960,1.0058] 1.0026 [0.9891,1.0162] 1.0191 [0.9620,1.0795] 1.0818 [0.9688,1.2080]
AA 9 0.9964 [0.9830,1.0099] 0.9905 [0.9559,1.0263] 0.9767 [0.8513,1.1206] 1.0326 [0.8030,1.3277]
GA+AA 114 1.0006 [0.9958,1.0054] 1.0018 [0.9886,1.0151] 1.0153 [0.9604,1.0734] 1.0774 [0.9694,1.1975]
AA 119
AG 92 0.9954 [0.9865,1.0044] 0.9896 [0.9664,1.0133] 0.9628 [0.8919,1.0395] 0.9617 [0.8442,1.0956]
GG 25 0.9949 [0.9808,1.0092] 0.9878 [0.9522,1.0247] 0.9544 [0.8333,1.0931] 0.9292 [0.7367,1.1721]
AG+GG 117 0.9952 [0.9870,1.0035] 0.989 [0.9676,1.0108] 0.9607 [0.8929,1.0335] 0.9558 [0.8442,1.0822]
GG 99
GA 116 0.9946 [0.9869,1.0023] 0.9867 [0.9672,1.0066] 0.9676 [0.9036,1.0362] 0.9626 [0.8559,1.0825]
AA 34 0.9963 [0.9891,1.0036] 0.9923 [0.9730,1.0119] 1.0064 [0.9284,1.0909] 0.9645 [0.8306,1.1200]
GA+AA 150 0.996 [0.9890,1.0025] 0.9901 [0.9727,1.0078] 0.9816 [0.9210,1.0462] 0.9647 [0.8635,1.0779]
White (G/A)
NOx 24 hours NO2 24 hours PM10 24 hours PM2.5 24 hours
Asian (G/A)
Reference Reference Reference Reference
Black (A/G)
Reference Reference Reference Reference
Black (A/G)
Reference Reference Reference Reference
NOx 7 days NO2 7 days PM10 7 days PM2.5 7 days
Asian (G/A)
Reference Reference Reference Reference
White (G/A)
Reference Reference Reference Reference
Reference Reference Reference Reference
Reference Reference Reference Reference
NOx annual NO2 24 annual PM10 annual PM2.5 annual
Asian (G/A)
Reference Reference Reference Reference
Black (A/G)





When the 7 day exposure associations were examined, a similar relationship 
with the ‘A’ allele and observed, but this time in the Asian children, Table 5.10. In the 
Black childen when this exposure interval was considered the ‘GG’ genotype was 
associated with increased excretion of 8-isoP, again consistent with the protective action 
of the ‘A’ allele. No associations were evident with the annual exposure estimates. 
 
5.3.4.3 Interaction between Genotype and Biomarkers of Traffic Exposure  
 No significant modifying effects were noted with any of the studied 
SNPs in SOD3 on the relationship between 24 hour (Appendix J, Tables J6 and J7) 
and 7-day (Appendix J, Tables J10 and J11) exposure attributions and the urinary 
biomarkers of oxidative stress. In addition no influence of any of the studied SNPs, in 
the three examine genes, were noted on the relationship between the urinary markers 
and the annual exposure attributions (Appendix J, Tables J12-J15). 
The three genes related to aspects of the cellular response to oxidative stress 
were not a proiri selected for consideration for a modifying effect on the association 
between modeled air pollutant exposures and urinary traffic biomarkers. Here the 
associations are shown only for completeness. The impact of genetic variants in SOD3, 
Nrf2 and GLCM on the association between acute (24h), sub-chronic (7 day) and 
chronic (annual) exposures to the modeled pollutants and the measured urinary Cu and 
Ni concentrations are shown in Appendix J, Tables J16 to J27. Overall, following 
correction for multiple comparisons, no significant interactions were apparent between 
the examined genotypes and the association between pollutant exposure and urinary Cu 
and Ni. In the absence of any significant associations, I elected not to over interpret the 






5.4  DISCUSSION 
 
This study represents a comprehensive investigation of urinary biomarkers of 
response (oxidative stress) and exposure (metals) associated with urban gaseous and 
particulate air pollution. I hypothesized that children with high modeled exposures to 
pollution would show significantly elevated levels of urinary biomarkers of oxidative 
stress, in addition to increased urinary excretion of metals reflecting traffic emissions 
from exhaust and/or vehicular abrasion. In addition, I examined whether the urinary 
concentration of these biomarkers would be influenced by variation in genes related to 
protection (GCLM and SOD3) and adaption to oxidative stress (Nrf2).  
In the crude analysis I observed evidence that urinary concentrations of 8-oxo-
2’-deoxyguanosine (8-oxodG) were positively associated  with 24h exposures to NOx, 
NO2, PM2.5 and PM10, whilst the associations with 8-isoprostane were weakly negative 
for the same pollutants across all of the studied exposure durations. Following 
adjustment for the selected co-variants and multiple testing for the exposure attributions 
investigated, only the increase in 8-oxodG in relation to the 24h PM2.5 and PM10 
exposures and the negative associations between 8-isoprostane and 7-day average NOx 
and NO2 remained significant. The concentration of urinary 8-oxodG in relation to the 
acute to sub-chronic exposures to PM10 appeared to be increased in individuals carrying 
the 'C' allele in Nrf2, rs2364723. Urinary 8-isoprostane concentrations in relation to 
sub-chronic exposures to NO2, were also found to be increased in individuals possessing 
the 'C' allele in Nrf2, rs7557529, in the combined model; whilst they were decrease in 
the population with the 'A' allele in GLCM, rs3170633 with sub-chronic exposures to 
PM2.5. No associations were observed between the markers of oxidative stress and the 
long term exposure attributions suggesting that these markers are largely influenced by 
short periods of accrued exposure.  
I also observed increased metal concentrations (Ba, Mn, Sn and Ni) in spot urine 
samples from children exposed to ETS, which was associated with increased urinary 
concentrations of 8-oxodG and 8-isoprostane. When the urinary metal concentrations 
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were examined in relation to the acute to chronic exposure attributions, it was notable 
that the correlations were broadly negative with the shorter term attributions, but 
became significantly positive for Cu, Fe, Ba. Mn, Cd, As, Ni, and particularly Cr and V 
when annual exposure estimates were applied, particularly for PM2.5. More detailed 
analysis of the urinary metal data was restricted to Cu, (being indicative of an abrasion 
metal source) and Ni (reflecting long range oil combustion) (Gerlofs-Nijland et al. 
2007; Thorpe and Harrison 2008; Godri et al. 2011). These analyses confirmed the 
negative association between urinary Cu and sub-chronic exposures to NOx and acute 
exposure to PM2.5. A similar negative relationship was also noted between urinary Ni 
and sub-chronic exposures to PM10 and PM2.5, after adjustment for all of the studied 
covariants.  
In the present investigation urinary concentrations of 8-oxodG and 8-isoprostane 
were employed as markers of systemic oxidative stress as urinary concentrations have 
previously been shown to be increased in pulmonary conditions with an acknowledged 
component of oxidative stress (Igishi et al. 2003; Wu et al. 2007), in response to 
cigarette smoke (Campos et al. 2011; Mesaros et al. 2012; Chiang et al. 2012), 
occupational and environmental exposures to PAHs (Andreoli et al. 2012; Lee et al. 
2012; Fan et al. 2012), and indoor/outdoor pollution (Chuang et al. 2003; Lai et al. 
2005; Barbato et al. 2010; Ren et al. 2011; Huang et al. 2012; Beerappa et al. 2013; 
Commodore et al. 2013). 8-oxodG is a major water-soluble oxidized nucleoside formed 
by free radicals, which is cleaved from DNA and excreted in urine. The determination 
of urinary 8-oxodG concentrations therefore represents a non-invasive, technically 
simple procedure, which provides a measure of both oxidative damage and DNA repair 
capacity (Cooke et al. 2002). In vitro studies have demonstrated that constituents of 
diesel exhaust particulates and ambient PM have the ability to produce 8-oxodG lesions 
in DNA through the imposition of cellular oxidative stress (Arimoto et. al. 1999; 
Knaapen et. al. 2002). F2-isoprostanes, including 8-isoprostane are considered a good 
standard biomarker of oxidative stress in vivo as they are chemically stable and appear 
independent of dietary lipid intake (Il'yasova et al. 2012). Concentrations of 8-
isoprostane have been shown to be elevated in exhaled breath condensate of subjects 
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with respiratory disease (Kharitonov and Barnes 2004) and after exposure to  inhaled 
irritants, including ambient air pollution (Huang et al. 2012; Patel et al. 2013). In 
addition, urinary concentrations of this stable lipid peroxidation marker have been 
shown to be increased in populations exposed to traffic fumes (Rossner et al. 2007), 
particulate matter derived from wood combustion (Barregard et al. 2006) and exposure 
to cigarette smoke (Noakes et al. 2007; Seet et al. 2011).  
Previous studies have shown significant differences in the level of oxidative 
DNA damage between ethnicities, with oxidative DNA damage reported to be lower in 
African-Americans compared with white subjects by Huang et al. (2000). Similarly, in 
the present study urinary 8-oxodG and 8-isoprostane concentrations varied significantly 
between the studied ethnicities, but did not accord with the previous observations, with 
the Asian children having the highest concentrations of these two biomarkers. This 
variation may in part be related to the children's diet, as diets rich in antioxidants may 
protect against oxidative stress (Kelly 2004). However, antioxidant supplementation 
studies have not definitively shown evidence of reduced urinary 8-oxodG levels (Huang 
et al. 2002) and it is therefore likely that the difference observed reflects either genetic 
difference in DNA repair pathways, or exposure to exogenous pro-oxidants. Gender has 
also been previously reported as an important confounder for biomarkers of oxidative 
stress, mainly due to differences in metabolic rates amongst males and females (Loft 
and Poulsen 1998). In the present study, I observed significant differences in the 
concentrations of 8-oxodG and 8-isoprostane between the males and female subjects in 
the crude analysis, but these differences were lost in the fully adjusted model. 
 Exposure to tobacco smoke (ETS) was also associated with increased 
concentrations of 8-oxodG and 8-isoprostane in the crude analysis, with the difference 
in the later remaining in the adjusted model. Children exposed to ETS also showed 
elevated metal concentrations, with increased urinary concentrations of Ba, Mn, Ni and 
Sn. This concurred with previous reports of elevated metal concentrations in  passive 
and active smokers (Richter et al. 2009). This is plausible as many of the metals shown 
to be elevated in the children's urine are known to be present in the cigarette smoke 
aerosol (Chiba and Masironi 1992). Previous work has also shown that the metal 
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content of cigarette smoke PM is responsible for the induction of oxidative stress (Ghio 
et al. 2008; Pappas 2011).  It was notable however, that Fe and Cu, which are known to 
be abundant in ETS particulate, were not elevated in the urine implying their 
bioaccumulation in vivo. 
  Urban particulate matter also contains a variety of transition metals adsorbed on 
their surfaces which have potential to produce reactive oxygen species in vivo resulting 
in oxidative stress ( Costa and Dreher 1997; Li et al. 2003; Kelly et al. 2011). In this 
study I therefore performed exploratory analysis to examine whether there were 
associations between the modeled pollutant attributions and urinary metals that would 
support their use as biomarkers of either, non-tail pipe (Cu, Sb, Ba, Fe etc.), or tail pipe 
(Cr, Ni, V etc.) sources (Thorpe and Harrison 2008). In addition, as many of the studied 
metals are either redox catalysts (Fe, Cd, Ni, V, Cr, Mn and Cu) (Valko et al. 2005), or 
can deplete cellular antioxidant pools through the formation of GSH mercaptides (Cd, 
Cu, Zn, As and Pb) (Ballatori 1994), they also provide a mechanistic basis for the 
induction of systemic oxidative stress in populations with high exposures to traffic 
pollutants. The potential of metals and particularly Fe to influence air pollutant, health 
associations can be inferred from the series of papers arising out of the Normative 
Aging study, in which SNPs in hemochromatosis protein (HFE) has been shown to 
modify the relationship between PM2.5 and traffic exposures and heart rate variability 
(Park et al. 2006) and cognitive decline (Power et al. 2013).  
 Of the metals examined detailed analysis was restricted to just Cu and Ni, as 
being reflective of abrasion and tail pipe / oil combustion sources respectively. Whilst 
there was some evidence of weakly positive correlations with both Cu and Ni with 
annual PM2.5 and PM10 exposure attributions, the relationship over the shorter term 
exposure intervals was predominately negative; a pattern seen with the majority of the 
trace elements examined. After adjustment for the covariants in the full model only the 
negative associations with sub-chronic exposures remained significant, though the basis 
for this inverse relationship was not clear. These data therefore do not support the 
contention that urinary metals can be used as biomarkers of traffic exposure. Whilst 
many trace elements are excreted in the urine, Cu, Fe, Zn and Mn (all potentially useful 
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biomarkers of vehicular abrasion processes) are predominately excreted through faecal 
route, which may limit their usefulness as simple exposure biomarkers (Iyengar 1998). 
The positive association observed in the present study between urinary 8-oxodG 
concentrations and 24h exposures PM2.5 and PM10, broadly fits with the increase in 8-
oxodG reported in aged subjects by Ren et al. (2011), though in this later study the 
associations with the pollutant metrics examined (significant for PM2.5, NO2, ozone, 
sulphate and organic carbon, but not black carbon, CO or particle number 
concentration) were based on 10-21 day moving average exposures, similar to the sub-
chronic attributions used in the present analysis. The associations observed were argued 
to reflect evidence that the observed DNA oxidation was related to secondary, rather 
than primary air pollutants. A subsequent analysis of the same data demonstrated that 
the observed associations between sulphate and organic carbon exposures with urinary 
8-oxodG concentrations were modified by polymorphisms in GSTP1, GSTM1 and 
catalase, though the direction of the modification varied with the polymorphisms 
examined and the mechanistic basis for the observed effect modifications remained 
oblique (Ren et al. 2010). A study performed on 894 (6-10 year old) children in the 
Czech Republic also reported positive associations between urinary 8-oxodG 
concentrations and ambient PM10, PM2.5, particulate PAH and benzo(a)pyrene 
exposures considering a variety of exposure durations, 3-7 days (Svecova et al. 2009). 
In addition urinary 8-oxodG concentrations have been found to be significantly elevated 
in children living in Bangkok compared with rural areas of Thailand (Buthbumrung et 
al. 2008). Increased urinary 8-oxodG concentrations have also been reported in 
Taiwanese traffic conductors compared with office workers, with a positive association 
with urinary 1-hydroxypyrene-glucuronide, a biomarker of traffic derived PAHs (Huang 
et al. 2012), as well as in long-distance bus drivers (Han et al. 2010). Other studies have 
failed to demonstrate a simple relationship between the exposure to high ambient 
pollutant concentrations and urinary 8-oxodG levels, even in the presence of increased 
urinary PAH metabolites (Fan et al. 2012; Rossner et al. 2013). A comparison of high 
versus low pollution communities in the Czech Republic showed no association 
between PM2.5 exposures (both short and multi-day) and urinary 8-oxodG 
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concentrations, despite evidence of  associations with other markers of systemic 
oxidative stress (plasma 15F2t-isoprostane and protein carbonyls) (Rossner et al. 2013).  
In the present study, the increase in urinary 8-oxodG concentrations associated 
with the previous 24 hour exposure to PM2.5 and PM10 occurred in parallel to a decrease 
in excreted 8-isoprostane, in relation to 7 days NOx and NO2 exposures. This disparity 
in part suggests that different components of the urban aerosol are acting through 
separate pathways in response to different pollutant triggers. As the presence of 8-
oxodG in the urine not only reflects damage to DNA and oxidation of the nucleotide 
pool (Sorensen et al. 2003), but also the excision repair capacity of the organism (Cooke 
et al. 2003), its increased concentrations implies the activation of the base excision 
repair pathway, i.e. both oxidative damage and cellular adaptation. Given that there is 
evidence that Nrf2 plays a role in 8-oxoguanine DNA glycosylase (OGG1) expression 
(Singh et al. 2013), it is therefore possible that the decrease in urinary 8-isoprostane 
might reflect the up-regulation of antioxidant genes under the regulation of this 
transcription factor. Hence, whilst the associations are in the opposite direction, they 
might reflect the same ongoing process.  
As the formation of DNA base and lipid oxidation markers reflects the presence 
of oxidative stress, I investigated whether genetic variants in the antioxidant enzyme 
extra-cellular superoxide dismutase (SOD3), as well as regulators of the antioxidant 
response (GCLM and Nrf2) would potentially modify any underlying association 
between pollutant exposure and systemic oxidative stress. Nrf2, a basic leucine zipper 
transcription factor plays an essential role in the regulation of cyto-protective responses,   
through the induction of a series of antioxidant and detoxification enzymes that 
neutralize ROS and other electrophiles, including glutamate cysteine ligase regulatory 
subunit (-GCS) and superoxide dismutase (SOD) (Cho and Kleeberger 2010). It has 
been hypothesized that functional polymorphism in Nrf2 may be associated either with 
a change in the expression of basal Nrf2 or may cause an inability of Nrf2 to translocate 
from cytoplasm to its binding sites in nucleus. This would then result in attenuation of 
ARE (antioxidant response element)-related gene transcription exposing the individuals 
to a higher risk of oxidative stress. SNPs in the Nrf2 promoter region have previously 
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been shown to influence transcriptional activity and Nrf2 expression in vitro (Marzec et 
al. 2007). Several recent studies have investigated genetic polymorphisms in Nrf2 in 
relation to respiratory disease susceptibility, either singularly or associated with other 
polymorphisms, related to  acute lung injury (Marzec et al. 2007), lung function decline 
due to smoking exposure ( Siedlinski et al. 2009; Henderson et al. 2010; Masuko et al. 
2011) and asthma in children exposed to highly polluted environments  (Ungvári et al. 
2012).  
In the present study, urinary 8-oxodG concentrations in relation to sub-chronic 
exposures to PM10 and PM2.5 appeared to be increased in individuals carrying the 'C' 
allele in Nrf2, rs2364723 (G/C). Previous studies have shown that heterozygous (GC) of 
rs2364723 is negatively associated with the FEV1 in a large Caucasian cohort 
(Siedlinski et al. 2009). Similarly, in a small study examining Asian lung cancer 
smokers (Sasaki et al. 2013), mean FEV1 was found to be significantly lower in the 
groups homozygous for  CC compared to wild type GG. 
 Urinary 8-isoprostane concentrations in relation to sub-chronic exposures to 
NOx and NO2, were also found to be increased in individuals possessing the 'C' allele in 
Nrf2, rs7557529 (T/C), in the combined model. This is a novel interaction, with no 
previous reports of effect modification with this SNP. In contrast, possession of the 'A' 
allele in the combined model for GLCM, rs3170633 (G/A) conferred protection against 
urinary 8-isoprostane in relation to sub-chronic PM2.5 exposures. Glutamate-cysteine 
ligase (GCL), the first rate-limiting enzyme, catalyzes synthesis of GSH and is induced 
by Nrf2 (Jyrkkänen et al. 2008). Polymorphisms in GCLM  has been associated with 
lower promoter activity, significantly lower plasma GSH concentration (Nakamura et al. 
2002) and increased susceptibility to oxidative stress (Yang et al. 2002). GCLM has 
been investigated by various researchers as a protective candidate gene in lung function 
(Siedlinski et al. 2009), COPD (Chappell et al. 2008) and susceptibility to schizophrenia 




Several studies have shown a role for polymorphisms in SOD3 in mediating the 
susceptibility of the lung to oxidative stress and lung function changes in respiratory 
disease (Dahl et al. 2008; Ganguly et al. 2009), COPD (Dahl et al. 2008; Juul et al. 
2006; Young et al. 2006), acute lung injury (Arcaroli et al. 2009), cancer risk (Kang et 
al. 2007) and risk factor for cardiovascular disease (Naganuma et al. 2008a; 2008b). 
Extracellular SOD is expressed abundantly in the lungs, within the respiratory tract 
lining fluids, at the respiratory epithelium and vascular endothelium (Oury et al. 1994, 
1996). The SOD3 gene has been localized to chromosome 4 and consists of three exons 
and two introns. In the present study, we studied five polymorphisms of SOD3. One 
was excluded due to deviation from Hardy-Weinberg (rs2284659). Two other SNPs 
located in intron region (rs8192287 G/T, rs8192288 G/T) and another two found to be 
in promoter region (rs699473 C/T, rs13306703 C/T). I observed no significant effect 
modification with any of these SNPs following adjustment for multiple comparisons. 
  In summary, these data provide evidence that short term PM exposures in 
children are associated with increased DNA oxidation. As an inverse relationship was 
observed with the lipid oxidation biomarker 8-isoprostane, this strongly argues that this 
is not simplistically related to pollutant induced oxidative stress, but rather the induction 
of a robust DNA repair response. One might therefore conjecture that the absence of 
increased urinary 8-oxodG following short term exposures, is the more detrimental 
observation, implying that oxidatively damaged nucleotides are not being cleaved from 
DNA, increasing potential coding errors and the risk of mutations. Thus SNPs in genes 
promoting increased 8-oxodG concentrations, such as rs7557529 might actually be 
considered beneficial. To fully substantiate this view it would be necessary to examine a 
broader range of oxidative biomarkers, both in plasma and urine, and to examine 
associations over shorter durations, which might capture associations prior to the 
induction of Nrf2 mediated adaptations. In this chapter, I also examined a panel of 
metals in urine as potential biomarkers of exposure to traffic pollution. At this time, the 
results of this analysis do not appear promising, though ETS metal signatures were 






Summary and Conclusion 
 
 In this thesis, I examined the impact of urban, specifically traffic-related 
pollution, on the respiratory health of children living within East London. The study 
was conducted over the first three years of the lifetime of London's Low Emission Zone, 
and as such represents a baseline study to evaluate the later impacts of the scheme, 
notwithstanding the fact that some year-on-year improvements in air quality might have 
been expected due to modernization of the vehicle fleet over this period.  
The key findings arising from this study were as follows: 
 Over the first three years of the LEZ lifetime I observed no evidence of 
measureable improvements in urban air quality. 
 Significant associations were observed between annual pollutant exposures 
(oxides of nitrogen, NO2, PM2.5 and PM10) with current rhinitis and FVC in 
children living within Tower Hamlets and Hackney.  
 Through the development of a temporal scaling tool (NOWCAST) and its 
application to our annual dispersion models I was able dissect out the short, 
versus long-term influence of air pollution on the health endpoints examined. As 
the reduction in FVC was only associated with annual and not short-term (1-day 
to 1-week) exposures, I have argued that this provides evidence of reduced lung 
growth.  
 I observed evidence that polymorphisms in CYP1A1 modify acute and sub-
chronic effect of air pollution on lung function. One protective (rs2198843) and 
one sensitizing SNP (rs2606345) were identified. Notably, these associations 
were most marked within the black and Asian children studied. 
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 Acute 24h exposures to PM10 and PM2.5 were associated with increased, 
excretion of urinary 8-oxodG, with the effect most marked in white children 
heterozygous for the 'C' allele in rs2364723 (Nrf2). In contrast, urinary 
concentrations of 8-isoP were decreased in relation to 24h NO2 and NOx 
exposures. 
 Urinary metals, Ni and Cu, reflecting tail pipe oil combustion and vehicular 
abrasion sources, were investigated as biomarkers of traffic exposure. This 
exploratory analysis demonstrated some evidence of weakly positive 
correlations with both Cu and Ni and annual PM2.5 and PM10 exposure 
attributions. However over shorter term exposure intervals the relationship was 
predominately negative. At this time therefore these data do not support the of 
these urinary metals as traffic biomarkers. 
 
Study Strengths and Limitations: 
 Whilst initially conceived to study the period running up to and after the 
introduction of the LEZ, due to funding issues and the time required to obtain ethics this 
study was only able start after the first two phases of the LEZ had already been 
introduced. It would clearly have been better to have had a run in period, as it now 
appears that by the beginning of 2008 most of the HGV fleet targeted by the tighter 
emission standards had already upgraded (personal communication, Dr Ben Barratt). 
Nethertheless it was hoped (and predicted by pre and post scheme modelling exercises) 
that phase 3 of the LEZ would produce a sufficient improvement in air quality to detect 
a signal in respiratory endpoints. The impact of the political decision to delay this phase 
had significant ramifications on this study and its power to detect an air pollution signal. 
The LEZ however was not the only instrument acting over this period that had the 
potential to improve urban air quality, as natural fleet turnover and the increased 
proportion of newer vehicles with EURO IV and V engines should also have produced 
air quality improvements. Hence throughout all of the analysis we have included year in 
our models, but have failed to see any annual improvements in respiratory symptoms or 
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lung function. In terms of lung function, especially in relation to restrictive patterns in 
children that might reflect deficits in optimal growth, a critical question is how long 
would be required for measureable decrements to manifest. In the original rationale for 
the study it was thought that this would reflect the proportion of life each cross sectional 
panel of children had lived within the zone. For year 1, between 8-13 months depending 
on the date the schools were visited; for year 2, 20-25 months and so on. Thus for  a 
cohort aged between 8-9 years, the proportion of their life spent within the zone would 
be approximately , 7.4-13.5% in year 1, raising to 27.8-38.5% in year 3. By the final 
year of the study, assuming children have remained within the study area for the full 6 
year duration, the proportion of their lifetime lived within this traffic management area 
will be between 63.9-76.0%. Given the rate of lung growth at the age selected and the 
accrued effects of living within the LEZ, it was reasonable to expect signals related to 
long term effects on lung function. 
 The current study was focused in an area of East London with very poor air 
quality and examined respiratory health in a deprived and multi-ethnic cohort of 
children. In particular, this is the first time a central Asian population of children have 
been examined in this regard. It employed a validated high resolution dispersion model 
to provide estimates of annual exposures, as well as scaling factors to provide shorter 
term exposure attributions based on measurements made within and surrounding the 
study area, on the same spatial scale. It was thus able to discriminate between short and 
long term impacts of air pollution on lung function and systemic oxidative stress. This 
permitted inferences to be made on lung growth, which otherwise would not have been 
possible in a cross sectional study. Clearly a longitudinal follow up addressing lung 
function in these children would be required to confirm this inference. In term of lung 
function, this is the only study to date that has examined lung function post 
bronchodilator in relation to pollutant exposures and made use of the same trained 
personal throughout the three years of the study, both for the actual measurements and 
data quality control. In addition, each child also provided a questionnaire on respiratory 
symptoms in the past year, as well as FeNO as a measure of allergic airway 
inflammation (Rolla et al. 2007). Urine samples were also provided for the assessment 
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of biomarkers of pollutant exposure and systemic oxidative stress, as well as saliva and 
mouth swabs for the determination of vitamin D status and collection of DNA for the 
genotyping component of the project.  
Whilst examining the ethnically diverse population within central London was 
one of the strengths of the current study, it brings with it inherent difficulties in the 
analysis and interpretation of the genetic data. Population stratification is capable of 
producing spurious findings in gene association studies, especially when the study 
population consists of two or more ancestral populations. In addition, differences in the 
admixture proportion of individuals may also produce false positives if the outcome is 
sensitive to the ancestry proportion. Although, I adjusted for self-reported ethnicity in 
the regression models employed to control for the effect of confounding by population 
stratification, as the allele frequencies for some of the SNPs differ across ethnic groups, 
the use of ancestry markers to control population structure might have improved the 
analysis. However, my attempt to correct the population structure using ancestry 
markers was not successful at this point, though based only on a limited number of 
random SNPs. In addition, using these ancestry markers did not substantially modify the 
results, though they were only really effective at separating out the black from Eurasian 
populations. Better separation might have been achieved using a more comprehensive 
set of ancestral informative markers as has been previously been shown (Winkler et al. 
2010).  In this thesis I have therefore also analysed the associations identified as 
significant within the whole population separately for the three main ethnic groups, with 
reference to that population’s major allele for the SNPs investigated. Overall these 
analyses produced results coherent with that observed for the whole population, though 
they did demonstrate that some polymorphisms had their effect predominately in only 
one of the ethnicities. 
In the present investigations defined panels of polymorphisms in genes were 
selected for each set of endpoints, based either on pre-published evidence of 
associations with air pollutant exposures (such as with the glutathione S transferases), or 
a prior hypothesis based on the known, or purported mechanisms of air pollutant 
toxicity (CYP1A1 and the AhR). This approach was taken to avoid the high statistical 
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penalty inherent in examining large numbers of SNPs. The human genome has been 
shown to contain a haplotype block structure, consisting of various distinct blocks 
within which SNPs are strongly related. Within each block, a number of SNPs called 
‘tag SNPs’ can be utilized to differentiate a large fraction of the haplotypes. These 
tagging SNPs are very useful in the association studies as they eliminates the need of 
genotyping all SNPs within the same block and hence eliminate the high statistical 
penalty of examining multiple SNPs.  Haplotype-based association studies are therefore 
preferred over the genotype-by-genotype studies in the genes, containing multiple 
susceptible alleles as they are thought to be more effective (Zhang  2002). Gauderman 
et al. (2007) reported that using multiple SNPs that capture underlying genetic 
architecture for the disease/outcome are more powerful at detecting gene-environment 
interactions. Going forward such a haplotype block approach should be favoured, as the 
size of the current cohort, even after inclusion of the children recruited across years 4-6 
of the study (approx. 2,200) remains too small for a successful GWAS. Of the panels of 
SNPs examined, had funds permitted, it would have been good to have examined 
polymorphisms in genes related to the base excision repair pathway (Wilson et al. 2011) 
to more fully define the nature of increased urinary concentrations of 8-oxodG 
observed. As was inferred in the discussion to chapter 5 it remains unclear whether this 
increase should be viewed as an adverse response, or evidence of the appropriate 
induction of DNA repair at this time. Finally, whilst there is a considerable evidence 
base relating genetic variation in phase I and II xenobiotic and antioxidant genes to the 
relationship between respiratory and cardiovascular responses to air pollutant exposures 
(Minelli et al. 2011), there are considerably fewer studies addressing key inflammatory 
genes. This literature was recently reviewed (Vawda et al. 2013) and reported evidence 
supporting a role for both toll-like receptor 4 and transforming growth factor β1 in 
mediating the association between lung function and air pollutant exposures. Further 





Future and Ongoing Work 
The use of models to assign pollution exposures is difficult, mainly due to the 
fact that the models assumed that subjects reside at the residential address 24h a day for 
365 days a year, which is implausible. Whilst we attempted to evaluate home, versus 
home plus school exposures, we made no attempt to model exposures within the home, 
or to take into account the children's journey to and from school. As such, similar to 
many other studies, there is a considerable risk of exposure misclassification. Indoor 
exposures to pollutants are also likely to be high in households using gas cookers, which 
was not controlled for in the current study until years 4-6.  Kornartit et al. (2010) found 
that personal exposure to NO2 was strongly correlated to indoor NO2 concentrations. 
Future work is required to establish the magnitude of this exposure misclassification 
comparing personal to modelled exposures in large cohorts, though it is likely this is 
smaller in children than adults, due to the more restricted geographical area they move 
through. It should be stated that the number of children within our cohort who did not 
walk to school was very low, <10%, suggesting that in vehicle exposures were unlikely 
to confound our results. Much of this uncertainty could be dealt with if good biomarkers 
of traffic exposure could be identified. In this study, I examined urinary metals, but 
from these preliminary analyses, these do not appear to be useful in characterizing 
primary vehicle exposures. As a further extension to this study, metabolomics analyses 
are currently ongoing in an attempt to isolate an exposure biomarker using both NMR 
and LC-MS based approaches, using urine samples from the 400 children with the 
highest and lowest NOx exposures within our cohort. Should such a biomarker be 
identified it would greatly improve our understanding of the contribution of traffic, 
specifically diesel exhaust, to the health endpoints examined.  
Of the routinely measured parameters in this report, I have only reported on 
respiratory symptoms, lung function and the urinary biomarkers. Though FeNO 
measurements were made in all subjects, these were often below the detection limit of 
the NIOX instrument used and at the time of analysis these data would not converge in 
the models employed, either as a continuous or categorical variable. Despite this 
limitation the FeNO measurements were found to align well with the reported 
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symptoms of asthma, hay fever and rhinitis (data not shown) suggesting that they were 
discriminating between individuals with and without allergic inflammation. As with the 
other major endpoints employed in this study a panel of SNPs were selected a priori to 
interrogate any observed associations between FeNO concentration and air pollutant 
attributions, focused on polymorphisms in iNOS, arginase 1 and 2 based on earlier work 
by Salam et al. (2011, 2012) and as such analysis of this data remains a priority moving 
forward. 
The determination of vitamin D in saliva was not possible after a considerable 
period spent developing the pre-existing analysis methodology (Martineau et al. 2011), 
despite previous reports (Higashi et al. 2008). The saliva was therefore used for the 
determination of markers of innate IgA, (Ewing et al. 2010) and allergic inflammation, 
IgE (Mimura et al. 2010), as well as the assessment of cortisol, as a measure of activity 
of the hypothalamic-pituitary-adrenal axis (Stenius et al. 2011). In a small subset of 
children, induced sputum was also performed on a second visit to examine particle 
uptake according to the method of Kulkarni et al. (2006) as an alternative biomarker of 
exposure.  
 The LEZ school study is ongoing due to the delay in the implementation of 
phases III and IV, and is due for completion in March 2014. At this time, the full 
effectiveness of the scheme will be evaluated, with an increased power than was 
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Details of School Locations and Subject Recruitment in the  
London LEZ Schools Study 
 Figure A1 illustrates the location of the schools in Tower Hamlets and Hackney. 
The number of children recruited at each school is summarised in Table A1 and the 















Figure A1 Map of the schools locations participating in the London LEZ Schools Study 
(Year 1-3). 






Schools participated in Year 1- Year 3 
Schools participated in Year 3 only 
Schools added for Year 2 and participated in Year 3 
Schools participated in Year 1 only 
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School Years 1-3 Year 1 Year 2 Year 3
(2008-11) (2008-09) (2009-10) (2010-11)
Bygrove 50 (55) 6 (20) 29 (94) 15 (50)
Christ Church# 18 (75) 18 (75)
Colvestone# 14 (56) 14 (56)
Gayhurst* 80 (54) 39 (52) 41 (57)
Harbinger 47 (57) 20 (74) 14 (54) 13 (43)
Holy Family 53 (62) 22 (85) 14 (47)^ 17 (57)
Lansbury Lawrence 109 (63) 37 (69) 41 (68) 31 (52)
Lauriston* 41 (69) 14 (48) 27 (90)
London Fields* 52 (61) 30 (57) 22 (69)
Manorfield 58 (39) 23 (40) 28 (47) 7 (23)
Mayflower 38 (42) 12 (40) 15 (50) 11 (37)
Morningside* 32 (38) 16 (30) 16 (57)
Orchard* 53 (49) 33 (61) 20 (36)
Sir John Cass# 27 (93) 27 (93)
St Agnes 65 (74) 23 (79) 21 (70) 21 (72)
St Edmund’s* 20 (42) 13 (54) 7 (29)
St Luke's* 40 (68) 20 (67) 20 (69)
St Monica’s 49 (86) 17 (59) 28 (93) 21 (78)
St Paul with St Luke* 21 (36) 14 (50) 7 (23)^
St Paul's with St Michael's* 23 (50) 11 (38) 12 (71)
St Saviour’s 55 (63) 19 (63) 19 (66) 17 (61)
Virginia* 37 (73) 17 (77) 20 (69)
Whitmore 20 (40) 20 (40)
TOTAL (%) 1019 (56) 199 (55) 416 (57) 404 (56)



















Notes: figure in brackets indicate % of participants; * new school for Year 2; # new school for 










Table A2 Details of data collected during health assessments each year 
 
Ɨ Total number of different schools visited throughout Year 1- 3 (2008-11) study. 
Details of Measurement Year 1- 3 (2008-11)
n % n % n % n
Participating schools 10 19 22 Ɨ23
Participating children 199 55 416 57 404 56 1019
Height & weight measured 191 96 416 100 403 99.8 1010
Exhaled nitric oxide (eNO) 185 93 401 96 400 99 986
Post bronchodilator FEV1 150 75 402 97 399 99 951
Post bronchodilator FVC 148 74 384 92 388 96 920
Urine sample 178 89 398 96 398 98 973
Successfully DNA extracted (from saliva sample) 173 87 413 99 401 99 987
DNA samples passed genotyping QA/QC 170 85 406 98 398 99 974
Modelled air quality variables matched to home address 196 98 415 99.8 404 100 1015
Returned respiratory health questionnaire 129 65 383 92 389 96 901
Additional questionnaires (returned by children who 
declined to participate in health assessments)
3 36 55 94





Preliminary Study on DNA Extraction and Quantification Optimization 
 
 For the preliminary optimization studies, saliva was obtained from 10 
volunteers. Each subject was asked to provide two samples, one obtained by spitting 
directly into the Oragene collection pots, the other one using the sponge swab provided 
in the Oragene - DNA collection kit. A series of preliminary experiments were 
performed to optimize the extraction methods, ultimately to maximize the quality and 
yield of genomic DNA. Table B1 shows DNA yield from the saliva spit (SP) and saliva 
sponge (SS) samples obtained from the 10 volunteers. 
 The average total DNA yield from the undiluted samples was 30.53 μg (range 
9μg-110μg) and 22.44μg (range 2μg-57μg) for the saliva spit and saliva swab, 
respectively. The manufacturer (DNA Genotek Inc, Canada) recommends a minimum 
of 2 ml of saliva for an adequate yield of DNA. Each storage vial contains 1.9 ml of a 
DNA stabilization solution, equating to a total volume of 3.9 ml. Overall, the DNA 
yield increased proportionally to the saliva volume, Table B1; with DNA purified from 
saliva spit samples having a higher yield relative to saliva swab samples. DNA yield 
may be reduced by the presence of contaminants like glycoprotein (mucin), protein, salt, 
and alcohol during DNA collection and isolation procedures. As seen in Table B1, 
acceptable A260/A280 ratios (1.8–2.0) were obtained from all but two samples (SP6 and 
SP7) demonstrating low protein and organic contamination of their DNA products. 
Furthermore, protein contamination in the saliva swab was far less than in saliva spit 
samples, the average A260/A280 ratios being 1.82 ± 0.12 and 1.64 ± 0.12 (mean ± SD) for 
SP and SS samples, respectively. In addition, the A260/A230 ratio provides qualitative 
information on the degree of alcohol, glycoprotein and salt contamination and thus 
provides information on DNA purity. The ratios of A260/A280 and A260/A230 should be in 
the range of 1.8-2.0 to ensure low contamination levels, with lower values reflecting 
impurities due to EDTA, glycoprotein, buffer, salts and ethanol that absorb at 230nm 
and protein and organic contaminants, which have absorbance maxima near 280 nm. On 
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this basis, the saliva swab samples provided lower contaminant values (Table B1) and 
therefore provided a better quality of DNA. These observations were supported by the 
similar values obtained from Genotek (Birnboim 2004) and other published data 
(Barker et al. 2004; Hansen et al. 2007; Rogers et al. 2007; Rylander-Rudqvist et al. 
2006). 
 To identify the potential contaminants, genomic DNA from samples SP1, SP4, 
SP9 and, SP10 were precipitated again using 3M sodium acetate and ethanol to reduce 
the impurities. In this secondary analysis the DNA pellet was left to dry for 1 hour to 
ensure complete removal of ethanol. The outcome shows that there were only minor 
changes in both the A260/A280 and A260/A230 ratios compared to previous results (Table 
B2). Consequently, contamination at 230 nm by ethanol or salt carryover can be 
excluded as a significant issue in these samples. Thus, the observed 230 nm 
contamination probably reflects residual glycoproteins within the saliva samples.  
 To investigate the likely impact of increased hydration buffer volume or 
extending the DNA hydration period on final yield samples, SP5 and SP6 underwent 
both an overnight hydration step in TE buffer (50 [sample ‘a’] and 100 µl [sample b]), 
as opposed to the recommended protocol of 2 hours at 50°C. This is an important step 
because if the DNA yield is low, one might consider using a reduced volume of buffer 
for resuspension; yet high yields of genomic DNA require a sufficient volume and time 
to be efficiently dissolved.  The comparison of the ‘a’ and ‘b’ samples for SP5 and 6 
illustrated no consistent difference between the yields of DNA with increased TE buffer 
volume (Table B1). Similarly, the yields observed with the 2 hour and overnight 
incubation were broadly similar, samples SP5/6, ‘a’ versus ‘c’ and ‘b’ versus ‘d’ (Table 
B1). 
 An overnight incubation step at 50°C has also been recommended by the 
manufacturer instead of standard 2 hours incubation to promote complete cell lysis and 
release of DNA from the Oragene - DNA/saliva samples. To test whether an increased 
incubation period enhanced DNA yields from the saliva samples SP7 and SP8 were 
divided into two samples ‘a’ and ‘b’ with the former undergoing a 2 hour incubation 
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and the later the overnight.  The outcome was inconsistent between the two samples 
suggesting little additional advantage of performing the extended incubation (Table 
B1). 
 
Table B1 DNA yield and quality in saliva spit and saliva swab samples quantified by 
UV spectrophotometer 
Notes: SP=saliva spit and SS=saliva swab samples. For SP5 and SP6 ‘a’ indicates that the 
sample was re-suspended in 50 µl of TE buffer and ‘b’ indicates that the sample was re-
suspended in 100 µl of the buffer, with samples incubated for the standard 2 hours at 50
°
C. SP5 
and 6 samples labeled ‘c’ and ‘d’ reflect DNA concentrations in samples re-suspended in 50 and 
100 µl TE buffer respectively, but with an overnight incubation at room temperature. Samples 
SP7 and 8 underwent either the standard 2 hour pre-incubation, ‘a’ to permit DNA extraction, or 
an overnight treatment, ‘b’. 
Sample Total [DNA] Total [DNA] Ratio Ratio 
Undiluted (µg) Diluted (µg) A260/A280 A260/A230
SP 1 79.82 82.20 1.70 0.78
SP 2 44.59 44.05 1.72 0.93
SP 3 9.60 12.36 1.65 0.60
SP 4 80.43 78.30 1.70 0.92
SP 5a 9.34 9.15 1.69 0.83
SP 5b 14.27 12.56 1.68 0.82
SP 5c 14.29 9.13 1.70 0.87
SP 5d 15.46 12.71 1.68 0.83
SP 6a 18.24 16.65 1.50 0.59
SP 6b 17.80 18.90 1.51 0.57
SP 6c 20.94 22.45 1.51 0.60
SP 6d 19.76 22.70 1.52 0.59
SP 7a 13.21 12.72 1.47 0.51
SP 7b 8.93 8.36 1.38 0.43
SP 8a 17.31 20.20 1.80 1.16
SP 8b 23.22 23.40 1.76 1.04
SP 9 109.67 110.08 1.76 1.06
SP 10 32.73 35.00 1.73 0.96
SS 1 15.85 16.88 1.90 1.52
SS 2 2.20 2.60 1.69 0.99
SS 3 9.13 22.73 2.00 0.50
SS 4 40.05 41.38 1.66 0.51
SS 5 57.15 73.20 1.90 1.36
SS 6 56.83 70.35 1.86 1.23
SS 7 3.02 3.60 1.78 0.94
SS 8 2.83 3.41 1.65 0.71
SS 9 27.15 27.30 1.94 1.60
SS 10 10.20 11.25 1.85 1.11
Mean ± SD (SP) 30.53 ± 29.25 30.61 ± 29.49 1.64 ± 0.12 0.78 ± 0.21
Mean ± SD (SS) 22.44 ± 21.76 27.27 ± 26.43 1.82 ± 0.12 1.05 ± 0.39
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Table B2 Comparison of DNA quality after genomics DNA clean-up 
 
 
 Despite the protein contamination being within an acceptable range, 
quantification by absorbance is still subject to interferences that can impact on the 
absolute quantification of the sample DNA content. Therefore, an alternative method 
using fluorescence was employed to derive a more accurate quantification of the 
genomic DNA concentration. The picogreen (fluorescence dye) method uses a 
fluorophore that exclusively intercalates into double-stranded DNA, yielding values 
based only on DNA and avoiding the interference from contaminants. Table B3 shows 
the summary of the picogreen results with comparison to the quantification obtained by 
absorbance. Overall, the DNA estimates based on absorbance were 3.5 fold higher 
compared with the picogreen results in both saliva spit and saliva swab samples. As 
shown in Table B3, there was a statistically significant difference between the DNA 
yield quantified using the two methods (Wilcoxon Mann Whitney test) (p = 0.001). 
Furthermore, the respective concentrations obtained using the two quantitation methods 
were broadly in agreement with previous reports (Mulot et al. 2005; Nishita et al. 2009; 
Rylander-Rudqvist et al. 2006), suggesting that quantitation by fluorescence, 
particularly picogreen, is the more precise method (Rengarajan et al. 2002). Despite the 
reduced concentrations determined using the Nanodrop, the concentrations using the 




Sample Total [DNA] Total [DNA] New Previous New Previous 
precipitated* (µg) recovered* (µg) A260/A280  A260/A280 A260/A230 A260/A230
SP1 undiluted 19.96 22.06 1.69 1.7 0.76 0.78
SP1 diluted 22.61 1.74 0.74
SP4 undiluted 20.11 23.39 1.7 1.7 1.11 0.92
SP4 diluted 24.54 1.76 0.89
SP9 undiluted 15.67 17.74 1.77 1.76 1.11 1.06
SP9 diluted 17.16 1.66 0.91
SP10 undiluted 8.18 9.31 1.72 1.73 0.98 0.96
SP10 diluted 9.36 1.79 1.02
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Table B3 Comparison of DNA yield by quantitation method  
 
  
 The quality of the DNA extracted by using the Oragene DNA kit was further 
examined by agarose gel electrophoresis (Figure B1). A visible band of intact high 
molecular weight DNA (> 23kb) with limited or no degradation was observed 
indicating that the integrity and quality of the DNA was excellent. For lane 5 and 10, 
more than 100ng of total DNA was loaded. Conversely, 10ng was loaded in lanes 22, 
23, 28 and 29. Furthermore, the absence of bands at the bottom of the lane indicates that 
the genomic DNA was free from RNA contaminants. 
 
 
Donor Picogreen Absorbance Ratio [DNA] Saliva volume 
Total [DNA] Total [DNA] Picogreen/
(µg) (µg) Absorbance (ml)
SP 1 14.59 79.82 1.80 5.35
SP 2 13.83 44.59 3.10 5.50
SP 3 2.58 9.60 2.70 2.90
SP 4 18.26 80.43 2.30 3.20
SP 5 17.37 53.36 3.70 4.00
SP 6 26.72 76.75 3.90 6.40
SP 7 5.77 62.66 2.30 3.20
SP 8 19.29 40.52 3.30 3.20
SP 9 32.12 109.67 2.90 5.20
SP 10 14.95 32.73 4.60 3.20
SS 1 2.20 15.85 1.40 2.20
SS 2 0.20 2.20 0.90 1.95
SS 3 6.03 9.13 6.60 ≈1.9
SS 4 9.74 40.05 2.40 1.95
SS 5 17.23 57.15 3.00 2.18
SS 6 17.66 56.83 3.10 2.22
SS 7 0.47 3.02 1.60 ≈1.9
SS 8 0.79 2.83 2.80 ≈1.9
SS 9 7.35 27.15 2.70 2.40
SS 10 3.84 10.20 3.80 2.10
Mean ± SD (SP) 16.55 ± 8.71 59.01 ± 28.87
Mean ± SD (SS) 6.55 ± 6.54 22.44 ± 21.76
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M   1   2   3   4   5   6    7   8   9  10  11 12  13 14  M                  M  18 19  20  21 22 23 24  25 26 27 28 29 30 31 32 M   
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                                                                          4,361 
                                                                         
             
             2,322 
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             564 
 
Figure B1 Integrity of DNA in saliva spit and saliva swab samples. Lanes 2-15 and 18-
21, show DNA purified from saliva spit samples and lanes 22 - 31, DNA purified from 
saliva swab samples. A Lamda Hind III digest marker (M) was ran in lanes 1, 16, 17 
and 32.  
 
 The objective of the preliminary work described in this section was to compare 
the quality and quantity of DNA extracted from two different collection methods; saliva 
spit and saliva swab. The Oragene DNA Saliva Collection Kit (SCK), employing a 
saliva swab appeared ideal for the collection, stabilization and purification of samples of 
young children. Although, DNA purified from saliva showed glycoprotein 
contamination, it has been stated by the Oragene technical support that its performance 
in genotyping assays is similar to the DNA purified from other matrices. The SCK 
provided DNA yields in spit samples for all participants greatly exceeded our baseline 
requirements for genotyping 96 SNPs on Illumina platform, with minimum of 250ng of 
total DNA. The saliva swab samples also provided sufficient DNA in all individuals 
except for few cases. Therefore the use of the SCK, coupled with RNA digestion, 
provide high quality DNA for genetic analyses with sufficient quantities for archiving 
for future studies.  
 Based on the preliminary results, an optimized extraction protocol was 
developed for the ‘Schools’ study samples, including a 20 minutes drying step (post-
precipitation) to ensure complete removal of ethanol. Taking into consideration 
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sufficient buffer to dissolve the DNA pellet, 100 µl of TE buffer is to be added to the 
pellet followed by 2 hour incubation at 50°C. DNA concentrations were quantified with 
both methods to accurately estimate both the yield in the samples, and to provide 
absorbance information for quality control purposes. As many of the saliva samples of 
the school study failed to yield sufficient DNA yields for our downstream application, 
whole genome amplification was applied to all the samples, regardless of the yield, as 
described previously (Beckett et al. 2008; Chartier and Pinard 2005; Rylander-Rudqvist 







Assessment of DNA Concentration and Quality for Saliva Samples 
 
 Overall, the DNA yield increased proportionally to the saliva volumes (Table 
C1). Therefore, DNA purified from Year 2 and Year 3 samples have higher DNA yield 
compared to Year 1. The average DNA yield recovered was 7.54 ± 2.96 ng/µl (1.79-
30.01 ng/µl), 21.96 ± 14.71 (2.37-89.50 ng/µl), and 68.52 ± 54.77 (4.37- 459.44 ng/µl) 
for year 1, year 2 and year 3 samples, respectively. 
 
Table C1 DNA Yield in Year 1, Year 2 and Year 3 quantified by Picogreen Assay and 
Absorbance 
 
Notes: * Absorbance measurement for Year 3 samples was only performed on 36 samples to 
minimize the usage of genomic DNA for future application. Ŧ Include 1.9ml of preservation 
solution. 
 
 In addition, average OD260/280 ratios for Year 1 and Year 2 samples are within 
the acceptable range (1.8–2.0). This demonstrated low protein and organic 
contamination of their DNA products. Meanwhile, the A260/230 contamination may be 
due to glycoprotien (mucin) in the present work as DNA were extracted from saliva 
samples. In addition, extracted genomic DNA was still intact and in the high molecular 




Total [DNA] (µg) 
(Mean ± SD)
ŦSaliva volumes 
(ml)             
(Mean ± SD)
A260/A280 ratio A260/A230 ratio
Year 1 
(n=173)
7.54 ± 2.96 1.53 ± 0.75 1.91 ± 0.20 1.83 ± 0.21 0.76 ± 0.27
Year 2 
(n=413)
22.04 ± 14.76 5.96 ± 4.35 2.26 ± 0.34 1.85 ± 0.13 1.09 ± 0.34
Year 3 
(n=402)











Figure C1 Integrity of genomic DNA purified from saliva samples. Approximately 
100ng of gDNA from 36 samples is visualized on a 0.75% agarose gel (1 x TBE buffer, 
90 V, 60 minutes) stained with ethidium bromide. Lanes 2-19: genomic DNA; Lanes 1 









 SNP genotyping strategies typically involve two steps: allele-discrimination and 
allele-detection. Allele-discrimination is achieved by primer extension, hybridization, 
ligation, or enzymatic cleavage, whereas most allele-detection methods are based on 
mass, fluorescence, or chemiluminescence. The more straightforward and less costly 
options permit only a limited numbers of SNPs to be identified, whilst newer methods 
permit up to one-million SNPs to be investigated simultaneously, albeit at a greater cost 
and ultimately at a greater ultimate statistical penalty. Generally, SNPs analysis can be 
categorized in 4 groups based on their molecular method: allelic specific hybridization, 
primer extension, allele-specific oligonucleotide ligation and enzymatic cleavage. 
 Allele discrimination is performed using allele-specific biochemical reactions, 
with four main methods employed: hybridization, primer extension, ligation, and 
enzymatic cleavage. Allele specific oligonucleotide hybridization exploits differences in 
the thermal stability of double-stranded DNA to distinguish between perfect and 
mismatched target-probe pairs to achieve allelic discrimination (Figure D1). Allele 
specific probes are then immobilized on a solid phase, ‘target SNPs’, to which 
fluorescent labeled PCR fragments are hybridized. Subsequent to stringent 
hybridization and washing, the unbound targets are removed. From the location of the 
probes, one can determine the genotype for the DNA sample. As hybridization does not 
involve enzymes in allelic discrimination, this is the easiest method of SNP detection. 
High-throughput SNP analysis such as Affymetrix and Illumina platforms employ this 















Figure D1 Allele-specific hybridization. In this approach, two allele-specific probes 
are designed to distinguish between two alleles on the target DNA sequence with one 
mismatch base. Hybridization only occurs with a perfect match to the DNA sequence. 
Source: Kwok (2001). 
 
 There are two methods of SNPs detection by primer extension: sequencing 
(allele-specific nucleotide incorporation) and allele specific primer extensions. In both 
approaches, PCR amplification is performed, followed by single base extension using 
primers that anneal to one base of polymorphic site. Sequencing determines the alleles 
(homozygote, heterozygote or wild type) present in the DNA samples (Figure D2), with 
the sequence of amplified DNA subsequently identified by mass spectrometry or 
fluorescently labeled primers, where the PCR products are run on gel electrophoresis or 
capillary electrophoresis. Recently, the sequencing field has progressed rapidly with the 
production of instruments capable of typing millions of DNA sequences in a single run 
making GWA studies rapid and cost effective. The Illumina genome analyzer, Applied 















Figure D2 Allele-specific nucleotide incorporation. Amplified PCR product is 
sequenced to determine the presence of the base at the locus. This could be achieved 
either by fluorescence labeled primer or mass spectrometry. Source: Kwok (2001). 
 
 Alternatively, in the allele specific primer extension method, the target sequence 
is only amplified when the 3’ end is complementary with the template after successful 
extension of the one base of the polymorphic site. Otherwise, the primer extension or 
amplification of the target sequence will be terminated (Figure D3). Therefore, by 
knowing whether the PCR product is produced or not, one can determine the allele 
types by running the PCR products on an electrophoresis gel. One method which 
employs this approach is PCR-DGGE (PCR-denaturing gradient gel electrophoresis), 
which employs fluorescent labels in the SNPs detection. This approach is robust and 
minimal primers are required to carry out the genotyping. In addition, primer design and 

















Figure D3 Allele-specific primer extensions. Primer is only extended when it is 
complimentary to the base at the locus. Therefore, the allele could be inferred only if 
PCR product is generated. Source: Kwok (2001). 
 
  In this allele-specific oligonucleotide ligation, complimentary oligonucleotides 
with alleles specific to the polymorphic site are designed at its 5’ and 3’ end. By using 
DNA ligation, two adjacent oligonucleotides are joined to each other after annealing to 
a DNA template (Figure D4). Ligation can only occur when it perfectly matches the 
sequence of DNA on the template. This method is very slow in the detection and 
requires a high number of the probes in the analysis. However, ligation is the simplest 
















Figure D4 Allele-specific oligonucleotide ligation. The presence of allele at the locus is 
determined only when oligos are ligated with probes. Source: Kwok (2001). 
 
             Enzymatic cleavage for allele discrimination is based on the ability of certain 
classes of enzymes to cleave DNA by recognition of specific sequences and structures. 
Such enzymes can be used for discrimination between alleles when SNP sites are 
located in an enzyme recognition sequence and allelic differences affect recognition. 
This allelic discrimination method employs 5’ – 3’ nuclease activity with two probes 
(reporter and universal) for each allele, such that the SNP located at the overlapping site 
of the DNA strand should be centered over the mismatched base where the probes only 
differ by one base. 
 The probes for these assays have a lower Tm requirement than the DNA 
polymerase in PCR assays. During the PCR amplification, once the specific enzymes 
(probes) have bound to its specific piece of the template DNA after denaturation (high 
temperature) and the reaction cools, the primers anneal to the DNA. Subsequently, Taq 
polymerase adds nucleotides and removes the probes from the template DNA. They are 
dependent on each other because both probes and primers are working simultaneously 
and therefore, must hybridize to their targets for amplification and cleavage to occur. 
When labeled reporter is separated from the cleavage site, this allows the reporter to 
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emit its light. The more amplification takes place, the more chance for the reporter 
probe to bind and in turn more emitted light is detected (Figure D5). Thus, SNP 
determination relies on the signals generated if the target DNA sequence is successfully 
amplified during PCR. The TaqMan allelic discrimination assay and PCR-restriction 
fragments length polymorphism (PCR-RFLP) are an example of this approach.  
 
 
Figure D5: Invasive cleavage allelic discrimination. Probe will only bind to specific 
target but not with a one base-mismatch. The second probe is employed to identify the 




Table D1 Single nucleotide polymorphism sequences 
 
 
SNP Index SNP ID Base Change Location Top Genomic Sequence
1 rs2917666 [G/C] Intergenic ATTATGAAAGGGCTTATTGGCAGAGAAAAAGTAGAGGGGTCCAGAGACTCAAGTTCCTAA[C/G]GAGGCTGAAGTAAGAGTGGGGGATTAAATAAGGGCAAAAACTGAGAGAATAAAAAAAGTG
2 rs7782389 [T/C] Intron AAATGCACATTATTAATCAAAAAACAGCAAAGTACGTATATGTAAATTGTATCTATAGAC[G/A]GAGGGACACCAGTGGAGAGAGGTTTAGGAGATGGCCACCTAGTTTCCTTACATGTTTCCT
3 rs997279 [A/G] Intron GCTTGTGCTACCCAGAACACGGTATTATGCAGTTTAAGAGATTCTTTACATGCTTGGCGC[A/G]GTCAAACATCAATAGTTCTACCTTGATAGACTTTCAAGTCTGGAAAAAGCTTAATGAAGT
4 rs4147581 [G/C] Intron CCTACCTCGAACTGGGAAATAGACCACGGTGTAGGGCGGCACTGCAGCGAACAAAGAAAA[C/G]TTTGCTGGAGCCCGGGGGAGGATGCCAAGGCGCGGTGAGCGCAGCCTGCCCCCCCCTCCC
5 rs3759757 [G/C] Intergenic ACGTGGGCCAGACCAGCACCAATGGAGGACCACCAAACCCATGTACAATGAGGAGCTCTA[C/G]ACTAACGCCACTGATGGCGGCCGTCATCCATAAGATGCCCCTGGGCTATGACCACTTCAT
6 rs1137933 [A/G] Nonsynonymous ACACCTTCATCTGGCCAGCTGGGCTGGCTGGGTTACCTCCAGGATGTTGTAGCGCTGGAC[A/G]TCACAGAAGTCCCGGACTCCGATCTCTGTGCCCATGTACCAGCCATTGAAGGGGCACCCT
7 rs2826003 [A/G] Intergenic CCTAAGTGTTAATCATTTGTTGTTTAATGTGGTTTAGAAACTGTTCTGTGTGCTTTGCCC[G/A]TATTACTTAAATTCTGACAACAACTCTACAAGGTTGGTTCTATTTTCCCTTATAAGGGAT
8 rs17072738 [A/G] Intergenic GGGCCTTGGAAGTATTCTTAATTTTCATGAGTCAAAAGGAAGGAAAGGTAGCAAATACAT[A/G]TCAATGACTTAATTCTAATCATCTTCTGTCCTATATCTGCCCACTTCTCTTTAAAAAGCA
9 rs2246012 [A/G] Intron TGTTATTATCATTATTACTGTTTTATTTTATTTTATTTCACAAATAGGGGTCCTCTTGCT[G/A]GTAGCATACTTCCTGCTGCACCTTGCCTTCCATTTGCTGTTCCCCCGGCTCCCCTACCAT
10 rs2074113 [T/G] Intergenic ATATTACATACACTGTATGTTTTACATGCTAAGAGAGACTTACTGAAACATAATGTACAT[C/A]CAATAAAATAAAAGTGAAAAAGTCTCACTTACTTGGCATCACAACCAATAGGTGTGAAGT
11 rs7232792 [T/C] Intergenic GTCTGCAATGGAGAATCCACAGGTATGGCCAAGGTTGGTTCAGTTGAGTTCAGCAAAACT[G/A]ATGGAACACCAACTACATGGCACGTACTTTGCTAGGTACAATTTTATTAAAAAAATGAGT
12 rs2284659 [T/G] Intergenic AGTTTTCTGAAGTTGCAGCTGAACACTTTATGAAGCACTTTCTCATATAGTATCGTATTT[C/A]ATGCTTGCAATACTTTTTGTGGGGTGGATATTAATTTGGCAACTTTGTTTATAAGAAAAT
13 rs2781668 [A/G] Intergenic ATGATATAAAATGTCCTAGTAACAAAAACAGGATGCCCTTAACACTGTTGGGGACAGGGT[G/A]TGTCAGTAAAGGCTGCAAGAAATAAATGCTGTTTAAGCTGAGTCTTGCGACATGAGTAGG
14 rs2066853 [A/G] Nonsynonymous GTAAAAACAGTGACTTGTACAGCATAATGAAAAACCTAGGCATTGATTTTGAAGACATCA[A/G]ACACATGCAGAATGAAAAATTTTTCAGAAATGATTTTTCTGGTGAGGTTGACTTCAGAGA
15 rs2733262 [T/C] Intergenic GAGGCATCAGGAGATATTCACAGCCAGAATAGAACAGATGAAAATCCAGCATTACCTTTA[G/A]ATACCACTCTATACAGACGGCTCGCTCTGTTAGGAAGAGGTAAATAACATTTCAATTACA
16 rs1138272 [T/C] Nonsynonymous AGCAGGGTCTCAAAAGGCTTCAGTTGCCCGGGCAGTGCCTTCACATAGTCATCCTTGCCC[G/A]CCTCCTGCCAGACACCACCATGTATCATCCTACTCTCATCCCTCCCAGCCCCTGAGACAC
17 rs17599586 [T/C] Intron ACCGATGGAAAACACTTTAGTTATTGCATCATGTGACTGATGGACATTCTGAAAGTGTCA[G/A]CTGGGACTTGGTTTCAGGTCAAGGAGGTATAAATATATATTAGTCAAGTGTACACTTGCT
18 rs742869 [A/G] Intron TGTGTTGCTCTAAACTTACCCTGTGGGTGGCAGAAGAAAGCAGATTGCATACCCACGGAC[A/G]CACATGATAATGATCTTGGTGAGAACAAGAATTCTTGATTAATCCTGTCCATTTCTCCCT
19 rs17883901 [A/G] Intergenic GGCCTGAAGCCCGGTGGGAACCGCGGGGGCTCAGGAGGCGTGTGCAAGGGTGATTGGGTC[A/G]CAGTTGAGGGGAGCAGCTCGCGAGAAGGGGGCGTGCGGTCGGCCTCGCTTTACGCAAACG
20 rs2364723 [C/G] Intron TCTTAGTGCCAAATTCTTCCTGCATACTGAAAAGTTAACCCAGGCTTGAGGAACAGTTAA[C/G]GAGGAAATATTGACACAAAACCCCCTTTAAATGTCTTCAGTCAGGACAGAGGAAATTCCC
21 rs8078340 [T/C] Intergenic TAATTATAGTACAGAGTGATATCTGTAGTGATGGAGGGATGGTATGGTGCTGATGTAGCT[G/A]GTTCTGCCTTGTTCAAGGAAAGTTTACAAGGGAGAGGACACCAGGGCAGGGTTTTGAGGG
22 rs3742879 [A/G] Intron TAAATATGCTAGAGTCTCTTGCCTGCAAAGGATCTTTTCTGCTATTCCACATCATTGCAG[A/G]GTTTGTTTTTGCTTAAACTTTTGTAGCTAAAAATTATATGGCCATGCTAATAAAAAGGAT
23 rs268691 [A/G] Intron GAAGCGAGAGAACTAGGGTCAAGGATTCTTGGGACTCCAAGACGCACTGGCGGGGGAAGG[G/A]GGTTGCCGGGAAGAGTTCAATGTTCGGGTCTTGGAGCCGGACAGCGAGTTTGGAGGTGAA
24 rs2301022 [T/C] Intron TTGATTTCTTGATGCTCAGAGTCACACACCACAGTTTGTAAAACATTGTTCAAAGGACTA[G/A]TTCTGGTTTCTAGTGTTTTATTTAGGGTGCTTCATAACAGTAGGATAAAACTAAAGAAAC
25 rs3170633 [A/G] Intergenic TATGCTCCTTTAACACTGTCTTTCTAGATTTTTCACCCAGTATTTTCAAAATTTGGGAAT[G/A]TAAACAATTGATATATTTATTGTATGTTGGCTAGCAGTTCATCCTTCTGCAAAATATGCA
26 rs2779251 [A/G] Intergenic CCTACGGCTTCCTGGGCCTGCACGGCTGCCTTCTTCTTGGCCCTGCCCACCCAGCAGGCC[A/G]CATTCCTGGCCTCTTCTGATGATGGATGCAGCAGGTGAATTCTGCTGGGGAGAAATCAAA
27 rs7132743 [A/G] Intergenic CTTCTCCAAAATGCTTTTCTTGATACGTTTAGTTGGAGTCCCTTTTTCTTCTTTGTTTTC[G/A]TGGTGCTGGATTTATATCCATATTTTTCCTTTTACAATACTTATTTCACTAACTTATTCA
28 rs1871042 [T/C] Intron ATGGATCAGCAGCAAGTCCAGCAGGTTGTAGTCAGCGAAGGAGATCTGCAGGGCAGGGGG[G/A]CCAGGGACTCAGCCAGCGGGAGCAGGCTGGAGGAATTGGGGGCAGAGGGCCTAAGCCCAT
29 rs6770096 [T/C] Intergenic TGGTTTCAATTAACAGATAATCCTTTACAATAAATAATTGAGATCTGGTTTCATCACTTC[G/A]CTAATTGTTTCTTCATACATCTGGCTCAATGGAATATACTTTGCCTGAGATATGTTATTA
30 rs7557529 [T/C] Intergenic AGGTTTTTTTTTAATTCTAATATTACTCAAAGGGCAAAATGAGAGTCCATGGAATAGAAA[G/A]TGTCAGGAGACAATTATGTTGGCAAATCTCATTTCCCTTTTTTATTTTCCAGCCTCCAAG
31 rs2779253 [A/C] Intergenic AGGCTGCAGGTTGCTATGTCTCTACTTGATGCAGGTCCTCAGGGAAGCAGGCTGTCCCAC[C/A]AAAATCAGAGCTCAGAACTCAGGGTCAGGTATCTACTCCCATATGtccatccatccatcc





SNP Index SNP ID Base Change Location Top Genomic Sequence
33 rs8192287 [T/G] Intergenic AGGCTGTCCACCCCGCACGCCCACCGTGAAGATCCAATGAGATCATTACTCGCCCAGTGA[C/A]AACACAGTGGCTGGCACTAGCCGCACTCATAAGTAATCATCATTGTCATTGTCGTTACCG
34 rs2781666 [T/G] Intergenic ATTTTATGTGAAGTCTCATCATTGGTGCCATTATACTGATGAATAAACTGAAGCTCAGAC[C/A]CGTTGCCAACATAGGCTGTAGAAGAAAAGTCGGGATTTAGTCTCTGCCATTCTGAATCCA
35 rs4795080 [A/T] Intergenic GGTGAGAGAGGGCTGCCTTGAGCCTCAGACCGGTGGTGTCCCTAAGATGCTCCTCCCAGA[A/T]GCATTTGGAATCAAATGGACCTGAATCTTGGTTCTGCAGCTTTAGCTGTATGATCTTGGG
36 rs7144243 [T/C] Intergenic ACGCCCGGCCTGGACGTGAGTATTTTTAAAAAGCTCCCAAGTTATTTTTAGGGAGCTGCC[A/G]GAGTTGAGCACTCTTGGGAGGATATCTTTCCCTCTGCCATCCCAGGCTCTAAAGTTAGAG
37 rs17722841 [T/C] Intron AAAAAATATTATTGTCAATTTCATAGGCAAAAGTGTGGTTGGTAATTAAAGTTATATGTT[A/G]GGATCATGGTTATGTATAGGAGAAGCACTTGTATTTGCAGATTTTCTACTTAGGGTGTCC
38 rs699473 [A/G] Intergenic TAAGTCAATAACTTATTGACTTATTTTTGCTGCATGGAAATGGGCACCTTGCAAATGTGC[G/A]TGGCATTTGCTCCAGAGCTGTGCTGTCATACCTATGAGAGCAGAGCAGCGGGTGGGTCGT
39 rs1889022 [T/C] Intergenic ACTTAATTTATGGAGTGCTCAGCTGAGGTTGCCACTAGCTGCTTACGAGAGGCCAGCAGC[A/G]CCGTGAGCCAGGCCCACTTAGGGAAGATTCTTGGCTCATCCATGTGACTCACCTTCCTCA
40 rs9282799 [T/C] Intergenic ACAACTACATTAGGGAGAAGTTGAGAAGCAAAGGGAAAAAAAGTCACCCTTGATCTCACC[G/A]TCCCAACACTTTGCTACCACTGTCCACTCATTTCCTTCTTGTCTTTCCCAAGTTAAATTC
41 rs7591449 [T/C] Intron GGAGACTGAGGCTCAGAAAATGGGGAGATTTGTAGCCAGGTCATTTGGCTTTGTAGGATA[G/A]GAATTCAAGTCCACGCATGCCAAATCTAAGCTGAGAGGTTAATTTTCAAAATCCACCACC
42 rs3894194 [T/C] Nonsynonymous CAGAGACAATGACCATGTTTGAAAATGTCACCCGGGCCCTGGCCAGACAGCTAAACCCTC[A/G]AGGGGACCTGACACCACTTGACAGCCTCATCGACTTCAAGCGCTTCCATCCCTTCTGCCT
43 rs1442293 [C/G] Intron CCCCTCCTTGGGGCCTCTGAGTTCCTCAGGAAGTATTTCCAGTATGGGCTGTGGGTTGCT[C/G]CAAGGCCTGGGGTTTTCTTGGTAATAGGCACTTTGCCACATGAGCATTTGACAGTCCAGT
44 rs749174 [A/G] Intron GGGTAAGGAGATAGAGATGGGCGGGCAGTAGGCCCAGGTCCCGAAGGCCTTGAACCCACT[G/A]GTTTGGAGTCTCCTAAGGGCAATGGGGGCCATTGAGAAGTCTGAACAGGGCTGTGTCTGA
45 rs689453 [T/C] Synonymous AAGAGCACTGATCGTACTGGCTCACTCAGAGAGGACGTCCTTCAACTATGCCATGAAGGA[G/A]GCTGCTGCAGCGGCTTTGAAGAAGAAAGGATGGGAGGTGGTGGAGTCGGACCTCTATGCC
46 rs3796644 [A/G] Intron GCTTTATTTTATTTTAACTCAGTCCCAATGGTTAATTTAAATCCTTTCTTTCTTTCATCA[A/G]TGATACAAAGAGCTCACTTTACTACAGTCTCATCTTGACAGAGTCAAATGCAGAGGCTGT
47 rs2234922 [T/C] Nonsynonymous TCCCCCCAGGGCTGGACATCCACTTCATCCACGTGAAGCCCCCCCAGCTGCCCGCAGGCC[A/G]TACCCCGAAGCCCTTGCTGATGGTGCACGGCTGGCCCGGCTCTTTCTACGAGTTTTATAA
48 rs17779352 [A/G] Synonymous CAACTTATTAATAACATCTTGTGGGAAAGGCAGCAGGCTAGCCAAACGGTCCAACTCTGT[G/A]TTAAGTCGGTCTCTATGCCGCTTGGAAGGATTTGACTTGATTCCTTCAGCTGGGATTGGC
49 rs2128238 [A/T] Intergenic tagagttaacctgtcctttatgccttaaatcttggtgcttgctttttttcccatgctaat[A/T]aatgtcctttttgccatttttcccccagaataggacactttcatctatattaaatacttg
50 rs1799814 [T/G] Nonsynonymous AGGTGTTAAGTGAGAAGGTGATTATCTTTGGCATGGGCAAGCGGAAGTGTATCGGTGAGA[C/A]CATTGCCCGCTGGGAGGTCTTTCTCTTCCTGGCTATCCTGCTGCAACGGGTGGAATTCAG
51 rs10454231 [A/G] Intergenic TACGTTATTAGAAACTCCTACGAAGTGAATCTAAATGCCACGGTCCTTGTAGGGGGCTAC[A/G]TGGCTGATGCGGCAGGTCAGGAAAATGCATACCTTTGCGTGAGTTCCTCCAAACTCAAGA
52 rs7776785 [T/G] Intergenic ccttgattcattcagtcattcaattacctcatctgtgaagtgagggTAGTGTGTAGGGAT[A/C]AACTGGAACACAGAGGGGGCTTTAGGAAGCCAAGAATCACATCAACTTGTATAGAAAATA
53 rs8192290 [T/C] UTR CGCAGTACTGAATTGCTGAATTTTTAATCTGTAACACAAAGGTTGCCAAACATTCCCCCA[G/A]AGGAGCAGCTCTCAGTGGGGTGGCGGTGGATGCGAAACAGCTGAAGACGCGGGGCAGTTG
54 rs7140310 [A/C] Intron ATCTGTGGTAATCACATTGATCAGTGGTCCCCAAACAGTGAGACTTGACCAGAACTCAGA[C/A]CAGCAGACAGACTTAATAAATTTCCAGAGACTACACTGAGAAAGGAGGCAGGAGACTTGC
55 rs1800566 [A/G] Nonsynonymous CTTCCAGGATTTGAATTCGGGCGTCTGCTGGAGTGTGCCCAATGCTATATGTCAGTTGAG[A/G]TTCTAAGACTTGGAAGCCACAGAAATGCAGAATGCCACTCTGAGGATACAGAAAGCACAG
56 rs17861115 [A/G] Intergenic AATGTCACGCACATGGCTTCTCTCACAGGAACTGTCCAGCCAACAACTTGACACCATCAT[G/A]GGGTCTTCTGGAGATACAATTTGCCTCCCACAGTGGTTCGGATGGTGGCCATTTAGGTAC
57 rs11735827 [T/C] Intron CTTGGGATCTGCATGACTACTAATGTCAGAAGCTGGTTACTATTTTAAATAGAACACCCA[A/G]TTTAGCACCAGAGAAGGTATTCACTAAGGAACCTCCAACCCCATCCTGCTGAAAAATGAA
58 rs2531866 [T/C] Intergenic AGAAGTAGGGCTAGAAATGTTGGAGATGGACTTGAAGATGAATTTATATGGAAGATAAGG[A/G]AGCAGAGGTGACAGCAGTGACTTCTGGGTTTCTGGCTGTTGAGACTGGGGGGCAGGGATG
59 rs9900426 [T/C] Intergenic tgagcaggcaccatccaattggctgtaggccccaagagaacaaaaacagaggaaaggcaa[A/G]ttggtttagctttcccctggagctaggatacacttctttctcctgtccttcaatatcaga
60 rs10517 [A/G] UTR TTGATAAAACTCTAGGTTTACAATTGTACCCCAAGGTCATGGGACTGGACCCCATCCCAT[A/G]GTAAGTCATCAGTTTAGCAATGATAAAGAAAATAACCTTCTGAAAATTTGTATAGATCAG
61 rs2282885 [A/G] Intron AAGCTTGCAGGGCTTCTAAACAGAAGCATGGCATGCAGTCAGCTGGAGTCTTGATTTCAT[A/G]ACAATTTTACAGATTGGGACAAGATTTTTGAGGTAAAGGTTTCAAAAAATAATAAGTTAC
62 rs2001350 [T/C] Intron CTTCCTGGGCTCAAGCAATCCTCTCACTTCAGTCTCCCTAATAGTTGGGACTACAGGCTC[G/A]TATCACCACGTGCAACTAATTTGTTTTGATTTTGGGTAGAAACAGGTGTCACTATGGTGC
63 rs527705 [T/G] Intron CAAAGAGAATGACCAAGGAGTTAAGAAAGCTACCTCCAGCCATGCTACTCAAGTATGCAA[A/C]CCCGTCAGTGGCTTTCAAGGACACCTGTAAGGTGCGGGGGGCGGGTAGGGAACATAGAGA




SNP Index SNP ID Base Change Location Top Genomic Sequence
65 rs7875663 [A/G] Intergenic TGAGAGGTGCCTAATGAACACCAGAGGAAGAGAATCTGAAAACAATTCCTAACAATGTGG[A/G]GTGTCGTTAGTTAAATCCAGACCTCTACTTCTGTGTCTGATTCTTCTTTAACATAGAGCA
66 rs407257 [G/C] Intron TGCCCCCTTTGCCAACCTGGTGGGCAGGTGCTGAGTTCACAAGGTCCTAGAATCCCACAA[C/G]GAAGCCAGGGTGCCTGGTGGGAGCCCAGGGAGTCCCAGCTGCTGTTCATTCCCCCTTCTC
67 rs2531872 [T/C] Intergenic TGTTTGGTGAACATATTATGCACACATTTTGTGCTATTGTCTTAGTAGTTACTGCCAAGC[G/A]GTTTCTCAAAGCAGTGGTACCAAAGCACACTCCACTAGTAAAGTTGCTTCACATTCTCAA
68 rs2472299 [T/C] Intergenic AAATGAGGTGAGAGAAGAGTAGGAACTGGCTCACATGTTGAGCTGAGGAGTTCAAGCTTT[A/G]TTCTGAATGCCTGAAGAAATTGATAAGGGATTTTGATTAGAGATCTGACATGCTCAGATT
69 rs221454 [T/C] Intron TTTTTTCAGATTTTAATCAATAGTTGATGTACAAGTGGTCAGAATAACTCAAATAGGGTG[G/A]GAGGATCAAATGAGGAACCTGTAACATACCTGCTCATTCACCTATtggaagaaagttctc
70 rs2781667 [A/G] UTR GTGTATTCAATGTTGCTGGCATGTGTGGATTCACAGCTCGTGGCTGTAAGGAAATCTGGG[G/A]GTTTCATAAATCCATTAAAATCCTTTTAGAGTTGCCAACCCGCAGTAGGATTTTCTTTCT
71 rs13306703 [T/C] Intergenic GCTAAAGCCTAGATTTACTTTCATTTTGATGGCATTCTAGAGGAAATCTGCCTTTTTCTC[G/A]CCACCGCCCCCAACCTCCCCACCATGGCAACAT
72 rs2198843 [G/C] Intergenic GTATTCCTGGGGACCTAGAAGCCAGGTGTCCTCCCCAAGCATCACAAGGGTTAGACCACT[C/G]TGCAGGGTATTTAGGAGTCCAGGGCACTTCTGTGTGTTACCCACAACCCAGATGGATGAA
73 rs778233 [T/C] Intergenic agattgctgtgtcatgcagtaattctatttttaatttgtttagaaaaatccacacaattt[A/G]cataatggctataccattccacatgcccacaaacactgtaaaagattcccttttctccac
74 rs7156352 [A/G] Intron TGGACACTTGGGTTGCTTCCACCTTTTGGCTATTGTTAATACTGCTGTGAACATGGGTAC[G/A]CAACTACTTCAAGATCCTGCTTTCAGTCCTTTTGGGTACATACCCAGAAGTGGAATTGCT
75 rs2074175 [T/C] Intron GTGCGGCTGCAGAGTCAGATGGGGCGGGGATTTCGGGGCACCGGGTCCTCACCTTCACGA[A/G]AAAGGCCCCACAGCACGTCCCCACTACCCGACGACTCACTCTTCGTGGCTTCTCTCTCCT
76 rs3824781 [T/C] Intron GGGGACTGGCTGTCCAATCTGCAGGGCTGGCTGCAAGGGCTGGAGCAGAAGTCAGGCCTC[G/A]GCTCAGGCCATCGGAGGCTTCTTCCTTCTCTTGCCCCTCCCTCTCCCAGGCCTAATCACA
77 rs2236687 [T/C] Intergenic AAAACTTTACAAGAATAAAGAAAAAAATTCCCAAAGTAGCAATTTTAGAAATTTAATCGG[G/A]AAGATTATCAAATAGCTGGTCTTTCAGACAGATGAAACATTAAGCACTTATACCTACACG
78 rs10459953 [G/C] UTR CAGTCCCCTCATCAAAGGTGGCCGAGAGATTTTAAAGCAGGAATGAGGCTGAGTTCTCTG[C/G]GGCCGGAGCCTCAGTTTTCGACTCGCTACAAAGTTATGAACACACTGGCAGCCAAGAAGT
79 rs10483801 [A/C] Intron GCTCTAACAGATACAGATAACACATTAGAGTTCAAAAGTGGGAATGCAGTTTGGCTAGTG[A/C]AAGTGGCAGATTTCCTCTGCCTTCATACTTGATTCATTTCCAGGCAGGCATCTGGAAGGT
80 rs2153747 [T/C] Intergenic AAAGAAGCTTGTCATTTTCTCTTGTGTCATGGTAAGTTGCTACCAAATAAGCTTTATATT[G/A]TTTGTGACCAAAAGATTTTCTTCTCCCTTTCCATGTTATTTGACAGAGTCATACTGACAA
81 rs10853181 [A/G] Intergenic CGTTATGTGGCAGTTACTGTCTAACTCAGGGAATCCTTCAGGAAGATCCTCAGCTCCCCT[A/G]CTACCTTCCACATACCCAAGCTGCTGTCTGTCTGAATATGCTTTTCCCCATGTAACTCAG
82 rs1014025 [T/C] Intergenic CTGCCACATACCAAACACTGTCACACTCTGTGGTTCTCCTCGAACAGAGAAACAAAGGAC[G/A]GAGGACTCTCCAGGCCTCTCAAAACAGAATTTGGACATCTTCAGAAATGCCCCCAGTGTG
83 rs2779248 [A/G] Intergenic AGATGCTGAAAGTGAGGCCATGTGGCTTGGCCAAATAAAACCTGGCTCCGTGGTGCCTCT[G/A]TCTTAGCAGCCACCCTGCTGATGAACTGCCACCTTGGACTTGGGACCAGAAAGAGGTGGG
84 rs8192288 [T/G] Intergenic ACACACTCAGGCTGCAGAGTCCCAGCCTTGTCACTTCCTATCTGTGTACGCCTGAAGCAG[C/A]TGCACCACTCCCTGCACCTCCTTTTCATCATCTGTAAAATGGGGGTGTGAGGCTGTCCAC
85 rs470411 [G/C] Intergenic GGAAGGTGATCGCTCCCCAAGCTCCCCAGGCCCTCACTCAGGACCTGACTACAGGCAACC[C/G]CGTCTGCTGAGGTCCTGCCCCTCTCCAGCCTCAAACTCAGTTGCACAGGTTCCATAAAGG
86 rs9394047 [A/C] Intergenic AGGGAGAGAGGGCAGGAGACCAAAGCAGAAGAGGAGCCCTAGAAGGAGGGCAGGAGCTGA[A/C]TGGGTCTGAAAATTTGTCTCAGAAAGCACAGGGACTCCCGTGTGCAGGGGCTGCCCTGGG
87 rs11809289 [T/C] Intergenic CGAAACACTTTTATCCACCCCCATTTATCTCTTCCTGACTCATGATCATCCTACAAAACT[A/G]TATTGGGCTTCACCTCCTCCCAGATTTCCTTCTCTCCTGCTCCTGTCCGGATTGTCGGCT
88 rs12885261 [T/C] Intergenic TCACCTATTTACAACAAAGGCACTATCTCAATTAGGGGGGAAGGGTAGTCTTTTCAACAC[G/A]TGCTGCTGGGAAACAAAATGACCCTTAACCTCTACAAACAAAAATTAGTTCAAAATGGAT
89 rs2297518 [A/G] Synonymous GTAGGACAACGGAAAAAGCTTTACCTGAATTTGTTGTTGAGCTCTTTCAGCATGAAGAGC[A/G]ATTTCTTCAGTTTCTAGAAAGAGAGGGAATGACAGAGTTCTCAAGCCAGGATGAATAAAA
90 rs1695 [A/G] Synonymous CAGGAGGCAGCCCTGGTGGACATGGTGAATGACGGCGTGGAGGACCTCCGCTGCAAATAC[A/G]TCTCCCTCATCTACACCAACTATGTGAGCATCTGCACCAGGGTTGGGCACTGGGGGCTGA
91 rs2305480 [T/C] Synonymous CACGCGCTTCTACCAAGACCCCAGCAGCATTAAAAAGGCTGCTTAGGAGAGGCTTGTCTG[A/G]GTCCTCCATGTGTAGCTCCCCGGAAATCAGGACCTCAGATACCTAGGGCCAGGAAGTGTG
92 rs2781659 [A/G] Intergenic CATGAGTTCACCAAGAACTGGACCTGTCAAGGTCAGCCCATCAACTTTGACAGGGAAGTC[A/G]GATTGGCAGAAGAAAAGGTAGTAAAGTGTGATGAGATTTTATTGAGACACCGGATAAATT
93 rs366631 [A/G] Intergenic TCGTTTTTATCAATTGGATCTAGACATCTTATCTTTCACAGCTCAAGACCCATTAACTCA[G/A]AATCATAAACTCTTAATGCATAATGAGAAATATAATGATTCCTAGGGCCAGGCACTTGTG
94 rs6599689 [T/C] Intergenic TCCCCTGTACAAAGCCAGCAAGGAAATAATTGAAGCTTTGTGGGCCCTGCAGTCTCTAAA[A/G]GCATGCTCACCTCTGCTGCCACAGCACAAAAGCAGCTGTTGAGAAAATGTCAGTGAGTGG
95 rs1051740 [T/C] Synonymous CATCCCTCTCTGGCTGGCGTTTTGCAAACATACCTTCAATCTTAGTCTTGAAGTGAGGGT[G/A]TCTGTTGAGAATCTCCACCTGCTTCTTCCAGTCAAATTCATTCCGCCAGTAGGAGATGAC





Control Dashboards for All Samples in the Study 
 
 Illustration of controls dashboards, which is part of quality control procedure is 
presented in Figure E1 for control dashboard of allele-specific extension, while Figure 
E2 provides information on PCR Uniformity, the efficiency test of extension gap is 
shown in Figure E3. Figure E4 demonstrates sample sex verification, while Figure E5 
and Figure E6 represent first and second hybridization controls. 
 
Figure E1 Allele Specific Extension (sample dependent). This control tests how effectively a 
correctly bound oligo is extended.  AA (red) and GG (yellow) mismatches both have U3 and are 
detected with Cy3, whereas GT (blue) and CC (green) mismatches both have U5 and are 
detected with Cy5. Cy3 has a Theta value of 0, whereas Cy5 has a Theta value of 1 here. The 
important feature of this control is where the points lie on Theta, and the two controls that are 
detected together generally overlap. Based on the samples table in the GenomeStudio, the allele-
specific controls for plates 5 and 11 have no intensities and thus failed. This pattern was 
observed in all controls. This control failure was of concern, but  while looking at the good call 
rates, it was obvious, that this was a manufacturing issue with the controls (possibly not added 
to the OPA tube). If the call rates were very low, then failed controls would be an indicator of 




Figure E2 PCR Uniformity (sample dependent). The control tests the efficiency of the 
PCR amplification for high AT and GC regions. I found no GC bias in my samples, as 
the high GC controls show a lower signal. We would normally expect the GC signal to 
be slightly below the AT signal. It is a bit lower than normal; however, it is not 
expected to cause any problem.  
Figure E3 Extension Gap (sample dependent). The extension gap control measures the 
efficiency of filling the gap by 15 bases extension between the 3’-end of the allele 
specific oligo (ASO) and the 5’-end of the locus specific oligo (LSO). The failed 
controls were those from plates 5 and 11 and can be explained as outlined above in the 
Allele Specific Extension section. There are some controls with slightly lower 
intensities, but these are for samples with both high and slightly lower call rates, and 





Figure E4 Gender (sample dependent). The gender estimate function in GenomeStudio 
works off the assay data from the gender controls. Essentially, there are 2 bead types 
(probes) on the array related to gender, therefore, each sample should be represented 
twice for each probe. The bead intensities for the gender control assays are used to 
compute a theta value for these loci. There is no specific cut off for the theta values at 
which clusters for male and female samples should appear in the Gender Control panel. 
However, the gender controls in GoldenGate are designed against human sequences 
such that females (XX) should be in the homozygous cluster at small theta values 
(usually <0.2), and males (XY) should be in the heterozygous cluster around 0.6. The 
theta value is based on intensity in green vs red channel. Overall, the Gender control 
dashboard looked fine; the Homozygote (XX) samples are ~0 and Heterozygote 
samples clustering at ~0.6. However, 40 samples demonstrated mismatch gender based 
on the reported sex and inferred sex. Again, the samples with low R (intensity) were 













Figure E5 First Hybridization Controls (sample dependent). This control investigates 
the effect of various melting temperatures (Tm) on the efficiency of annealing allele 
specific oligos (ASOs) to the specific DNA locus. The compatibility between the two 
signals would decide a Cy5 match and therefore we expect the signal to be Theta ~1. 
Overall, both the oligos bound (Cy5 match) and exhibit good signal with single 
clustering. If they had failed we might have expected one or both to give no or a low 
signal, or for there to be a significant difference between the two signals. Samples with 
low intensity reflect poor quality of DNA. Once again, the zero intensity represents 
plates with absence of control oligos. (Personal Communication with Marianne 








Figure E6 Second Hybridization Controls. This is a sample independent test, which 
signifies the capability of the single stranded PCR products to hybridize to the array 
beads. These oligos are designed to give signals as if they were homozygotes (both AA 
and BB) and heterozygotes (AB). Therefore, the important feature here is that the red 
and blue, which showed fluoresce in the green channel, have a Theta value of ~0. 
Whereas, the yellow and green, which showed fluoresce in both channels, are around 
Theta ~0.5 (it is fine if this is shifted a bit as long as it is clearly distinct from the 
homozygous groups) and the blue and the purple which showed fluoresce in the red 
channel have a Theta ~1. Based on the plot, it appears that data originate from three 
different batches, thus, we may find several clusters at different positions, each 
representing the data from one batch. These probably different scanners were used for 
scanning, had different parameters settings and maybe there were slight differences in 
the way the plates were processed. Nevertheless, this does not affect the hybridization 
process. Since, samples that are dropping out in the sample dependent controls seem not 
affected with regard to call rates, this does not seem to be a sample quality issue, but 
rather related to the absence of controls oligos (Personal communication with Susanne 





Samples Evaluation for Genotyping Quality Control 
 
 
 Samples were assessed to identify any poorly performing samples to improve 
the quality of the genotype dataset in general. The examination was performed based on 
the call rate and GenCall (GC) for each sample. Figure F1 illustrates raw data of all 
samples before exclusion of any SNPs. Each sample is represented by one data point. 
Viewing the call rate of all samples quickly reveals poorly performing samples with 
abnormally low call rates (red highlighted). Subsequent to exclusion of samples with 
call rates <0.9, the dataset improved greatly as in Figure F2. 
    Figure F3 shows raw data of all samples based on GenCall before reprocessing 
of samples. The poorly performing samples are in the lower left quadrant (blue 
highlighted samples were re-amplified) Figure F4 demonstrates raw data of 988 
samples before exclusion of any samples and SNPs. The poorly performing samples are 







Figure F1 Scatter plot of call rates across the set of samples before exclusion of any 
SNPs.  
Figure F2 Scatter plot of call rates across the set of samples subsequent to exclusion 









   





Figure F3 Scatter plot of 10% GC score compared to call rates of the sample set before 
reprocessing of samples. Figure F3 Scatter plot of 10% GC score compared to call rates 
of the sample set before exclusion of any samples and SNPs. Each sample is represented 
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 Figure G1 demonstrates comparison of original GenTrain score prior and 
subsequent to manual editing for each SNP. Overall, GenTrain score has improved 
following the manual editing, which reflected good cluster separation. In general, all the 
SNPs have GenTrain score above 0.60. The zero score implies SNPs, which have failed 
(zeroed), therefore, have been excluded from the final dataset.  
 
Figure G1 Line plot of edited GenTrain score and original GenTrain score vs SNP 
number. Whereas Table G1 provides details of cluster separation, SNP frequency, 
GenTrain score and other distribution scores for all 96 SNPs. SNP graph for each failed 
SNPs was based on the overlap cluster (Figure G2), low SNP frequency (Figure G3) 
and low AB R mean (Figure G4). Some of the successfully genotyped SNPs prior to 






Table G1 SNP Table with Quality Check Distribution 
SNP Index SNP ID No Calls Calls Call Frequency Gentrain Score Cluster Separation AB T Mean AB R Mean
1 rs2917666 0 974 1 0.6813 0.3349 0.62 1.828
2 rs7782389 0 974 1 0.7903 0.3201 0.727 0.556
3 rs997279 1 973 0.999 0.8235 0.5387 0.451 1.222
5 rs3759757 1 973 0.999 0.8839 0.4863 0.469 1.353
6 rs1137933 1 973 0.999 0.7218 0.2535 0.187 1.099
7 rs2826003 0 974 1 0.7816 0.4403 0.666 1.542
9 rs2246012 1 973 0.999 0.7313 0.3447 0.76 0.886
10 rs2074113 4 970 0.996 0.8129 0.3705 0.793 0.904
11 rs7232792 1 973 0.999 0.6635 0.2968 0.854 1.319
12 rs2284659 2 972 0.998 0.6717 0.4614 0.604 1.408
13 rs2781668 0 974 1 0.8571 0.4809 0.41 1.211
14 rs2066853 1 973 0.999 0.8384 0.4775 0.704 1.229
15 rs2733262 4 970 0.996 0.8103 0.3432 0.707 0.803
17 rs17599586 1 973 0.999 0.821 0.3745 0.711 1.264
18 rs742869 3 971 0.997 0.8233 0.3572 0.315 1.092
20 rs2364723 0 974 1 0.6775 0.4999 0.549 1.322
21 rs8078340 4 970 0.996 0.7713 0.3502 0.226 1.141
22 rs3742879 0 974 1 0.8423 0.399 0.642 1.1
23 rs268691 2 972 0.998 0.8034 0.2916 0.256 1.318
24 rs2301022 3 971 0.997 0.8739 0.529 0.562 1.229
25 rs3170633 1 973 0.999 0.8499 0.4357 0.616 0.533
26 rs2779251 2 972 0.998 0.7452 0.2471 0.193 1.328
27 rs7132743 2 972 0.998 0.7666 0.2673 0.755 1.021
29 rs6770096 0 974 1 0.7446 0.3468 0.848 1.263
30 rs7557529 3 971 0.997 0.884 0.4946 0.563 0.908
31 rs2779253 1 973 0.999 0.8723 0.4846 0.619 1.875
32 rs2606345 0 974 1 0.8518 0.403 0.346 1.215
33 rs8192287 4 970 0.996 0.6103 0.5094 0.616 1.042
34 rs2781666 0 974 1 0.7841 0.3131 0.691 1.085
35 rs4795080 6 968 0.994 0.8202 0.3997 0.629 0.549
36 rs7144243 4 970 0.996 0.7898 0.3599 0.743 1.071
37 rs17722841 1 973 0.999 0.8221 0.4165 0.742 1.092
38 rs699473 2 972 0.998 0.826 0.339 0.313 0.504
39 rs1889022 1 973 0.999 0.7671 0.2527 0.312 0.651
40 rs9282799 0 974 1 0.8585 0.5415 0.534 1.472
41 rs7591449 10 964 0.99 0.8283 0.3787 0.288 1.343
42 rs3894194 1 973 0.999 0.7487 0.4008 0.356 0.805
43 rs1442293 1 973 0.999 0.7383 0.2919 0.205 0.449
44 rs749174 0 974 1 0.8107 0.4045 0.595 1.079
45 rs689453 0 974 1 0.7417 0.2609 0.18 0.853
46 rs3796644 2 972 0.998 0.7631 0.2482 0.78 0.679
48 rs17779352 1 973 0.999 0.8521 0.5223 0.32 1.11





SNP Index SNP ID No Calls Calls Call Frequency Gentrain Score Cluster Separation AB T Mean AB R Mean
50 rs1799814 10 964 0.99 0.7688 0.3999 0.589 0.53
51 rs10454231 9 965 0.991 0.8666 0.518 0.474 1.096
52 rs7776785 1 973 0.999 0.9069 0.7308 0.454 1.608
54 rs7140310 1 973 0.999 0.8398 0.4932 0.483 1.11
55 rs1800566 0 974 1 0.7376 0.4178 0.75 1.074
56 rs17861115 0 974 1 0.8665 0.4979 0.6 0.835
57 rs11735827 0 974 1 0.859 0.4379 0.425 0.923
58 rs2531866 0 974 1 0.8978 0.5444 0.471 0.732
59 rs9900426 2 972 0.998 0.8465 0.4513 0.573 1.101
60 rs10517 1 973 0.999 0.7337 0.2662 0.827 0.725
61 rs2282885 4 970 0.996 0.7946 0.4164 0.727 0.539
62 rs2001350 1 973 0.999 0.8324 0.602 0.622 0.834
63 rs527705 2 972 0.998 0.6737 0.2436 0.828 0.892
64 rs4902503 1 973 0.999 0.8067 0.4395 0.311 0.426
65 rs7875663 1 973 0.999 0.7408 0.3105 0.828 1.115
66 rs407257 2 972 0.998 0.674 0.4977 0.543 1.567
67 rs2531872 3 971 0.997 0.8316 0.3528 0.321 1.379
69 rs221454 2 972 0.998 0.7918 0.3568 0.718 1.162
70 rs2781667 2 972 0.998 0.6509 0.4547 0.347 1.668
71 rs13306703 3 971 0.997 0.8012 0.4032 0.289 1.374
72 rs2198843 1 973 0.999 0.8767 0.4932 0.418 1.196
73 rs778233 1 973 0.999 0.6798 0.4963 0.527 1.643
74 rs7156352 6 968 0.994 0.7238 0.506 0.416 1.354
76 rs3824781 2 972 0.998 0.7849 0.4882 0.346 0.536
77 rs2236687 3 971 0.997 0.8299 0.4657 0.672 0.949
78 rs10459953 0 974 1 0.8073 0.4723 0.603 1.191
79 rs10483801 7 967 0.993 0.808 0.5269 0.496 0.221
80 rs2153747 2 972 0.998 0.8253 0.3516 0.277 1.301
81 rs10853181 0 974 1 0.87 0.5048 0.423 1.049
82 rs1014025 3 971 0.997 0.8433 0.4709 0.582 1.091
83 rs2779248 0 974 1 0.8598 0.4616 0.414 1.118
84 rs8192288 0 974 1 0.7223 0.3726 0.534 0.27
85 rs470411 0 974 1 0.8009 0.3529 0.195 1.135
86 rs9394047 1 973 0.999 0.7701 0.4106 0.36 1.229
87 rs11809289 1 973 0.999 0.8369 0.4776 0.295 1.226
88 rs12885261 1 973 0.999 0.8394 0.4813 0.619 1.054
89 rs2297518 1 973 0.999 0.8148 0.4615 0.387 0.428
90 rs1695 1 973 0.999 0.8499 0.4442 0.376 0.758
91 rs2305480 1 973 0.999 0.8479 0.5163 0.529 0.963
92 rs2781659 3 971 0.997 0.8567 0.5253 0.407 1.286
93 rs366631 1 973 0.999 0.6365 0.2877 0.254 1.407
95 rs1051740 7 967 0.993 0.8368 0.4643 0.599 1.073





Figure G2 SNPs with Overlap Clusters. The AB, BB and AA clusters undergo 










Random SNP (SNP 8) GSTP1 Exon 6 Ala114Val (SNP 16) 































GSTP1 C/G (SNP 4) 
This SNP has too low intensities, overlap 
clusters, and low SNP frequency. 
EPHX1 His139Arg (SNP 47) 
Diffused clusters. Significantly high number of 
unresolved “no call” samples and poorly separated 
clusters produces unreliable genotyping data. 
GCLC A/G (SNP 19) 
This SNP has excess of heterozygosity, therefore, this causes 
problems in manual editing of the locus for correct genotyping call. 
  





Figure G4 SNPs with Low AB R Mean. Very low intensities (Norm R). The normalized 
R values of clusters are extremely low for the successful manual editing of the 



















GSTP1 C/T (SNP 28) Random SNP G/A (SNP 75) 






Figure G5 SNP graphs for successfully manually edited SNP3 and SNP5. In the right 
panel (top and bottom) are the SNPs, after the editing. Exclusions of outlier samples for 
SNP3 and SNP5 and correcting genotype call improve call frequency for both SNPs.  
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Figure G6 SNP graphs for successfully manually edited SNP9 and SNP62. Following 
exclusion of poorly performing samples, SNPs cluster were manually edited. In the 
right panel (top and bottom) are the SNPs, after the editing. More samples were 
included for AA and AB clusters to improve call frequency of the SNPs. Three distinct 
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Population Structure Analysis 
 
 In the current study, a unique set of SNPS were selected without prior 
knowledge of their function in stratification of population to act as potential ancestral 
informative markers (AIMS). One marker was identified on the long and short arm of 
each autosome using computer random number generator to identify the genomic 
position. Only SNPs not associated with specific diseases and showing the greatest 
frequency variation across the HapMap populations (within 20kb of the selected 
position) were included in the analytical SNP set – further detail of the selection criteria 
are provided below. Our approach was to determine whether we could obtain sub-
division of ancestral populations, based on a limited set of genetic loci. This represents 
an alternative to employing established AIMS, which have been used to stratify between 
population continental and inter-continental origins, where 100’s to 1000’s of genetic 
loci are generally employed (Kidd et al., 2011; Kosoy et al., 2008; Tian et al., 2008).  
 
The AIMS selection criteria included the following: (1) Informativeness (In) - 
This measure was applied to identify highly informative markers with large allele 
frequency differences between populations. Thus, the AIMS set were evaluated using 
analysis of Fst to determine the ability of the markers to distinguish between various 
sub-population group.  (2) Linkage disequilibrium - The SNP selection also requied a 
uniform genome-wide distribution and to minimal linkage disequilibrium. The markers 
with highest In, with a minimum inter-SNP distance >500 Kb, were selected and any 
SNP with strong LD (r
2
 > 0.8) was removed (Tian et al. 2008). These aspects are 





 A measure of the divergence of each subpopulation from their ancestral origin is 
usually measured by Fixation indices statistics (Fst) (Wright 1965). This describes the 
degree of differentiation in the variations of two alleles (heterozygosity) between the 
subpopulations. It also explains that the degree of the ancestors of the two investigated 
alleles is similar and samples are taken from unrelated subpopulations. The Fst 
measurement is usually described as a single value based on the variance of allele 
frequencies on a locus deviated from the overall allele frequency of the subpopulations 
using the following formula: 
     FST = Var(p) 
                    (1 - ) 
 FST equals to the variance of the allele frequencies of the subpopulations divided 
by the expected mean allele frequency (heterozygotes) across all subpopulations 
(Holsinger and Lewis 2002).  
 It is possible to identify the level of deviation in the evolution of subpopulations 
only when the average Fst involving a vast number of multiallelic loci is taken into 
consideration. Therefore, in STRUCTURE the Fst that refers to the F model was 
applied to multiallelic loci based on correlated allele frequencies model. This model was 
adopted from Nicholson et al. (2002) and assumes that individuals in a population 
diverged from the same “ancestral population” at different rate and that therefore the 
ancestral allele frequencies are correlated to the subpopulations. The allele frequencies 
of closely linked subpopulations, are likely to be related and therefore form the basis of 
the correlated frequencies model (Falush et al. 2003). Thus, the capability of 
STRUCTURE to identify related but diverged populations is significantly enhanced 
when the correlation model is added in the population structure model (Rosenberg et al. 
2005). By making a minor modification in the traditional model, representation of the 
allele j at locus l in the correlated population by pAlj, represents p where the Fk 
characterizes Fst in the classical model. The use of a distinct F value such as F1, F2, F3, 
and FK for each population instead of one value for a range of populations indicates that 
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allele frequencies for each K population in the study population, have independently 
deviated from ancestral allele frequencies at specific rates (Falush et al. 2003). 
     
    Var(pklj) = FkpAlj(1 - pAlj) 
 
 Generally, small Fst values (close to zero) represent similar allele frequencies 
within the distinct population whereas large Fst values (close to 1) indicating large 
variation in the allele frequencies. Thereby, we would thus expect that an increase in Fst 
signifies the lack of migration in natural population, which is reflected by the higher 
subdivision amongst the main population and the populations become static for distinct 
alleles (Holsinger and Weir 2009). Conversely, significantly admixed populations offer 
challenge in accurate determination of the Fst values. The Fst values would be greater at 
a locus that shows preference over alleles under the natural selection, compared to the 
Fst values at a locus where genetic variation amongst population is mainly due to 
genetic drift (Guo et al. 2009).   
 Table H2 shows the STRUCTURE simulation summary for Fst, likelihood 
probability and variance values for all the chains. Most of the cluster populations 
produced similar likelihood at different run at each K values. On the other hand, 
similarities observed in the probability values in all of the 5 chains denote that 
convergence was achieved by undertaking sufficient iterations. In addition, some of the 
distinct and most occurring patterns observed during the single run analysis were rather 
consistent (see Figure H1). A plateau for the log probability values in the 
STRUCTURE attained between the K values of 3 to 5, suggesting that most possible of 
the clusters fall in this category of K values. The highest value of LnP(D) (-28261.3) 
was obtained for K=3 of pattern B (Run 8) which indicates the best fit for the sampled 
populations and it is the most common pattern seen. 
 From these analyses there appeared to be a marked segregation between the 
black and the Eurasian (European/White & Asian) populations at all of the K values, 
suggesting little or insignificant admixture between the two populations, with the first 
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recognizable major split observed at K=2. However, the North African (Population 4: 
Sudanese, Moroccan, Somali) possesses population structure intermediate between 
Asian and the African populations. This is observed in all patterns at each K value. The 
population ‘Other’ in the ethnicity classification, consisting of mixed and difficult to 
define ethnicities showed a gradient mirroring the Eurasian cluster. Additionally, there 
was some uniformity in the clustering of the populations across the K=2 to K=5.  
 Overall, there was no clear separation between the clusters in Eurasian 
populations at K=3 (see Figure H2). On the contrary, the black population (blue) 
presented significantly visible genetic structure at K=3, distinguishing them from the 
other populations and again suggesting little admixture. The European (Population 6) 
population demonstrated uniformity of cluster formation, with a gradient across 
European population to Asian populations, ending with the East Asia & South East 
Asian (Population 8). The rest of Asian population consisted of South Central Asian 
(Population 7: Afghan, Indian, Nepali, Pakistani and Bangladeshi), and other Asian 
background (Population 9). Noticeably, the South East Asian (Chinese, Filipino, Hong 
Kong Chinese and Vietnamese) shows distinct red cluster compared to all of the Asian 
subpopulations. The South West Asian population (Population 5: Kurdish, Turkish and 
White Turkish) did not form separate cluster but was broadly in line with the European 
whites. When the population structure was analysed at higher K values, K=4 and K=5, 
the cluster formation was more complex with some enhanced division between the 
Eurasian and ‘Other’ populations (see Figure H1).  
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Individuals are grouped in subpopulations, according to self-reported ethnicity. Subpopulations are ordered according to geographical region 
beginning from Africa, to South West Asia (Middle East), then Europe to Asia, followed by America and ends with “Others Mixed” populations. 
The entire mixed ethnicity groups were grouped in one subpopulation, “Others”, as there are very few of them in each subgroup. Asia is the 
major subpopulation in the study, which consists of ~35% of the investigated populations, followed by 27% of Europe subpopulation, and 25% of 
Africa subpopulations. The ‘main ethnicity’ category is used for the ethnicity classification in the association analysis whereas the 11 




Subpopulations Code Subpopulations Detail Main Ethnicity Self-reported Ethnicity No. of Individuals
1 Africa Black African, Caribbean 150
2 West Africa Black Ghanaian, Guinea, Nigeria, Sierra Leon, Togolese 66
3 South & Central Africa Black Angolan, Congolese 12
4 North & East Africa Black Sudanese, Moroccan, Somali 19
5 South West Asia Others Kurdish, Turkish, White Turkish 36
6 Europe White English, Albanian, Portuguese, Traveller 267
7 South Central Asia Asian Afghan, Indian, Nepali, Pakistani, Bangladeshi 316
8 East Asia & South East Asia Asian Vietnamese,  Filipino, Chinese, Hong Kong Chinese, Oriental 26
9 Other Asia Asian Any other Asian background 5
10 America Others Brazillian Latin 11
11 Other Mixed Others Any other mixed, Mixed White and Asian, Mixed White and Black, Mixed Black and Asian, Other 66
Total Number of Children 974
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Table H2 shows the simulation analysis representing likelihood, variance, 
Alpha and Fst values. Structure was run 10 times for each K value (K=2 to K=5). The 
run with highest likelihood (-28261.3) is highlighted in red and was obtained for K=3, 
which represent the best fit for the sampled populations. 
 
Table H2 STRUCTURE Simulation Summary 
 
 
K Run Name LnP(D) Var[LnP(D)] α1 Fst_1 Fst_2 Fst_3 Fst_4 Fst_5
2 Run 1 -28277 433.5 0.1095 0.16 0.1203 - - -
2 Run 2 -28271.1 429 0.1201 0.1248 0.1588 - - -
2 Run 3 -28294.5 471.6 0.1162 0.1148 0.1663 - - -
2 Run 4 -28297.8 466.6 0.102 0.1537 0.1203 - - -
2 Run 5 -28282.4 444 0.1089 0.1364 0.1406 - - -
2 Run 6 -28285.9 453.2 0.1104 0.1624 0.1201 - - -
2 Run 7 -28310.9 487 0.0989 0.2083 0.0486 - - -
2 Run 8 -28285.8 441.7 0.1004 0.1302 0.1405 - - -
2 Run 9 -28280.1 434.3 0.1033 0.159 0.117 - - -
2 Run 10 -28287.4 463.1 0.1227 0.1283 0.1556 - - -
3 Run 11 -28263.1 804.4 0.0796 0.0016 0.0535 0.263 - -
3 Run 12 -28269 813.5 0.0779 0.0536 0.0007 0.2627 - -
3 Run 13 -28270.1 816.3 0.0813 0.0523 0.0042 0.2631 - -
3 Run 14 -28274.2 826.3 0.0825 0.265 0.0535 0.0016 - -
3 Run 15 -28261.3 798.2 0.0773 0.0046 0.2603 0.0522 - -
3 Run 16 -28290.5 856.3 0.0799 0.263 0.002 0.053 - -
3 Run 17 -28276.3 829.4 0.0797 0.0532 0.0023 0.2641 - -
3 Run 18 -28275.4 822.9 0.0773 0.0024 0.2605 0.0524 - -
3 Run 19 -28270 815.8 0.0789 0.0516 0.0046 0.2622 - -
3 Run 20 -28279.9 830.8 0.0769 0.0519 0.2608 0.0038 - -
4 Run 21 -28905.4 2167.6 0.0664 0.0168 0.2745 0.0329 0.0272 -
4 Run 22 -28723.8 1771.5 0.0646 0.041 0.2731 0.0035 0.0253 -
4 Run 23 -28784.1 1872.8 0.0657 0.2765 0.0318 0.0144 0.0186 -
4 Run 24 -28789.9 1941.5 0.0655 0.0273 0.0241 0.2734 0.0245 -
4 Run 25 -28886.7 2139 0.0678 0.0165 0.0207 0.041 0.2757 -
4 Run 26 -28913.2 2177.2 0.0628 0.0273 0.2718 0.0238 0.0254 -
4 Run 27 -28905.8 2168.5 0.0644 0.0319 0.0273 0.0175 0.2742 -
4 Run 28 -28726.2 1770.7 0.0644 0.0361 0.0042 0.2753 0.0268 -
4 Run 29 -28873.6 2087.9 0.0669 0.0079 0.0376 0.0264 0.2761 -
4 Run 30 -28904.8 2176.4 0.0699 0.0271 0.0374 0.0137 0.2767 -
5 Run 31 -28976.1 2349.5 0.0594 0.0361 0.2877 0.0158 0.0265 0.0149
5 Run 32 -29167.4 2724.6 0.0627 0.0159 0.0189 0.2905 0.0303 0.0295
5 Run 33 -28987.4 2374 0.0616 0.2892 0.0231 0.0141 0.0142 0.0434
5 Run 34 -29127.8 2644.7 0.0586 0.0401 0.0163 0.2878 0.0145 0.0197
5 Run 35 -28833.9 2019.8 0.0623 0.0108 0.0054 0.2924 0.0161 0.0504
5 Run 36 -28655.6 1651.4 0.059 0.0511 0.0087 0.2892 0 0.0207
5 Run 37 -29189.1 2736.8 0.0609 0.2873 0.0175 0.0028 0.039 0.0303
5 Run 38 -28906.5 2198.1 0.062 0.0114 0.0263 0.0135 0.2914 0.04
5 Run 39 -29172 2704.4 0.0587 0.0238 0.02 0.0001 0.0412 0.2888













Figure H1 Structure Summary with Highest Likelihood in Each K Value (K=2 to K=5).  
Illustration of structure pattern with the highest likelihoods for all K values with the run number out of ten runs. K represents number 
of different clusters simulated in the structure analyses. A distinct thin vertical line indicates each individual and these lines are 
subdivided into various coloured divisions of respective K clusters. Black lines represent segregation of various populations. 
Population labels are as in Table H1. A plateau for the log probability values in the STRUCTURE attained between the K values of 3 
to 5, suggesting that most possible of the clusters fall in this category of K values. There appears to be a marked division between the 
black and the Eurasian populations at all of the K values, suggesting little or insignificant admixture between the two populations and 
the first recognizable major split was observed at K=2. When the population is analysed at higher K value, K=4 and K=5, the cluster 












Figure H2 Population Structure Pattern at K = 3.  
Illustration of structure pattern for the best possible K value in the study populations. Line 
graphs indicate likelihood of each run while dashed lines represent actual K value. Bar 
plots are showing different clustering pattern observed across 10 runs in each K, in this case 
K=3. Vertical bars signify individuals in populations while solid lines segregate individuals 
according to subpopulations. Distinct colour indicates classification of populations in 
specific cluster. The highest likelihood is obtained for K=3 of pattern B (Run 8) which 
indicates the best fit for the sampled populations and it is the most common pattern 
observed overall. There is some distinct cluster for Europeans (mostly red) and Asian 
































 The mean Fst values based on the K=3 for cluster 1, 2 and 3 were 0.0046, 0.2603 
and 0.0522 respectively. Here, Cluster 1 represents Asian, Cluster 2 represents mostly 
Black and Cluster 3 characterizes European subpopulations. The low Fst values severely 
affect the capability of the STRUCTURE to identify differences in related subpopulations. 
This was apparent for Asian and White populations, which is reflected in the pattern 
observed in the bar plots. There are several possibilities for the observed conditions. Fst 
determines the extent of allele frequency deviation in a sample taking into consideration the 
probability of most likely deviation possible. An estimate of 0.46% probably indicates that 
there are very few common alleles among the studied populations. Therefore a rare allele 
might lower the Fst value when low allele frequency is observed in the subpopulation 
divided by the allele frequency of the total population. Another condition could be that 
when the Asian and White population have similar allele frequencies (see Table H3 for 
allele frequency for each SNPs investigated in the STUCTURE analysis), this does not 
clearly separate populations from each other, but demonstrates a high level of admixture. 
Therefore, it indicates little divergence amongst the populations. The allele frequency 
divergence among the Cluster 1 vs Cluster2, Cluster 1 vs Cluster 3 and Cluster 2 vs Cluster 
3 were 0.0834, 0.0069 and 0.0927 respectively. This indicates that there is weak separation 
between Asian and White ethnicity/Europe subpopulations reflecting evidence observed in 
Fst value. Overall, average distances estimation (average expected heterozygosity for all 
loci) between individuals in the same cluster for cluster 1, cluster 2 and cluster 3 is 0.3664, 
0.3454 and 0.3389 respectively.  
The probability of population admixture depends on the mean Dirichlet parameter, 
denoted by the alpha (α). The high value of α (>1) suggests significantly higher admixture 
amongst the populations and lower α values (close to zero) categorise individuals to the 
distinct populations (Falush et al. 2003). For instance, at K=3 the mean Dirichlet parameter 
calculated for the highest likelihood is 0.0773 and is representative of the three major 








CEU= Utah residents with Northern and Western European ancestry 
GIH = Gujarati Indians in Houston, Texas 
HCB= Han Chinese in Bejing, China 
YRI = Yoruba in Ibadan, Nigeria 
LWK= Luhya in Webuye, Kenya 
 
   
SNPs Index SNPs Chr European (CEU) South Asian(GIH) East Asian (HCB) West African (YRI) East African (LWK)
Allele 1 Allele 2 Allele 1 Allele 2 Allele 1 Allele 2 Allele 1 Allele 2 Allele 1 Allele 2 
2 rs7782389 7 0.513 0.487 0.523 0.477 0.651 0.349 0.712 0.288 0.534 0.466
3 rs997279 6 0.611 0.389 0.699 0.301 0.895 0.105 0.633 0.367 0.606 0.394
7 rs2826003 21 0.898 0.102 0.852 0.148 0.570 0.430 0.327 0.673 0.311 0.689
8 rs17072738 18 0.017 0.983 0.222 0.778 0.475 0.525
11 rs7232792 18 0.814 0.186 0.744 0.256 0.547 0.453 0.659 0.341 0.600 0.400
15 rs2733262 1 0.544 0.456 0.676 0.324 0.767 0.233 0.168 0.832 0.206 0.794
23 rs268691 19 0.509 0.491 0.472 0.528 0.733 0.267 0.097 0.903 0.191 0.809
27 rs7132743 12 0.822 0.178 0.944 0.056 0.237 0.763
29 rs6770096 3 0.898 0.102 0.812 0.188 0.756 0.244 0.699 0.301 0.800 0.200
41 rs7591449 2 0.118 0.882 0.364 0.636 0.605 0.395 0.580 0.420 0.694 0.306
43 rs1442293 15 0.759 0.241 0.544 0.456 0.892 0.108
46 rs3796644 4 0.371 0.629 0.335 0.665 0.488 0.512 0.168 0.832 0.211 0.789
49 rs2128238 16 0.643 0.357 0.686 0.314 0.679 0.321 0.811 0.189
51 rs10454231 3 0.071 0.929 0.216 0.784 0.244 0.756 0.686 0.314 0.539 0.461
52 rs7776785 7 0.042 0.958 0.100 0.900 0.175 0.825
57 rs11735827 4 0.951 0.049 0.892 0.108 0.977 0.023 0.819 0.181 0.800 0.200
59 rs9900426 17 0.442 0.558 0.356 0.644 0.733 0.267
63 rs527705 9 0.544 0.456 0.426 0.574 0.628 0.372 0.805 0.195 0.811 0.189
65 rs7875663 9 0.558 0.442 0.540 0.460 0.581 0.419 0.314 0.686 0.228 0.772
69 rs221454 14 0.420 0.580 0.477 0.523 0.337 0.663 0.956 0.044 0.978 0.022
73 rs778233 5 0.535 0.465 0.670 0.330 0.429 0.571 0.274 0.726 0.264 0.736
75 rs2074175 19 0.469 0.531 0.602 0.398 0.243 0.757
76 rs3824781 10 0.095 0.905 0.034 0.966 0.155 0.845 0.054 0.946 0.103 0.897
77 rs2236687 21 0.500 0.500 0.573 0.427 0.283 0.717
80 rs2153747 13 0.863 0.137 0.920 0.080 0.667 0.333 0.518 0.482 0.661 0.339
85 rs470411 11 0.271 0.729 0.678 0.322 0.325 0.675
86 rs9394047 6 0.942 0.058 0.801 0.199 0.814 0.186 0.929 0.071 0.961 0.039
87 rs11809289 1 0.992 0.008 0.878 0.122 0.658 0.342
94 rs6599689 10 0.482 0.518 0.648 0.352 0.296 0.704
96 rs6017870 20 0.788 0.212 0.875 0.125 0.392 0.608
13 SNPs SNPs which don't clearly separate between CEU (European) and GIH (South Asian) or East Asian when the GIH populations was not genotyped
2 SNPs SNPs which don't clearly separate between main ancestry (CEU/GIH (or HCB when the GIH was not genotyped)/YRI)
9 SNPs SNPs which have different MAF between HCB (East Asian) and GIH (South Asian) 
2 SNPs SNPs which don't clearly separate CEU (European) and YRI (African)
3 SNPs Failed SNPs (excluded from the final dataset)
 326 
 
  Triangle plot of all 11 subpopulations were shown in Figure H3 whereas Figure 
H4 shows the triangle plot at K=3 representing the clustering behaviour involving 
individuals of the three major populations (Asians=red coded), (Whites=blue coded) and 
(Black=green coded) as observed in the bar plot. Unsurprisingly, the Asians and White 
failed to form independent clusters and instead clustered at the edge of the major cluster, 
which is formed of rest of the individuals (admixed). On the other hand, majority of the 
black population (green) appeared to be clustering at the vertex of the triangle plot although 
a small percentage appeared to be scattered throughout the triangle area particularly at the 
centre of the triangle plot. Individuals with missing genotype data, which are coded with 
red colour, can be seen at the centre of the plot. The marked difference observed in some 
populations signifies possibilities of population stratification; however, investigation of 






Figure H3 Triangle Plot at K = 3. Triangle plot represents each 11 subpopulations analysed 
in the population structure. Each subpopulation coded with different colour for 
identification. Cluster 1, cluster 2 (All Others) and cluster 3 denote Asian, Black and White 
ethnicity in the population study.  
 
(Pop 1) Africa 
(Pop 2) West Africa 
(Pop 3) South & Central Africa 
(Pop 4) North & East Africa 
(Pop 5) South West Asia 
(Pop 6) Europe 
(Pop 7) South Central Asia 
(Pop 8) East Asia & South East Asia 
(Pop 9) Other Asia 
(Pop 10) America 





Figure H4 Triangle plot showing results of STRUCTURE analysis for K=3. Each point 
represents an individual for the specific cluster based on the colour code. There is no true 
separation for Asian and White and both are rather shown as admixed populations 
(Eurasian).  
 Cluster 1: Asian 
 Cluster 2: Black  
 Cluster 3: White 
 Other Mixed ethnicity 
 
 It is important to have strong population structure because with weak population 
structure they appear admixed at K=2 causing individuals to fall in to unspecified clusters 
with characteristics similar to all of the tested clusters as observed in the present data. The 
degree of admixture amongst the populations depends on the population sample size. 
Differences in the sample size of the individual populations also affect the allele 
frequencies of the said cluster and the differentiation (if any) would be representative of the 
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population with large number of individuals compared to the population with the small 
number of individuals. This will lead to the scenario where small population flanked by 
large number of cline populations appearing to be admixed at the most extreme areas of the 
cline (Kidd et al. 2011). This is reflected at K=3 for North & East Africa population 
(Sudanese, Moroccan & Somali) and South West Asian (Turkish) populations. Our data set 
consist of ~3%, ~4% and ~2% of East Asian & South East Asian, South West Asian, and 
North & East African populations respectively of the total sample. Whereas the major 
subpopulation, which is South Central Asian, consists of 32.4% of the whole population 
studied. In addition, at higher K values, the small subpopulation flanked by bigger 
subpopulation that appeared admixed, have the potential to form a single cluster due to 
estimation of the extreme clusters of the cline. This is illustrated in Population 2: West 
African and Population 8: East Asian & South East Asian at K=5. It should be noted that 
none of the subpopulations appear as clear cluster except for African subpopulations 
(exceptional for Population 4). Therefore, determination of K value for the populations 
investigated was rather an ad hoc approximation, thus, allele frequencies for a particular 
cluster to be suggestive of their ancestors may not essentially be true. In addition, allocation 
of subpopulations to more than one cluster could not be inferred as true admixture. 
Moreover, it is highly likely that deviation of data from HWE will result in K value being 
unreliable. Although, deviation from the HWE would significantly affect the closely related 
population but it hardly has any effect on the unrelated populations.  
 There appears to be a lack of discrete structure in the current dataset. However, an 
increase in the subjects in each population or increased markers could potentially enhance 
chances of identifying any discernible structure in the data. As observed in the data, the 
Eurasian and African populations showed poor cluster separation. This suggests that the 
random markers in our panel do not stratify the Central, South and East Asian origin 
effectively. Probably, the inclusion of large number of SNPs with significantly high level of 
allele frequency variations relative to Eurasians could result in greater segregation of the 
west and east Eurasian populations. This set of SNPs also does not optimally segregate 
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even the populations amongst the individuals of the East Asian origin. A similar outcome 
was shown in Kidd et al. (2011) study. However, we should bear in mind that the SNPs 
employed in this analysis were selected randomly without prior knowledge of the function 
in structure analysis. These SNPs have never been tested in any other studies. Therefore, 
we could propose the SNPs panel selected in this study to best distinguish between White 
and African. As South West African (Somali) cline with Asian population, therefore, it is 
recommended not to employ this panel on this group. 
 Global population structure is complicated by intermediate populations such as the 
South West Asian, South East Asian and the West African. At high frequency of these 
populations, it leads to the structure and genetic differences cline instead of clustering. In 
addition, major population groups such as Africans, Caucasians and Asians are rather 
heterogeneous and further divided into complicated subpopulations. The statistical power 
of the study significantly depends on the sample size and any change in the population size 
would affect the overall deviation. An increase in the sample size may cause small allele 
frequencies variation in the samples compared to the allele frequencies in the primary 
population (Holsinger and Weir 2009). On the other hand, it is impossible to control the 
deviation in the populations related to the underlying genetics, which is an inherent genetic 
material in evolutionary process leading to diversity between populations. This leads to the 
conclusion as before that K values heavily depend on the population sample size and 












Figure I1: Correlations between chronic, sub-chronic and acute exposure NOx attributions 
modeled using 20m radius buffers around each subject residential address (home), or 










Figure I2: Correlations between chronic, sub-chronic and acute exposure NO2 attributions 
modeled using 20m radius buffers around each subject residential address (home), or 












Figure I3: Correlations between chronic, sub-chronic and acute exposure PM10 attributions 
modeled using 20m radius buffers around each subject residential address (home), or 











Figure I4: Correlations between chronic, sub-chronic and acute exposure PM2.5 attributions 
modeled using 20m radius buffers around each subject residential address (home), or 




Table I1: Hardy-Weinberg equilibrium (HWE) p-values for SNPs in GSTM1, GSTP1 and 
NQO1 genes by ethnicity 
SNP ID Asian Black White Others 
GSTM1     

rs366631 - - - - 
GSTP1      
rs749174  0.28 0.86 0.79 1.00 
rs1695 0.89 0.12 0.59 1.00 
NQO1     
rs2917666 0.33 0.69 0.48 0.45 
 rs689453 0.91 0.53 0.55 0.52 
rs1800566 0.90 0.64 0.84 0.34 
rs10517 0.40 1.00 0.19 1.00 
     
 
*HWE p value is not calculated 
  Table I2: Hardy-Weinberg equilibrium (HWE) p-values for SNPs in CYP1A1 and AhR 
genes for total populations and stratified by ethnicity  
 
        * SNP which is not in HWE (p<0.05).  
 
SNP ID Total Population Asian Black White Others 
AhR 
rs2074113 0.90 0.71 1.00 0.72 0.43 
 rs2066853 0.002 0.58 0.30 0.35 0.80 
 rs17722841 0.48 0.60 0.70 0.40 0.56 
rs17779352 0.48 0.26 0.58 0.70 0.66 
rs2282885 0.07 1.00 0.58 0.9 0.12 
CYP1A1 
rs2606345 2.46E-11 0.46 0.14 1.00 0.58 
? 
rs1799814 4.40E-04 0.07 0.82 0.02 0.27 
 rs17861115 0.004 0.13 0.44 0.36 0.05 
rs2198843 1.90E-04 0.49 1.00 0.55 0.14 
 336 
 
Table I3: SNP linkage disequilibrium (D’ values >0.7 highlight in bold text) for genes 
within the confirmatory and exploratory panel. Based on data from the 1000 genomes 
study: intergrated phase 1, version 3 (March 2012). Calculated using the linkage 
disequilibrium calculator, caprica.genetics.kcl.ac.uk. 
GSTP1 GSTP1 GSTP1 GSTP1 GSTP1 
rs4147581 rs1138272 rs1871042 rs749174 rs1695
GSTP1 rs4147581 - -1.000 -0.983 -0.983 -0.983
GSTP1 rs1138272 - 1.000 1.000 1.000
GSTP1 rs1871042 - 1.000 0.963
GSTP1 rs749174 - 0.969
GSTP1 rs1695 -
NQO1 NQO1 NQO1 NQO1
rs2917666  rs689453 rs1800566 rs10517
NQO1 rs2917666 - 1.000 -0.971 0.945
NQO1  rs689453 - -1.000 1.000
NQO1 rs1800566 - 1.000
NQO1 rs10517 -
Ahr Ahr Ahr Ahr Ahr
rs2074113 rs2066853 rs17722841 rs17779352 rs2282885
Ahr rs2074113 - 1.000 -0.866 -1.000 -0.942
Ahr rs2066853 - -0.869 -1.000 -0.944
Ahr rs17722841 - 0.030 0.987
Ahr rs17779352 - -0.509
Ahr rs2282885 -
CYP1A1 CYP1A1 CYP1A1 CYP1A1 CYP1A1
rs2606345 rs1799814  rs17861115 rs2472299 rs2198843
CYP1A1 rs2606345 - -1.000 -0.946 0.170 -0.973
CYP1A1 rs1799814 - -1.000 1.000 1.000
CYP1A1  rs17861115 - 0.659 0.916












Table I4: Unadjusted and adjusted beta-coefficients (β) and 95% confidence intervals (95% CI) 
for the association between GSTM1, GSTP1 and NQO1 genotypes and lung function 
 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and 
study year including effect for school. ***p<0.001, ** p<0.01, *p<0.05, #p<0.1 (interaction 
terms)  
Genotype Crude Adjusted Crude Adjusted
(n=898) (n=866) (n=867) (n=837)
GSTM1
rs366631  (C/T)
CT Reference Reference Reference Reference
TT 0.0526**[0.0166,0.0886] 0.0198[-0.0054,0.0451] 0.0552*[0.0128,0.0975] 0.0086[-0.0207,0.0379]
GSTP1
 rs749174   (Intron, 5 C/T)
CC Reference Reference Reference Reference
CT -0.0109[-0.0483,0.0265] -0.0198[-0.0458,0.0063] -0.0179[-0.0617,0.0260] -0.0278[-0.0579,0.0022]
TT 0.0608[-0.0057,0.1273] -0.0012[-0.0476,0.0451] 0.0497[-0.0286,0.1280] -0.0197[-0.0731,0.0337]
CT + TT 0.0015[-0.0341,0.0371] -0.0166[-0.0413,0.0080] -0.0063[-0.0480,0.0354] -0.0264[-0.0548,0.0020]
rs1695 (Exon 5, Ile105Val) 
Ile/Ile Reference Reference Reference Reference
Ile/Val -0.0366[-0.0748,0.0017] -0.0340*[-0.0604,-0.0075] -0.0505*[-0.0953,-0.0058] -0.0436**[-0.0741,-0.0132]
Val/Val -0.0180[-0.0736,0.0376] -0.0249[-0.0639,0.0141] -0.0405[-0.1058,0.0248] -0.0369[-0.0818,0.0080]
Ile/Val + Val/Val -0.0321[-0.0680,0.0038] -0.0319*[-0.0567,-0.0071] -0.0480*[-0.0901,-0.0059] -0.0422**[-0.0707,-0.0136]
NQO1
rs2917666 (3´ UTR (C/G))
CC Reference Reference Reference Reference
CG -0.0150[-0.0577,0.0276] -0.0081[-0.0384,0.0221] -0.0184[-0.0686,0.0319] -0.0039[-0.0390,0.0311]
GG -0.0321[-0.0818,0.0175] 0.0108[-0.0254,0.0471] -0.0360[-0.0944,0.0223] 0.0241[-0.0180,0.0661]
CG + GG -0.0208[-0.0608,0.0192] -0.0026[-0.0313,0.0261] -0.0244[-0.0715,0.0228] 0.004[-0.0293,0.0374]
rs689453 (Exon 2, Glu24 (G/A))
GG Reference Reference Reference Reference
GA 0.0157[-0.0511,0.0824] -0.0207[-0.0675,0.0261] 0.0026[-0.0765,0.0817] -0.0243[-0.0789,0.0304]
AA -0.0622[-0.4388,0.3144] 0.0884[-0.1690,0.3457] -0.2044[-0.6381,0.2292] -0.0280[-0.3202,0.2641]
GA + AA 0.0136[-0.0522,0.0793] -0.0174[-0.0632,0.0284] -0.0035[-0.0814,0.0744] -0.0244[-0.0778,0.0291]
rs1800566 (Exon 6, Pro187Ser) 
Pro/Pro Reference Reference Reference Reference
Pro/Ser 0.0137[-0.0242,0.0515] 0.0195[-0.0071,0.0461] 0.0186[-0.0257,0.0629] 0.0354*[0.0048,0.0660]
Ser/Ser -0.0292[-0.1068,0.0485] 0.0104[-0.0440,0.0649] -0.0350[-0.1264,0.0564] 0.0140[-0.0491,0.0772]
Pro/Ser + Ser/Ser 0.0077[-0.0285,0.0439] 0.0184[-0.0070,0.0438] 0.0113[-0.0312,0.0537] 0.0327*[0.0034,0.0620]
rs10517 (3´ UTR (C/T))
CC Reference Reference Reference Reference
CT -0.0035[-0.0428,0.0358] 0.0109[-0.0162,0.0380] -0.0118[-0.0576,0.0341] 0.0145[-0.0166,0.0456]
TT -0.0037[-0.1124,0.1049] -0.0094[-0.0849,0.0661] 0.0064[-0.1240,0.1368] -0.0207[-0.1082,0.0669]





Table I5: Effects of GSTM1, GSTP1 and NQO1 genotypes on FEV1 and acute pollutant 
exposures (24 hour) 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and 
study year including effect for school. ***p<0.001, ** p<0.01, *p<0.05, #p<0.1 (interaction 
terms)  
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) β(95% CI) β(95% CI) β (95% CI) β (95% CI)
GSTM1
rs366631  C/T
CT 482 Reference Reference Reference Reference
TT 383 45.9E-06[-0.0005,0.0006] -21.4E-06[-0.0023,0.0022] -0.0005[-0.0031,0.0021] -0.0012[-0.0049,0.0025]
GSTP1
 rs749174   Intron 5 C/T
CC 455 Reference Reference Reference Reference
CT 340 30.6E-06[-0.0006,0.0006] -0.0001[-0.0024,0.0023] -0.0004[-0.0031,0.0023] -0.0002[-0.0041,0.0036]
TT 71 -0.0002[-0.0012,0.0009] -0.0004[-0.0044,0.0036] -0.0005[-0.0058,0.0049] -0.0021[-0.0095,0.0052]
CT + TT 411 2.40E-06[-0.0006,0.0006] -0.0001[-0.0024,0.0021] -0.0004[-0.0030,0.0022] -0.0004[-0.0041,0.0033]
rs1695 Exon 5 Ile105Val 
Ile/Ile 379 Reference Reference Reference Reference
Ile/Val 371 0.0005[-0.0001,0.0011] 0.0021#[-0.0004,0.0045] 0.0012[-0.0016,0.0040] 0.0018[-0.0021,0.0058]
Val/Val 115 0.0005[-0.0005,0.0014] 0.0015[-0.0020,0.0050] 0.0026[-0.0017,0.0070] 0.0035[-0.0027,0.0096]
Ile/Val + Val/Val 486 0.0005#[-0.0001,0.0010] 0.0019#[-0.0003,0.0042] 0.0015[-0.0011,0.0041] 0.0022[-0.0015,0.0059]
NQO1
rs2917666 3  ´UTR (C/G)
CC 231 Reference Reference Reference Reference
CG 424 0.0001[-0.0005,0.0008] 0.0001[-0.0026,0.0027] 0.0013[-0.0018,0.0044] 0.0021[-0.0023,0.0066]
GG 211 0.0003[-0.0005,0.0011] 0.0015[-0.0016,0.0047] 0.0013[-0.0024,0.0050] 0.0021[-0.0033,0.0074]
CG + GG 635 0.0002[-0.0004,0.0008] 0.0005[-0.0019,0.0030] 0.0013[-0.0016,0.0042] 0.0021[-0.0021,0.0063]
rs689453 Exon 2 Glu24 (G/A)
GG 799 Reference Reference Reference Reference
GA 65 -0.0001[-0.0011,0.0009] -0.0007[-0.0046,0.0032] 0.0004[-0.0041,0.0048] 0.0012[-0.0050,0.0075]
AA 2 -0.0092[-0.0298,0.0115] -0.0268[-0.0868,0.0331] -0.0721[-0.2379,0.0938] 0.0750[-0.0981,0.2482]
GA + AA 67 -31.3E-06[-0.0010,0.0009] -0.0006[-0.0044,0.0032] 0.0006[-0.0038,0.0049] 0.0016[-0.0046,0.0077]
rs1800566 Exon 6 Pro187Ser 
Pro/Pro 505 Reference Reference Reference Reference
Pro/Ser 311 47.4E-06[-0.0005,0.0006] 0.0003[-0.0020,0.0027] 0.0006[-0.0021,0.0033] 0.0007[-0.0031,0.0046]
Ser/Ser 50 0.0002[-0.0016,0.0020] -0.0006[-0.0061,0.0048] 0.0012[-0.0046,0.0070] 0.0051[-0.0037,0.0140]
Pro/Ser + Ser/Ser 361 0.0001[-0.0005,0.0006] 0.0002[-0.0021,0.0024] 0.0007[-0.0019,0.0032] 0.0012[-0.0025,0.0049]
rs10517 3  ´UTR (C/T)
CC 584 Reference Reference Reference Reference
CT 257 -0.0001[-0.0006,0.0005] -0.0004[-0.0029,0.0021] 0.0010[-0.0019,0.0038] 0.0004[-0.0036,0.0044]
TT 24 0.0005[-0.0017,0.0026] 0.0021[-0.0053,0.0096] -0.0018[-0.0120,0.0083] -0.0036[-0.0190,0.0118]




Table I6: Effects of GSTM1, GSTP1 and NQO1 genotypes on FVC and acute pollutant 
exposures (24 hour) 
 
 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) β(95% CI) β(95% CI) β (95% CI) β (95% CI)
GSTM1
rs366631  C/T
CT 466 Reference Reference Reference Reference
TT 370 0.0003[-0.0004,0.0009] 0.0008[-0.0019,0.0034] -0.0001[-0.0032,0.0029] -0.0002[-0.0045,0.0041]
GSTP1
 rs749174   Intron 5 C/T
CC 438 Reference Reference Reference Reference
CT 330 0.0001[-0.0006,0.0007] -0.0001[-0.0028,0.0026] 0.0002[-0.0029,0.0034] -0.0001[-0.0045,0.0044]
TT 69 -0.0004[-0.0016,0.0008] -0.0024[-0.0071,0.0023] -0.0002[-0.0063,0.0059] -0.0022[-0.0106,0.0063]
CT + TT 399 0.6E-06[-0.0006,0.0006] -0.0005[-0.0031,0.0021] 0.0002[-0.0028,0.0032] -0.0003[-0.0046,0.0039]
rs1695 Exon 5 Ile105Val 
Ile/Ile 364 Reference Reference Reference Reference
Ile/Val 361 0.0005[-0.0002,0.0012] 0.0019[-0.0008,0.0047] 0.0017[-0.0015,0.0049] 0.0025[-0.0021,0.0071]
Val/Val 111 0.0003[-0.0007,0.0014] 0.0004[-0.0037,0.0044] 0.0032[-0.0018,0.0082] 0.0043[-0.0028,0.0114]
Ile/Val + Val/Val 472 0.0005[-0.0002,0.0011] 0.0016[-0.0010,0.0042] 0.002[-0.0010,0.0050] 0.0029[-0.0014,0.0072]
NQO1
rs2917666 3  ´UTR (C/G)
CC 220 Reference Reference Reference Reference
CG 411 0.0002[-0.0006,0.0010] 0.0003[-0.0027,0.0033] 0.0018[-0.0018,0.0054] 0.0030[-0.0023,0.0082]
GG 206 0.0006[-0.0004,0.0015] 0.0018[-0.0018,0.0055] 0.0018[-0.0025,0.0061] 0.0035[-0.0027,0.0097]
CG + GG 617 0.0003[-0.0004,0.0010] 0.0008[-0.0020,0.0036] 0.0018[-0.0016,0.0052] 0.0031[-0.0018,0.0081]
rs689453 Exon 2 Glu24 (G/A)
GG 774 Reference Reference Reference Reference
GA 61 -0.0003[-0.0014,0.0009] -0.0010[-0.0054,0.0035] 0.0001[-0.0050,0.0052] 0.0020[-0.0052,0.0092]
AA 2 -0.0055[-0.0290,0.0180] -0.0160[-0.0842,0.0522] -0.0436[-0.2321,0.1449] 0.0459[-0.1509,0.2427]
GA + AA 63 -0.0003[-0.0014,0.0009] -0.001[-0.0053,0.0033] 0.0001[-0.0049,0.0050] 0.002[-0.0050,0.0091]
rs1800566 Exon 6 Pro187Ser 
Pro/Pro 487 Reference Reference Reference Reference
Pro/Ser 302 -0.0001[-0.0007,0.0006] -37.0E-06[-0.0028,0.0027] 0.0007[-0.0025,0.0038] 0.0008[-0.0037,0.0052]
Ser/Ser 48 0.0001[-0.0019,0.0022] 0.0002[-0.0059,0.0064] 0.0001[-0.0066,0.0068] 0.0032[-0.0069,0.0134]
Pro/Ser + Ser/Ser 350 -44.7E-06[-0.0007,0.0006] -25.4E-06[-0.0026,0.0026] 0.0006[-0.0024,0.0036] 0.0011[-0.0032,0.0053]
rs10517 3  ´UTR (C/T)
CC 562 Reference Reference Reference Reference
CT 252 0.0002[-0.0005,0.0008] 0.0005[-0.0023,0.0034] 0.0015[-0.0018,0.0047] 0.0012[-0.0034,0.0058]
TT 23 0.0002[-0.0023,0.0028] 0.0005[-0.0085,0.0095] -0.0014[-0.0130,0.0101] -0.0039[-0.0215,0.0138]




Table I7: Effects of GSTM1, GSTP1 and NQO1 genotypes on the association between FVC and 
sub-chronic pollutant exposures (7 day averages) 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) β(95% CI) β(95% CI) β (95% CI) β (95% CI)
GSTM1
rs366631  C/T
CT 482 Reference Reference Reference Reference
TT 383 0.0006[-0.0010,0.0021] 0.0009[-0.0034,0.0052] -0.0015[-0.0062,0.0031] -0.0015[-0.0082,0.0053]
GSTP1
 rs749174   Intron 5 C/T
CC 455 Reference Reference Reference Reference
CT 340 -0.0005[-0.0020,0.0011] -0.0019[-0.0062,0.0024] -0.0027[-0.0074,0.0020] -0.0033[-0.0103,0.0037]
TT 71 -0.0005[-0.0037,0.0027] -0.0010[-0.0093,0.0072] -0.0005[-0.0102,0.0093] -0.0057[-0.0193,0.0078]
CT + TT 411 -0.0005[-0.0020,0.0010] -0.0019[-0.0059,0.0022] -0.0025[-0.0070,0.0020] -0.0038[-0.0104,0.0029]
rs1695 Exon 5 Ile105Val 
Ile/Ile 379 Reference Reference Reference Reference
Ile/Val 371 0.0010[-0.0005,0.0026] 0.0018[-0.0026,0.0062] 0.0002[-0.0047,0.0050] 0.0014[-0.0058,0.0086]
Val/Val 115 0.0004[-0.0020,0.0027] 0.0015[-0.0048,0.0078] 0.0009[-0.0060,0.0078] -0.0009[-0.0109,0.0092]
Ile/Val + Val/Val 486 0.0009[-0.0006,0.0023] 0.0018[-0.0023,0.0058] 0.0004[-0.0040,0.0048] 0.0008[-0.0057,0.0074]
NQO1
rs2917666 3  ´UTR (C/G)
CC 231 Reference Reference Reference Reference
CG 424 0.0006[-0.0011,0.0023] 0.0013[-0.0035,0.0060] 0.0046#[-0.0006,0.0097] 0.0064#[-0.0011,0.0140]
GG 211 0.0006[-0.0014,0.0025] 0.0011[-0.0044,0.0066] -0.0001[-0.0061,0.0059] 1.48E-06[-0.0090,0.0090]
CG + GG 635 0.0006[-0.0009,0.0021] 0.0012[-0.0031,0.0055] 0.0029[-0.0018,0.0075] 0.0042[-0.0027,0.0112]
rs689453 Exon 2 Glu24 (G/A)
GG 799 Reference Reference Reference Reference
GA 65 -0.0012[-0.0040,0.0017] -0.0024[-0.0099,0.0051] 0.0015[-0.0077,0.0106] 0.0001[-0.0125,0.0127]
AA 2 -0.0546[-0.1784,0.0692] -0.1405[-0.4569,0.1760] 0.0403[-0.0505,0.1312] 0.0371[-0.0473,0.1214]
GA + AA 67 -0.0011[-0.0039,0.0017] -0.0022[-0.0097,0.0052] 0.0016[-0.0074,0.0106] 0.0009[-0.0115,0.0133]
rs1800566 Exon 6 Pro187Ser 
Pro/Pro 505 Reference Reference Reference Reference
Pro/Ser 311 -0.0001[-0.0017,0.0015] -0.0003[-0.0047,0.0042] -0.0008[-0.0056,0.0040] -0.0020[-0.0091,0.0050]
Ser/Ser 50 -0.0007[-0.0040,0.0026] -0.0040[-0.0128,0.0049] -0.0022[-0.0137,0.0093] 0.0011[-0.0156,0.0179]
Pro/Ser + Ser/Ser 361 -0.0002[-0.0017,0.0013] -0.0009[-0.0051,0.0032] -0.0009[-0.0055,0.0037] -0.0016[-0.0084,0.0051]
rs10517 3  ´UTR (C/T)
CC 584 Reference Reference Reference Reference
CT 257 0.0007[-0.0010,0.0023] 0.0015[-0.0031,0.0062] 0.0038[-0.0016,0.0092] 0.0052[-0.0026,0.0131]
TT 24 0.0009[-0.0042,0.0061] 0.0023[-0.0123,0.0168] 0.0089[-0.0033,0.0212] 0.0135[-0.0044,0.0314]




Table I8: Effects of GSTM1, GSTP1 and NQO1 genotypes on the association between FVC and 
sub-chronic pollutant exposures (7 day averages) 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) β(95% CI) β(95% CI) β (95% CI) β (95% CI)
GSTM1
rs366631  C/T
CT 466 Reference Reference Reference Reference
TT 370 0.0010[-0.0008,0.0028] 0.0019[-0.0031,0.0069] -0.0013[-0.0068,0.0042] -0.0007[-0.0087,0.0073]
GSTP1
 rs749174   Intron 5 C/T
CC 438 Reference Reference Reference Reference
CT 330 -0.0002[-0.0019,0.0016] -0.0017[-0.0066,0.0033] -0.0016[-0.0071,0.0039] -0.0033[-0.0115,0.0050]
TT 69 -0.0018[-0.0056,0.0021] -0.0056[-0.0157,0.0045] -0.0039[-0.0151,0.0073] -0.0091[-0.0247,0.0064]
CT + TT 399 -0.0004[-0.0021,0.0013] -0.0022[-0.0069,0.0025] -0.002[-0.0072,0.0033] -0.0042[-0.0120,0.0036]
rs1695 Exon 5 Ile105Val 
Ile/Ile 364 Reference Reference Reference Reference
Ile/Val 361 0.0008[-0.0010,0.0026] 0.0006[-0.0044,0.0056] 0.0020[-0.0038,0.0077] 0.0026[-0.0058,0.0111]
Val/Val 111 0.0006[-0.0021,0.0033] 0.0022[-0.0052,0.0096] 0.0001[-0.0078,0.0080] -0.0022[-0.0137,0.0094]
Ile/Val + Val/Val 472 0.0008[-0.0009,0.0024] 0.001[-0.0037,0.0057] 0.0015[-0.0037,0.0067] 0.0014[-0.0063,0.0090]
NQO1
rs2917666 3  ´UTR (C/G)
CC 220 Reference Reference Reference Reference
CG 411 0.0013[-0.0007,0.0032] 0.0037[-0.0018,0.0091] 0.0083**[0.0024,0.0143] 0.0123**[0.0035,0.0211]
GG 206 0.0010[-0.0013,0.0032] 0.0021[-0.0042,0.0084] 0.0038[-0.0033,0.0109] 0.0075[-0.0032,0.0181]
CG + GG 617 0.0012[-0.0005,0.0029] 0.0032[-0.0017,0.0082] 0.0067*[0.0013,0.0121] 0.0107**[0.0026,0.0188]
rs689453 Exon 2 Glu24 (G/A)
GG 774 Reference Reference Reference Reference
GA 61 -0.0009[-0.0042,0.0024] -0.0019[-0.0106,0.0068] 0.0028[-0.0076,0.0132] 0.0037[-0.0109,0.0182]
AA 2 -0.0323[-0.1732,0.1086] -0.0839[-0.4444,0.2766] 0.0257[-0.0775,0.1290] 0.0243[-0.0715,0.1202]
GA + AA 63 -0.0009[-0.0042,0.0024] -0.0018[-0.0104,0.0068] 0.0031[-0.0072,0.0133] 0.0042[-0.0101,0.0185]
rs1800566 Exon 6 Pro187Ser 
Pro/Pro 487 Reference Reference Reference Reference
Pro/Ser 302 -0.0004[-0.0023,0.0014] -0.0010[-0.0061,0.0042] 0.0007[-0.0049,0.0064] -0.0002[-0.0085,0.0081]
Ser/Ser 48 -0.0003[-0.0040,0.0035] -0.0027[-0.0129,0.0075] 0.0008[-0.0123,0.0140] 0.0070[-0.0124,0.0264]
Pro/Ser + Ser/Ser 350 -0.0004[-0.0022,0.0013] -0.0013[-0.0061,0.0035] 0.0008[-0.0046,0.0062] 0.0007[-0.0072,0.0086]
rs10517 3  ´UTR (C/T)
CC 562 Reference Reference Reference Reference
CT 252 0.0013[-0.0006,0.0032] 0.0030[-0.0024,0.0083] 0.0058#[-0.0004,0.0120] 0.0085#[-0.0006,0.0175]
TT 23 0.0006[-0.0057,0.0070] -0.0002[-0.0184,0.0180] 0.0107[-0.0036,0.0250] 0.0152[-0.0059,0.0364]




Table I9: Unadjusted and adjusted beta-coefficients (β) and 95% confidence intervals (95% CI) for the association between AhR 
genotypes and lung function 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for 
school. *p<0.5, **p<0.01, ***p<0.001. 
Genotype Unadjusted Adjusted Unadjusted Adjusted
(n=894) (n=862) (n=864) (n=834)
rs2074113  C/A
CC Reference Reference Reference Reference
CA -0.0201[-0.0614,0.0212] -0.0080[-0.0366,0.0206] -0.0202[-0.0686,0.0283] -0.0055[-0.0386,0.0275]
AA -0.0605[-0.1790,0.0580] -0.0089[-0.0913,0.0736] -0.0700[-0.2068,0.0667] -0.0040[-0.0976,0.0897]
CA+AA -0.0236[-0.0636,0.0164] -0.0083[-0.0359,0.0192] -0.0246[-0.0715,0.0223] -0.0059[-0.0377,0.0259]
 rs2066853 Exon 10 Arg554Lys (G/A)
Arg/Arg Reference Reference Reference Reference
Arg/Lys -0.0250[-0.0638,0.0138] -0.0069[-0.0347,0.0209] -0.0368[-0.0824,0.0088] -0.0066[-0.0388,0.0256]
Lys/Lys -0.1084**[-0.1777,-0.0390] -0.0471[-0.0972,0.0030] -0.1213**[-0.2017,-0.0410] -0.0391[-0.0963,0.0181]
Arg/Lys+Lys/Lys -0.0398*[-0.0765,-0.0031] -0.0131[-0.0397,0.0134] -0.0522*[-0.0953,-0.0091] -0.0119[-0.0426,0.0188]
 rs17722841  G/A
GG Reference Reference Reference Reference
GA 0.1028***[0.0504,0.1551] 0.0275[-0.0107,0.0658] 0.1149***[0.0533,0.1764] 0.0068[-0.0372,0.0509]
AA 0.0647[-0.1362,0.2656] 0.0355[-0.1026,0.1736] 0.0445[-0.1878,0.2767] -0.0033[-0.1603,0.1537]
GA+AA 0.1012***[0.0502,0.1523] 0.0281[-0.0090,0.0653] 0.1116***[0.0516,0.1715] 0.0067[-0.0361,0.0495]
rs17779352 T/C
TT Reference Reference Reference Reference
TC 0.0159[-0.0366,0.0684] -0.0006[-0.0372,0.0359] 0.0130[-0.0488,0.0748] 0.0008[-0.0415,0.0432]
CC 0.1695[-0.0491,0.3880] 0.0397[-0.1423,0.2216] 0.0990[-0.1770,0.3749] -0.0106[-0.2172,0.1960]
TC+CC 0.0229[-0.0285,0.0743] 0.0004[-0.0354,0.0361] 0.0164[-0.0443,0.0771] 0.0003[-0.0411,0.0417]
rs2282885 T/C
TT Reference Reference Reference Reference
TC 0.0685***[0.0291,0.1078] 0.0313*[0.0023,0.0604] 0.0816***[0.0355,0.1277] 0.0340*[0.0004,0.0675]
CC 0.0381[-0.0389,0.1152] 0.0116[-0.0435,0.0668] 0.0564[-0.0349,0.1477] -0.0042[-0.0686,0.0602]




Table I10: Unadjusted and adjusted beta-coefficients (β) and 95% confidence intervals (95% CI) for the association between 
CYP1A1 genotypes and lung function 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 





Genotype Unadjusted Adjusted Unadjusted Adjusted
(n=888) (n=856) (n=857) (n=827)
rs2606345 G/T
GG Reference Reference Reference Reference
GT Ŧ0.0691***[0.0290,0.1091] 0.0144[-0.0166,0.0454] 0.0762**[0.0293,0.1231] 0.0090[-0.0267,0.0448]
TT Ŧ0.0836***[0.0339,0.1333] -33.8e-06[-0.0409,0.0408] 0.1150***[0.0563,0.1737] -0.0010[-0.0487,0.0466]
GT+TT Ŧ0.0740***[0.0378,0.1102] 0.0107[-0.0189,0.0402] Ŧ0.0890***[0.0464,0.1316] 0.0065[-0.0276,0.0407]
 rs17861115 C/T
CC Reference Reference Reference Reference
CT -0.0529[-0.1074,0.0016] -0.0122[-0.0506,0.0262] -0.0687*[-0.1324,-0.0051] -0.0147[-0.0591,0.0296]
TT -0.0664[-0.2281,0.0953] ` -0.1211[-0.3072,0.0650] -0.0155[-0.1411,0.1101]
CT+TT -0.0544*[-0.1066,-0.0022] -0.0088[-0.0454,0.0278] -0.0738*[-0.1347,-0.0129] -0.0146[-0.0568,0.0275]
rs2198843 G/C
GG Reference Reference Reference Reference
GC -0.0466*[-0.0854,-0.0078] -0.0125[-0.0406,0.0156] Ŧ-0.0636**[-0.1092,-0.0181] -0.0146[-0.0471,0.0179]







Table I11: Effect modification of AhR genotypes on the association between FEV1 and acute pollutant exposures (24 hour) 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 
#p<0.1, *p<0.5. 
 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) β (95% CI) β (95% CI) β (95% CI) β (95% CI)
rs2074113  C/A
CC 624 Reference Reference Reference Reference
CA 218 -0.0003[-0.0010,0.0004] -0.0008[-0.0035,0.0020] -0.0011[-0.0043,0.0020] -0.0010[-0.0054,0.0035]
AA 20 -0.0005[-0.0034,0.0024] -0.0027[-0.0125,0.0072] -0.0034[-0.0132,0.0065] -0.0055[-0.0190,0.0081]
CA+AA 238 -0.0003[-0.0010,0.0003] -0.0009[-0.0036,0.0017] -0.0013[-0.0043,0.0017] -0.0013[-0.0056,0.0029]
 rs2066853 Exon 10 Arg554Lys (G/A)
Arg/Arg 516 Reference Reference Reference Reference
Arg/Lys 281 0.0003[-0.0003,0.0009] 0.0020[-0.0005,0.0045] 0.0007[-0.0022,0.0036] 0.0009[-0.0031,0.0050]
Lys/Lys 68 -0.0006[-0.0021,0.0008] -0.0021[-0.0067,0.0025] -0.0019[-0.0072,0.0034] -0.0032[-0.0112,0.0049]
Arg/Lys+Lys/Lys 349 0.0002[-0.0003,0.0008] 0.0013[-0.0010,0.0036] 0.0002[-0.0024,0.0029] 0.0003[-0.0035,0.0041]
 rs17722841  G/A
GG 742 Reference Reference Reference Reference
GA 116 -0.0001[-0.0009,0.0008] -0.0002[-0.0035,0.0031] 0.0013[-0.0026,0.0051] 0.0014[-0.0039,0.0068]
AA 7 0.0026*[0.0004,0.0048] 0.0119#[-0.0006,0.0245] 0.0130*[0.0014,0.0246] 0.0161*[0.0020,0.0302]
GA+AA 123 0.0002[-0.0006,0.0010] 0.0005[-0.0027,0.0037] 0.0022[-0.0014,0.0058] 0.0029[-0.0021,0.0079]
rs17779352 T/C
TT 746 Reference Reference Reference Reference
TC 115 -0.0004[-0.0012,0.0004] -0.0013[-0.0045,0.0019] -0.0013[-0.0052,0.0026] -0.0022[-0.0076,0.0031]
CC 4 0.0016[-0.0005,0.0038] 0.0085[-0.0025,0.0195] 0.0117[-0.0026,0.0261] 0.0128[-0.0035,0.0291]
TC+CC 119 -0.0002[-0.0009,0.0006] -0.0007[-0.0038,0.0025] -0.0004[-0.0041,0.0033] -0.0008[-0.0059,0.0043]
rs2282885 T/C
TT 547 Reference Reference Reference Reference
TC 264 -0.0002[-0.0008,0.0004] 0.0001[-0.0024,0.0026] 0.0014[-0.0016,0.0045] 0.0012[-0.0032,0.0056]
CC 51 -0.0003[-0.0011,0.0006] -0.0010[-0.0053,0.0034] 0.0003[-0.0042,0.0048] 0.0003[-0.0058,0.0063]
TC+CC 315 -0.0002[-0.0008,0.0003] -0.0001[-0.0024,0.0022] 0.001[-0.0017,0.0037] 0.0007[-0.0031,0.0045]
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Table I12: Effect modification of AhR genotypes on the association between FVC and acute pollutant exposures (24 hour) 
 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 
*p<0.5. 
 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) β (95% CI) β (95% CI) β (95% CI) β (95% CI)
rs2074113  C/A
CC 604 Reference Reference Reference Reference
CA 210 -0.0001[-0.0009,0.0006] 48.5E06[-0.0031,0.0032] 0.0006[-0.0031,0.0042] 0.0005[-0.0046,0.0056]
AA 20 -0.0011[-0.0044,0.0022] -0.0003[-0.0115,0.0108] -0.0002[-0.0114,0.0110] -0.0011[-0.0165,0.0142]
CA+AA 230 -0.0002[-0.0010,0.0006] -8.75E-06[-0.0031,0.0031] 0.0005[-0.0030,0.0040] 0.0004[-0.0046,0.0053]
 rs2066853 Exon 10 Arg554Lys (G/A)
Arg/Arg 498 Reference Reference Reference Reference
Arg/Lys 270 0.0006[-0.0001,0.0013] 0.0031*[0.0002,0.0059] 0.0027[-0.0006,0.0060] 0.0032[-0.0014,0.0079]
Lys/Lys 68 -0.0007[-0.0024,0.0009] -0.0021[-0.0073,0.0031] 0.0003[-0.0058,0.0063] 0.0003[-0.0089,0.0095]
Arg/Lys+Lys/Lys 338 0.0004[-0.0002,0.0011] 0.0022[-0.0005,0.0048] 0.0023[-0.0008,0.0053] 0.0028[-0.0016,0.0072]
 rs17722841  G/A
GG 717 Reference Reference Reference Reference
GA 113 0.0001[-0.0009,0.0011] -46.1E-06[-0.0039,0.0038] 0.0004[-0.0041,0.0049] 0.0008[-0.0054,0.0071]
AA 7 0.0013[-0.0012,0.0038] 0.0054[-0.0089,0.0198] 0.0075[-0.0057,0.0208] 0.0099[-0.0062,0.0260]
GA+AA 120 0.0002[-0.0007,0.0011] 0.0002[-0.0034,0.0039] 0.0009[-0.0033,0.0051] 0.0017[-0.0041,0.0074]
rs17779352 T/C
TT 722 Reference Reference Reference Reference
TC 110 -0.0003[-0.0012,0.0006] -0.0009[-0.0046,0.0029] -0.0012[-0.0056,0.0033] -0.0014[-0.0076,0.0047]
CC 4 0.0011[-0.0013,0.0036] 0.0057[-0.0069,0.0182] 0.0078[-0.0085,0.0241] 0.0094[-0.0092,0.0279]
TC+CC 114 -0.0001[-0.0010,0.0007] -0.0004[-0.0040,0.0032] -0.0007[-0.0049,0.0036] -0.0005[-0.0064,0.0053]
rs2282885 T/C
TT 528 Reference Reference Reference Reference
TC 257 -0.0001[-0.0008,0.0006] 0.0007[-0.0022,0.0035] 0.0011[-0.0023,0.0046] 0.0004[-0.0046,0.0055]
CC 48 -0.0001[-0.0013,0.0010] -0.0013[-0.0065,0.0040] 0.0003[-0.0052,0.0059] 0.0002[-0.0073,0.0077]
TC+CC 305 -0.0001[-0.0008,0.0005] 0.0002[-0.0024,0.0029] 0.0008[-0.0024,0.0039] 29.2E-06[-0.0044,0.0045]
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Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 
#p<0.1. Blank cells indicate non-converged data. 
 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) β (95% CI) β (95% CI) β (95% CI) β (95% CI)
rs2074113  C/A
CC 624 Reference Reference Reference Reference
CA 218 0.0002[-0.0013,0.0018] 0.0012[-0.0031,0.0056] -0.0008[-0.0056,0.0039] -0.0015[-0.0086,0.0055]
AA 20 0.0027[-0.0026,0.0079] 0.0091[-0.0043,0.0225] 0.0037[-0.0151,0.0225] 0.0016[-0.0245,0.0277]
CA+AA 238 0.0017[-0.0025,0.0059] -0.0006[-0.0053,0.0040] -0.0014[-0.0083,0.0055]
 rs2066853 Exon 10 Arg554Lys (G/A)
Arg/Arg 516 Reference Reference Reference Reference
Arg/Lys 281 0.0014#[-0.0002,0.0030] -0.0018[-0.0064,0.0029] -0.0036[-0.0106,0.0033]
Lys/Lys 68 0.0002[-0.0020,0.0024] 0.0014[-0.0076,0.0105] -0.0017[-0.0145,0.0111]
Arg/Lys+Lys/Lys 349 0.0029[-0.0012,0.0069] -0.0015[-0.0059,0.0029] -0.0035[-0.0101,0.0030]
 rs17722841  G/A
GG 742 Reference Reference Reference Reference
GA 116 -0.0025#[-0.0052,0.0001] -0.0050[-0.0119,0.0019] -0.0027[-0.0111,0.0057] -0.0078[-0.0196,0.0041]
AA 7 0.0048[-0.0023,0.0120] 0.0099[-0.0149,0.0347] 0.0146[-0.0149,0.0441] 0.0234[-0.0155,0.0623]
GA+AA 123 -0.0016[-0.0041,0.0009] -0.0039[-0.0105,0.0028] -0.0015[-0.0096,0.0066] -0.0052[-0.0164,0.0060]
rs17779352 T/C
TT 746 Reference Reference Reference Reference
TC 115 0.0002[-0.0021,0.0024] 0.0014[-0.0047,0.0074] 0.0009[-0.0080,0.0098]
CC 4 0.0093[-0.0024,0.0210] 0.0756[-0.0189,0.1702] 0.0633[-0.0160,0.1426]
TC+CC 119 0.0004[-0.0018,0.0026] 0.0017[-0.0044,0.0078] 0.0015[-0.0045,0.0074] 0.0013[-0.0075,0.0100]
rs2282885 T/C
TT 547 Reference Reference Reference Reference
TC 264 -0.0002[-0.0019,0.0015] 0.0010[-0.0040,0.0060] -0.0001[-0.0074,0.0072]
CC 51 0.0001[-0.0032,0.0034] 0.0056[-0.0068,0.0180] 0.0092[-0.0079,0.0264]
TC+CC 315 -0.0002[-0.0018,0.0014] 0.0005[-0.0039,0.0049] 0.0014[-0.0033,0.0062] 0.0009[-0.0060,0.0078]
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Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 
 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) β (95% CI) β (95% CI) β (95% CI) β (95% CI)
rs2074113  C/A
CC 604 Reference Reference Reference Reference
CA 210 0.0004[-0.0014,0.0022] 0.0017[-0.0033,0.0068] 0.0019[-0.0037,0.0074] 0.0031[-0.0052,0.0114]
AA 20 0.0012[-0.0047,0.0072] 0.0084[-0.0068,0.0236] 0.0051[-0.0163,0.0264] -0.0014[-0.0310,0.0283]
CA+AA 230 0.0004[-0.0013,0.0022] 0.0021[-0.0028,0.0070] 0.002[-0.0034,0.0074] 0.0029[-0.0052,0.0109]
 rs2066853 Exon 10 Arg554Lys (G/A)
Arg/Arg 498 Reference Reference Reference Reference
Arg/Lys 270 0.0015[-0.0003,0.0034] 0.0043[-0.0009,0.0095] 0.0008[-0.0047,0.0062] 0.0005[-0.0077,0.0087]
Lys/Lys 68 -0.0001[-0.0026,0.0024] 0.0002[-0.0068,0.0072] 0.0029[-0.0074,0.0132] -0.0003[-0.0150,0.0143]
Arg/Lys+Lys/Lys 338 0.0011[-0.0006,0.0027] 0.0031[-0.0016,0.0078] 0.0009[-0.0043,0.0061] 0.0001[-0.0075,0.0078]
 rs17722841  G/A
GG 717 Reference Reference Reference Reference
GA 113 -0.0014[-0.0045,0.0016] -0.0031[-0.0111,0.0049] -0.0035[-0.0133,0.0064] -0.0080[-0.0218,0.0058]
AA 7 0.0021[-0.0061,0.0102] 0.0017[-0.0266,0.0300] 0.0090[-0.0246,0.0425] 0.0161[-0.0281,0.0604]
GA+AA 120 -0.001[-0.0039,0.0019] -0.0025[-0.0102,0.0051] -0.0027[-0.0120,0.0067] -0.0061[-0.0191,0.0069]
rs17779352 T/C
TT 722 Reference Reference Reference Reference
TC 110 0.0008[-0.0018,0.0034] 0.0029[-0.0045,0.0103] 0.0005[-0.0067,0.0077] 0.0020[-0.0087,0.0127]
CC 4 0.0066[-0.0067,0.0199] 0.0180[-0.0270,0.0630] 0.0500[-0.0575,0.1575] 0.0446[-0.0454,0.1347]
TC+CC 114 0.001[-0.0015,0.0035] 0.0033[-0.0039,0.0104] 0.0007[-0.0064,0.0078] 0.0025[-0.0080,0.0130]
rs2282885 T/C
TT 528 Reference Reference Reference Reference
TC 257 0.0003[-0.0017,0.0022] 0.0021[-0.0034,0.0075] 0.0005[-0.0053,0.0062] -0.0012[-0.0096,0.0072]
CC 48 -0.0001[-0.0040,0.0039] -0.0036[-0.0148,0.0075] 0.0038[-0.0113,0.0188] 0.0050[-0.0156,0.0256]





Table I15: Effect modification of CYP1A1 genotypes on the association between FEV1 and acute pollutant exposures (24 hour) 
 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 




Genotype Subjects NOx NO2 PM10 PM2.5 
(n) β (95% CI) β (95% CI) β (95% CI) β (95% CI)
rs2606345 G/T
GG 391 Reference Reference Reference Reference
GT 319 -0.0003[-0.0010,0.0003] -0.0020[-0.0044,0.0005] -0.0014[-0.0044,0.0015] -0.0008[-0.0050,0.0035]
TT 156 -0.0006#[-0.0014,0.0001] -0.0029#[-0.0060,0.0002] -0.0026[-0.0061,0.0008] -0.0030[-0.0078,0.0018]
GT+TT 475 -0.0004[-0.0010,0.0001] -0.0023*[-0.0045,-16.1E-06] -0.0019[-0.0045,0.0008] -0.0017[-0.0054,0.0021]
 rs17861115 C/T
CC 749 Reference Reference Reference Reference
CT 106 -0.0003[-0.0011,0.0006] -0.0007[-0.0041,0.0027] -0.0028[-0.0070,0.0013] -0.0019[-0.0081,0.0042]
TT 11 -0.0080**[-0.0139,-0.0020] -0.0172#[-0.0347,0.0003] -0.0161#[-0.0348,0.0027] -0.0365*[-0.0683,-0.0047]
CT+TT 117 -0.0004[-0.0012,0.0004] -0.0035#[-0.0075,0.0006] -0.0032[-0.0092,0.0027]
rs2198843 G/C
GG 373 Reference Reference Reference Reference
GC 349 6.94E-06[-0.0006,0.0006] 0.0003[-0.0021,0.0027] -0.0003[-0.0031,0.0025] -0.0001[-0.0041,0.0040]
CC 144 0.0013*[0.0003,0.0023] 0.0048**[0.0012,0.0085] 0.0035#[-0.0006,0.0075] 0.0042[-0.0014,0.0098]





Table I16: Effect modification of CYP1A1 genotypes on the association between FVC and acute pollutant exposures (24 hour) 
 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 





Genotype Subjects NOx NO2 PM10 PM2.5 
(n) β (95% CI) β (95% CI) β (95% CI) β (95% CI)
rs2606345 G/T
GG 380 Reference Reference Reference Reference
GT 310 -0.0007#[-0.0014,37.6E-06] -0.0033*[-0.0062,-0.0005] -0.0034#[-0.0068,19.4E-06] -0.0033[-0.0082,0.0016]
TT 147 -0.0006[-0.0015,0.0003] -0.0028[-0.0064,0.0008] -0.0027[-0.0068,0.0014] -0.0037[-0.0094,0.0019]
GT+TT 457 -0.0007*[-0.0013,-9.29E-06] -0.0032*[-0.0057,-0.0006] -0.0031*[-0.0061,-0.0001] -0.0035[-0.0078,0.0009]
 rs17861115 C/T
CC 723 Reference Reference Reference Reference
CT 103 -49.2E-06[-0.0010,0.0009] -0.0002[-0.0041,0.0038] -0.0012[-0.0060,0.0036] 0.0003[-0.0068,0.0073]
TT 11 -0.0080*[-0.0148,-0.0012] -0.0155[-0.0354,0.0044] -0.0100[-0.0313,0.0114] -0.0298[-0.0660,0.0064]
CT+TT 114 -0.0002[-0.0011,0.0008] -0.0007[-0.0045,0.0032] -0.0016[-0.0062,0.0030] -0.0007[-0.0076,0.0061]
rs2198843 G/C
GG 354 Reference Reference Reference Reference
GC 340 -34.1E-06[-0.0007,0.0006] -0.0005[-0.0032,0.0023] -0.0005[-0.0037,0.0028] 0.0007[-0.0040,0.0053]
CC 143 Ŧ0.0018**[0.0006,0.0030] Ŧ0.0066**[0.0024,0.0107] 0.0055*[0.0008,0.0101] 0.0067*[0.0003,0.0131]










Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 




Genotype Subjects NOx NO2 PM10 PM2.5 
(n) β (95% CI) β (95% CI) β (95% CI) β (95% CI)
rs2606345 G/T
GG 391 Reference Reference Reference Reference
GT 319 -0.0023**[-0.0039,-0.0008] -0.0070**[-0.0117,-0.0023] -0.0086*[-0.0157,-0.0015]
TT 156 0.0001[-0.0022,0.0023] 0.0026[-0.0056,0.0108] 0.0029[-0.0081,0.0139]
GT+TT 475 -0.0018*[-0.0033,-0.0003] -0.0051*[-0.0091,-0.0010] -0.0052*[-0.0097,-0.0008] -0.0061#[-0.0126,0.0004]
 rs17861115 C/T
CC 749 Reference Reference Reference Reference
CT 106 0.0003[-0.0019,0.0026] 0.0001[-0.0072,0.0074] 0.0034[-0.0071,0.0139]
TT 11 -0.0017[-0.0108,0.0074] -0.0090[-0.0595,0.0414] -0.0093[-0.0723,0.0536]
CT+TT 117 0.0002[-0.0020,0.0024] 0.0008[-0.0051,0.0067] -0.0001[-0.0073,0.0071] 0.003[-0.0073,0.0133]
rs2198843 G/C
GG 373 Reference Reference Reference
GC 349 0.0008[-0.0008,0.0023] 0.0018[-0.0032,0.0068] 0.003[-0.0044,0.0104]
CC 144 0.0037**[0.0014,0.0061] 0.0055#[-0.0008,0.0118] 0.0071[-0.0020,0.0162]









Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for 
school.#p<0.1, *p<0.05, **p<0.01, ***p<0.001. Significant after the multiple testing procedures has been applied. 
 
  
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) β (95% CI) β (95% CI) β (95% CI) β (95% CI)
rs2606345 G/T
GG 380 Reference Reference Reference Reference
GT 310 Ŧ-0.0029**[-0.0047,-0.0012] Ŧ-0.0085***[-0.0135,-0.0035] -0.0092**[-0.0148,-0.0036] -0.0119**[-0.0203,-0.0035]
TT 147 -0.0007[-0.0033,0.0020] -0.0026[-0.0100,0.0047] 0.0011[-0.0084,0.0107] 0.0016[-0.0113,0.0144]
GT+TT 457 Ŧ-0.0024**[-0.0041,-0.0008] Ŧ-0.0072**[-0.0118,-0.0025] -0.0072**[-0.0124,-0.0020] -0.0088*[-0.0164,-0.0011]
 rs17861115 C/T
CC 723 Reference Reference Reference Reference
CT 103 0.0009[-0.0017,0.0035] 0.0022[-0.0051,0.0094] 0.0045[-0.0047,0.0137] 0.0109[-0.0023,0.0240]
TT 11 -0.0032[-0.0136,0.0072] -0.0087[-0.0344,0.0170] -0.0143[-0.0717,0.0430] -0.0275[-0.0990,0.0439]
CT+TT 114 0.0007[-0.0018,0.0032] 0.0014[-0.0055,0.0084] 0.004[-0.0050,0.0130] 0.0097[-0.0031,0.0226]
rs2198843 G/C
GG 354 Reference Reference Reference Reference
GC 340 0.0007[-0.0010,0.0025] 0.0035[-0.0016,0.0086] 0.0052#[-0.0007,0.0110] 0.0075#[-0.0013,0.0162]
CC 143 Ŧ0.0052***[0.0026,0.0079] Ŧ0.0140***[0.0071,0.0210] 0.0094*[0.0022,0.0166] 0.0120*[0.0016,0.0224]










Table J1: Hardy-Weinberg equilibrium (HWE) p-values for SNPs in Nrf2, GCLM and SOD3 




Table K1 shows the Hardy-Weinberg equilibrium p-values for SNPs Nrf2, GCLM and SOD3 
genes for total population and stratified by ethnicity. Overall, all the SNPs have p-value >0.05 
except for one SNP in SOD3, rs2284659 which was not in HW for either in total population or 





Genes/SNP ID Total Population Asian Black White Others
rs2364723 3.00E-04 0.06 0.44 0.88 0.84
rs7557529 0.20 0.50 1.00 0.33 0.05
rs2001350 0.43 0.61 0.78 0.33 0.25
rs2301022 0.02 0.13 0.52 0.18 0.16
rs3170633 2.96E-08 0.37 0.45 1.00 0.18
Ŧrs2284659 1.45E-08 0.39 0.001 0.52 0.57
rs8192287 0.54 0.20 0.90 0.05 1.00
rs699473 0.004 0.52 0.74 0.51 0.57
rs13306703 0.07 1.00 0.73 2.99E-04 0.30






Table J2: Linkage disequilibrium (D’ values >0.7 highlight in bold text for selected 
SNPs within Nrf2, GCLM and SOD3. Based on data from the 1000 genomes study: 
intergrated phase 1, version 3 (March 2012). Calculated using the linkage 
disequilibrium calculator, caprica.genetics.kcl.ac.uk. 
Nrf2 Nrf2 Nrf2
rs2364723 rs7557529 rs2001350
Nrf2 rs2364723 - 0.983 0.960




GCLM rs2301022 - 0.661
GCLM rs3170633 -
EC-SOD EC-SOD EC-SOD EC-SOD EC-SOD EC-SOD 
rs2284659 rs8192287 rs699473 rs8192290 rs13306703 rs8192288
EC-SOD rs2284659 - -1.000 0.988 -0.945 -1.000 -1.000
EC-SOD rs8192287 - -1.000 -1.000 0.972 -1.000
EC-SOD rs699473 - -0.946 -1.000 -1.000
EC-SOD rs8192290 - 0.885 -1.000































n % n % n % n % n %
rs2364723 G/C
GG 77 0.22 154 0.62 137 0.52 45 0.39 413 0.42
GC 154 0.44 85 0.34 107 0.40 55 0.48 401 0.41
CC 116 0.33 8 0.03 22 0.08 14 0.12 160 0.16
Allele G 308 0.44 393 0.80 381 0.72 145 0.64 1227 0.63
Alelle C 386 0.56 101 0.20 151 0.28 83 0.36 721 0.37
rs7557529 T/C
TT 187 0.54 85 0.35 70 0.26 39 0.34 381 0.39
TC 131 0.38 119 0.49 125 0.47 64 0.56 439 0.45
CC 28 0.08 41 0.17 71 0.27 11 0.10 151 0.16
Allele T 505 0.73 289 0.59 265 0.50 142 0.62 1201 0.62
Allele C 187 0.27 201 0.41 267 0.50 86 0.38 741 0.38
rs2001350 A/G
AA 268 0.77 187 0.76 209 0.79 92 0.81 756 0.78
AG 72 0.21 57 0.23 56 0.21 22 0.19 207 0.21
GG 6 0.02 3 0.01 1 0.00 0 0.00 10 0.01
Allele A 608 0.88 431 0.87 474 0.89 206 0.90 1719 0.88
Allele G 84 0.12 63 0.13 58 0.11 22 0.10 227 0.12
rs2301022 G/A
GG 169 0.49 57 0.23 127 0.48 48 0.42 401 0.41
GA 136 0.39 118 0.48 120 0.45 46 0.40 420 0.43
AA 40 0.12 72 0.29 18 0.07 20 0.18 150 0.15
Allele G 474 0.69 232 0.47 374 0.71 142 0.62 1222 0.63
Allele A 216 0.31 262 0.53 156 0.29 86 0.38 720 0.37
rs3170633 G/A
GG 227 0.65 25 0.10 107 0.40 44 0.39 403 0.41
GA 111 0.32 98 0.40 123 0.46 48 0.42 380 0.39
AA 9 0.03 124 0.50 35 0.13 22 0.19 190 0.20
Allele G 565 0.81 148 0.30 337 0.64 136 0.60 1186 0.61






Minor allele for this ethnicity is different with other ethnicities for the particular SNP.
Genotype distribution for this ethnicity are not similar with other ethnicity group despite sharing same major/minor allele.
Similar genotype/allele frequencies within the block for the particular SNP but not in all ethnicity.
Similar genotype/allele frequencies within the block for the particular SNP but not in all ethnicity.
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Table J4: Distribution of genotypes and allele frequencies in extra-cellular superoxide 










n % n % n % n % n %
rs8192287 G/T
GG 247 0.72 241 0.98 230 0.86 92 0.81 810 0.84
GT 94 0.27 4 0.02 32 0.12 21 0.18 151 0.16
TT 4 0.01 0 0.00 4 0.02 1 0.01 9 0.01
Allele G 588 0.85 486 0.99 492 0.92 205 0.90 1771 0.91
Allele T 102 0.15 4 0.01 40 0.08 23 0.10 169 0.09
rs699473 C/T
CC 91 0.26 139 0.56 40 0.15 30 0.26 300 0.31
CT 167 0.48 91 0.37 119 0.45 61 0.54 438 0.45
TT 88 0.25 17 0.07 106 0.40 23 0.20 234 0.24
Allele C 349 0.50 369 0.75 199 0.38 121 0.53 1038 0.53
Allele T 343 0.50 125 0.25 331 0.62 107 0.47 906 0.47
rs13306703 C/T
CC 213 0.62 141 0.57 217 0.82 82 0.73 653 0.67
CT 117 0.34 93 0.38 39 0.15 27 0.24 276 0.28
TT 15 0.04 13 0.05 10 0.04 4 0.04 42 0.04
Allele C 543 0.79 375 0.76 473 0.89 191 0.85 1582 0.81
Allele T 147 0.21 119 0.24 59 0.11 35 0.15 360 0.19
rs8192288 G/T
GG 249 0.72 243 0.98 229 0.86 91 0.80 812 0.83
GT 94 0.27 4 0.02 33 0.12 22 0.19 153 0.16
TT 4 0.01 0 0.00 4 0.02 1 0.01 9 0.01
Allele G 592 0.85 490 0.99 491 0.92 204 0.89 1777 0.91
Allele T 102 0.15 4 0.01 41 0.08 24 0.11 171 0.09
PopulationAsian OthersWhiteBlack
Ethnicity Total
Minor allele for this ethnicity is different with other ethnicities for the particular SNP.
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Table J5: Effect modification of Nrf2 and GCLM Genotypes on the association between 8-isoprostane and acute pollutant exposure (24 hour) 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school.  *p<0.05, 
**p<0.01. Ŧ Significant after the multiple testing procedures has been applied. 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs2364723 G/C
GG 394 Reference Reference Reference Reference
GC 382 1.0017**[1.0005,1.0029] 1.0058*[1.0008,1.0109] 1.0072*[1.0015,1.0130] 1.0092*[1.0010,1.0175]
CC 155 1.0004[0.9985,1.0022] 1.0029[0.9961,1.0098] 1.0065[0.9982,1.0148] 1.0082[0.9959,1.0206]
GC+CC 537 1.0014*[1.0002,1.0025] 1.0050*[1.0003,1.0096] 1.0071**[1.0017,1.0125] 1.0090*[1.0013,1.0167]
rs7557529 T/C
TT 358 Reference Reference Reference Reference
TC 426 1.001[0.9996,1.0023] 1.003[0.9979,1.0081] 1.0027[0.9968,1.0087] 1.0043[0.9956,1.0131]
CC 145 0.9993[0.9976,1.0009] 0.9975[0.9909,1.0042] 0.9981[0.9904,1.0058] 0.9971[0.9860,1.0082]
TC+CC 571 1.0005[0.9992,1.0018] 1.0015[0.9967,1.0063] 1.0014[0.9958,1.0071] 1.0023[0.9941,1.0106]
rs2001350 A/G
AA 721 Reference Reference Reference Reference
AG 200 0.9992[0.9979,1.0005] 0.9975[0.9921,1.0030] 0.9974[0.9913,1.0036] 0.9938[0.9851,1.0026]
GG 10 1.0012[0.9931,1.0093] 1.001[0.9741,1.0287] 1.0084[0.9721,1.0460] 1.0226[0.9603,1.0889]
AG+GG 210 0.9993[0.9980,1.0005] 0.9977[0.9924,1.0031] 0.9977[0.9916,1.0038] 0.9943[0.9857,1.0030]
rs2301022 G/A
GG 384 Reference Reference Reference Reference
GA 403 1.0009[0.9997,1.0021] 1.0019[0.9969,1.0069] 1.0043[0.9986,1.0099] 1.0062[0.9981,1.0144]
AA 141 0.9994[0.9974,1.0013] 0.9983[0.9913,1.0054] 0.9975[0.9890,1.0061] 0.9942[0.9815,1.0070]
GA+AA 544 1.0006[0.9995,1.0018] 1.001[0.9964,1.0057] 1.0028[0.9974,1.0082] 1.0038[0.9961,1.0115]
rs3170633 G/A
GG 386 Reference Reference Reference Reference
GA 360 0.9991[0.9978,1.0004] 0.9965[0.9914,1.0017] 0.9933*[0.9873,0.9992] 0.9913*[0.9827,0.9999]
AA 184 1.0009[0.9994,1.0024] 1.0026[0.9965,1.0089] 0.9953[0.9883,1.0023] 0.9948[0.9847,1.0050]





















Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school.  
#p<0.1, *p<0.05, **p<0.01.  
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs2364723 G/C
GG 374 Reference Reference Reference Reference
GC 366 1.0018#[0.9998,1.0039] 1.0109*[1.0024,1.0194] 1.0129**[1.0032,1.0226] 1.0168*[1.0028,1.0310]
CC 145 1.001[0.9980,1.0041] 1.0042[0.9927,1.0158] 1.0063[0.9925,1.0203] 1.0111[0.9900,1.0327]
GC+CC 511 1.0016#[0.9997,1.0035] 1.0090*[1.0012,1.0168] 1.0113*[1.0023,1.0204] 1.0156*[1.0024,1.0290]
rs7557529 T/C
TT 340 Reference Reference Reference Reference
TC 406 1.0016[0.9994,1.0038] 1.0096*[1.0010,1.0182] 1.0118*[1.0018,1.0218] 1.0135#[0.9987,1.0286]
CC 138 0.9983[0.9955,1.0010] 0.9918[0.9808,1.0029] 0.9939[0.9812,1.0067] 0.9881[0.9698,1.0067]
TC+CC 544 1.0007[0.9986,1.0028] 1.0046[0.9965,1.0127] 1.0065[0.9971,1.0160] 1.0061[0.9920,1.0203]
rs2001350 A/G
AA 684 Reference Reference Reference Reference
AG 191 1.0012[0.9990,1.0033] 1.0085#[0.9994,1.0176] 1.0087#[0.9985,1.0191] 1.01[0.9953,1.0249]
GG 10 1.0036[0.9904,1.0170] 1.0148[0.9706,1.0609] 0.9882[0.9312,1.0487] 0.9879[0.8925,1.0936]
AG+GG 201 1.001[0.9989,1.0032] 1.0077#[0.9988,1.0167] 1.0075[0.9973,1.0178] 1.0086[0.9939,1.0234]
rs2301022 G/A
GG 360 Reference Reference Reference Reference
GA 385 1.0003[0.9983,1.0023] 1.0013[0.9930,1.0097] 1.0026[0.9932,1.0121] 1.0047[0.9910,1.0186]
AA 137 0.9995[0.9963,1.0027] 1.0001[0.9884,1.0120] 1.0029[0.9887,1.0173] 1.0058[0.9842,1.0278]
GA+AA 522 1.0002[0.9983,1.0021] 1.0012[0.9934,1.0090] 1.0027[0.9938,1.0118] 1.0051[0.9921,1.0183]
rs3170633 G/A
GG 366 Reference Reference Reference Reference
GA 347 0.9994[0.9973,1.0016] 0.9975[0.9888,1.0062] 1.0016[0.9916,1.0117] 1.0001[0.9856,1.0147]
AA 171 0.9995[0.9970,1.0021] 0.9988[0.9884,1.0093] 1.0052[0.9933,1.0173] 1.0027[0.9851,1.0206]






Table J7: Effect modification of SOD3 Genotypes on the association between 8-isoprostane and acute pollutant exposure (24hour) 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. *p<0.05. 
**p<0.01. 
 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs8192287 G/T
GG 773 Reference Reference Reference Reference
GT 145 0.9997[0.9980,1.0013] 0.9987[0.9924,1.0051] 0.9991[0.9919,1.0063] 0.9994[0.9887,1.0103]
TT 9 1.0115#[0.9980,1.0251] 1.0286#[0.9978,1.0604] 1.0343[0.9605,1.1139] 1.0629[0.9504,1.1888]
GT+TT 154 0.9998[0.9982,1.0015] 0.9998[0.9935,1.0061] 0.9995[0.9924,1.0067] 1.0002[0.9895,1.0110]
rs699473 C/T
CC 291 Reference Reference Reference Reference
CT 418 1.0004[0.9991,1.0018] 1.0009[0.9954,1.0064] 1.0021[0.9958,1.0084] 1.0025[0.9935,1.0115]
TT 220 1.0009[0.9994,1.0023] 1.0016[0.9955,1.0078] 1.002[0.9951,1.0090] 1.003[0.9932,1.0128]
CT+TT 638 1.0006[0.9994,1.0019] 1.0012[0.9962,1.0063] 1.002[0.9964,1.0077] 1.0027[0.9947,1.0108]
rs13306703 C/T
CC 622 Reference Reference Reference Reference
CT 267 0.9999[0.9985,1.0012] 0.9999[0.9946,1.0052] 1.0017[0.9958,1.0076] 1.0021[0.9936,1.0107]
TT 40 0.9982[0.9952,1.0012] 0.9965[0.9851,1.0081] 0.9875#[0.9729,1.0023] 0.9839[0.9642,1.0041]
CT+TT 307 0.9996[0.9983,1.0009] 0.9993[0.9943,1.0044] 1.0001[0.9944,1.0058] 0.9998[0.9917,1.0080]
rs8192288 G/T
GG 775 Reference Reference Reference Reference
GT 147 0.9998[0.9982,1.0014] 0.999[0.9927,1.0054] 0.9992[0.9920,1.0064] 1.0002[0.9895,1.0109]
TT 9 1.0116#[0.9981,1.0252] 1.0288#[0.9980,1.0605] 1.0343[0.9606,1.1138] 1.0629[0.9506,1.1885]
GT+TT 156 1[0.9983,1.0016] 1.0001[0.9938,1.0063] 0.9996[0.9925,1.0068] 1.001[0.9903,1.0117]
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Table J8: Effect modification of SOD3 Genotypes on association between 8-oxodG and acute pollutant exposure (24hour) 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school.                         
#p<o.1, *p<0.05, **p<0.01. 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs8192287 G/T
GG 734 Reference Reference Reference Reference
GT 138 1.0009[0.9981,1.0036] 1.0046[0.9939,1.0154] 1.0032[0.9912,1.0153] 1.0096[0.9911,1.0283]
TT 9 1.0001[0.9784,1.0223] 0.9948[0.9464,1.0457] 0.911[0.8076,1.0275] 0.8592[0.7169,1.0297]
GT+TT 147 1.0009[0.9981,1.0036] 1.0043[0.9938,1.0149] 1.0023[0.9904,1.0144] 1.008[0.9897,1.0266]
rs699473 C/T
CC 276 Reference Reference Reference Reference
CT 398 0.9982[0.9959,1.0005] 0.9939[0.9848,1.0030] 0.9914[0.9810,1.0018] 0.9872[0.9721,1.0025]
TT 209 0.9975*[0.9951,1.0000] 0.9884*[0.9783,0.9986] 0.9865*[0.9752,0.9979] 0.9812*[0.9651,0.9974]
CT+TT 607 0.9979*[0.9959,1.0000] 0.9918#[0.9835,1.0002] 0.9895*[0.9801,0.9989] 0.9848*[0.9713,0.9985]
rs13306703 C/T
CC 587 Reference Reference Reference Reference
CT 255 1.0018[0.9995,1.0041] 1.0084#[0.9996,1.0173] 1.0053[0.9954,1.0153] 1.0118[0.9972,1.0266]
TT 40 0.9974[0.9926,1.0023] 0.9853[0.9669,1.0041] 0.996[0.9721,1.0206] 0.9905[0.9584,1.0236]
CT+TT 295 1.0011[0.9990,1.0033] 1.0049[0.9966,1.0134] 1.0042[0.9947,1.0138] 1.0088[0.9949,1.0229]
rs8192288 G/T
GG 737 Reference Reference Reference Reference
GT 139 1.001[0.9983,1.0037] 1.005[0.9943,1.0157] 1.0033[0.9914,1.0154] 1.0101[0.9918,1.0288]
TT 9 1.0003[0.9786,1.0224] 0.9951[0.9467,1.0460] 0.9115[0.8081,1.0281] 0.8606[0.7182,1.0312]
GT+TT 148 1.001[0.9982,1.0037] 1.0046[0.9942,1.0152] 1.0025[0.9906,1.0145] 1.0086[0.9904,1.0271]
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Table J9: Effect modification of Nrf2 and GCLM genotypes on the association between 8-isoprostane and sub-chronic pollutant 
exposure (7 day averages) 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school.                        
#p<0.1, *p<0.05, **p<0.01.  Ŧ Significant after the multiple testing procedures has been applied. 
Ŧ
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs2364723 G/C
GG 394 Reference Reference Reference Reference
GC 382 1.0013[0.9979,1.0046] 1.0019[0.9928,1.0112] 1.0087[0.9979,1.0197] 1.0119[0.9959,1.0282]
CC 155 0.9976[0.9936,1.0018] 0.9941[0.9824,1.0060] 1.0056[0.9931,1.0183] 1.0095[0.9911,1.0281]
GC+CC 537 1.0001[0.9970,1.0031] 0.9996[0.9912,1.0080] 1.0077[0.9976,1.0179] 1.0111[0.9963,1.0261]
rs7557529 T/C
TT 358 Reference Reference Reference Reference
TC 426 1.0049**[1.0015,1.0082] Ŧ1.0151**[1.0058,1.0246] 1.0037[0.9938,1.0137] 1.0059[0.9913,1.0208]
CC 145 1.0018[0.9978,1.0058] 1.007[0.9955,1.0186] 0.9995[0.9852,1.0140] 0.9973[0.9763,1.0187]
TC+CC 571 1.0038*[1.0008,1.0068] 1.0125**[1.0040,1.0210] 1.0026[0.9935,1.0118] 1.0038[0.9902,1.0175]
rs2001350 A/G
AA 721 Reference Reference Reference Reference
AG 200 1[0.9962,1.0038] 1.0041[0.9934,1.0150] 1.0068[0.9960,1.0177] 1.0085[0.9923,1.0250]
GG 10 1.001[0.9852,1.0171] 0.9978[0.9552,1.0423] 0.9947[0.9655,1.0248] 0.9921[0.9496,1.0366]
AG+GG 210 1.0001[0.9964,1.0038] 1.0039[0.9934,1.0145] 1.0057[0.9953,1.0162] 1.0069[0.9913,1.0227]
rs2301022 G/A
GG 384 Reference Reference Reference Reference
GA 403 1.0021[0.9988,1.0054] 1.0046[0.9954,1.0139] 1.002[0.9924,1.0117] 1.0005[0.9862,1.0150]
AA 141 1.0006[0.9960,1.0052] 1.0019[0.9898,1.0142] 0.9846[0.9692,1.0002] 0.9824[0.9598,1.0055]
GA+AA 544 1.0017[0.9987,1.0048] 1.0038[0.9953,1.0124] 0.9987[0.9896,1.0079] 0.9971[0.9835,1.0108]
rs3170633 G/A
GG 386 Reference Reference Reference Reference
GA 360 0.9987[0.9953,1.0022] 0.9963[0.9866,1.0060] 0.9863**[0.9767,0.9959] 0.9774**[0.9632,0.9917]
AA 184 1.0022[0.9982,1.0061] 1.0052[0.9942,1.0163] 0.9866#[0.9729,1.0005] 0.9800*[0.9604,1.0000]





Table J10: Effect modification of Nrf2 and GCLM genotypes on the association between 8-oxodG and sub-chronic pollutant exposure (7 
day averages) 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 
#p<0.1, *p<0.05,**p<0.01.  Ŧ  Significant after the multiple testing procedures has been applied. 
Ŧ
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs2364723 G/C
GG 374 Reference Reference Reference Reference
GC 366 1.005#[0.9996,1.0105] 1.0184*[1.0031,1.0340] 1.0302**[1.0114,1.0493] 1.0318*[1.0041,1.0604]
CC 145 1.0029[0.9956,1.0101] 1.0105[0.9898,1.0315] 1.0212[0.9974,1.0456] 1.022[0.9873,1.0578]
GC+CC 511 1.0044#[0.9994,1.0095] 1.0163*[1.0022,1.0306] Ŧ1.0279**[1.0100,1.0460] 1.0290*[1.0029,1.0559]
rs7557529 T/C
TT 340 Reference Reference Reference Reference
TC 406 1.0041[0.9985,1.0097] 1.0169*[1.0013,1.0327] 1.0088[0.9913,1.0266] 1.0058[0.9800,1.0324]
CC 138 0.9969[0.9902,1.0036] 0.9909[0.9721,1.0101] 0.9787#[0.9552,1.0028] 0.9746[0.9403,1.0102]
TC+CC 544 1.0017[0.9966,1.0068] 1.0089[0.9947,1.0233] 1.0007[0.9846,1.0171] 0.9982[0.9743,1.0226]
rs2001350 A/G
AA 684 Reference Reference Reference Reference
AG 191 1.0006[0.9943,1.0069] 1.0133[0.9955,1.0315] 1.0014[0.9829,1.0201] 0.9989[0.9713,1.0273]
GG 10 0.9926[0.9672,1.0187] 0.9797[0.9126,1.0518] 0.9672[0.9209,1.0158] 0.9571[0.8906,1.0286]
AG+GG 201 0.9998[0.9937,1.0059] 1.0105[0.9931,1.0282] 0.9976[0.9799,1.0157] 0.9939[0.9674,1.0211]
rs2301022 G/A
GG 360 Reference Reference Reference Reference
GA 385 1.0005[0.9951,1.0060] 0.9996[0.9843,1.0152] 0.9981[0.9802,1.0163] 1.0037[0.9770,1.0310]
AA 137 1.0005[0.9929,1.0081] 1.0045[0.9843,1.0250] 1.0061[0.9799,1.0331] 1.0037[0.9652,1.0437]
GA+AA 522 1.0006[0.9955,1.0057] 1.0012[0.9870,1.0156] 0.9999[0.9832,1.0168] 1.0033[0.9784,1.0289]
rs3170633 G/A
GG 366 Reference Reference Reference Reference
GA 347 0.9967[0.9910,1.0026] 0.9898[0.9736,1.0062] 0.9935[0.9763,1.0111] 0.9901[0.9645,1.0163]
AA 171 1.002[0.9955,1.0086] 0.9989[0.9808,1.0173] 1.009[0.9843,1.0343] 1.0142[0.9783,1.0514]





Table J11: Effect modification of SOD3 genotypes on association between 8-isoprostane and sub-chronic pollutant exposure (7 day averages) 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. #p<0.1, 
*p<0.05, **p<0.01.  
 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs8192287 G/T
GG 773 Reference Reference Reference Reference
GT 145 0.9996[0.9956,1.0036] 0.9993[0.9879,1.0108] 0.9982[0.9857,1.0110] 0.9978[0.9784,1.0176]
TT 9 1.0135[0.9949,1.0324] 1.0485[0.9922,1.1080] 1.0096[0.9645,1.0569] 1.0225[0.9504,1.1000]
GT+TT 154 1.0001[0.9961,1.0040] 1.0009[0.9896,1.0123] 0.9988[0.9865,1.0112] 0.999[0.9801,1.0183]
rs699473 C/T
CC 291 Reference Reference Reference Reference
CT 418 0.9982[0.9946,1.0017] 0.9928[0.9830,1.0026] 0.9859*[0.9749,0.9970] 0.9757**[0.9596,0.9920]
TT 220 0.9988[0.9946,1.0029] 0.9908[0.9795,1.0023] 0.9914[0.9792,1.0039] 0.9842#[0.9660,1.0027]
CT+TT 638 0.9985[0.9952,1.0017] 0.9923[0.9833,1.0015] 0.9880*[0.9777,0.9984] 0.9790**[0.9638,0.9943]
rs13306703 C/T
CC 622 Reference Reference Reference Reference
CT 267 1.0002[0.9968,1.0036] 0.9996[0.9904,1.0090] 1.0036[0.9937,1.0136] 1.0062[0.9913,1.0213]
TT 40 1.002[0.9943,1.0098] 1.011[0.9877,1.0349] 1.0129[0.9826,1.0440] 1.0241[0.9833,1.0665]
CT+TT 307 1.0004[0.9972,1.0036] 1.0007[0.9918,1.0097] 1.0042[0.9946,1.0140] 1.0078[0.9933,1.0224]
rs8192288 G/T
GG 775 Reference Reference Reference Reference
GT 147 0.9999[0.9959,1.0039] 0.9999[0.9885,1.0114] 0.9999[0.9880,1.0119] 1.0011[0.9827,1.0199]
TT 9 1.0136[0.9951,1.0324] 1.0488#[0.9926,1.1082] 1.0099[0.9648,1.0570] 1.023[0.9510,1.1004]
GT+TT 156 1.0003[0.9964,1.0043] 1.0015[0.9903,1.0129] 1.0003[0.9887,1.0121] 1.0021[0.9841,1.0205]
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Table J12: Effect modification of SOD3 genotypes on association between 8-oxodG and sub-chronic pollutant exposure (7 day 
averages) 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. #p<0.1, 
*p<0.05. 
 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs8192287 G/T
GG 734 Reference Reference Reference Reference
GT 138 0.9982[0.9916,1.0048] 0.9987[0.9800,1.0178] 0.9915[0.9704,1.0130] 0.9798[0.9477,1.0130]
TT 9 1.0222[0.9919,1.0533] 1.0392[0.9496,1.1373] 1.0073[0.9349,1.0854] 1.0447[0.9274,1.1768]
GT+TT 147 0.9991[0.9927,1.0057] 1.0001[0.9816,1.0189] 0.9926[0.9721,1.0135] 0.984[0.9527,1.0164]
rs699473 C/T
CC 276 Reference Reference Reference Reference
CT 398 0.9985[0.9927,1.0044] 0.9985[0.9822,1.0150] 0.9992[0.9795,1.0192] 0.9936[0.9646,1.0235]
TT 209 0.9936#[0.9868,1.0005] 0.9800*[0.9616,0.9989] 0.9849[0.9639,1.0063] 0.9745[0.9434,1.0066]
CT+TT 607 0.9971[0.9916,1.0025] 0.9924[0.9774,1.0078] 0.9936[0.9755,1.0120] 0.9867[0.9599,1.0142]
rs13306703 C/T
CC 587 Reference Reference Reference Reference
CT 255 1.0033[0.9978,1.0089] 1.01[0.9946,1.0256] 0.9961[0.9790,1.0135] 0.9993[0.9736,1.0257]
TT 40 0.9837*[0.9714,0.9962] 0.9571*[0.9214,0.9941] 0.9766[0.9293,1.0264] 0.9531[0.8917,1.0187]
CT+TT 295 1.0009[0.9956,1.0062] 1.0043[0.9895,1.0193] 0.9946[0.9779,1.0115] 0.9947[0.9700,1.0201]
rs8192288 G/T
GG 737 Reference Reference Reference Reference
GT 139 0.9982[0.9917,1.0048] 0.9988[0.9801,1.0178] 0.9903[0.9696,1.0115] 0.9786[0.9466,1.0115]
TT 9 1.0223[0.9921,1.0534] 1.0397[0.9501,1.1377] 1.0075[0.9350,1.0855] 1.045[0.9278,1.1771]
GT+TT 148 0.9992[0.9927,1.0057] 1.0002[0.9817,1.0189] 0.9915[0.9713,1.0121] 0.9828[0.9516,1.0149]
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Table J13: Effects modification of Nrf2 and GCLM genotypes on the association between 8-isoprostane and annual mean pollutants 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. #p<0.1. 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs2364723 G/C
GG 394 Reference Reference Reference Reference
GC 382 1.0006[0.9966,1.0046] 1.0018[0.9912,1.0125] 1.0069[0.9686,1.0469] 1.029[0.9623,1.1002]
CC 155 0.9987[0.9945,1.0029] 0.9967[0.9853,1.0082] 0.9897[0.9452,1.0363] 0.9978[0.9170,1.0858]
GC+CC 537 0.9997[0.9962,1.0033] 0.9997[0.9903,1.0092] 1.0009[0.9661,1.0370] 1.0193[0.9587,1.0837]
rs7557529 T/C
TT 358 Reference Reference Reference Reference
TC 426 1.0015[0.9973,1.0057] 1.0043[0.9934,1.0154] 1.0039[0.9659,1.0434] 0.9675[0.9049,1.0344]
CC 145 1.001[0.9967,1.0054] 1.0025[0.9906,1.0146] 1.0054[0.9565,1.0568] 0.9755[0.8939,1.0646]
TC+CC 571 1.0013[0.9978,1.0047] 1.0035[0.9944,1.0128] 1.0044[0.9701,1.0398] 0.9699[0.9120,1.0315]
rs2001350 A/G
AA 721 Reference Reference Reference Reference
AG 200 0.9999[0.9945,1.0053] 0.9996[0.9856,1.0139] 0.9907[0.9423,1.0415] 0.9732[0.8975,1.0553]
GG 10 1.0001[0.9844,1.0161] 0.9999[0.9610,1.0404] 1.0032[0.8737,1.1520] 0.9832[0.7701,1.2552]
AG+GG 210 0.9999[0.9947,1.0050] 0.9996[0.9862,1.0131] 0.9918[0.9455,1.0404] 0.9737[0.9007,1.0527]
rs2301022 G/A
GG 384 Reference Reference Reference Reference
GA 403 1.0008[0.9973,1.0044] 1.0023[0.9928,1.0118] 1.0132[0.9772,1.0505] 1.0199[0.9556,1.0885]
AA 141 0.9957[0.9887,1.0028] 0.9888[0.9710,1.0070] 0.9424#[0.8852,1.0032] 0.9424[0.8558,1.0378]
GA+AA 544 1.0001[0.9967,1.0035] 1.0002[0.9912,1.0094] 1.001[0.9668,1.0365] 1.0022[0.9422,1.0660]
rs3170633 G/A
GG 386 Reference Reference Reference Reference
GA 360 0.9996[0.9957,1.0035] 0.999[0.9885,1.0095] 1.0003[0.9622,1.0400] 1.0147[0.9476,1.0865]
AA 184 1.0015[0.9971,1.0058] 1.0038[0.9923,1.0155] 1.0199[0.9748,1.0670] 1.0158[0.9375,1.1005]





Table J14: Effects modification of Nrf2 and GCLM genotypes on association between 8-oxodG and annual mean pollutants 
 Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 
 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs2364723 G/C
GG 374 Reference Reference Reference Reference
GC 366 1.0035[0.9968,1.0102] 1.0101[0.9924,1.0282] 1.0329[0.9676,1.1026] 1.0143[0.9058,1.1358]
CC 145 1.0014[0.9936,1.0094] 1.005[0.9842,1.0262] 1.0196[0.9420,1.1037] 0.9994[0.8658,1.1536]
GC+CC 511 1.0028[0.9967,1.0088] 1.0084[0.9923,1.0247] 1.0286[0.9690,1.0919] 1.0101[0.9108,1.1203]
rs7557529 T/C
TT 340 Reference Reference Reference Reference
TC 406 1.0027[0.9955,1.0100] 1.0079[0.9892,1.0268] 1.0201[0.9556,1.0890] 1.0137[0.9056,1.1348]
CC 138 1.002[0.9947,1.0095] 1.0049[0.9848,1.0253] 1.0418[0.9577,1.1332] 1.1124[0.9605,1.2884]
TC+CC 544 1.0024[0.9964,1.0084] 1.0066[0.9909,1.0226] 1.026[0.9674,1.0882] 1.0411[0.9382,1.1553]
rs2001350 A/G
AA 684 Reference Reference Reference Reference
AG 191 1.0009[0.9918,1.0100] 1.0031[0.9796,1.0272] 1.0096[0.9288,1.0975] 0.9769[0.8530,1.1188]
GG 10 1.0098[0.9841,1.0362] 1.026[0.9617,1.0946] 1.1235[0.8968,1.4075] 1.3075[0.8784,1.9461]
AG+GG 201 1.0022[0.9935,1.0109] 1.0065[0.9840,1.0296] 1.0234[0.9449,1.1083] 1.0086[0.8849,1.1495]
rs2301022 G/A
GG 360 Reference Reference Reference Reference
GA 385 0.9977[0.9913,1.0042] 0.9939[0.9773,1.0108] 0.9778[0.9192,1.0402] 0.9765[0.8742,1.0907]
AA 137 1.0018[0.9898,1.0140] 1.0033[0.9727,1.0349] 0.9836[0.8851,1.0930] 0.9635[0.8193,1.1331]
GA+AA 522 0.9985[0.9925,1.0046] 0.9958[0.9800,1.0118] 0.9797[0.9237,1.0391] 0.974[0.8775,1.0811]
rs3170633 G/A
GG 366 Reference Reference Reference Reference
GA 347 1.0043[0.9971,1.0114] 1.0124[0.9937,1.0315] 1.0399[0.9730,1.1115] 1.0976[0.9775,1.2323]
AA 171 1.0014[0.9943,1.0086] 1.0034[0.9844,1.0228] 1.0056[0.9330,1.0840] 0.9975[0.8723,1.1406]





Table J15: Effects modification of SOD3 genotypes on association between 8-isoprostane and annual mean pollutants 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. #p<0.1. 
 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs8192287 G/T
GG 773 Reference Reference Reference Reference
GT 145 0.9991[0.9943,1.0038] 0.9973[0.9847,1.0101] 0.9935[0.9483,1.0410] 0.9963[0.9158,1.0839]
TT 9 1.0351#[0.9937,1.0783] 1.0799[0.9778,1.1927] 1.3887[0.8088,2.3844] 1.1988[0.6625,2.1692]
GT+TT 154 0.9996[0.9949,1.0043] 0.9987[0.9861,1.0114] 0.9972[0.9520,1.0445] 1.0033[0.9233,1.0904]
rs699473 C/T
CC 291 Reference Reference Reference Reference
CT 418 0.9987[0.9942,1.0033] 0.9968[0.9849,1.0088] 0.9961[0.9536,1.0405] 0.9863[0.9165,1.0615]
TT 220 0.9993[0.9943,1.0043] 0.9979[0.9848,1.0111] 1.0009[0.9554,1.0485] 0.9849[0.9067,1.0699]
CT+TT 638 0.9989[0.9946,1.0032] 0.9971[0.9858,1.0085] 0.998[0.9586,1.0390] 0.9854[0.9204,1.0551]
rs13306703 C/T
CC 622 Reference Reference Reference Reference
CT 267 1.0003[0.9963,1.0044] 1.001[0.9901,1.0119] 1.0096[0.9707,1.0500] 1.0288[0.9602,1.1022]
TT 40 1.0018[0.9841,1.0199] 1.0075[0.9613,1.0559] 1.0587[0.8748,1.2813] 0.9978[0.7965,1.2500]
CT+TT 307 1.0003[0.9963,1.0043] 1.001[0.9903,1.0117] 1.0096[0.9713,1.0495] 1.0237[0.9573,1.0946]
rs8192288 G/T
GG 775 Reference Reference Reference Reference
GT 147 0.9989[0.9942,1.0036] 0.997[0.9844,1.0097] 0.9919[0.9470,1.0389] 0.9902[0.9108,1.0764]
TT 9 1.0353#[0.9940,1.0784] 1.0806[0.9786,1.1932] 1.3917[0.8114,2.3870] 1.1966[0.6620,2.1629]
GT+TT 156 0.9994[0.9947,1.0041] 0.9984[0.9858,1.0111] 0.9956[0.9508,1.0425] 0.9972[0.9182,1.0830]
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Table J16: Effects modification of SOD3 genotypes on association between 8-oxodG and annual mean pollutants 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. 
 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs8192287 G/T
GG 734 Reference Reference Reference Reference
GT 138 1.0045[0.9963,1.0127] 1.0114[0.9897,1.0337] 1.0446[0.9620,1.1344] 1.0983[0.9477,1.2727]
TT 9 0.989[0.9251,1.0573] 0.9802[0.8333,1.1531] 1.1524[0.4766,2.7860] 0.9214[0.3507,2.4207]
GT+TT 147 1.0042[0.9961,1.0124] 1.0108[0.9893,1.0329] 1.0445[0.9624,1.1335] 1.0923[0.9445,1.2632]
rs699473 C/T
CC 276 Reference Reference Reference Reference
CT 398 1.002[0.9943,1.0099] 1.0044[0.9842,1.0250] 1.0177[0.9452,1.0959] 1.0306[0.9098,1.1674]
TT 209 0.9993[0.9910,1.0076] 0.9971[0.9757,1.0191] 0.9865[0.9132,1.0657] 1.0125[0.8810,1.1636]
CT+TT 607 1.0009[0.9936,1.0082] 1.0013[0.9825,1.0205] 1.0037[0.9381,1.0739] 1.0236[0.9119,1.1489]
rs13306703 C/T
CC 587 Reference Reference Reference Reference
CT 255 0.9994[0.9925,1.0064] 0.9977[0.9795,1.0163] 0.9845[0.9202,1.0532] 0.9679[0.8600,1.0893]
TT 40 0.9947[0.9659,1.0242] 0.9902[0.9169,1.0694] 0.9685[0.7089,1.3230] 1.0122[0.7006,1.4625]
CT+TT 295 0.9991[0.9923,1.0060] 0.9971[0.9792,1.0153] 0.9825[0.9194,1.0499] 0.9682[0.8634,1.0857]
rs8192288 G/T
GG 737 Reference Reference Reference Reference
GT 139 1.0046[0.9964,1.0128] 1.0118[0.9901,1.0340] 1.0472[0.9648,1.1367] 1.1051[0.9545,1.2793]
TT 9 0.9887[0.9248,1.0569] 0.9793[0.8327,1.1518] 1.1445[0.4738,2.7646] 0.9162[0.3490,2.4049]
GT+TT 148 1.0043[0.9962,1.0125] 1.0112[0.9897,1.0332] 1.0471[0.9652,1.1358] 1.099[0.9512,1.2699]
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Table J17: Effect modification of Nrf2 and GCLM Genotypes on the association between Cu and acute pollutant exposure (24 hour) 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. #p<0.1.  
Notes: Blank indicates non-converged data. 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs2364723 G/C
GG 387 Reference Reference Reference Reference
GC 377 1.0000[0.9999,1.0001] 1.0002[0.9998,1.0007] 1.0001[0.9997,1.0005] 1.0002[0.9996,1.0008]
CC 148 1.0001[1.0000,1.0003] 1.0005#[1.0000,1.0011] 1.0002[0.9996,1.0009] 1.0006[0.9996,1.0015]
GC+CC 525 1.0001[1.0000,1.0002] 1.0001[0.9997,1.0005] 1.0001[0.9997,1.0005] 1.0003[0.9997,1.0009]
rs7557529 T/C
TT 351 Reference Reference Reference Reference
TC 418 1.0000[0.9999,1.0001] 0.9999[0.9995,1.0003] 0.9999[0.9994,1.0004] 0.9998[0.9992,1.0005]
CC 141 0.9999[0.9998,1.0001] 0.9996[0.9990,1.0001] 0.9995[0.9989,1.0002] 0.9995[0.9987,1.0004]
TC+CC 559 1.0000[0.9999,1.0001] 0.9998[0.9994,1.0002] 0.9999[0.9994,1.0003] 0.9998[0.9991,1.0004]
rs2001350 A/G
AA 707
AG 195 1.0000[0.9998,1.0001] 0.9997[0.9993,1.0002] 0.9997[0.9992,1.0002] 0.9995[0.9989,1.0002]
GG 10 1.0000[0.9994,1.0006] 1.0004[0.9983,1.0025] 0.9999[0.9971,1.0026] 0.9988[0.9944,1.0032]
AG+GG 205 1.0000[0.9999,1.0001] 0.9998[0.9993,1.0002] 0.9997[0.9992,1.0002] 0.9995[0.9988,1.0002]
rs2301022 G/A
GG 375 Reference Reference Reference Reference
GA 394 1.0000[0.9999,1.0001] 1.0001[0.9997,1.0005] 1.0000[0.9996,1.0005] 1.0000[0.9994,1.0006]
AA 140 1.0001[0.9999,1.0003] 1.0006#[1.0000,1.0012] 1.0005[0.9998,1.0012] 1.0003[0.9993,1.0013]
GA+AA 534 1.0000[0.9999,1.0001] 1.0002[0.9998,1.0006] 1.0001[0.9997,1.0006] 1.0001[0.9995,1.0007]
rs3170633 G/A
GG 380 Reference Reference Reference Reference
GA 352 1.0000[0.9999,1.0001] 0.9998[0.9994,1.0002] 0.9997[0.9993,1.0002] 0.9996[0.9989,1.0003]
AA 179 0.9999[0.9998,1.0001] 0.9997[0.9992,1.0002] 0.9996[0.9991,1.0002] 0.9993#[0.9986,1.0001]






Table J18: Effect modification of Nrf2 and GCLM Genotypes on the association between Ni and acute pollutant exposure (24hour) 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. #p<0.1. 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs2364723 G/C
GG 393 Reference Reference Reference Reference
GC 383 1.0001[0.9997,1.0004] 1.0004[0.9987,1.0020] 1.0003[0.9985,1.0020] 1.0005[0.9982,1.0029]
CC 155 1.0004[0.9998,1.0010] 1.0016[0.9993,1.0039] 1.0014[0.9989,1.0040] 1.0031[0.9993,1.0069]
GC+CC 538 1.0001[0.9998,1.0005] 1.0006[0.9992,1.0021] 1.0006[0.9989,1.0022] 1.0010[0.9988,1.0033]
rs7557529 T/C
TT 359 Reference Reference Reference Reference
TC 425 0.9999[0.9995,1.0003] 0.9996[0.9979,1.0013] 0.9986[0.9966,1.0005] 0.9983[0.9956,1.0009]
CC 145 0.9997[0.9992,1.0002] 0.999[0.9969,1.0011] 0.9979[0.9956,1.0003] 0.998[0.9948,1.0012]
TC+CC 570 0.9998[0.9994,1.0002] 0.9994[0.9979,1.0010] 0.9990[0.9972,1.0008] 0.9974#[0.9948,1.0001]
rs2001350 A/G
AA 721 Reference Reference Reference Reference
AG 200 1.0000[0.9996,1.0004] 1.0000[0.9983,1.0017] 0.9995[0.9977,1.0014] 0.9994[0.9969,1.0019]
GG 10 0.9999[0.9979,1.0020] 1.0008[0.9935,1.0082] 0.9975[0.9878,1.0072] 0.9945[0.9798,1.0095]
AG+GG 210 1.0000[0.9996,1.0004] 0.9997[0.9979,1.0015] 0.9994[0.9975,1.0013] 0.9991[0.9965,1.0018]
rs2301022 G/A
GG 384 Reference Reference Reference Reference
GA 402 0.9999[0.9996,1.0003] 0.9996[0.9979,1.0013] 0.9996[0.9978,1.0014] 0.9998[0.9974,1.0021]
AA 142 1.0000[0.9993,1.0006] 1.0004[0.9980,1.0029] 1.0003[0.9974,1.0032] 0.9996[0.9955,1.0038]
GA+AA 544 0.9999[0.9996,1.0003] 0.9998[0.9982,1.0013] 0.9997[0.9980,1.0014] 0.9997[0.9975,1.0020]
rs3170633 G/A
GG 386 Reference Reference Reference Reference
GA 360 0.9999[0.9995,1.0003] 0.9995[0.9978,1.0011] 0.9991[0.9972,1.0009] 0.9982[0.9957,1.0008]
AA 184 0.9999[0.9995,1.0004] 0.999[0.9971,1.0010] 0.9985[0.9964,1.0006] 0.9979[0.9949,1.0009]





Table J19: Effect modification of SOD3 Genotypes on the association between Cu and acute pollutant exposure (24hour) 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. #p<0.1, 
*p<0.05. Notes: Blank indicates non-converged data. 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs8192287 G/T
GG 754 Reference Reference Reference Reference
GT 145 0.9999[0.9998,1.0001] 0.9999[0.9994,1.0005] 0.9996[0.9990,1.0001] 0.9994[0.9985,1.0002]
TT 9 1.0002[0.9991,1.0012] 1.0007[0.9981,1.0032] 1.0041[0.9986,1.0096] 1.0039[0.9952,1.0126]
GT+TT 154 1.0000[0.9998,1.0001] 0.9999[0.9994,1.0004] 0.9996[0.9991,1.0002] 0.9994[0.9986,1.0003]
rs699473 C/T
CC 754 Reference Reference Reference Reference
CT 145 1.0001[1.0000,1.0002] 1.0003[0.9998,1.0007] 1.0005[0.9998,1.0012]
TT 9 1.0001*[1.0000,1.0002] 1.0003[0.9998,1.0008] 1.0006[0.9999,1.0013]
CT+TT 154 1.0001[1.0000,1.0002] 1.0003[0.9999,1.0007] 1.0003[0.9999,1.0008] 1.0006#[0.9999,1.0012]
rs13306703 C/T
CC 606 Reference Reference Reference Reference
CT 264 0.9999[0.9998,1.0000] 0.9999[0.9994,1.0003] 0.9996#[0.9991,1.0001] 0.9995[0.9988,1.0001]
TT 39 1.0000[0.9997,1.0002] 0.9998[0.9989,1.0008] 0.9996[0.9984,1.0009] 0.9999[0.9984,1.0015]
CT+TT 303 0.9999[0.9998,1.0000] 0.9999[0.9995,1.0003] 0.9996#[0.9991,1.0001] 0.9994#[0.9988,1.0001]
rs8192288 G/T
GG 757 Reference Reference Reference Reference
GT 146 1.0000[0.9998,1.0001] 0.9999[0.9994,1.0004] 0.9995[0.9990,1.0001] 0.9995[0.9986,1.0003]
TT 9 1.0002[0.9991,1.0012] 1.0005[0.9981,1.0030] 1.0041[0.9986,1.0096] 1.0039[0.9952,1.0126]
GT+TT 155 1.0000[0.9998,1.0001] 1.0000[0.9995,1.0006] 0.9996[0.9990,1.0001] 0.9995[0.9987,1.0004]
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Table J20: Effect modification of SOD3 Genotypes on the association between Ni and acute pollutant exposure (24hour) 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. Notes: 
Blank indicates non-converged data 
 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs8192287 G/T
GG 773 Reference Reference Reference Reference
GT 145 0.9999[0.9994,1.0004] 0.9993[0.9972,1.0013] 0.9982[0.9960,1.0004] 0.9978[0.9948,1.0009]
TT 9 0.9981[0.9943,1.0020] 0.996[0.9873,1.0048] 0.9935[0.9727,1.0146] 0.9945[0.9636,1.0264]
GT+TT 154 0.9997[0.9994,1.0003] 0.9996[0.9975,1.0017] 0.9987[0.9964,1.0010] 0.9980[0.9949,1.0010]
rs699473 C/T
CC 291 Reference Reference Reference Reference
CT 418 1.0000[0.9996,1.0004] 1.0002[0.9985,1.0020] 1.0009[0.9990,1.0028] 1.0015[0.9987,1.0042]
TT 220 1.0002[0.9998,1.0006] 1.0007[0.9988,1.0026] 1.0015[0.9994,1.0035] 1.0026[0.9996,1.0055]
CT+TT 638 1.0001[0.9998,1.0005] 1.0005[0.9988,1.0021] 1.0011[0.9994,1.0028] 1.0014[0.9991,1.0038]
rs13306703 C/T
CC 621 Reference Reference Reference Reference
CT 267 0.9999[0.9995,1.0003] 0.9995[0.9978,1.0012] 0.9983[0.9965,1.0001] 0.9982[0.9957,1.0006]
TT 40 1.0001[0.9993,1.0010] 1.0008[0.9975,1.0041] 1.0001[0.9960,1.0042] 1.0011[0.9955,1.0067]
CT+TT 307 0.9999[0.9995,1.0003] 0.9998[0.9981,1.0015] 0.9986[0.9969,1.0003] 0.9986[0.9963,1.0010]
rs8192288 G/T
GG 775 Reference Reference Reference Reference
GT 147 0.9999[0.9994,1.0005] 0.9993[0.9972,1.0013] 0.9982[0.9960,1.0003] 0.9977[0.9947,1.0008]
TT 9 0.9994[0.9953,1.0035] 0.9962[0.9875,1.0050] 0.9933[0.9725,1.0145] 0.9945[0.9636,1.0264]
GT+TT 156 0.9999[0.9994,1.0003] 0.9995[0.9974,1.0016] 0.9982[0.9960,1.0004] 0.9979[0.9948,1.0009]
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Table J21: Effect modification of Nrf2 and GCLM genotypes on the association between Cu and sub-acute pollutant exposure (7 days averages) 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. #p<0.1, 
*p<0.5. Notes: Blank cells indicates non-converged data. 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs2364723 G/C
GG 387 Reference Reference Reference Reference
GC 377 1.0001[0.9998,1.0003] 0.9999[0.9992,1.0007] 1.0005[0.9996,1.0014] 1.0014*[1.0000,1.0027]
CC 148 1.0002[0.9999,1.0006] 1.0006[0.9996,1.0016] 1.0006[0.9994,1.0018] 1.0018*[1.0000,1.0035]
GC+CC 525 1.0001[0.9998,1.0003] 1.0001[0.9994,1.0008] 1.0005[0.9997,1.0014] 1.0008[0.9996,1.0020]
rs7557529 T/C
TT 351 Reference Reference Reference Reference
TC 418 0.9998[0.9995,1.0001] 0.9996[0.9988,1.0004] 0.9995[0.9987,1.0004] 0.9987[0.9975,1.0000]
CC 141 1.0000[0.9996,1.0003] 0.9999[0.9989,1.0009] 0.9995[0.9983,1.0007] 0.9994[0.9976,1.0012]
TC+CC 559 0.9999[0.9996,1.0001] 0.9995[0.9989,1.0002] 0.9996[0.9988,1.0004]
rs2001350 A/G
AA 707 Reference Reference Reference Reference
AG 195 0.9999[0.9996,1.0003] 0.9999[0.9990,1.0007] 0.9998[0.9989,1.0008] 0.9994[0.9980,1.0007]
GG 10 0.9997[0.9984,1.0010] 1.0002[0.9969,1.0035] 1.0004[0.9979,1.0030] 1.0005[0.9969,1.0042]
AG+GG 205 0.9999[0.9996,1.0002] 0.9999[0.9991,1.0008] 1.0001[0.9992,1.0010] 0.9995[0.9982,1.0008]
rs2301022 G/A
GG 375 Reference Reference Reference Reference
GA 394 1.0000[0.9997,1.0002] 1.0000[0.9992,1.0007] 0.9994[0.9985,1.0003] 0.9994[0.9981,1.0007]
AA 140 0.9999[0.9996,1.0003] 1.0003[0.9993,1.0012] 0.9988#[0.9975,1.0001] 0.9977*[0.9958,0.9996]
GA+AA 534 1.0000[0.9998,1.0003] 1.0001[0.9994,1.0009] 0.9993#[0.9984,1.0001] 0.9992[0.9980,1.0004]
rs3170633 G/A
GG 380 Reference Reference Reference Reference
GA 352 0.9999[0.9996,1.0001] 0.9996[0.9988,1.0004] 0.9994[0.9986,1.0003] 0.999[0.9977,1.0003]
AA 179 1.0001[0.9998,1.0004] 1.0004[0.9995,1.0013] 0.9993[0.9980,1.0005] 0.9986[0.9968,1.0003]





Table J22: Effect modification of Nrf2 and GCLM genotypes on the association between Ni and sub-acute pollutant exposure (7 days averages) 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. #p<0.1, 
*p<0.5. Notes: Blank cells indicates non-converged data. 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs2364723 G/C
GG 393 Reference Reference Reference Reference
GC 383 0.9998[0.9987,1.0009] 1.0002[0.9972,1.0031] 1.002[0.9986,1.0055] 1.0029[0.9981,1.0077]
CC 155 1.0006[0.9992,1.0021] 1.0017[0.9976,1.0057] 1.0019[0.9973,1.0065] 1.0036[0.9974,1.0099]
GC+CC 538 1.0000[0.9993,1.0012] 1.0002[0.9973,1.0031] 1.0020[0.9987,1.0053] 1.0032[0.9986,1.0077]
rs7557529 T/C
TT 359 Reference Reference Reference Reference
TC 425 0.9990[0.9979,1.0001] 0.9976[0.9945,1.0007] 0.9979[0.9946,1.0012] 0.9956[0.9909,1.0002]
CC 145 0.9995[0.9983,1.0008] 0.9986[0.9949,1.0024] 0.9982[0.9937,1.0027] 0.9979[0.9916,1.0042]
TC+CC 570 0.9992[0.9982,1.0002] 0.9979[0.9950,1.0007] 0.9980[0.9949,1.0010] 0.9961#[0.9918,1.0004]
rs2001350 A/G
AA 721 Reference Reference Reference Reference
AG 200 0.9991[0.9979,1.0003] 0.9978[0.9944,1.0013] 0.9962*[0.9928,0.9995]
GG 10 0.9997[0.9954,1.0040] 0.9982[0.9866,1.0099] 0.9985[0.9898,1.0073]
AG+GG 210 0.9990[0.9978,1.0002] 0.9978[0.9945,1.0012] 0.9964*[0.9931,0.9997] 0.9956#[0.9909,1.0003]
rs2301022 G/A
GG 384 Reference Reference Reference Reference
GA 402 0.9998[0.9988,1.0009] 0.9997[0.9966,1.0028] 0.9987[0.9952,1.0022] 0.9988[0.9940,1.0037]
AA 142 1.0001[0.9987,1.0016] 1.0020[0.9981,1.0060] 0.9979[0.9926,1.0033] 0.9949[0.9878,1.0021]
GA+AA 544 0.9999[0.9989,1.0009] 1.0006[0.9977,1.0035] 0.9985[0.9953,1.0017] 0.9979[0.9934,1.0025]
rs3170633 G/A
GG 386 Reference Reference Reference Reference
GA 360 1.0001[0.9990,1.0013] 1.0007[0.9975,1.0040] 0.9998[0.9964,1.0031] 0.9987[0.9939,1.0035]
AA 184 1.0011[0.9998,1.0024] 1.0024[0.9988,1.0061] 1.0009[0.9961,1.0058] 1.0009[0.9936,1.0082]





Table J23: Effect modification of SOD3 genotypes on the association between Cu and sub-acute pollutant exposure (7 days averages) 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. #p<0.1, 
*p<0.05, **p<0.01. 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs8192287 G/T
GG 754 Reference Reference Reference Reference
GT 145 0.9998[0.9995,1.0001] 0.9993[0.9984,1.0002] 0.9997[0.9987,1.0008] 0.9996[0.9980,1.0011]
TT 9 1.0001[0.9986,1.0016] 1.0002[0.9959,1.0046] 1.0017[0.9976,1.0058] 1.0024[0.9967,1.0082]
GT+TT 154 0.9998[0.9995,1.0001] 0.9995[0.9985,1.0004] 0.9998[0.9988,1.0008] 0.9998[0.9983,1.0013]
rs699473 C/T
CC 754 Reference Reference Reference Reference
CT 145 1.0001[0.9998,1.0004] 1.0003[0.9994,1.0011] 1.0002[0.9992,1.0012] 1.0004[0.9990,1.0018]
TT 9 1.0002[0.9999,1.0006] 1.0004[0.9995,1.0014] 1.0013*[1.0002,1.0023] 1.0019*[1.0004,1.0035]
CT+TT 154 1.0002[0.9999,1.0005] 1.0002[0.9995,1.0010] 1.0007[0.9997,1.0016] 1.0012#[0.9999,1.0025]
rs13306703 C/T
CC 606 Reference Reference Reference Reference
CT 264 0.9998[0.9995,1.0001] 0.9995[0.9987,1.0003] 0.9995[0.9986,1.0004] 0.9991[0.9978,1.0004]
TT 39 0.9998[0.9992,1.0004] 0.999[0.9970,1.0010] 0.9995[0.9969,1.0020] 0.9985[0.9953,1.0019]
CT+TT 303 0.9998#[0.9995,1.0000] 0.9995[0.9988,1.0003] 0.9995[0.9986,1.0003] 0.999[0.9977,1.0003]
rs8192288 G/T
GG 757 Reference Reference Reference Reference
GT 146 0.9998[0.9995,1.0002] 0.9994[0.9985,1.0003] 0.9993[0.9983,1.0003] 0.9992[0.9977,1.0008]
TT 9 1.0001[0.9986,1.0016] 1.0001[0.9957,1.0044] 1.0016[0.9975,1.0057] 1.0024[0.9967,1.0081]
GT+TT 155 0.9998[0.9995,1.0001] 0.9995[0.9986,1.0005] 0.9993[0.9983,1.0003] 0.9996[0.9980,1.0012]
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Table J24: Effect modification of SOD3 genotypes on the association between Ni and sub-acute pollutant exposure (7 days averages) 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. Notes: 
Blank cells indicate non-converged data. 
Genotype Subjects NOx NO2 PM10 PM2.5 
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs8192287 G/T
GG 773 Reference Reference Reference Reference
GT 145 0.9994[0.9981,1.0006] 0.9985[0.9947,1.0023] 0.999[0.9932,1.0049]
TT 9 0.9960[0.9904,1.0016] 0.9992[0.9844,1.0142] 1.0013[0.9793,1.0237]
GT+TT 154 0.9993[0.9980,1.0007] 0.9972[0.9935,1.0009] 0.9985[0.9948,1.0022] 0.9992[0.9936,1.0049]
rs699473 C/T
CC 291 Reference Reference Reference Reference
CT 418 1.0000[0.9988,1.0012] 0.9998[0.9966,1.0030] 1.0004[0.9965,1.0044] 1.001[0.9956,1.0063]
TT 220 1.0007[0.9993,1.0021] 1.0025[0.9988,1.0061] 1.0033[0.9991,1.0074] 1.0046[0.9989,1.0104]
CT+TT 638 1.0004[0.9993,1.0014] 1.0007[0.9978,1.0037] 1.0017[0.9981,1.0053] 1.0024[0.9974,1.0074]
rs13306703 C/T
CC 621 Reference Reference Reference Reference
CT 267 0.9998[0.9987,1.0010] 0.999[0.9960,1.0021] 0.9986[0.9952,1.0020] 0.9991[0.9944,1.0039]
TT 40 1.0001[0.9978,1.0025] 1.0002[0.9935,1.0069] 0.9987[0.9893,1.0082] 1.0014[0.9900,1.0129]
CT+TT 307 0.9993[0.9962,1.0024] 0.9986[0.9953,1.0019] 0.9994[0.9948,1.0039]
rs8192288 G/T
GG 775 Reference Reference Reference Reference
GT 147 0.9993[0.9980,1.0006] 0.9973[0.9936,1.0011] 0.9984[0.9944,1.0024] 0.9989[0.9931,1.0047]
TT 9 0.996[0.9904,1.0015] 0.9897[0.9737,1.0060] 1.0020[0.9865,1.0177] 1.0012[0.9793,1.0237]
GT+TT 156 0.9991[0.9979,1.0004] 0.9971[0.9934,1.0008] 0.999[0.9934,1.0047]
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Table J25: Effects modification of Nrf2 and GCLM genotypes on the association between Cu and annual mean pollutant attributions 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. #p<0.1, *p<0.5.  
 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs2364723 G/C
GG 387 Reference Reference Reference Reference
GC 377 0.9998[0.9995,1.0001] 0.9994[0.9985,1.0003] 0.9988[0.9957,1.0019] 0.9959[0.9903,1.0015]
CC 148 1.0000[0.9996,1.0004] 0.9997[0.9987,1.0008] 0.9995[0.9958,1.0033] 0.9965[0.9893,1.0037]
GC+CC 525 0.9999[0.9996,1.0002] 0.9997[0.9990,1.0005] 0.9990[0.9962,1.0019] 0.9967[0.9918,1.0017]
rs7557529 T/C
TT 351 Reference Reference Reference Reference
TC 418 1.0002[0.9998,1.0005] 1.0002[0.9993,1.0011] 1.0012[0.9981,1.0043] 1.0009[0.9956,1.0063]
CC 141 1.0001[0.9998,1.0005] 1.0001[0.9991,1.0011] 1.0011[0.9970,1.0052] 1.0026[0.9955,1.0097]
TC+CC 559 1.0001[0.9998,1.0003] 1.0004[0.9997,1.0012] 1.0013[0.9984,1.0042] 1.0015[0.9965,1.0065]
rs2001350 A/G
AA 707 Reference Reference Reference Reference
AG 195 1.0003[0.9999,1.0008] 1.0008[0.9997,1.0020] 1.0023[0.9979,1.0066] 1.0026[0.9957,1.0095]
GG 10 0.9996[0.9984,1.0008] 0.9997[0.9968,1.0027] 0.9964[0.9857,1.0073] 0.9954[0.9757,1.0154]
AG+GG 205 1.0003[0.9999,1.0007] 1.0006[0.9994,1.0017] 1.0023[0.9983,1.0062] 1.0020[0.9953,1.0086]
rs2301022 G/A
GG 375 Reference Reference Reference Reference
GA 394 1.0000[0.9997,1.0003] 1.0002[0.9993,1.0010] 1.0005[0.9976,1.0035] 1.0020[0.9965,1.0075]
AA 140 1.0005#[1.0000,1.0011] 1.0006[0.9991,1.0021] 1.0050*[1.0001,1.0100] 1.0063[0.9983,1.0145]
GA+AA 534 1.0001[0.9998,1.0004] 1.0003[0.9996,1.0011] 1.0012[0.9982,1.0041] 1.0040[0.9990,1.0090]
rs3170633 G/A
GG 380 Reference Reference Reference Reference
GA 352 1.0000[0.9997,1.0003] 1.0000[0.9991,1.0009] 1.0006[0.9973,1.0039] 1.0005[0.9951,1.0059]
AA 179 1.0001[0.9997,1.0004] 1.0004[0.9994,1.0013] 1.0012[0.9974,1.0050] 0.9996[0.9930,1.0062]





Table J26: Effects modification of Nrf2 and GCLM genotypes on the association between Ni and annual mean pollutants 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. Notes: 
Blank indicates non-converged data. 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs2364723 G/C
GG 393 Reference Reference Reference Reference
GC 383 0.9992[0.9977,1.0008] 0.9973[0.9932,1.0014] 0.9918[0.9781,1.0058] 0.9788[0.9567,1.0014]
CC 155 1.0003[0.9983,1.0022] 1.0011[0.9960,1.0063] 1.0030[0.9852,1.0213] 0.9926[0.9635,1.0226]
GC+CC 538 0.9996[0.9982,1.0009] 0.9953[0.9827,1.0081] 0.9829[0.9626,1.0036]
rs7557529 T/C
TT 359 Reference Reference Reference Reference
TC 425 0.9997[0.9980,1.0014] 0.9993[0.9951,1.0036]
CC 145 1.0001[0.9982,1.0019] 1.0003[0.9955,1.0052]
TC+CC 570 0.9998[0.9984,1.0013] 0.9997[0.9959,1.0035] 0.9987[0.9854,1.0122] 1.0008[0.9788,1.0232]
rs2001350 A/G
AA 721 Reference Reference Reference Reference
AG 200 1.0004[0.9983,1.0024] 1.0005[0.9954,1.0057] 1.0019[0.9842,1.0199] 1.0037[0.9760,1.0322]
GG 10 0.9969[0.9930,1.0009] 0.9923[0.9825,1.0022] 0.9861[0.9525,1.0209] 0.9533[0.8862,1.0256]
AG+GG 210 0.9999[0.9980,1.0017] 0.9993[0.9945,1.0041] 0.9983[0.9815,1.0154] 0.9999[0.9742,1.0263]
rs2301022 G/A
GG 384 Reference Reference Reference Reference
GA 402 0.9973[0.9935,1.0011] 0.9928[0.9787,1.0072] 1.0031[0.9798,1.0269]
AA 142 0.9994[0.9932,1.0057] 0.9926[0.9709,1.0148] 1.0034[0.9704,1.0375]
GA+AA 544 0.9988[0.9973,1.0003] 0.9970[0.9931,1.0008] 0.9928[0.9791,1.0066] 1.0032[0.9812,1.0256]
rs3170633 G/A
GG 386 Reference Reference Reference Reference
GA 360 1.0032[0.9988,1.0076] 1.0086[0.9936,1.0238] 1.0117[0.9871,1.0369]
AA 184 1.0009[0.9966,1.0052] 1.0016[0.9858,1.0175] 1.0033[0.9755,1.0318]





Table J27: Effects modification of SOD3 genotypes on the association between Cu and annual mean pollutants 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. #p<0.1, 
*p<0.05. 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs8192287 G/T
GG 754 Reference Reference Reference Reference
GT 145 1.0000[0.9996,1.0003] 0.9999[0.9989,1.0009] 1.0002[0.9963,1.0041] 1.0013[0.9943,1.0085]
TT 9 1.0008[0.9976,1.0041] 1.0015[0.9935,1.0097] 1.0013[0.9570,1.0476] 0.9914[0.9433,1.0421]
GT+TT 154 1.0000[0.9996,1.0004] 0.9999[0.9989,1.0010] 1.0003[0.9967,1.0040] 1.0021[0.9955,1.0087]
rs699473 C/T
CC 754 Reference Reference Reference Reference
CT 145 0.9996*[0.9992,0.9999] 0.9989*[0.9979,0.9999] 0.9974[0.9936,1.0012] 0.9953[0.9894,1.0012]
TT 9 0.9997#[0.9993,1.0001] 0.9993[0.9982,1.0003] 0.9981[0.9942,1.0021] 0.9969[0.9903,1.0035]
CT+TT 154 0.9996*[0.9992,1.0000] 0.9991*[0.9981,1.0000] 0.9975[0.9942,1.0008] 0.9971[0.9913,1.0029]
rs13306703 C/T
CC 606 Reference Reference Reference Reference
CT 264 0.9999[0.9996,1.0002] 0.9997[0.9988,1.0006] 0.9982[0.9950,1.0015] 0.9972[0.9918,1.0027]
TT 39 1.0005[0.9991,1.0019] 1.0004[0.9965,1.0042] 0.9970[0.9815,1.0128] 0.9969[0.9799,1.0142]
CT+TT 303 0.9999[0.9996,1.0002] 0.9997[0.9989,1.0006] 0.9984[0.9952,1.0016] 0.9959[0.9903,1.0015]
rs8192288 G/T
GG 757 Reference Reference Reference Reference
GT 146 1.0000[0.9996,1.0004] 1.0000[0.9990,1.0010] 1.0011[0.9972,1.0050] 1.0038[0.9971,1.0105]
TT 9 1.001[0.9976,1.0044] 1.0015[0.9935,1.0097] 1.0014[0.9572,1.0477] 0.9969[0.9520,1.0440]




Table J28: Effects modification of SOD3 genotypes on the association between Ni and annual mean pollutants 
 
Models are adjusted for age, sex, ethnicity, height, BMI, IMD, urinary CCR for smoking exposure and study year including effect for school. #p<0.1, p<0.01.  
Notes: Blank indicates non-converged data 
Genotype Subjects NOx 20m NO2 20m PM10 20m PM2.5 20m
(n) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI) Exp(β) (95% CI)
rs8192287 G/T
GG 773 Reference Reference Reference Reference
GT 145 0.9982[0.9961,1.0003] 0.9953[0.9898,1.0007] 0.9849[0.9669,1.0032]
TT 9 0.9893[0.9770,1.0018] 0.9717[0.9433,1.0010] 0.8219**[0.7109,0.9501]
GT+TT 154 0.9986[0.9966,1.0007] 0.9963[0.9909,1.0018] 0.9843#[0.9666,1.0024] 0.9825[0.9534,1.0125]
rs699473 C/T
CC 291 Reference Reference Reference Reference
CT 418 0.9989[0.9972,1.0007] 0.9975[0.9929,1.0021] 0.9965[0.9811,1.0122] 0.9867[0.9616,1.0125]
TT 220 1.0002[0.9981,1.0023] 1.0009[0.9956,1.0063] 1.0055[0.9883,1.0230] 0.9997[0.9708,1.0294]
CT+TT 638 0.9987[0.9943,1.0031] 0.9989[0.9839,1.0141] 0.9915[0.9680,1.0156]
rs13306703 C/T
CC 621 Reference Reference Reference Reference
CT 267 0.9987[0.9970,1.0003] 0.9878[0.9734,1.0024] 0.9861[0.9628,1.0099]
TT 40 0.9959[0.9903,1.0014] 0.9498[0.9003,1.0019] 0.9642[0.9049,1.0273]
CT+TT 307 0.9986#[0.9970,1.0002] 0.9897[0.9753,1.0043] 0.9862[0.9638,1.0090]
rs8192288 G/T
GG 775 Reference Reference Reference Reference
GT 147 0.9982[0.9961,1.0003] 0.9952[0.9898,1.0007] 0.9845[0.9665,1.0028] 0.9784[0.9493,1.0085]
TT 9 0.9892[0.9769,1.0016] 0.9714[0.9430,1.0007] 0.8198**[0.7097,0.9471] 0.9506[0.7984,1.1319]
GT+TT 156 0.9986[0.9965,1.0008] 0.9963[0.9909,1.0018] 0.9890[0.9709,1.0073]
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